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Abstract 
A review of the relevant literature suggested a number of unresolved 
issues in the 
most efficacious use of TENS for pain-relief 
including the degree of control and 
the frequency of TENS. The study investigated the 
influence of giving subjects 
control of the TENS stimulus on reported pain 
intensity and unpleasantness 
during experimental ischaemic pain induction of the arm. The pain 
induction and 
assessment procedures were established during an initial series of three 
experiments. Subjects in these and the subsequent experiments were healthy 
female student volunteers from Queen Margaret College. A further series of 
experiments investigated the influence of control of the TENS intensity on VAS 
scores of pain intensity and unpleasantness. When used, TENS (symmetrical 
biphasic current; pulse duration 200ýts; intensity `just perceptible') was applied for 
the 15 minutes prior to cuff inflation and during the 15 minutes of pain induction 
(electrodes placed over Erb's point and lateral to C6/7). The first TENS 
experiment investigated the. influence of three different conditions (experimenter 
controlling TENS intensity; subject controlling TENS intensity; no TENS) using 
high frequency (100Hz) TENS. All subjects (n=12) were randomly exposed to the 
three testing conditions using a repeated measures design. A 2-way ANOVA with 
repeated measures on both factors showed no statistically significant effects 
(p>_0.05) on either VAS pain intensity or unpleasantness scores. The procedure 
was repeated with different subjects (n=12) using low frequency (5Hz) TENS. 
The results showed that mean pain scores were statistically significantly lower 
(p<_0.05) in the subject control condition than in the other two conditions 
(experimenter control and no TENS). A final experiment (n=12) compared VAS 
pain intensity and unpleasantness scores between the three conditions of, subject 
controlling 100Hz TENS, subject controlling 5Hz TENS and no TENS. The 
results demonstrated a trend for the 5Hz TENS condition to give lower mean pain 
scores than the other two conditions with both intensity (p=0.239) and 
unpleasantness scores (p=0.110). From the results and discussion it was suggested 
that the pain-relieving benefit of TENS was enhanced when the subjects were 
given control of the current intensity, especially when using low frequency TENS. 
The clinical implications of the results are discussed. 
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CHAPTER 1: PAIN MANAGEMENT AND THE ROLE OF 
TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) 
Pain has long since been identified and recognised by mankind and throughout 
history attempts have been made to explain and define the pain experience. 
Problems in the past have been encountered when the meaning of pain has been 
restricted to concepts which can be the subject of rigorous scientific analysis. 
These have included definitions of pain such as `the physical adjunct of a 
protective reflex' (Sherrington, 1900, in Cervero, 1986) which ignore painful 
sensations not associated with protective mechanisms and abnormalities with the 
peripheral or central nervous system. The definition of pain used today by the 
International Association for the Study of Pain is; 
`a sensory and emotional experience associated 
with actual or potential tissue damage, or 
described in terms of such damage. ' (Merskey, 1979) 
The modern definition not only allows inclusion of those factors ignored in 
Sherrington's earlier definition of pain (Sherrington, 1900, in Cervero, 1986) but 
also recognises that pain consists of both a physical and emotional component 
which interact with one another to contribute to the resultant experience. 
The modem definition of pain is also reflected in the way in which pain is dealt in 
our society with the rising development of multidisciplinary pain clinics for the 
treatment of chronic pain and a more holistic approach to pain management 
programmes in general. It has now been well recognised by those working in the 
area of pain management that pain is a subjective experience and as such can be 
modified by a wide range of factors which will be identified and expanded on later 
in the thesis. The recognition of multiple influences on a person's pain has also 
meant that a greater number of treatment interventions are now available to the 
patient and their therapists. As well as surgical and drug oriented interventions 
patients now have available to them, either as adjunctive or alternative 
approaches, treatments such as acupuncture, cognitive-behavioural therapy or 
transcutaneous electrical nerve stimulation (TENS) (Fields, 1987). 
It is on the last of these interventions, TENS, that this thesis is based. TENS has 
been established as a pain-relieving modality which operates through the 
stimulation of peripheral nerve fibres. It is used by both physiotherapists and 
physicians for the treatment of pain and is thought to be appropriate in a wide 
variety of clinical situations (Kahn, 1994). Physiotherapists play an important role 
within the multidisciplinary field of pain management and provide treatment such 
as exercise therapy, manipulation, massage and electrotherapy. TENS, within the 
component of electrotherapy, is a popular choice of modality and it has been 
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suggested that physiotherapists can modify a person's pain at peripheral, spinal, 
supraspinal and cortical level with the application of TENS (Walsh, 1991). In this 
way it is suggested that TENS not only relieves pain by physical means but also 
takes into account the multidimensional nature of pain and the effect that the 
modality has on cognitive processing. The multiple mechanisms of action of 
TENS are discussed in greater detail in Chapter 4. 
The place of TENS within the science of pain management has become 
increasingly more prominent in the past two decades and this is reflected in part 
by the inclusion of TENS sessions at recent major international pain conferences 
such as those staged in Paris (7th World Congress on Pain, 1994) and Vancouver 
(8th World Congress on Pain, 1996). A chapter has also been dedicated to the 
modality in updated editions of the highly esteemed Textbook of Pain and papers 
appear on a regular basis in peer-reviewed journals such as Pain and the British 
Journal of Anaesthesiology. 
TENS is used for a variety of different clinical pain conditions but its efficacy is 
still in question due to varied and often contradictory study outcomes. A major 
contributing factor to this state of confusion within study outcomes is due to the 
large number of TENS studies carried out without a rigorous study design. This 
point is highlighted by a number of recent TENS clinical review papers (Carroll, 
Tramer, McQuay, Nye and Moore, 1996; Carroll, Tramer, McQuay, Nye and 
Moore, 1997; Robinson, 1996) (see Chapter 6) which compared the outcomes of 
randomised controlled trials (RCTs) with less rigorously performed studies and, in 
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the instance of acute post-operative pain (Carroll et al, 1996), found that the 
studies which were not classed as RCTs produced a greater number of positive 
treatment outcomes than those in the RCT category (2 out of 17 RCTs produced 
a positive outcome compared with 17 out of 19 non RCTs). In this way the 
respective authors addressed methodological issues and assist the reader in 
understanding the relative value of TENS studies. The gold standard in clinical 
study design has been considered to be the RCT which, with its random allocation 
of treatment groups and inclusion of a control group is thought to increase the 
validity of the results and reduce the possibility of subjective experimenter bias 
(Ernst and Resch, 1996). For these reasons the majority of clinical studies 
reviewed in this thesis are selected on their basis to fulfil the criteria for a RCT. 
Reviewed clinical studies which do not meet the required standards to be classed 
as a RCT are commented on and the validity of the outcomes questioned in light 
of their shortcomings. A similar critique of possible methodological and design 
flaws are also highlighted in the laboratory based studies. The difference in study 
outcomes, however, can also be attributed to the wide number of variables 
between the studies including the selected current parameters of TENS, the 
environmental context of the treatment and the type of patients being used. 
Review of clinical TENS studies (see Chapter 6) shows the diversity between 
methodologies, particularly with reference to control. Both acute and chronic pain 
are treated using TENS in many ways ranging from complete selection of 
parameters and operation of the TENS unit by the therapist (Conn, Marshall, 
Yadav, Daly and Jaffer, 1986; Lehmann, Russell, Spratt, Colby, Liu, Fairchild and 
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Christensen, 1986) to a more active role for the patient where they select their 
preferred parameters and are taught how to apply the modality themselves 
(Johnson, Ashton and Thompson, 1991 a and 1991b; Smith, Egbert, Markowitz, 
Mosteller and Beecher, 1986). It has been recognised within the health care 
system that positive outcomes can be achieved from giving patients greater 
control of their pain-relief and through this the system of patient controlled 
analgesia (PCA) has evolved (Thomas, Heath, Rose and Flory, 1995). The 
proposed reason for the avocation of PCA has been that the rise in consumerism 
in modern day society has brought with it an increased desire for control in all 
aspects of life (Heath and Thomas, 1993). Heath and Thomas (1993) reported 
that when it comes to health, the doctor (or other care provider) is the equivalent 
of authority and needs to be an enabler rather than an absolute controller. In this 
sense, TENS can be viewed as a particularly useful treatment intervention for 
pain-relief as its portable design allows for increased patient involvement in their 
own management programme. 
TENS is a relatively inexpensive modality, it is portable and has few 
contraindications to use (Walsh, 1997). It is therefore a treatment which can be 
used by patients for use in their own homes with the aim of managing their pain 
and subsequently reducing their reliance on medication and medical care (Ellis, 
1995). The drive away from reliance on hospital-based treatment is also in line 
with recent NHS reforms to encourage primary health care within the community. 
The documented clinical use of TENS indicates that the modality is presently used 
under conditions of both patient and provider control and so in the present study 
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it is investigated whether pain measures are influenced by who controls the TENS 
current intensity. 
The aim of the present study is to establish the influence that control of the 
current intensity has on the pain-relieving effects of TENS. There is a body of 
literature which has linked control with pain but to date the influence of control 
has not been investigated in relation to TENS. Walsh (1997), amongst other 
authors (Kahn, 1994; Low and Reed, 1990; Mannheimer, 1985), have stated that 
an advantage with TENS is that it is portable and so it is practical for patients to 
apply the modality themselves. The purpose of the present study, therefore, is to 
establish if whether giving the patient control of the TENS current intensity 
reduces their pain to a greater extent than if the therapist controls the current 
intensity. In this way the results of the present study can provide an indication as 
to how in-patient use of the modality can be adapted to improve treatment 
outcome and identify a factor which may influence outcome success with TENS 
when used by patients at home. 
A major difficulty with carrying out a clinical trial is the large number of variables 
that must be controlled for if it is to fulfil the criteria required for a RCT. One 
way of reducing the number of external variables in a human pain study is to use 
an experimental model of pain induction (Gracely, 1994). It was, therefore, 
considered advantageous to adopt a laboratory based approach to the present 
study. The rationale for the selection of the pain induction procedure is explained 
later in the thesis (see Section 7.4.1), along with the chosen study design and the 
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methodology (see Section 7.4). The rationale is based on an extensive review of 
the relevant literature and this is encompassed in the succeeding six chapters. The 
aim of this substantial component of the thesis is to highlight the theoretical 
building blocks and the conceptual framework of the present study and to 
establish the current state of knowledge in these areas. The review of the 
literature, therefore, aims to identify gaps in the body of knowledge and carries 
implications for the experimental procedure of the present study. The six chapters 
attempt, systematically and in a logical order, to address each main topic area 
related to the present study and, briefly, the chapter topic areas read as follows; 
Chapter 2: The opening chapter of the review of literature introduces TENS as a 
pain-relieving modality. The chapter outlines the theory of how TENS operates 
and the various parameters it possesses which can alter the current characteristics. 
Chapter 3: This chapter provides a general introduction to the neurophysiology 
of the pain experience and highlights the differences between clinical and 
experimentally-induced pain. 
Chapter 4: This chapter is linked closely with Chapter 2 and outlines how TENS, 
through a number of different neural mechanisms, can modify a person's pain. 
Chapter 5: The psychological component of the pain experience is introduced in 
Chapters 2 and 3 and is then expanded on in this chapter. Variables which are 
thought to influence the psychological aspect of the pain response, in general and 
also specifically to TENS, are identified. The psychological variable of control, 
the crux of the present study, is defined in greater detail and its influence on pain 
addressed. 
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Chapter 6: The efficacy of TENS is addressed in both the clinical and 
experimental setting. Reports of TENS' clinical efficacy include review papers of 
RCTs treating a variety of pain conditions. An overview is given of experimental 
pain induction techniques and a review is given of papers closely related to the 
present study. 
Chapter 7: Throughout the review of literature pain assessment scales are 
referred to and in this chapter greater detail is provided on the proposed criteria 
for ideal pain assessment. Three of the most commonly used scales in the 
reviewed studies are specifically addressed and the relative merits of each 
commented on. 
Once the review of literature is fully covered the rationale for the present study is 
outlined. Each of the series of experiments in the present study is then 
documented in full, followed by the results and a discussion of the findings. The 
final two chapters in the thesis (Chapters 14 and 15) are dedicated to a global 
discussion of the results and their clinical inferences, respectively. In this way the 
limitations of the present experimental study are identified and their bearing on the 
clinical relevance of the results explored. The present study is contextualised 
within the science of pain management and recommendations are given for future 
research. 
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CHAPTER 2: TRANSCUTANEOUS ELECTRICAL NERVE 
STIMULATION (TENS) 
2.1 : Introduction 
Transcutaneous Electrical Nerve Stimulation (TENS) involves the transmission of 
electrical energy across the skin surface to the nervous system. The modality is 
used in the clinical setting primarily for pain-relief but recent research has also 
identified TENS' effects on circulation and autonomic function (reviewed in 
Walsh, 1997). This chapter outlines the historical perspective of TENS, as well as 
its theoretical principles and application and aims to provide the reader with 
background information about the modality used in the present study. The 
literature is based on a selection of publications in this area (Kahn, 1994; Low and 
Reed, 1990; Mannheimer, 1985; Scott, 1994; Walsh, 1997; Woolf and Thompson, 
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1994) and will not be referenced further unless additional information is added. In 
such instances specific references will be given. 
Documented historical references to electricity as a pain-relieving modality begin 
in the year 46 A. D., several hundred years before the first written description of 
electrotherapy, when a Roman physician named Scripbonius Largus described 
how the electric stimulus for a Torpedo fish (electric eel) produced pain-relief for 
gout and headache (Kane and Taub, 1975). It was much later, in the 1700s, that 
electrotherapy was reintroduced with the use of electrostatic generators combined 
with Leyden jar condensers. This was recognised as a major breakthrough in the 
methodology of electrical stimulation as the device was able to both generate and 
store quantities of electric charge. The development of the battery during the 
nineteenth century further developed the advance of electrotherapy. John Wesley, 
the founder of Methodism, supported the advances of clinical electrotherapy 
activity and published one of the earliest texts detailing electrotherapy application 
in 1759. The medical profession met the new concepts with a degree of scepticism 
and, combined with conflicting clinical findings, electrotherapy declined towards 
the end of the 1800s. 
In modem times, one of the first commercially available TENS units claimed to be 
a pain-controlling modality appeared in 1919. It was known as the Electreat and 
was battery powered. The pain-relieving efficacy of TENS was discovered almost 
by accident as the Electreat was used as a screening device for those people about 
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to undergo dorsal column stimulation (DCS), a procedure which involved the 
surgical implantation of battery-operated electrodes within the dorsal column of 
the spinal cord. Dr. Norman Shealy, developer of the Electreat, discovered that 
some of his patients responded more favourably to transcutaneous stimulation 
than to DCS and so a version of TENS was launched. There was, however, no 
accepted theoretical explanation as to how the effects were achieved. 
The publication of the gate control theory of pain (discussed further in Chapter 3) 
by Melzack and Wall in 1965 provided this much needed theoretical explanation 
of pain-relief by electrotherapy and sparked renewed interest in the use of 
electrical stimulation for the control of pain. The theory proposed possible 
neurophysiological mechanisms for pain relief based on peripheral sensory 
stimulation and was supported further by Meyer and Fields (1972) who were 
among the first to report the efficacy of TENS in relieving chronic pain within the 
clinical setting. Our increased knowledge of neurophysiology and 
neuropharmacology since that period has been reflected in the prolific increase in 
pain research and since 1990 there has been an increase in publications in both 
clinical and experimental TENS studies. 
An increase in scientific research has also meant an increase in the number of 
commercial TENS units available on the market. The increased technology 
benefits both the purchaser and user as specifically designed units can now be 
made which are portable and relatively inexpensive. The popularity of TENS as a 
non-invasive and non-addictive modality was shown in a recent survey carried out 
by Pope, Mockett and Wright in 1995. The authors carried out a postal survey 
among 139 NHS physiotherapy departments throughout England to establish the 
use of electrotherapy modalities in clinical practice. The study received replies 
from 116 hospitals, representing a 83.5% return and 213 participants. TENS rated 
second on the list of electrotherapy modalities which were owned and, more 
importantly, used (n=201). TENS was surpassed only by ultrasound as the most 
frequently owned and used modality (n=212) and yet unpublished work by Walsh 
(1995, cited in Walsh, 1997) revealed that, in a survey of 181 Northern Ireland 
chartered physiotherapists, 79.1% were dissatisfied with the lack of stimulation 
guidelines for TENS. These findings suggested that clinicians, although reporting 
TENS as a popular modality, were unsure as to which variables were affecting 
pain perception and treatment outcome. 
2.2 : Principles of electrical stimulation 
Modern TENS machines, unlike the early Electreat which only offered alterable 
current intensity, possess a range of parameters which can change the current 
characteristics. These parameters will now be discussed in more detail under the 
following headings: waveform, pulse duration, pulse frequency and current 
intensity. 
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2.2.1 : Waveform 
The waveform of a current refers to its shape on a graph showing amplitude (or 
intensity) against time. TENS is most accurately described as a pulsed current and 
as such can be uni-directional or alternating in nature. The latter possesses both 
positive and negative phases of current polarity and in most instances efforts are 
made to make both phases equal so that a net current component of zero is 
obtained. Current impedance at the electrode-skin interface and the resulting 
discomfort can be minimised when electrochemical changes are avoided and there 
is a zero charge flow. 
Different shapes of waveform are also available but to date there has been little or 
no clear evidence of physiological benefit of any specific waveform over another. 
A study by Delitto and Rose (1986) investigated comparative patient comfort 
when using three different waveforms (sinusoidal, triangular and square - see 
figure 1) to produce a quadriceps contraction. Twenty-one healthy volunteers 
(sex and age not stated) were seated at an isokinetic dynamometer and asked to 
perform an isometric maximum voluntary contraction (MVC) of the left 
quadriceps femoris muscle group (knee positioned at 45 degrees of flexion). The 
MVC was repeated and the highest of the two torque recordings used in the 
study. A current intensity was then calculated for each of the current waveforms 
which was theoretically required to produce a knee extension torque level equal 
to 60% of the MVC. All three waveforms were then delivered in a randomised 
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Figure 1: Different biphasic waveforms as shown on an oscilloscope tracing of 
the carrier current. (adapted from Delitto and Rose, 1986) 
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order three minutes apart with the same current characteristics of 2500 Hz pulse 
frequency and 10 ms pulse duration. The subjects rated their perceived discomfort 
following each muscle contraction on a 20 cm long visual analogue scale (VAS) 
labeled `intolerable' at the left extreme and `no discomfort' at the right. 
A one-way analysis of variance (ANOVA) was conducted using the comfort 
scores for each waveform. The results showed no statistically significant 
difference between the waveforms (F=1.57; d. f. =2,38; p=NS). The authors 
concluded that it was impossible to differentiate whether the tolerance level was a 
result of differences in current characteristics specific to each stimulator or 
increased subject arousal levels at various contraction levels. A current intensity 
theoretically required to produce a knee extension torque equal to 60% of the 
MVC was used for each subject in the study. It was not stated in the paper how 
the required current intensity was calculated and it appears to be a potentially 
large source of error in the study. The methodology of the study chose to 
compare currents which produced a similar muscle torque which means that the 
actual current intensity levels were most probably different for each waveform. 
The actual current intensity selected for each waveform type was not stated and, 
therefore, any differences in perceived discomfort may have been due to variations 
in the amount of current being applied to each subject. 
A later study comparing the effects of waveform on subject comfort during 
neuromuscular electrical stimulation was carried out by Baker, Bowman and 
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McNeal in 1988. Unlike previous research, such as that undertaken by Delitto and 
Rose (1986), the authors attempted to directly compare the various parameter 
combinations, therefore identifying those that caused least discomfort to the 
subjects. Healthy females (n=43; age range 21-35) were used for the study 
although the authors did not state how the sample was collected. The subjects 
were exposed to a variety of the six selected waveforms to either the wrist 
flexor/extensor muscle group (n=20) or to the quadriceps femoris muscle group 
(n=23) whilst seated in a standardised position. Testing took place over three days 
during which time a different pair of stimulus waveforms were directly compared 
with each other on separate days. Two electrodes were placed over the selected 
muscle group at the point of optimal muscle contraction and the locations marked 
for consistent placements in later sessions. Stimulus pairs were given for a period 
of 1.5 seconds each with a 15-18 second rest in between. A one minute rest was 
allowed between stimulus pairs and during each daily session the pairs were 
repeated at least ten times in a random order. The subject was asked to select the 
preferred waveform after exposure to each set of paired stimuli and was required 
to select the same waveform on at least four out of five occasions before being 
categorised as having a preference. 
As in the previous study by Delitto and Rose (1986), an attempt to standardise the 
different current waveforms was made by calculating the current intensity needed 
to produce a muscle contraction in the selected muscle group (`fair +'). The 
authors reported that torque assessment was carried out through a ring strain- 
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gauge tensiometer but offered no explanation as to how a `fair +' muscle 
contraction was determined. The procedure appears open to subjective bias and 
also lacks rigour as no attempt was made to standardise the other current 
characteristics such as pulse frequency or pulse duration. There was no evidence 
of statistical analysis of results and for this reason the authors were unable to 
identify the degree to which a waveform was preferred. The authors, however, did 
conclude that particular waveforms were perceived as being more comfortable in 
both the upper and lower limb. The clinical relevance of these findings remains 
questionable in light of the methodology. 
2.2.2 : Pulse duration 
The pulse duration of a current is the length of time of each individual electrical 
stimulus. The parameter is usually expressed in microseconds (µs) and in modern 
units the available frequency range is typically between 50µs and 400µs. 
2.2.3: Pulse frequency 
The pulse frequency of a current indicates the number of stimuli being transmitted 
each second and is usually measured in Hertz (Hz). In the case of pulsed currents, 
the time for one stimulus is taken as the pulse width as well as the time elapsed 
between pulses. The range of current frequencies available for treatment varies 
between stimulators but Mannheimer and Lampe (1984) suggested that 
frequencies commonly used in clinical practice range from 4 Hz to 110 Hz. As 
well as current being supplied at a constant rate, stimuli can also be supplied in 
17 
trains with variable rest intervals. TENS in this form is more commonly referred 
to as burst TENS. 
The effect of different frequency muscle stimulators on perceived discomfort was 
investigated by Grimby and Wigerstad-Lossing in 1989. Fifteen healthy female 
physiotherapists (age range 24-48 years; mean age 35 years) participated in the 
study and all were exposed to a high frequency sinusoidal wave stimulator (pulse 
frequency 2500Hz in trains of 50Hz frequency; pulse duration IOµs) and a lower 
frequency rectangular wave stimulator (pulse frequency 30Hz; pulse duration 
0.34s) in a randomised order. The subjects were seated in a standardised position 
at an isokinetic dynamometer while two carbon rubber electrodes were placed in 
precise anatomical positions over the right quadriceps femoris muscle group. Each 
subject was asked to perform a MVC three times and the maximum torque was 
recorded. This figure was then used to establish the current intensity required to 
produce a MVC using each stimulator. Testing involved subjects receiving thirty 
exposures to each stimulator (10 seconds on /8 seconds off) and rating their 
discomfort after the 10th, 20th, and 30th stimulation periods. 
The assessment tools used to measure discomfort were Borg's exponential 10- 
point scale (no other details regarding the scale were given in the paper) and a 7- 
point adjective scale in which the subjects had to choose two words that best 
described the stimulus sensation (adjectives were chosen from a previous pilot 
study carried out by the authors). A VAS (no details given) was also marked after 
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the 30th stimulation period. The results of the study showed a statistically 
significant correlation between the Borg and the VAS discomfort ratings 
(Spearman's rank correlation test: high frequency stimulator, p<0.01; low 
frequency stimulator, p<0.05). The Wilcoxon test showed no statistically 
significant difference between the stimulators in the level of discomfort they 
produced, although this may have been due to the other unstandardised properties 
of the stimulators such as the waveform, current intensity and pulse duration. 
2.2.4: Current intensity 
The parameter of current intensity refers to the magnitude of current applied by 
the unit and is measured in milliamps (mA). Current is the flow of electric charge 
from the unit and the driving force required to move this electric charge is known 
as the voltage (measured in volts). Most TENS units are designed with either 
constant current or constant voltage output, the relationship between the two 
variables being provided by Ohm's Law; 
V=IR 
where V is the voltage, I is the electric charge, and R is a resistance to the electric 
charge such as the skin's surface. A unit that supplies a constant current output 
will alter the voltage intensity, within limits, as the resistance changes. The reverse 
holds true for the constant voltage unit and therefore care should be taken to 
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maintain a consistent electrode-skin interface so that potentially painful increases 
in current intensity are avoided. 
There is still a great deal of controversy among clinicians as to the ideal current 
intensity for TENS administration but it is agreed that current intensity is best 
rated subjectively by the person receiving TENS rather than by a milliamp or 
voltage readout from the unit. Authors recommend current intensities ranging 
from `just detectable' to `just tolerable' and even sub threshold currents have been 
used in clinical practice. The most common level of current, however, used in 
clinical practice is one which is perceived by the patient to be strong but 
comfortable (Frampton, 1996). Lehmann, Russell, Spratt, Colby, Liu, Fairchild 
and Christensen (1986) categorised 53 patients with chronic low back pain (>3 
months) into 3 groups based on previous back surgery. The patients were then 
randomly assigned to 1 of 3 treatment groups which consisted of TENS (n=18), 
placebo TENS (dead battery) (n=18) and electroacupuncture (n=17). The 
treatment programme consisted of 3 weeks in-patient care during which time the 
patients received TENS (frequency 60Hz; pulse duration 40µs; sub threshold 
current intensity) or placebo TENS daily except for weekends. The duration of 
each treatment session was not stated in the paper. Patients in the 
electroacupuncture group received treatment twice a week at a frequency of 2- 
4Hz and a high current intensity at pain tolerance level. 
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Patients were asked to rate their general and peak pain on a 10cm long VAS 
periodically but it is not clear how long apart these assessments took place or 
when they were relative to receiving treatment. An analysis of variance showed a 
statistically significant treatment effect, with respect to time (F=2.99; d. f. =4,91; 
p<0.03), but there was no statistically significant difference between the groups' 
pain scores between admission and discharge. It is difficult to compare the two 
TENS groups with the group receiving electroacupuncture as the treatment 
regimes were so dissimilar. The results, however, did suggest that in this 
particular study sub threshold current intensity in conjunction with the selected 
parameters was no more effective in reducing pain than placebo TENS. This 
result is hardly surprising as a subthreshold current would be theoretically 
incapable of stimulating even large diameter afferent fibres and would therefore be 
no different from a placebo treatment. 
2.3: Modes of TENS 
TENS can be classified into different modes depending on the selected parameter 
combination of pulse duration, current frequency and current intensity. The two 
most common modes of TENS currently in use in clinical practice are called 
conventional TENS and acupuncture-like TENS. The former is typically a high 
frequency (>_ l 00Hz) with a low current intensity and usually a short pulse 
duration (50-80µs). Acupuncture-like TENS shares none of the conventional 
TENS properties and instead is typically of low frequency (1-4Hz), a high enough 
intensity to produce visible muscle contractions and possesses a long pulse 
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duration (about 200µs). A variation of both modes is burst TENS which, by 
definition, has high frequency trains of pulses delivered at a low frequency. 
2.4 : Nerve stimulation by TENS 
Nerve fibres in a resting state have a potential or charge difference between the 
intracellular fluid and the extracellular fluid. The resting potential is approximately 
-70mV, the minus sign indicating that the inside of the cell has a negative charge 
relative to the exterior. The unequal distribution of charged ions across the cell 
membrane in the nerve cells forms the basis for the generation of action potentials 
and these can be initiated by the transient reversal of the membrane potential 
(depolarisation) with an electric pulse. The electrical stimulus allows the opening 
of voltage-activated ionic channels in the cell membrane and subsequent 
movement of ions down concentration gradients. As the stimulus is increased, the 
potential difference across the cell membrane decreases until the critical threshold 
level is reached. Once threshold is reached, the stimulus will lead to the automatic 
generation of an action potential (Guyton, 1991) (see Figure 2). 
The minimum amount of electrical current required to reach threshold is known as 
the rheobase. Greater amounts of current do not result in larger action potentials 
and any increased sensory effects which may be experienced with higher current 
intensities are due to a larger number of fibres being stimulated. An action 
potential only occurs if threshold is reached and therefore nerve stimulation is 
referred to as an all-or-none response. While a nerve fibre is depolarised from a 
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Figure 2: Generation of an action potential. (not drawn to scale) (adapted from 
Walsh, 1997) 
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preceding action potential, a second action potential cannot be generated. An 
action potential returns to its resting value in about I millisecond and during this 
time no stimulus, however large, will initiate another action potential. This time 
span is known as the absolute refractory period and is followed by another time 
span known as the relative refractory period. The relative refractory period 
represents a residual inactivation of the ionic channels and a larger stimulus than 
normal is required during this time span to reach threshold. 
The refractory period of a nerve fibre is inversely proportional to its conduction 
velocity which, in turn, is determined primarily by two anatomical features. The 
first is nerve diameter with larger diameter nerves offering less electrical 
resistance and, therefore, greater conduction velocities. The second feature is the 
presence of myelin on the nerve fibre. The myelin is wrapped around the nerve 
fibre and is interrupted at intervals along its length at junctions called nodes of 
Ranvier. The myelin not only insulates the fibre but allows the action potential to 
be conducted quickly from node to node; a process referred to as saltatory 
conduction. The increased diameter of a nerve and presence of myelin, therefore, 
alter the refractory periods of individual nerves and results in mixed bundles of 
fibres possessing different rheobases. The structure of particular nerve fibres will 
be discussed in Chapter 3. 
It is important to note that electrical activity cannot be transferred directly from 
one nerve to another and requires a chemical substance (neurotransmitter) to be 
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released into the junction (synapse) between the adjacent nerves. The 
neurotransmitter is released from the end terminal membrane of the active nerve in 
a response to depolaristion. Many different types of neurotransmitter act in the 
nervous system and include acetylcholine, noradrenaline and substance P. Once 
released into the synapse, the neurotransmitter then binds itself to the receptor 
sites of the other nerve involved. The effect which the neurotransmitter has on the 
receiving nerve is dependent on the nature of both the neurotransmitter and the 
receptors. The resultant effect can be due to activity at either the pre-synaptic or 
post-synaptic membrane but there are basically two forms of synapse; (1) the 
excitatory synapse and (2) the inhibitory synapse. The former initiates 
depolarisation which in turn helps to generate an action potential in the receiving 
nerve. The latter brings about hyperpolarisation and resists the generation of an 
action potential in a neighbouring nerve cell. It is the combination of these two 
types of synapse which results in the complex interaction of neural pathways and 
pain perception (Bond, 1984; Guyton, 1991) (discussed further in Chapter 3). 
In order to stimulate a nerve, the stimulus has to be of sufficient intensity and 
pulse duration to depolarise the nerve membrane. Strength-duration curves are 
graphs of the current intensity needed to generate a nerve impulse plotted against 
the duration of the pulses (see Figure 3a). Stimuli which have not reached 
threshold will have parameter combinations that fall left of the strength-duration 
curve and are therefore unable to generate an action potential. Figure 3a indicates 
the response of sensory, motor and nociceptive fibres to an electrical stimulus and 
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Figure 3a : Strength-Duration curve for different types of nerve fibre. (adapted 
from Walsh, 1997) 
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Figure 3b : Relationship between frequency and current intensity. (adapted from 
Woolf and Thompson, 1994) 
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Figure 3c : Relationship between frequency and pulse duration. (adapted from 
Woolf and Thompson, 1994) 
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shows that if a mixed nerve is stimulated the person will first report a non-painful 
skin sensation, followed by muscle contractions and finally pain. 
The relationship between current intensity and pulse duration is such that at low 
pulse durations, a greater intensity of current is required to produce an action 
potential. This remains true until the rheobase is achieved, at which point an 
increase in pulse duration makes no difference to the nerve's ability to generate an 
action potential. 
There is also a relationship between current frequency and the two parameters 
already mentioned (see figures 3b and 3c). The relationships shown in Figures 3b 
and 3c are based on theoretical electrical principles of pulse charge and allows 
parameters to be calculated if not already pre-determined by the TENS unit. 
2.5: TENS application 
The following section is concerned with the practical issues regarding the use of 
TENS, including the equipment needed and its application. 
2.5.1 : Electrodes 
TENS aims to deliver electrical current to a pair of electrodes in order to excite 
afferent nerve fibres. The current must be sufficient to stimulate the nerve in a 
controllable manner without causing any damage to the skin. A number of 
different electrode types are now available, the most common material being a 
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carbon-silicone combination. This material combination has the advantages of 
being strong and inert, as well as being able to follow the shape of the body's 
contours. The main disadvantage that the carbon-silicone electrodes possess is 
that they require adhesive tape to secure them to the skin. Self-adhesive 
electrodes are now available for use with TENS and can be either disposable or 
reusable. 
A transmission medium is needed to pass current from the electrode to the skin. 
The impedance of the skin and tissues below the electrodes is non-homogenous 
and localised areas of low impedance are produced by perspiration. Various 
conductive electrolyte gels have been designed for the purpose of current 
transmission and without such gel TENS current can produce thermal damage to 
the corneal layer of the skin. Electrode size determines the current density flowing 
to the underlying tissues with smaller electrodes giving a higher localised current 
density at the point of skin contact. Woolf and Thompson (1994) reported that 
the current density required for TENS was typically 1-5 mA/cmI and suggested 
that electrodes should be at least 4 cm` in size to prevent skin irritation. 
2.5.2 : Electrode placement 
The question of ideal electrode placement remains a controversial topic in TENS, 
with no one method reported as being consistently more successful in reducing 
pain. Techniques which are most frequently used are dermatone levels, 
acupuncture trigger points, peripheral nerve courses and the site of pain. Jones, 
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Lee, Holzberger and Jones (1990) compared the pain-relieving efficacy of TENS 
using different electrode placements in twelve elective post-cholecystectomy 
patients (2 male, 10 female; age range 16-70). All received the same relative 
amount of analgesia during surgery and on post-operative day one the patients 
were visited once in the morning and again in the afternoon (3 hours apart). On 
each occasion TENS (frequency 99Hz; pulse duration 175µs; current intensity 
`maximum without discomfort') was applied for 20 minutes with electrode 
placement dependent on which group the patient had been randomly assigned to; 
one group (n=6) had the electrodes applied over the acupuncture points for the 
gall bladder, while the other group (n=6) had the two electrodes placed para- 
incisionally. The group which received acupuncture point TENS in the morning 
received para-incisional placement of the electrodes in the afternoon and vice 
versa. The whole procedure was repeated on the second day post-operatively but 
in the reverse order. 
During all four TENS sessions patients were asked to rate their pain on a 10cm 
long VAS before, immediately after, and 30 minutes post TENS treatment. 
Analysis of the results using a two-tailed t-test showed a statistically significant 
improvement in pain-relief immediately and 30 minutes after TENS treatment. 
This treatment was irrespective of electrode placement. The time of day which 
surgery was performed in each case was not stated and so it is difficult to establish 
if pain rating scores were dependent on the TENS stimulation or the effects of 
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intravenous analgesia. It would appear appropriate to try a number of different 
electrode placements in order to establish optimal placement for pain-relief. 
2.5.3: Duration of TENS treatment 
The stimulation of peripheral nerves by TENS is indiscriminate and all afferent 
nerves with a particular threshold will be activated by an electrical stimulus if it 
exceeds the threshold value. Pain-relief from TENS, therefore, is a result of 
activation of both rapidly and slowly adapting afferent nerves because they 
possess similar electrical thresholds. The mechanisms on which TENS are 
proposed to work will be discussed fully in Chapters 3 and 4 but the basis of pain- 
relief by TENS has been thought to be dependent on its mode of application. The 
mechanism of action of conventional TENS is considered to bring about a 
decrease in pain perception relatively quickly (less than 10 minutes) and continues 
for about 30 minutes (Eriksson, Sjolund and Nielzen, 1979; Sjolund and Eriksson, 
1979). The pain-relieving action of acupuncture-like TENS, on the other hand, is 
produced after approximately 15-30 minutes of stimulation and has a longer 
duration (several hours) of action once the stimulation has been removed 
(Eriksson et al, 1979; Sjolund and Eriksson, 1979). 
Textbook authors remain indecisive as to the optimal length of treatment time 
with TENS, with time spans of 20 minutes to periods of up to 8 hours being 
advised. It appears, therefore, that the treatment time of TENS may be dependent 
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on the type of pain being addressed and can be applied as long as necessary 
provided no skin irritation or other side-effects are noted. 
2.5.4: Contraindications with TENS 
As with any electrotherapy modality, it is necessary to assess the user for any 
contraindications to the modality before beginning treatment. TENS has relatively 
few contraindications, most of which are common sense. 
(1) TENS should not be used with those who have a cardiac pacemaker 
(2) Electrodes should not be placed over the pharyngeal region or the carotid 
sinus 
(3) Electrodes should not be placed over open wounds or any form of skin lesion 
(4) TENS should not be used with those who have an allergic reaction to the tape 
or gel 
(5) Electrodes should not be placed over the pregnant uterus in the third trimester 
of pregnancy 
(6) Finally, TENS should not be used with those that are unable to comprehend 
the use of the modality. 
2.6 : Conclusions 
(1) TENS is a popular electrotherapy modality used in the clinical setting 
primarily for pain-relief. 
(2) TENS possesses a number of parameters, all of which can alter the current 
characteristics and the resultant sensation of the person receiving the treatment. 
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CHAPTER 3: ANATOMICAL AND PHYSIOLOGICAL BASES FOR 
PAIN 
3.1 : Introduction 
Pain is a unique experience which can be classified into two major categories. The 
first category is acute pain which is characteristically triggered by harmful or 
potentially harmful (noxious) stimuli and is a necessary protective mechanism 
against further damage. The second category is chronic pain and is sometimes 
defined as a pain that persists a month beyond the usual course of an acute injury 
or disease (Cailliet, 1993). Chronic pain does not always serve a useful purpose 
and can become an abnormal and self-sustaining noxious agent in its own right. It 
is therefore important to differentiate between acute physiological pain and that 
which occurs when there is malfunctioning of the nervous system (pain in the 
absence of noxious stimuli). 
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There is also a difference between acute physiological pain and transient pain 
which is induced experimentally. Such is the case in the present study. With 
transient pain there is no, or minimal, tissue damage and the pain sensation 
remains only a short time after the removal of the painful stimulus (Johnson, 
1997). Acute clinical pain, on the other hand, is associated with tissue damage and 
its duration is expected to be related to the rate of tissue healing (Johnson, 1997). 
The tissue damage involved with acute clinical pain contributes to the body's 
mechanisms which serve to protect the injured site from further damage. Clinical 
symptoms of these protective mechanisms include exaggerated pain (hyperalgesia) 
and tenderness (allodynia) and occur as a result of increased sensitivity of the 
nociceptive system to afferent input (Johnson, 1997). Although transient 
experimental pain and acute clinical pain are physiologically different in that there 
is an absence of clinical symptoms in the former, they are both considered to be 
physiologically normal in their neural responses to noxious stimuli. This is 
different from the chronic pain situation where pain can be registered in the 
absence of a noxious stimulus. For the purposes of this thesis the normal 
physiological situation will be discussed. 
Before expanding on the subject, a distinction should be made between the terms 
nociception and pain. The former relates to the activation of the nervous system in 
response to noxious stimuli while the latter is concerned with the perception of 
this information by the cerebral cortex. The perception of pain is therefore a 
subjective experience which is basically a direct reflection of the nervous system's 
active processing of the neural input it has received. This processing can occur at 
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both spinal and supraspinal levels and can involve activity in a number of different 
pathways, explaining the multidimensional (physical and emotional) nature of the 
pain sensation. The pain processing system can be thought of in 3 stages 
interacting with each other; (1) peripheral nociception, (2) spinal cord modulation, 
and (3) higher centre, in particular cortical, involvement. 
3.2 : Peripheral nociception 
Nociceptors are primary afferent nerves with peripheral terminals which respond 
selectively, and preferentially, to noxious stimuli (Sherrington 1906, in Meyer, 
Campbell and Raja, 1994). Nociceptors respond to a range of stimuli, including 
those applied externally (e. g. intense levels of mechanical or thermal stimulation 
as well as extreme levels of light or noise) and also to physical and chemical 
products of internal tissue damage (nociceptors are receptive to chemical changes 
in the body such as increased levels of bradykinin, serotonin and substance P 
which are produced during tissue inflammation) (Fields, 1987; Meyer et al, 1994). 
The main functions of primary afferent nociceptors are transduction (the 
conversion of one type of energy i. e. chemical, mechanical or thermal to 
electrochemical nerve impulses) and transmission (the relaying of afferent impulse 
information onwards to pathways within the central nervous system which results 
in the sensation of pain ). Nociceptors are generally `free' nerve endings and are 
located anywhere in the body, superficially or deeply, where pain can be 
registered (Charman, 1989; Meyer et al, 1994). Different classes of nociceptors 
have been identified primarily from cutaneous receptor research. This is due to the 
fact that the skin is densely innervated and it is relatively easy to apply controlled 
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noxious stimuli to it. Findings from cutaneous studies have provided evidence to 
support that AS and C fibres are the afferents involved in nociception (Fields, 
1987; Jessell and Kelly, 1991; Meyer et al, 1994). 
Afferent fibres have been classified according to their diameter and conduction 
velocity, with these physical characteristics contributing to the variation in pain 
sensation that each nociceptor type produces (Lee and Warren, in Walsh, 1991). 
C fibres account for approximately three quarters of the total number of 
nociceptive afferents and have been found to respond to noxious levels of thermal, 
mechanical, and chemical stimuli in different combinations (Fields, 1987; Meyer et 
al, 1994). The fibres are small in diameter, un iyelinated and have a slow 
conduction velocity of between 0.5 -2 metres per second (Walsh, 1991). Early 
studies by Torebjork and Hallin (1973,1974) used selective stimulation of C 
fibres to show that their activity was associated with a prolonged burning 
sensation which had a slightly delayed onset (sometimes referred to as `second 
pain'). 
`First pain' has been attributed to AS fibre stimulation and has been described as 
"an early sharp pricking sensation" (Fields, 1987). A6 nociceptors fall into two 
categories (AS mechanical and A6 thermal), which respond preferentially to 
noxious levels of mechanical and heat / cold stimuli respectively (Meyer et al, 
1 994). Both types of receptor, as well as the C fibre class, experience a decrease 
in threshold value as they are repeatedly exposed to noxious stimuli -a property 
known as sensitisation (Cailliet, 1993; Jessell and Kelly, 1991). A8 fibres are 
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myelinated, slightly larger in diameter than C fibres and have a conduction 
velocity of between 12-30 metres per second (Walsh, 1991). The conduction 
velocities of both nociceptive classes are significantly lower than the large- 
diameter myelinated Aß fibres which are stimulated by non-noxious mechanical 
stimuli and can transmit afferent information at speeds of up to 100 metres per 
second (Walsh, 1991). The three types of nociceptor which have been identified 
each contribute uniquely to the resultant pain sensation (Meyer et al, 1994). There 
is no simple relationship between activity in an afferent nociceptor and the 
perceptual experience. The pain experience is a result of all the afferent impulses 
received from all the various receptors and their modulation within the central 
nervous system (Cailliet, 1993; Fields, 1987; Jessell and Kelly, 1991). 
3.3 : Spinal cord modulation 
Following noxious stimulation impulses are conducted along different nerve fibres 
and enter the spinal cord. The majority are thought to enter by way of the dorsal 
roots, but some also proceed to the dorsal horn via the ventral roots (Cailliet, 
1993). Their sites of termination in the spinal cord include the dorsal horns of the 
grey matter (Bond, 1984). The spinal cord grey matter is arranged in a laminar 
organisation and divided into ten layers (I - X) on the basis of each layer's 
physical characteristics. The synaptic endings of the C fibres are thought to 
terminate in the two most superficial layers (laminae I and II), while most 
projections of AS afferents terminate in lamina I or project deeper to lamina V 
(Fields, 1987). 
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Nociceptive afferent fibres synapse generally on interneurones within the 
superficial laminae and the information is then relayed to projection neurones 
which may be in lamina I or deeper laminae (Lima, 1997). Examples of cells 
which respond to nociceptive input in the dorsal horn are (1) nociceptive specific 
(NS) neurones (mainly in lamina I) which respond exclusively to stimulation 
within a noxious range and (2) wide dynamic range (WDR) neurones (mainly 
laminae III and IV) which respond to both noxious and non-noxious stimuli 
(Garrison and Foreman, 1994; Lima, 1997). The dorsal horn therefore represents 
a complex circuit of neurones that not only receives and transmits nociceptive 
input but also allows a high degree of sensory processing and interaction of 
noxious and non-noxious inputs. This local processing is a result of a combination 
of excitatory and inhibitory influences from a combination of sources. These 
include the periphery, local interneurones and axons descending from the brain 
stem in turn influenced by higher centres including the cerebral cortex (Cailliet, 
1993; Charman, 1989; Steedman, 1989). The relationship between noxious 
afferent input arriving at the spinal cord and the output is therefore complicated 
and variable, with considerable opportunity for modulation at this stage within the 
central nervous system. 
Lima (1997) suggested that the activation of certain cell types within the spinal 
cord, with particular reference to lamina I, may follow a pattern of input 
distribution. The author hypothesised that the distribution of variable amounts of 
nociceptive input through each cell type may be part of a tuning system which 
contributes to the qualitative characteristics of the stimulus but stressed that more 
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research into the area was required. This concept has important implications for 
sensory perception as once nociceptive impulses have been modulated within the 
spinal cord they either pass directly to interneurones which act on the motor or 
autonomic system, or they are transmitted to neurones whose axons make up 
ascending systems to the brain stem and higher centres (Fields, 1987; Guilbaud, 
Bernard and Besson, 1994). 
3.4 : Higher centre involvement 
The primary pathways for transmission of nociceptive information to the higher 
centres can be considered as parts of two main systems - the lateral and medial 
systems (Fields, 1987; Guilbaud et al, 1994; Jessell and Kelly, 1991). The lateral 
system includes the neospinothalamic tract (nSTT), dorsal column tract (DCT) 
and the spinocervical tract (SCT) which project through lateral thalamic nuclei. 
The DCT and nSTT are primarily concerned with non-noxious information but 
are also activated by noxious stimuli. All these tracts have relatively large 
diameter fibres (primarily AS fibres) with few synaptic junctions and therefore 
have a quick conduction velocity. There is evidence to suggest that the 
neospinothalamic tract within the lateral system is concerned with rapid 
transmission of nociceptive input which contains information about the physical 
qualities of the stimulus. This information can then be facilitated or inhibited by 
cognitive influences (Bond, 1984; Guilbaud et al, 1994; Jessell and Kelly, 1991) 
(see Figure 4). 
38 
Figure 4: Simplified diagram of spinal and supraspinal pain pathways. 
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The medial ascending system consists of the paleospinothalamic tract (pSTT), the 
spinoreticular tract (SRT), the spinomesencephalic tract (SMT) and the 
multisynaptic ascending systems (MAS) which project through medial thalamic 
nuclei (Cailliet, 1993; Jessell and Kelly, 1991). The fibres which make up these 
tracts are thinner than those in the lateral system (primarily C fibres) and have 
many more synaptic connections and for this reason impulses passing in this 
system are slower in reaching the higher centres than those in the lateral system. It 
is thought that the medial tracts play a role in transmitting information about the 
motivational-affective component of the pain response (Guilbaud et al, 1994) (see 
Figure 4). 
The properties which are perceived in response to a pain stimulus are dependent 
on the target sites of each of the neural pathways. The lateral system is quite 
specific regarding its higher centre destination, terminating in the primary 
somatosensory cortex (Jessell and Kelly, 1991; Lima, 1997). This area of the 
cerebral cortex is concerned with the physical characteristics of the stimulus and is 
therefore able to provide information about the stimulus intensity, frequency and 
duration - the sensory-discriminative component of pain (Jessell and Kelly, 1991). 
The medial system, on the other hand, has a wider range of destinations which 
include the basal ganglia, limbic cortical areas such as the cingulate gyrus and the 
pre-frontal cortex (Fields, 1987; Guilbaud et al, 1994; Jessell and Kelly, 1991; 
Lima, 1997). Some of these areas are not exclusively involved in nociceptive 
processing and so it has been suggested that the medial system is also responsible 
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for part of a non-specific arousal system (Jessell and Kelly, 1991; Guilbaud et al, 
1994). Areas such as the limbic system and the temporal lobe are under the 
influence of attentional mechanisms and so, as well as giving the pain stimulus 
affective component, they are also subject to modulation according to the 
emotional context in which the stimulus is delivered (Lima, 1997). This has 
important implications for pain assessment as it suggests that a person's 
immediate motivational-affective response to a painful stimulus is influenced 
directly by attentional mechanisms. In addition, activation of motivational- 
affective target sites can result in descending inhibition of noxious input from the 
cingulate gyrus and implies that 1 st stage pain perception (intensity and 
unpleasantness) can be modulated at both thalamic (brainstem) and spinal cord 
levels. 
This recent research has therefore provided a detailed neurophysiological rationale 
for the multi-dimensional model of the pain experience first elaborated on by 
Melzack and Casey in 1968. The authors proposed that there were three main 
components of pain: sensory-discriminative (physical component of pain), 
motivational-affective (emotional component of pain), and cognitive-evaluative 
(perception of pain based on cognitive processing) and that each were served by a 
particular physiological system which involved different areas of the supraspinal 
anatomy. This pain model implied that the sensory-discriminative and 
motivational-affective components of pain acted through two separate, parallel 
systems but more recent research has indicated that the two systems interact with 
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each other and have the ability to relay information to each other (Fields, 1987; 
Jessell and Kelly, 1991; Jones, 1997; Lima, 1997). 
Pain perception can therefore be considered as occurring in two stages. The initial 
stage is the immediate response to the pain stimulus and is composed of primarily 
the sensory-discriminative and motivational-affective components (Jones, 1997; 
Price and Harkins, 1992; Wade, Dougherty, Archer and Price, 1996). These are 
mediated at the level of termination of ascending systems within the cortex - 
principally in the primary somatosensory and limbic areas respectively. The pain 
components of the 1 st stage of pain perception (sensory-discriminative and 
motivational-affective) are though to play a larger role in cases of acute or 
experimental pain (Price and Harkins, 1992). The second phase of interactions in 
cortical association areas, which involve further stages of cognitive interpretation 
of the initial pain perception and places it into an emotional context (cognitive- 
evaluative component of pain), plays a larger role in chronic pain (e. g. frustration 
and anger because of being unable to go to work) (Price and Harkins, 1992). This 
has important implications for pain assessment as it demands distinction between 
different types of pain (i. e. acute, chronic or experimental) and also careful 
consideration of the times at which the pain measures are taken. 
Cognitive processing plays an important role in the pain experience and mental 
activities in cortical regions such as the frontal, temporal and parietal lobes 
influence pain through the corticofugal and subcortical descending pathways (see 
Figure 4). These descending influences can act on both sensory-discriminative and 
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motivational-affective components selectively and also, through connections in 
brainstem areas, modulate noxious input within the dorsal horn before it reaches 
the ascending pathways (Bond, 1984; Fields, 1987; Jessell and Kelly, 1991). In 
this way pain perception can be viewed as being the result of complex 
neurophysiological interactions at spinal, brainstem and cortical levels and is 
always a unique experience. 
3.5 : Conclusions 
(1) Pain perception is the conscious response to a noxious stimulus which can be 
modulated at spinal, brainstem and cortical levels. 
(2) Neurophysiological evidence supports a multi-dimensional response to pain 
consisting of sensory-discriminative, motivational-affective and cognitive- 
evaluative components acting in separate but interacting systems within the 
central nervous system. 
(3) Pain perception can be thought of as occurring in 2 stages; the 1st stage 
consisting primarily of the sensory-discriminative and motivational-affective 
components and the 2nd stage, the cognitive-evaluative component. 
(4) Based on (2) and (3) above, pain assessment outcomes are therefore 
dependent on the component of pain being assessed and the timing of the 
assessment. 
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CHAPTER 4: PAIN MECHANISMS AND THE RATIONALE FOR THE 
USE OF TENS 
4.1 : Introduction 
Much debate has arisen over the years regarding the rationale for the clinical use 
of TENS for pain-relief, with the literature supporting evidence for multiple 
mechanisms of action (Eriksson et al, 1979; Garrison and Foreman, 1994; 
Hughes, Lichstein, Whitlock and Harker, 1984). The aim of this chapter is to 
identify to the reader the underlying theories which are considered to explain why 
TENS reduces pain. Major differences in neurophysiological action of the 
proposed central mechanisms are thought to be associated with the chosen 
parameters, namely the intensity and frequency of the currents supplied (Hughes 
et al, 1984; Levin and Hui-Chan, 1993; Sjolund and Eriksson, 1979). Two main 
categories of TENS have already been identified in Section 2.3 and they are 
characterised as being either high frequency / low intensity (conventional TENS) 
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or low frequency / high intensity (acupuncture-like TENS). Both types of current 
can theoretically produce pain-relief by modulating nociceptive transmission of 
pain perception at a number of levels and all are initiated by the stimulation of 
peripheral afferent nerve fibres. A summary of proposed TENS mechanisms is 
shown in Figure 5. 
4.2 : Peripheral mechanisms 
It has been suggested that TENS modulates activity in afferent nerves as a result 
of blockage of small diameter fibres, specifically A6 and / or C, in the peripheral 
nerves (Campbell and Taub, 1973; Ignelzi and Nyquist, 1976). The blocking 
effect of nociceptive afferent fibres has been proposed as occurring before the first 
synapse and is, therefore, thought to be entirely a peripheral mechanism with no 
involvement of the central nervous system. Campbell and Taub (1973) carried out 
2 experiments stimulating the digital nerve of healthy human volunteers. The 
authors reported that the results of their 2 experiments supported a peripheral 
blocking mechanism of A8 fibres for pain-relief by electrical stimulation but 
stressed that the current had to be continuous and of both high frequency and high 
intensity. The findings of Ignelzi and Nyquist (1976) supported the concept of AS 
fibre peripheral blocking when they carried out an investigation of nerve 
compound action potentials in the sural or superficial radial nerves of 10 
anaesthetised cats. 
Direct contradiction to the proposal of peripheral nociceptive fibre blocking by 
electrical stimulation was offered in a paper published by Swett and Law (1983) in 
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Figure 5: Proposed mechanisms for TENS. 
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a study using chronic pain patients. Swett and Law (1983) compared their 
findings with those of Campbell and Taub (1973) and stated that the absence of 
painful sensations associated with the onset of high intensity electrical stimulation 
contradicted the conditions supposedly required for nerve block conduction. The 
authors did not rule out that some unspecified peripheral mechanism may interfere 
with action potential initiation in nociceptive fibres but stated that it was 
extremely unlikely to occur using the stimulus intensities selected by the majority 
of patients for pain-relief. The application of transcutaneous electrical stimulation 
employed by Campbell and Taub (1973) was equated by Swett and Law (1983) to 
rate in excess of 6-12 x sensory threshold intensity, as rated by their own scale 
and was therefore considered to be outwith the range commonly used in clinical 
practice. The findings of the paper by Swett and Law (1983), assuming similarity 
in action between the peripheral nerves of cats and humans, supported the theory 
that pain-relief by electrical stimulation is due primarily to large fibre stimulation 
and is produced by a central mechanism. This viewpoint was shared by Garrison 
and Foreman (1994) who reviewed the literature regarding peripheral mechanisms 
of pain-relief by electrical stimulation and summarised that the peripheral model 
was not in accordance with clinical experience and that pain-relief was most likely 
to be due to central nervous system involvement. 
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4.3 : Spinal mechanisms 
Afferent nerves contain varying properties of different axon types and the fibres 
which relay noxious information (AS and C) possess different physical 
characteristics from the non-noxious afferent fibres carrying information from the 
cutaneous mechanoreceptors (Aß). The relatively larger diameter and myelination 
possessed by the A13 afferent fibres have the resultant effect of these fibres having 
a lower threshold to electrical stimulation than the fibres relaying noxious 
information (Guyton, 1991; Howson, 1978). The Gate Control Theory of Pain, 
originally devised by Melzack and Wall in 1965, suggested a theoretical 
framework for the use of electrical stimulation of afferent fibres for pain-relief. 
The specific neurophysiological and pharmacological mechanisms involved are 
being continually revised and updated (Handwerker, Iggo and Zimmermann, 
1975; Steedman and Malony, 1987) but the main concept of the theory remains 
that selective activation of large diameter afferents such as the Aß group causes 
segmental modulation within the spinal cord at the level of stimulation by 
decreasing the amount of nociceptive transmission through the spinal cord. 
Research has clearly demonstrated that there is interaction between inputs in small 
and large afferent fibres within the dorsal horn and has associated this interaction 
with decrease in ascending noxious information projected onwards from the spinal 
cord and subsequent decrease in pain perception (Garrison and Foreman, 1994; 
Handwerker et al, 1975). The primary nociceptive areas of termination of A6 and 
C fibres within the dorsal horn are the two most superficial layers (laminae I and 
II), with only a few fibres terminating in deeper laminae (Watson, 1982). While it 
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was initially proposed by Melzack and Wall (1965) that this was the result of 
presynaptic inhibition of the afferent fibres, more recent intracellular research 
gives support for a postsynaptic action on interneurones within lamina II 
(Handwerker et al, 1975; Steedman and Malony, 1987). 
4.4 : Spinal mechanisms and relevant TENS parameters 
Spinal segmental pain mechanisms are thought to be activated by TENS when 
large diameter A13 afferent fibres are stimulated (Garrison and Foreman, 1994; 
Levin and Hui-Chan, 1993). Melzack and Wall's Gate Control Theory of Pain 
(1965) recognised the involvement of these fibre groups in their pain model and is 
supported by physiological evidence. It has been well established that if a mixed 
bundle of nerve fibres is stimulated by an electrical current the lower intensities 
will activate those fibres with the larger diameters due to their lower thresholds 
(Guyton, 1991; Woolf and Thompson, 1994). The relatively quick conduction 
velocity of Aß fibres compared with those of the small diameter nociceptive 
afferents also means that non-noxious information from mechanical stimuli from 
the periphery reaches the spinal cord before impulses relaying noxious input. 
With regards to parameter selection in order to selectively activate large diameter 
Aß fibres, Woolf and King (1987, in Woolf and Thompson, 1994) reported that a 
stimulation frequency of greater than 25 Hertz must be reached. At higher 
frequencies (>25Hz) the combination of the nerve potential duration and latency 
periods of both the small and large diameter afferents results in sufficient 
hyperpolarisation of C fibres to reduce ascending information (see Section 2.4). 
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The use of high frequency currents in reducing noxious activation (blocking 
conduction) of evoked dorsal horn cells during TENS is supported by Garrison 
and Foreman (1994). The authors, in their study using anaesthetised cats, selected 
both a low frequency (5-45 Hz) / high intensity (50-60 mA) and a high frequency 
(50-125 Hz) / low intensity (5-40 mA) TENS current. Extracellular recordings 
were taken from 83 dorsal horn cells that normally respond preferentially to 
noxious stimuli. It was found that cell activity was more frequently decreased 
when the high frequency / low intensity TENS current was applied (1 way 
ANOVA; p<0.001). 
Levin and Hui-Chan (1993) compared stimulus intensities of conventional TENS 
(frequency 100 Hz / intensity 3x sensory threshold) with two forms of 
acupuncture-like TENS (frequency 0.1 Hz / intensity >3x sensory threshold and 
frequency 100 Hertz bursts at 4 Hertz / intensity >3x sensory threshold). The 
authors stimulated the median nerve of 17 healthy human subjects (age range 19- 
30; no other details given), allowing a rest period of between 30 to 60 minutes 
between testing sessions. In the case of the acupuncture-like TENS the current 
intensity was increased until pain tolerance level was reached. The authors did not 
give details in the paper as to how long the electrical stimulation was applied. The 
results of the study found that the intensities used with the acupuncture-like 
TENS ranged from 3-7.1 x sensory threshold (mean ± S. D. 4.58 ± 0.93 x 
sensory threshold). It was concluded in the paper (Levin and Hui-Chan, 1993) 
that because small diameter nociceptive afferents usually require 6-7 times 
sensory threshold stimulation values to be stimulated, and that this intensity of 
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current cannot be tolerated by many people, that in almost all clinical situations 
TENS will be activating large diameter A fibres. This conclusion is in accordance 
with that by Swett and Law (1983) but raises an important issue regarding the 
difference between using animal and human subjects. Variations in nerve activity 
between animal species, as well as recording discrepancies between percutaneous 
and transcutaneous techniques, makes it extremely difficult to directly compare 
nerve conduction studies but the results do suggest that current intensities of less 
than 6-7 x sensory threshold only stimulate Aß fibres. 
4.5 : Brainstem mechanisms 
The Gate Theory of Pain (Melzack and Wall, 1965), although primarily proposing 
a spinal segmental model of pain modulation, also included a descending system 
which modulated spinal nociceptive transmission. The original theory proposed 
that input to this system was provided by ascending non-noxious information but 
more recent research supports the view that descending pain modulatory 
pathways which originate in the brainstem can be recruited by ascending noxious 
information and are, therefore, involved as part of a negative feedback loop 
(Basbaum and Fields, 1978; Belanger, 1985). 
The two main brainstem areas which appear to be involved in the descending 
modulatory mechanisms are the periaquaductal grey matter (PAG) and the raphe 
nuclei, in particular the nucleus raphe magnus (NRM) (Thompson, 1988; Watson, 
1982). It has been suggested that the PAG acts, via projections to the raphe 
nuclei, through the dorsolateral fasiculus (DLF) descending pathway to terminate 
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in the dorsal horn (Basbaum and Fields, 1978). The descending inhibitory 
mechanisms are thought to act at more than one level of the spinal cord and are 
therefore referred to as extrasegmental or diffuse noxious inhibitory control 
(DNIC) systems (Le Bars, Dickenson and Besson, 1979). There has been much 
research carried out investigating the exact chemical nature of the descending pain 
systems, with both opioid (e. g. enkephalins and beta-endorphins), and non-opioid 
(e. g. serotonin) substances being implicated (Belanger, 1986; Walsh, 1991; 
Wright, 1995). 
4.6 : Brainstem mechanisms and relevant TENS parameters 
It has been suggested that analgesia as a result of descending pain modulatory 
systems may partly be modulated through opioid pathways (Belanger, 1986; 
Walsh, 1991; Wright, 1995). Studies have been carried out using an opioid 
blocker (naloxone) to establish, indirectly, opioid involvement during TENS 
stimulation. Sjolund and Eriksson (1979) used 20 patients (no details given) 
diagnosed as having chronic pain and applied conventional TENS (frequency 50- 
100 Hz / intensity 2-3 x sensory threshold) to 10 patients and acupuncture-like 
TENS (frequency 100 Hz in 2 Hz bursts / intensity 3-5 x sensory threshold) to the 
other half of the sample. In each case electrodes were placed over the appropriate 
dermatome to treat the pain and all subjects had been using a portable TENS unit 
for at least 3 months (10-30 minutes, 1-4 times a day) prior to the study. 
Naloxone hydrochloride (0.8-1.6 mg) was administered to each subject while 
receiving TENS and injections (active or placebo) were repeated 4 to 8 times at 
30 minute intervals. The conditions were double-blinded and sterile saline was 
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used as a placebo. Subjects were asked to rate their relief in pain intensity on a 
VAS 10 minutes after each injection. The results found that 6 of the 10 patients 
using the acupuncture-like TENS reported a decrease in stimulation-produced 
analgesia when naloxone was administered. No such decrease was reported by 
any of the 10 patients receiving treatment from the conventional TENS. The 
authors concluded that opioid mechanisms were activated only by low frequency / 
high intensity acupuncture-like TENS. The results of this study should be viewed 
with caution, however, as the pain assessment technique employed was quite 
crude (based on percentage change of VAS scores) and no statistical analysis of 
the results was undertaken. 
Thompson (1988) summarised the results of 9 TENS studies which have used 
naloxone and reported that, in 4 of the 7 human studies and in both the animal 
studies, naloxone caused either a partial or total block of stimulation-produced 
analgesia. In general, naloxone was only able to affect analgesia produced by low 
frequency / high intensity acupuncture-like TENS, therefore supporting the 
findings of Sjolund and Eriksson (1979). Thompson stated, however, that it was 
not always possible to draw firm conclusions from the results, such as the study 
carried out by Freeman et al (1983, in Thompson, 1988) who was reported to 
have found that naloxone had no affect on stimulation-produced analgesia. These 
authors allowed their 9 subjects to select their own TENS parameters and used 
currents ranging from 10-100 Hertz frequency and unknown intensity. For this 
reason it could not be determined which types of afferent fibres were being 
stimulated. Another methodological issue with naloxone studies is the doses that 
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are administered. Woolf and Thompson (1994) suggested that the doses may not 
always be sufficient to block all types of opioid receptor and proposed that 
naloxone is not always an accurate indicator of opioid involvement. 
Hughes et al (1984) used a more direct method of assessing opioid involvement 
during TENS application and measured blood beta-endorphin levels in 36 healthy 
subjects (18 male, 18 female; mean age 25 years) following high frequency (101- 
108 Hz) / low intensity (26-44 mA) (n=9), and low frequency (4-7 Hz) / high 
intensity (45-65 mA) (n=12) TENS stimulation. No statistical difference in beta- 
endorphin levels was reported between the TENS groups (x`=3.68; d. f. =2, 
p>0.10) but both groups had an increase in beta-endorphin level compared with 
the control group (n=10) which had received no TENS stimulation. The authors 
proposed that both types of TENS induced analgesia by increasing opioid levels 
and suggested that, as well as current frequency and intensity, parameters such as 
pulse width and electrode placement should be considered in order to identify the 
underlying neural mechanisms. 
4.7: Cortical mechanisms 
Pain is well recognised as a multi-dimensional experience and pain perception has 
been found to be influenced by a variety of cognitive processes such as anxiety, 
depression, past pain experiences and cultural attitudes (Clancey and McVicar, 
1992; Watson, 1982). As mentioned in an earlier section (see Section 3.4), these 
affect not only the higher level processing which modifies the cognitive-evaluative 
component of pain but also the first stage processing. Further, they can give rise 
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to processing which act on both sensory-discriminative and motivational-affective 
(lateral and medial) transmission systems selectively and so sensory input can be 
modulated in the somatosensory and limbic areas even before it reaches the 
cortical areas. The role which cortical processing plays in perceived pain intensity 
and unpleasantness has important implications for pain perception during clinical 
TENS treatment programmes, suggesting that both the physical sensation of the 
TENS current and the entire patient-therapist interaction procedure can affect the 
patient's degree of pain-relief from the modality. Cortical influences play an 
important part in the efficacy of a pain-relieving treatment and, with particular 
reference to TENS, positive treatment effects have been attributed to placebo 
action (Conn, Marshall, Yadav, Daly and Jaffer, 1986; Marchand, Charest, Li, 
Chenard, Lavignolle and Laurencelle, 1993). Placebo, in the context of TENS, 
can be considered as encompassing everything except the current and will be 
discussed in greater detail in Chapter 5. 
4.8 : Conclusions 
(1) There is evidence to support multiple potential mechanisms of action of pain 
modulation during TENS application. These can occur at spinal, brainstem and 
cortical levels. 
(2) The level of pain modulation is thought to be dependent on a number of 
factors including TENS parameters, patient mood state and the patient-therapist 
interaction. 
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CHAPTER 5: PSYCHOLOGY AND TENS 
5.1 : Introduction 
When testing the efficacy of a pain-relieving modality it is beneficial for the 
clinician or experimenter to know, if pain-relief is achieved, what mechanisms 
brought about the outcome. This chapter aims to highlight the psychological 
component of the pain response and, with particular relevance to the present 
study, the influence of control. Turner, Deyo, Loeser, Von Korff and Fordyce 
(1994) proposed three general reasons for clinical improvement in a patient's 
condition: (1) The first was natural history, or regression to the mean, which is a 
return to the patient's more natural state and occurs naturally over a course of 
time. (2) The specific effects of the treatment were included in the second 
category of response mechanisms and were considered to be attributable to the 
characteristics of the intervention treatment (for example, ice reduces 
inflammation). (3) The third category listed by the authors was non-specific 
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effects of treatment. This term is often interchanged with the phrase `placebo 
effects' and encompasses all factors other than those considered to be specific to 
the active treatment (Turner et al, 1994) and, with particular reference to TENS, 
could be considered as encompassing everything except the current. 
5.2 : Placebo effects 
The word `placebo' stems back to the Greek translation of the Hebrew Bible 
where the phrase `I shall please' became `placebo' (Gielen, 1989). The definition 
given today for placebo in the New Shorter Oxford English Dictionary (1993) is; 
`A pill, medicine, procedure, etc., prescribed more for the 
psychological benefit to the patient of being given a prescription than 
for any physiological effect'. 
Gielen (1989) described the placebo effect as that which cannot be attributed to 
factors characteristic of a specific treatment but that which must be attributed to 
other incidental treatment factors. In the same paper the author carried out a non- 
critical analysis of the literature and suggested that the placebo effect, within the 
profession of physiotherapy, is a result of the quality of the patient-therapist 
relationship and the complexity of the treatment. It was suggested by Klaber 
Moffett and Richardson (1997) that the interaction between the therapist and 
patient has an important influence on pain reporting and proposed that this 
communication could affect treatment outcome by a number of models including 
patient education, increased patient compliance, increased patient self-efficacy and 
positive patient expectations. Turner et al (1994) proposed that therapist qualities 
such as friendliness, sympathy, interest and prestige were associated with positive 
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effects of placebo as well as active treatments. Efforts to identify patient 
characteristics which increase the placebo effect have been inconsistent across 
placebo administrations and Richardson (1994) suggested that if individual patient 
characteristics have any significance in determining the response to placebo then it 
is likely that they interact with other variables such as treatment type and the 
individual's mood state. With regards to the influence of the treatment type on 
placebo response, Petrie and Hazleman (1985, in Richardson, 1994) reported that 
the placebo effect with sham TENS was increased when a visual display was 
incorporated and a strong positive verbal suggestion about the effects of TENS 
was included in the treatment regime. The clinical significance of the results of 
this study were not discussed. 
Johnson, Ashton and Thompson (1993) carried out a detailed study investigating 
the influence of a selection of pre-existing patient factors (psychosocial variables, 
EEG variables and plasma concentrations of opioid peptides) on the efficacy of 
TENS. Twenty-nine patients (16 female, 13 male; age range 30-75; mean age 
52.2) with a range of chronic pain conditions were used in the study and tested 
once on an out-patient basis. A follow-up questionnaire was sent to all the 
subjects 4 months after their initial attendance at the clinic and recorded whether 
patients were still in possession of and using a TENS unit. All tests were based on 
patients using the TENS unit at the parameters most frequently selected by 
themselves and a positive correlation was reported between TENS responders 
(classified by VAS response to average pain-relief by TENS) and the incidence of 
increased cortical responsitivity (increased somatosensory and auditory evoked 
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potentials). The authors were unable to report any other relationships being the 
pre-existing factors being tested and the assessed efficacy of the modality. The 
authors proposed that the reported efficacy of TENS may have been due to 
differences in individuals' cortical responsitivity which determined the effects that 
all forms of sensory stimulation had on pain perception. With regards to the 
psychological measures taken during the study, these incorporated the Eysenck 
Personality Questionnaire and a Hospital, Anxiety and Depression scale. The 
results of the study, in terms of psychological variables and their effect on the 
reported efficacy of TENS, suggested that it is unlikely that any one psychological 
variable in isolation affects pain perception. 
Myths which surround the placebo response are that there is a fixed fraction 
(approximately one third) of people who respond to placebo and that the placebo 
response makes up a fixed fraction (again, one third) of the maximum possible 
response to a treatment intervention (McQuay, Carroll and Moore, 1995; Wall, 
1992). Wall (1992) attributed these ideas to the misreading of Beecher's work 
carried out in 1955. This paper reviewed 15 studies of patients with various acute 
pain conditions and reported that, on average, symptoms were `satisfactorily 
relieved' by the placebo in 35% of the patients treated. The placebo response rate, 
however, varied from 15% to 58% and corresponded with wide-ranging placebo 
responses reviewed by Wall (1992) from near 0% to almost 100%. It is difficult to 
compare placebo response rates across studies which employ different techniques 
of pain measurement and this is particularly true when percentage changes in pain 
are reported. Pain scales which rate percentage changes (often 50%) in pain 
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favour lesser pain intensities as lower initial markings require a smaller decrease in 
pain to rate a 50% change (Richardson, 1994). Problems with placebo rate 
reporting also emerge when other outcome measures such as grip strength or 
range of motion are taken with the assumption that they are directly related to 
pain perception (Richardson, 1994). The general consensus of placebo review 
papers (McQuay et al, 1995; Richardson, 1994; Turner et al, 1994; Wall, 1992) is 
that the placebo response is not consistent between studies and, more importantly, 
is not even consistent in individuals on different occasions. As mentioned earlier, 
the placebo response varies across treatment administrations and is due to 
countless factors of the patient-therapist interaction and the treatment being used. 
5.3 : Proposed mechanisms for placebo effects 
The exact physiological mechanism of action which placebo pain-relief employs 
was investigated by Levine, Gordon and Fields (1978) who conducted a study 
using 51 patients (27 male, 24 female; age range late teens to early thirties - no 
exact figures given) with dental post-operative pain. All patients were given the 
same dose of analgesia during surgery and afterwards were randomly assigned to 
one of three groups. One group was given naloxone, an opioid antagonist, two 
hours after surgery and a placebo one hour after that (n=11). The other groups 
were either given the two treatments in the opposite order (n=23) or were given 
placebo for both treatments (n=17) (5 subjects dropped out of the study). The 
authors asked subjects to rate their pain intensity on a 10cm long visual analogue 
scale 5 minutes before and 1 hour after receiving each treatment, as well as 
requesting a verbal response from each subject as to whether their pain had 
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decreased, increased or remained the same since the previous pain assessment. All 
subjects who received placebo first, followed by naloxone (n=23), were then 
categorised as placebo responders or non-responders based on their pain rating 
after the naloxone had been administered. Those subjects who reported that their 
pain had remained the same or decreased from 5 minutes before naloxone 
administration to the pain assessment 1 hour afterwards were defined as placebo 
responders (n=9) while those with increased pain during the same period were 
defined as placebo non-responders (n=14). The results indicated that subjects who 
were classified as placebo responders had a significant increase in pain reporting 
when administered naloxone (t-test; p<0.05 - no more statistical details given) and 
the authors concluded that placebo analgesia was involved with the release of 
opioid substances. It is difficult to accept the results of this study as the criteria 
used for defining placebo responders and non-responders was extremely crude 
and did not take into account the baseline pain intensity scores for each individual 
subject. It cannot be determined if the naloxone was solely responsible for 
changes in pain reporting and instead subjects who reported an increase in pain 
over the required time span may have been experiencing the wear-off of the 
surgical analgesia. 
A number of placebo mechanisms of a psychological nature have also been 
suggested including expectancy effects, decreased anxiety, conditioning (learning) 
process and cognitive dissonance (Turner et al, 1994; Richardson, 1994). 
Expectancy effects suggest that a patient's expectation of treatment may help 
them become more positive about their condition and result in them gaining more 
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control of the situation and decrease their anxiety levels (Turner et al, 1994). The 
conditioning theory is based on research on learning and suggests that positive 
past experiences regarding a treatment will encourage a person to adopt a more 
positive approach to the present treatment programme. This will then tie in with 
the expectancy and anxiety effects but obviously negative past experiences can 
operate in the exactly opposite manner. Finally, the cognitive dissonance approach 
to placebo mechanisms is concerned with the holding of two or more beliefs 
which are psychologically inconsistent (Richardson, 1994). An example of this 
would be a patient prepared to undergo a treatment they found unpleasant in the 
belief that it will help relieve their symptoms. It is thought that the more 
unpleasant the patient finds the treatment the greater the placebo effect will be as 
to undergo that amount of suffering it must be doing them some good 
(Richardson, 1994). 
It is difficult to completely separate any of these psychological processes as they 
more than likely interact with each other and also with physiological mechanisms 
such as that proposed by Levine et al (1978). Steps by clinicians and 
experimenters to increase the placebo response should, therefore, include physical 
and verbal cues that enhance any of the suggested psychological mechanisms. 
5.4 : Placebo effects and TENS 
The determination of either the specific, or the non-specific (placebo), effects of 
TENS is extremely difficult and is greatly dependent on the experimental design 
of the study and the criteria used as outcome measures of success. A wide range 
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of TENS studies have been carried out since the publication of the gate control 
theory of pain in 1965 by Melzack and Wall (see Chapter 4 for more detail). 
These TENS papers include animal and human experimental studies as well as 
those undertaken specifically in the clinical setting. In order to highlight the 
identification of placebo effects during TENS administrations three different types 
of study have been reviewed: (1) a human experimental pain study, (2) an acute 
clinical pain study and (3) a chronic clinical pain study. 
Walsh, Liggett, Baxter and Allen (1995) used an ischaemic model of experimental 
pain to investigate the pain-relieving effects of TENS. Thirty-two healthy female 
volunteers took part in the study and were tested twice, with 48 hours between 
the two tests. Each subject was exposed to 10 minutes of the sub-maximal 
tourniquet test (see Section 6.4.6 for more detail) in the initial session and was 
then randomly assigned to one of four groups for the second test: (1) control 
group (no TENS) (n=8), (2) placebo group (no battery TENS) (n=8), (3) high 
frequency group (110Hz TENS) (n=8) or (4) low frequency group (4Hz TENS) 
(n=8). The control group underwent the same pain induction procedure as before 
while the other three groups had one electrode attached to Erb's point and the 
other lateral to C6/7 during the ischaemic pain test. All the TENS subjects were 
instructed to adjust the current intensity to control their pain but the placebo 
group were told before testing that they may or may not feel any sensation under 
the electrodes. The whole testing procedure was double-blinded but it is obviously 
very difficult to effectively blind subjects to a treatment such as TENS which has 
a definite physical sensation. The subjects rated their pain intensity on a 
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computerised 10cm long VAS at one minute intervals during both pain induction 
sessions and the results of the study (one-factor ANOVA) showed a statistically 
significant differences between groups (p<0.02) for pain scores. Post-hoc Fisher 
tests indicated that there was no statistically significant difference between the low 
frequency TENS group and the subjects receiving placebo TENS although the 
same statistical test showed that the low frequency TENS group produced 
statistically significantly lower pain scores than both the high frequency TENS 
group and the group receiving no TENS (control group) (no statistical details 
given). 
An acute clinical pain study was carried out by Conn et al in 1986 investigating 
the effects of TENS following appendicectomy. Consecutive patients (n=42, no 
other details) undergoing an emergency form of the operation were randomly 
assigned to either a control group, sham TENS group or active TENS group. The 
two groups receiving TENS had an electrode placed either side of their wound 
and kept in situ for 48 hours. The authors gave no information as to the 
parameters of TENS employed in the active group and the methodology indicated 
that the clinicians were not blind to the group allocation. The patients were asked 
to rate their pain intensity post-operatively on a VAS and analgesia requirements 
were monitored over the 2 consecutive 24 hour periods of TENS placement. 
Analysis of the data found that, although both TENS treatments were significantly 
more effective in reducing pain (both outcome measures) (p<0.01) than the 
control group, there was no statistically significant difference between the sham 
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TENS and the active TENS groups. The authors concluded that TENS was not a 
suitable pain-relieving modality following surgery due to it being no better than 
placebo. This standpoint seems rather negative as pain-relief, regardless of the 
mechanisms by which it is induced, must surely be viewed as a clinical success. 
Greater detail of the parameters of the active TENS employed in the study may 
have revealed more answers as to the similarity in outcomes between the two 
TENS groups. 
Marchand et al (1993) undertook a clinical chronic pain study using TENS. Forty- 
two patients (18-60 years) who had experienced low back pain for more than six 
months were recruited to participate in the study by medical referral and 
newspaper advertisements. The patients were randomly assigned to either a TENS 
group (frequency 100Hz; pulse duration 125µs; intensity `clear but non-painful 
paraesthesia'), placebo-TENS group (no current) or control group. The group 
matching was done by controlling for sex, weight, diagnosis and pain severity so 
that the three groups possessed similar patient characteristics as their baseline 
measure. Placement of electrodes in the two TENS groups involved positioning in 
the appropriate dermatome level and these positions were replicated for each 30 
minute treatment session. Patients attended sessions on an out-patient basis twice 
a week for 10 weeks. Interestingly, the placebo TENS apparatus was fitted with a 
visual and sound feedback system which, as suggested by Petrie and Hazleman 
(1985, in Richardson, 1994), may increase the placebo response. An independent 
experimenter adjusted the current intensity for all the TENS patients until a 
sensation was reported. All the patients in the placebo group reported a sensation. 
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Patients in the control group received no treatment but were informed they would 
receive some six months later and were involved in the pain assessment 
procedure. The authors adopted a multi-dimensional approach to pain assessment 
and evaluated both pain intensity and pain unpleasantness on separate 10cm long 
VASs (see Section 7.2.1 for more detail). Patients were asked to rate their pain 
every 2 hours over 3 days following each treatment session. This procedure was 
then replicated 1 week, 3 months and 6 months after the 10 week treatment 
programme had been completed. 
Analysis of the pain scores using an ANOVA showed that immediately following 
treatment the reduction in pain intensity was significantly greater for TENS than 
placebo TENS (F=4.22; d. f. =1,24; p=0.05) but this was not the case for the pain 
unpleasantness scores (F=1.38; d. f. =1,24; p=0.252). Post-hoc Dunnett t-tests 
were then employed to investigate the long-term effects of TENS and at I week 
after treatment, once more, TENS was significantly more effective than placebo 
TENS in reducing pain intensity (t=2.50; d. f. =3,72; p<0.05) but not pain 
unpleasantness (no statistics given). No difference was found between the two 
groups (intensity and unpleasantness) at either the 3 month or 6 month pain 
assessment stages after the end of treatment. The results indicated the selective 
nature of the placebo response on the affective component of the pain response 
and also showed the long-term effects that both TENS and placebo TENS can 
have on chronic pain-relief. 
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5.5 : Control 
The issue of placebo effects within the field of pain management has been 
addressed and it has been identified that components of the treatment procedure, 
such as patient-therapist interaction and patient mood state, can alter the patient's 
pain perception (Gielen, 1989; Klaber Moffett and Richardson, 1997; Richardson, 
1994; Turner et al, 1994). An aspect of pain management procedure which has 
been investigated with regards to having an effect on pain perception is control. 
The concept of control has no formal definition but Thompson (1981) provided a 
general statement of ; 
"Control can be defined as the belief that one has at one's disposal a 
response that can affect the aversiveness of an event. " 
Importantly, Thompson's definition recognises that control does not have to be 
exercised, or even be real, to be effective. It is impotant to note, however, that 
within the context of the present study control is meant as being the ability of 
either the subject or experimenter to adjust the current intensity dial on the TENS 
machine. 
A number of studies which have investigated the influence of control on pain 
outcome measures are reviewed within this section. The majority of the studies 
refer to aversive electric shock application as the method of pain induction and are 
therefore not directly applicable to the present study but due to the lack of 
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literature which has looked at the relationship between pain and control it has 
been necessary to include the reviewed material. 
The relationship between perceived self-control of pain and pain reporting was 
investigated by Toomey et al (1991). Fifty-one subjects (34 females, 17 males; 
mean age 42 years +/- 13 years) were employed in the study, all of whom were 
patients attending an out-patient pain clinic with non-malignant myofacial pain. 
Subjects were requested to complete the Pain Locus of Control Scale (PLOC) to 
assess their perceived personal control of pain, as well as mark their average, 
worst and least pain intensity over the previous week on a 10cm long visual 
analogue scale. During the pain assessment procedure subjects were also asked to 
report about their pain frequency and the functional interference they experienced 
due to their pain. The authors did not state at which stage of the treatment 
programme any of the patients were at when taking part in the study. 
A total of 48 subjects completed the PLOC and these scores were divided into 
two groups, high scores (n=24) and low scores (n=24). The split in scores was 
achieved by dividing the scores at the median value. Both groups were compared 
on each of the dependent variables in the study and correlational analyses were 
carried out to establish the relative strengths of the relationships (Pearson or 
Spearman Correlation test, as appropriate). The results showed that patients 
reporting greater control of pain (high PLOC scores) rated their average pain 
level (p<_0.001) and least pain level (p<0.02) as significantly lower than patients 
reporting less personal control of pain (low PLOC scores). In addition, high 
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PLOC score patients rated significantly higher periods of time without pain 
(pS0.004) than the low PLOC score group. No statistically significant differences 
were reported between the two groups for functional interference due to their 
pain although the authors recognised that this may have been attributed to the 
assessment structure as well as the degree of patient willingness to report 
variations in pain-related behaviours during initial phases of treatment. 
Weisenberg, Wolf, Mittwoch, Mikulincer and Aviram (1985) conducted a 
laboratory study in which 50 healthy male subjects (mean age 24.3 years; age 
range 18-33 years) received electric shocks to their left wrist. All subjects were 
given the same number of shocks but 5 independent groups were used (n=10) for 
variations of perceived control. The variation in conditions was determined by the 
experimenter or the subject having control of attaching the electrodes and/or the 
decision to remove one of the electric shocks. The study also investigated the 
effect of predictability on pain response. Each group undertook two tests (each 
containing three trials), once warning the subjects in advance when the shock 
would arrive and once without a warning. The order of the testing was 
randomised and a5 minute rest was permitted between the two tests to allow 
recovery from shock adaptation. The experimenters assessed pain intensity after 
each electric shock using a VAS. Statistical analysis was carried out using an 
ANOVA and the results showed significant main effects in the relationships 
between VAS pain intensity scores and trials (F=4.80; d. f. =2,80; p<0.01) as well 
as for the interaction of conditions x trials (F=1.98; d. f. =2,80; p<0.06). Tests 
carried out to look for simple main effects showed that in all 3 trials subjects who 
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had control over both electrode attachment and shock administration produced 
the lowest pain intensity VAS scores. 
Before commencing the study, each subject completed a validated questionnaire 
to assess perceived self-efficacy. Self-efficacy is a measure of a person's 
perception of possessing coping abilities in aversive situations and has been 
thought to determine how much effort a person will give and how long they will 
tolerate noxious stimuli (Weisenberg, 1994). Evidence has even been produced to 
suggest that perceived self-efficacy can effect the body's endogenous opiate and 
immune systems thus altering the pain response (Wiedenfield, O'Leary, Bandura, 
Brown, Levine and Raska, 1990). Results linking VAS scores to self-efficacy 
showed that experimenter-control decreased the perceived pain intensity scores in 
those subjects with high self-efficacy but increased scores on the same measure in 
those with low self-efficacy. The authors (Weisenberg et al, 1985) concluded that 
giving control to a subject who was already anxious may have increased their pain 
response. They also suggested that control which was perceived as inadequate 
may have been more distressing to a subject than no control at all. 
Kanfer and Seidner (1973) conducted a study to compare pain tolerance between 
three randomly assigned groups of healthy female subjects (n = 45), all of whom 
had their hands immersed in ice cold water. Group 1 (n=15) had complete control 
over the slide show they were watching during the procedure, being able to 
change the pictures as they wished. Group 2 (n=15) had their slide show 
controlled by the experimenter, and the remaining subjects (n=15) acted as a 
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control group (no slide show). For Groups 1 and 2 the slide show consisted of 
travel scenes that were irrelevant to the study. Subjects were also asked to 
complete a post-test questionnaire, asking them about their thoughts during the 
immersion and asking for a discomfort rating of the icy water (8 pt VRS) and 
their general sensitivity to pain. The results of the study, using an ANOVA, 
showed a significant groups effect on tolerance times (F=15.89; d. f. =2; p<0.01). 
A Multiple Scheffe follow-up test showed that the subject-controlling mechanism 
was significantly more effective in increasing water tolerance times than the 
experimenter-controlled mechanism. No significant difference, however, was 
found between groups for the 8 point verbal rating scale (F=0.76; df--2,42; 
p>0.05). The authors were unable to attribute the variations they found in pain 
perception to variations in water tolerance times but this may have been due to 
the lack of sensitivity of the pain scale employed. The VRS only possessed 8 
response categories, meaning that a relatively large change in pain perception was 
probably required to register an alteration in pain reporting. The authors may have 
found quite different results if other descriptors had been used or more response 
categories had been offered to the subjects. 
Staub, Turskey and Schwartz (1971) carried out two experiments with 20 
different male college students participating in each (no further details given). 
During both experiments subjects were seated in a sound-proof room, observed 
by an examiner through a one-way mirror and spoken to through a two-way 
intercom system. In experiment 1 and 2 the subjects were divided into two 
groups, a self-control group (n=10) and a no-control (n=10) group. All subjects 
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were informed that they would receive electric shocks to the left forearm 
(1 second duration) and that the intensity would increase each time (2mA). Each 
subject was asked to report at four different levels of stimulation; (1) when they 
first felt the stimulus (sensation threshold), (2) when it became uncomfortable, (3) 
when it became painful (pain threshold) and (4) when they did not wish to go any 
higher (pain tolerance). The self-control subjects were given a switch which 
enabled them to administer the electric shocks themselves once a light was turned 
on. Neither the switch or the light was available to the no-control group where the 
examiner administered the electric shocks. Experiment 2 followed a similar 
procedure to experiment 1 except subjects in the self-control group were given a 
second switch which allowed them to control the increase in intensity of the 
electric current (1,2 or 3 increments - each 2mA). As in experiment 1, the self- 
control group received a light to inform them of when they could administer the 
next electric shock. Unlike the first experiment, however, the time that this light 
remained lit varied from 10 to 20 seconds so as to decrease predictability for the 
no-control subjects. 
Differences between the self-control and no-control groups for both experiments 
were evaluated using matched t-tests. In experiment I no significant differences in 
mean shock intensity was noted at any of the four levels of judgement. 
Differences, however, were noted in experiment 2 when self-control subjects were 
given the choice of altering the current intensity. Subjects in the self-control group 
reached significantly greater levels of current before they reported it as 
uncomfortable than subjects in the no-control group (t=2.44; d. f. =9; p<0.02). 
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Also, subjects in the self-control group tolerated significantly higher intensities of 
electric shock (t=1.82; d. f. =9; p<0.06) when they were allowed to administer 
them themselves as opposed to the experimenter controlling the current. 
Thompson (1981) suggested that decreased pain perception as a result of giving a 
person control over an aversive situation may be due to a reduction in anxiety by 
the person in pain. This viewpoint supported that reported by Pervin (1963) who 
carried out a study using 30 male undergraduate students. The apparatus 
consisted of three lights which acted as signals for an electric shock to the 
subject's calf and two levers which did (control switch), or did not (no control 
switch), produce the electric shock. The study took the form of a 3x2 
experimental design involving six conditions. The 2 components of the study were 
the certainty dimension (signal, no signal, inconsistent signal) and control 
dimension (control, no control). In the 6 conditions the subjects could (a) either 
control the application of the electric shock or have it administered by the 
experimenter and (b) they could predict when the shock would occur or could 
not. A trial consisted of a5 second duration light signal followed by a lever being 
thrown (shock or no shock) and a5 second rest. Each of the 6 conditions was 
made up of 12 trials and a paired comparison technique was used to investigate 
the relationship between the conditions. Each subject was tested over three 1 hour 
sessions spread over one week and a total of 450 paired comparisons were made 
(150 on each day). At the end of each paired comparison subjects rated both their 
pain intensity and anxiety on a 11 point verbal rating scale. Data analysis involved 
comparing the mean pain scores for each condition with the mean of the other 
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conditions combined. The authors reported no statistically significant interaction 
effects between the control and no control groups, although it was stated that the 
mean anxiety ratings of the former were lower than those for the latter (no 
statistics given). 
The results of laboratory studies are therefore inconclusive, although it appears 
that control can have an effect on pain behaviour without necessarily producing a 
significant change in perceived pain reporting. The non-significant results found in 
certain studies may be due to the insensitivity of the scale being used, in some 
cases a verbal rating scale (VRS) (Kanfer and Seidner, 1973; Staub et al, 1971). It 
could be necessary that more response categories are given to the subjects before 
a change in pain perception can be recorded, such as with a visual analogue scale 
(VAS) (see Chapter 7 for greater detail on pain assessment). 
Control raises other issues regarding pain assessment, including the timing of 
application. The review of pain neurophysiological mechanisms identified two 
distinct phases of pain perception and stressed the relative input of the three 
components of the pain response (sensory-discriminative, motivational-affective 
and cognitive-evaluative) during each of the two stages (see Section 3.4). The 
initial emotional response (motivational-affective) of a person in pain is thought to 
be influenced by the emotional context in which the stimulus is delivered, 
including attentional mechanisms (Lima, 1997). Anxiety is an emotional state 
which has been referred to (Weisenberg et al, 1985) and assessed (Pervin, 1963) 
during experimental studies investigating the influence of control on pain 
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perception. In turn, anxiety has been linked with attention during acute 
experimental pain induction (electric shock) (Janssen and Arntz, 1996) and it has 
been suggested by the authors that giving a person a diversion from the pain 
stimulus reduced their anxiety levels and pain perception. Giving a person control 
over an aversive situation could provide the subject with a diversion from the 
painful stimulus and instead allow them to focus their attention on their ability to 
control the pain (e. g. applying the stimulus themselves instead of the 
experimenter). It could be, therefore, that decreased pain perception under 
increased levels of subject control may, in part, be due to the subject's attention 
being diverted away from the painful stimulus. Miron, Duncan and Bushnell 
(1989) carried out an experiment investigating the effects of attention on the 
intensity and unpleasantness of experimental thermal pain. Healthy subjects (4 
male, 3 female; age range 20-25) were seated in front of a computer screen and 
exposed to varying levels of thermal (contact thermode attached above the lip) 
and visual (light placed on top of the computer screen) stimuli. An initial testing 
session was incorporated into the study during which the subjects were introduced 
to the experimental procedure and pain assessment scales. The pain scales 
consisted of two lists of words, one containing intensity descriptors and the other 
containing unpleasantness descriptors. Subjects were asked to rate each descriptor 
on a perceived line length using a VAS (cross-modality matching). In this way 
each descriptor was assigned a numerical value for the purposes of data analysis. 
The experimental procedure involved the subjects being exposed to 80 trials 
during which either the thermal or visual stimulus increased. Subjects were 
correctly or incorrectly informed (random ordering) as to which stimulus would 
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increase before each trial started (message on computer screen). The appropriate 
stimulus was increased during each trial until the subject detected the change 
(registered by the subject pressing the computer `return' key). After each trial 
subjects were asked to rate both the intensity and unpleasantness of the thermal 
stimulus by choosing a word on each of the descriptor scales. The results of the 
experiment, using a repeated measures ANOVA, showed that subjects rated both 
mean pain intensity and unpleasantness of the thermal stimulus higher on correctly 
signalled than incorrectly signalled trials (intensity F=13.54; d. f. =2,5; p=0.010: 
unpleasantness F=11.736; d. f. =2,5; p=0.013). The authors stated that the 
modulation of both components of the pain response by direction of attention 
suggested that changes in the subjects' perceived unpleasantness of the stimulus 
were at least partially a consequence of alteration of the perceived intensity of the 
stimulus. The finding that intensity and unpleasantness components of pain are 
altered to a similar degree by changes in attention is consistent with an 
interpretation that these effects are occurring at an early stage in sensory 
processing. This viewpoint is substantiated by neurophysiological research which 
was reported to have investigated monkeys trained to perform tasks while their 
attention was focused towards either visual or noxious thermal stimuli (Bushnell, 
Duncan, Dubner and He, 1984, in Miron et al, 1989). The results were reported 
to have shown an increased receptiveness of nociceptive neurones in the dorsal 
horn when the monkeys were attending to the noxious thermal stimulus than when 
attending to the visual stimulus. Giving a subject control of a pain-relieving 
modality such as TENS provides a distraction from a painful stimulus and 
neurophysiological research has provided evidence to support the view that 
76 
control can influence both Ist and 2nd stage pain perception (Guilbaud et al, 
1994; Lima, 1997). The effect of control, however, would be expected to have a 
greater influence on 2nd stage pain perception as higher levels of cortical 
processing in the association areas would allow for detailed evaluation of the 
treatment process. These research findings underline the importance of 
differentiating between the types of pain being treated (chronic, acute, 
experimental) when investigating the pain-relieving efficacy of TENS. 
An important point to note is that, with regards to the studies involving control, 
no literature has been published investigating the effect of perceived control on 
pain perception using TENS. TENS, due to its portability, is a pain-relieving 
modality which can be applied by patients themselves in their own home and so 
allow patients to take increased control of their pain management (Ellis, 1995). 
Indeed, it has been suggested by Toomey et al (1991) that TENS is a suitable 
modality with which to investigate the relationship between pain perception and 
the increased perception of personal ability to control pain. 
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5.6 : Conclusions 
(1) The literature has identified that factors not specific to a pain-relieving 
modality can influence treatment outcomes and that these factors can be referred 
to as placebo effects. 
(2) With reference to TENS, placebo effects can be considered as encompassing 
everything except the current and have been found to play a part in the outcome 
of TENS studies. 
(3) Control has been identified as a variable affecting pain perception and, based 
on neurophysiological principles, can influence pain assessment outcomes during 
both the 1st and 2nd phases of pain perception. 
(4) Research has yet to be published investigating the effect of increased subject 
control on pain perception using TENS but it has been suggested (Toomey et al, 
1991) that the modality is suitable for investigating such a relationship. 
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CHAPTER 6: THE EFFICACY OF TENS IN RELIEVING PAIN 
6.1 : Introduction 
Gracely (1994) identified 3 types of pain study: (1) those which use patients 
within a clinical environment, (2) research using laboratory animals, and (3) 
laboratory-based investigations using healthy human subjects. Each form of study 
has its limitations, with animal experiments encountering problems such as 
interspecies differences and the inability of animals to give a subjective response 
to painful stimuli. It is the pain assessment issue that poses the greatest difficulty 
in determining the pain-relieving efficacy of TENS and for that reason only human 
studies will be considered in this chapter. For the purposes of the present study it 
is important to establish the research basis for the pain-relieving efficacy of TENS 
in both the clinical and experimental setting. Differences between clinical and 
experimental human pain studies will be discussed later in the chapter (Section 
6.3), including the shortcomings unique to both types of study. 
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6.2 TENS and clinical pain 
As already mentioned in the previous chapter about placebo effects (Section 5.4), 
clinical pain studies can be divided into two major categories of acute (short- 
lasting) and chronic (long-lasting) pain. A large number of papers have been 
published in peer-reviewed journals within the past 15 years reporting the efficacy 
of TENS in a wide range of conditions but, as mentioned in Chapter 1, a lack of 
studies carried out with a rigorous study design has led to often contradictory 
study outcomes. The gold standard in clinical studies has been identified as being 
the randomised controlled trial (RCT) (Ernst and Resch, 1996) and so, within this 
section, a number of review papers will be included which report the outcomes of 
only those studies categorised as having the criteria to be RCTs. It is not the 
purpose of this section to report all the many conditions which have been treated 
with TENS but instead to review a sample of those acute and chronic clinical pain 
studies which have tested the pain-relieving efficacy of TENS. In the case of 
reviewed studies which have been carried out in a non-randomised or 
uncontrolled manner, methodological flaws are highlighted and the validity of the 
outcomes questioned with respect to the study design. 
Post-operative pain is a major use of TENS in acute clinical care and one such 
study was carried out by Cuschieri, Morran and McArdle in 1985. One hundred 
and six patients were included in the study, all of whom were patients undergoing 
elective abdominal surgery in a single hospital unit. Exclusions from the study 
included patients with a psychiatric history and those receiving narcotics prior to 
surgery. Immediately following surgery patients were randomly assigned to either 
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an active TENS group (frequency 80Hz, pulse duration 170µs, intensity `tingling 
sensation without discomfort') or a sham (no battery) TENS group where, in both 
groups, the 2 electrodes (size not given) were placed one either side of the 
incision. The authors assessed the qualitative differences between the two patient 
groups using a Chi square test and reported that the groups were comparable in 
terms of age, sex and weight. It was also reported that there was no difference 
between the groups with regards to number of smokers or upper abdominal 
incisions (no statistics provided). 
All the patients involved in the study were introduced to the TENS device prior to 
surgery and a short demonstration was carried out to establish the amount of 
current required to produce a `tingling sensation without discomfort'. The 
required intensity was recorded and set by a clinician post-operatively. Conditions 
throughout the study were double-blinded. The authors reported that the TENS 
was checked twice daily but it was not stated whether the TENS intensity was 
maintained at the same level or adjusted to allow for accommodation. It should be 
considered that the use of a predetermined current intensity does not allow for 
changes in sensory perception which may have occurred following surgery i. e. a 
TENS current that gave a `tingling sensation without discomfort' prior to surgery 
may have felt completely different once the surgery had been performed. 
Pain assessment following surgery was carried out using VASs (no further details 
given) which were completed by all the patients prior to administration of the first 
daily injection of analgesic and afterwards twice daily for 3 days. Patients were 
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asked to record their average pain over the previous 12 hours and morphine 
requirements were also noted. The pain scores were compared using the Mann 
Whitney U-test and the results showed no significant difference between the 
severity of pain experienced in either the active or sham TENS groups (no 
statistics given). The morphine requirements were also similar between the groups 
with the sham TENS group receiving a mean amount of 50mg (range 10-190mg) 
while the active TENS group received a mean amount of 59mg (range 10- 
140mg). 
The authors concluded that the results of the study did not support the use of 
TENS following abdominal surgery but this is difficult to accept with the absence 
of a true control group receiving no TENS. The results of the post-operative 
study carried out by Conn et al (1986) (see Section 5.4) found that, although 
there was no significant difference in pain-relieving efficacy between sham and 
active TENS, both were significantly more effective than the control group. The 
results of the Cuschieri et al (1985) study, therefore, support the presence of a 
placebo effect with TENS but cannot support the view that TENS (active or 
sham) is no better than receiving no TENS at all. 
A systematic review of the use of TENS with post-operative pain was carried out 
by Carroll et al in 1996. The authors, searching in both MedlineTM (1966-1995) 
and the Oxford Pain Relief Database (1950-1992), found 46 studies of which 17 
were categorised as RCTs. Inclusion criteria for the initial search was that the 
study was investigating acute post-operative pain, was written in the format of a 
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full paper and had a subject number greater than ten. Each study was scored by 
five independent readers on a three-point scale; (1) randomisation carried out, (2) 
randomisation and design carried out correctly and (3) subject number greater 
than ten and reasons given for any withdrawals. 
The results of the review paper (Carroll et al, 1996) found that of the 29 studies 
classed as RCTs, only 19 had pain outcomes. Of these 19 non-RCTs, 17 reported 
a positive outcome with TENS. This was in contrast with the 17 RCTs where 
only 2 studies reported a positive outcome. The authors concluded that non- 
randomisation of studies have the effect of over-estimating treatment effects and 
that this was evident from the TENS papers reviewed. 
Another form of acute pain which is commonly cited in TENS studies is obstetric 
pain. Carroll et al (1997) compiled another systematic review of the effects of 
TENS with respect to labour pain and, using the same search strategy as used for 
the post-operative pain review (MedlineTM and the Oxford Pain Relief Database), 
found eight studies which fulfilled the RCT criteria; (1) randomisation carried out, 
(2) randomisation and design carried out correctly e. g. blinding and (3) subject 
number greater than ten and reasons given for any withdrawals. Each of the eight 
studies were then read independently by five different researchers and given a 
score of between 1 and 5. 
A total of 712 women were included in the review, with 352 women receiving 
active TENS and 360 acting as controls. As a control three studies used 
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conventional analgesic administration (no TENS) while the remaining five used 
sham TENS. Of the eight studies, three were classed as having a positive outcome 
and five a negative outcome. Interestingly, however, none of the studies recorded 
any difference in pain scores during labour between TENS and control. One of 
the three positive results in the search was based on the number of additional pain 
relieving required as its only outcome and the other two positive results were 
based on time both to and between local anaesthetic outcomes. The authors 
concluded that the evidence from randomised trials for pain-relieving benefits 
from TENS during labour was not compelling but stated that the modality should 
still be viewed as useful as it was apparently not harmful (compared to, for 
instance, epidural local anaesthetics) and may do some good. 
The role of TENS in chronic pain, as in acute pain, covers a multitude of 
conditions. Robinson (1996) carried out a review of TENS studies investigating 
pain management in musculoskeletal disorders. The primary focus of the paper 
was the review of studies investigating non-specific low back pain but other areas 
discussed included arthritic conditions and soft tissue inflammatory disorders. The 
review was restricted to those studies which the author believed had held the 
greatest impact on clinical TENS use in patient populations. Robinson (1996) 
reviewed a number of studies in detail and then compiled a table listing 
methodological and documentation flaws within them. These included inadequate 
exclusion criteria, no control group, inappropriate statistical analysis and failure to 
describe the TENS stimulation parameters. The author was unable to either 
support or refute the efficacy of TENS for pain-relief in musculoskeletal disorders 
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and concluded that more well-designed, randomised, controlled prospective 
studies on TENS were required to answer questions about the modality. 
A major study carried out on the use of TENS with low back pain, and one which 
was mentioned in the review paper by Robinson (1996), was published by Deyo, 
Walsh, Martin, Schoenfeld and Ramamurthy in 1990. Individuals for the study 
were recruited by newspaper advertisement which raises the question of normality 
within the subject population. The exclusion criteria for the study were clearly 
stated and once these applicants had been declined a total of 145 subjects were 
included in the study (age range 18-70). The subjects were randomly assigned to 
1 of 4 groups; (1) active TENS (n=36), (2) active TENS and exercise (n=37), (3) 
sham TENS (n=36) or (4) sham TENS and exercise (n=36). 
The subjects in the 2 groups receiving TENS were given written and oral 
instructions regarding its use and were instructed to use the modality at least 3 
times a day for 45 minute periods during the 6 week study. The parameters of the 
TENS current were set at a frequency of 80-100Hz and intensity of 30mA (no 
other details given) for the first two weeks and then altered to a frequency of 2- 
4Hz and intensity of 100mA after the two week period had ended. The subjects 
were allowed, after the low frequency TENS trial, to select either of the two 
settings for the final two weeks of the study. In each case the 2 electrodes (no size 
stated) were placed at the site of pain but then moved as necessary to optimise 
pain-relief. The sham TENS units were used in exactly the same manner as the 
active TENS units except no current was supplied to the electrodes. Subjects 
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supplied with sham TENS were told that they might, or might not, perceive 
stimulation from the units. The groups receiving exercise as part of their 
treatment were given a series of 12 daily exercises (3 for relaxation; 9 for hip, 
spine and lower limb flexibility) of which they were instructed to carry out 2 or 3 
repetitions, then repeat in the reverse order. Subjects in all 4 groups attended a 
clinic twice weekly during the first 4 weeks of the study during which time they 
received moist heat treatments (hot packs) and advice about their treatment. Heat 
packs were also lent for home use and subjects were advised to use them on 
painful areas for 10 minutes a day. 
Assessment of the effects of the treatments was carried out at 2 and 4 weeks of 
the study programme and again 8 weeks after the treatments had ended. A 
multivariate analysis of variance investigated 9 outcome measures of function, 
pain and physiological outcome and found that, at the 4 week stage of treatment, 
there were no statistically significant differences in any outcome between the 
subjects receiving active TENS and those receiving sham TENS (p>0.2 in each 
case). The authors concluded that TENS was no better than placebo and added 
no apparent benefit to that of exercise alone. 
The study by Deyo et al (1990) raises a number of issues, many of which were 
addressed in letters to the authors following its publication. The introduction of 
another modality to the study, in the form of heat packs, makes it difficult to 
establish if it was the TENS and / or exercise contributing to the results. It has 
also been noted that the outcome measures were biased towards physical activity 
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levels and therefore would have favoured the assessment of exercise rather than 
TENS. Most importantly, the optimal parameters for relief of chronic low back 
pain cannot be established in the study as not all the subjects followed the same 
parameter settings. The authors reported that only 23% of the subjects in both the 
active and sham TENS groups remained using the high frequency TENS current 
after the initial 2 week period and so it can only be concluded that the low 
frequency current was the preferred one. The results of this study contradict those 
of Marchand et al (1993) (reviewed in Section 5.4) who found active TENS to be 
more effective than sham TENS in reducing pain intensity 1 week after treatment. 
It remains unclear if the results obtained in the Marchand et al (1993) study were 
due to different stimulating parameters or more sensitive pain assessment tools 
(pain intensity and pain unpleasantness VASs). 
An investigation as to how long-term users of TENS set their parameters was 
carried out by Johnson, Ashton and Thompson in 1991(a). One hundred and 
seventy-nine patients (female n=82, male n=97; age range 24-85, mean ± S. D. = 
55.2 ± 12.9), randomly selected from hospital files and in possession of a TENS 
machine (lent from the hospital) for more than 3 months to treat a chronic pain 
condition, took part in the study. All patients participating in the study were 
classified according to the anatomical region of their pain, aetiology and diagnosis 
clusters and were then requested to complete a questionnaire specific to TENS 
and designed by the authors. Of the total number of patients in the study, 107 
(female n=58, male n=49; age range 24-85) attended the hospital and had the 
electrical characteristics of their TENS machines tested at sensory threshold, 
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therapy and pain threshold levels. Patients who were free of pain at the time of the 
visit were asked to use `normal therapy settings' and in all cases a mean of 3 
repetitions was calculated. Four types of stimulators were used in the study and 
with those offering a burst facility the procedure was repeated in the burst mode. 
With regards to the efficacy of TENS in relieving pain, subjects were asked to 
rate their degree of pain-relief obtained from their TENS machine on a VAS 
labelled `no relief of pain' (assigned a value of 0) and `total relief of pain' 
(assigned a value of 10). The results of the study showed that 47% (n=79) of 
patients reported that TENS reduced their pain by half or more and that only 
13.7% (n=23) of patients stated that TENS produced no relief to their pain (score 
of between 0 and 1 on the VAS). A one-way analysis of variance (ANOVA) 
found that the VAS scores were not significantly different when classified in any I 
of the 3 categories of anatomical region of pain, aetiology of pain or diagnostic 
clusters. Regarding parameter preferences, 56% (n=72) reported using continuous 
TENS stimulation in preference to burst mode and 70% (n=6 1) used a current 
intensity less than IOmA above their sensory threshold. Over 75% (n=68) of 
patients in the study used frequencies in the range 1-70Hz but the authors stated 
that this finding may be due to the designs of the TENS machines. Interestingly, 
no correlation (Pearson correlation coefficient) was found between the selected 
current frequency and the degree of pain-relief achieved using TENS (r=0.132, 
d. f. =89, p>0.05). The authors commented on the lack of correlation between 
patient, stimulator and outcome variables and suggested that parameter 
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preference may be due to a combination of factor including those of a practical 
(type of stimulator), psychological (personality) and physiological (aetiology and 
type of pain) type. 
A review of clinical TENS studies shows the wide spectrum in which the modality 
can be used. The portable and relatively inexpensive nature of the modality makes 
it easily accessible to many different patient groups. The use of TENS ranges 
from the passive application of the modality to the patient post-operatively to the 
more active and informed usage that occurs when patients are taught about the 
machines and instructed how to apply them themselves in their own homes. The 
large number of variables that occur in the clinical setting and the influence which 
these can have on pain perception (see Chapter 5) may contribute to the often 
contradictory findings in clinical TENS studies. The variation in current 
parameters (frequency, intensity, pulse duration, waveform), application 
(electrode placement, length of treatment) and context (hospital /clinic or patients 
own home) in which TENS is applied compounds this difficulty of comparing 
results from different studies and underlines the need for systematic selection of 
optimal stimulating parameters within the context of randomised controlled trials. 
6.3 Differences between clinical pain and experimental pain 
There are inherent differences between clinical and experimental pain studies 
involving humans, and care must be taken when extrapolating the results of 
experimental pain studies to the clinical setting (Bromur, 1984; Gracely, 1994). 
Painful stimuli administered under laboratory conditions cannot duplicate the 
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physiological features of an acute or chronic pain condition, neither can they 
reproduce the accompanying psychological features such as anxiety and 
depression (Bromur, 1984). The usefulness of experimental studies is that external 
variables are easier to control than in the clinical setting and there is a pain 
stimulus of definable origin (Gracely, 1994). Any intervention used under 
laboratory conditions is also likely to show clinical efficacy, as well as possibly 
identifying the mechanisms of analgesic action (Gracely, 1994). There is, 
therefore, an important place in pain research for studies on healthy human 
volunteers, allowing information to be gained about the pathophysiology of pain 
and the efficacy of analgesics under controlled conditions. Researchers in the area 
of experimental pain have long been debating the qualities required of the ideal 
pain stimulus, the main qualities agreed being that it should be easily reproduced, 
quantifiable, and safe to administer (Bromur, 1984; Gracely, 1994; Procacci, 
Zoppi and Maresca, 1979). A pain stimulus possessing the required properties 
should, therefore, be able to provide information about the relationship between 
the stimuli being applied and pain reporting measures. 
6.4 : Overview of human experimental pain induction methods 
There are currently a number of experimental pain techniques being commonly 
used in human pain research. An overview of these techniques, under various 
headings indicating the type of stimulus used, will now be addressed. 
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6.4.1 : Chemical 
The use of chemical methods for the induction of experimental pain covers 
various techniques, ranging from intracutaneous injection of hypertonic saline 
solution (Veerasarn and Stohler, 1992) and topical application of mustard oil 
(Ward, Wright and McMahon, 1996) to the more recently developed technique of 
applying carbon dioxide pulses to the nasal mucosa (Anton, Euchner and 
Handwerker, 1992). All the techniques share the similar problems of risking tissue 
damage (Handwerker and Kobal, 1993), difficulty in accurately quantifying the 
stimulus (Humphries, Long and Johnson, 1994) and the long refractory periods 
required between stimuli (Procacci et al, 1979). These reasons have led to a 
decrease in their use in favour of other pain induction methods. 
6.4.2 : Mechanical 
The oldest form of mechanical stimulation in human pain research involved an 
arrangement of pressure cuff in conjunction with pointed projections which 
impinged on the skin (Von Frey, 1894, in Handwerker and Kobal, 1993). 
Techniques favoured in more recent times involve the application of pressure 
directly to the skin. These techniques, when encompassing a spring-loaded gauge 
(pressure algometer), allow quantitative measures of the load being applied, 
therefore increasing reproducibility of stimuli (Brennum, Kjeldsen and Jensen, 
1989; Jensen, Rasmussen, Pederson, Lous and Olesen, 1992). 
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Ultrasound stimulation has been used for the mechanical induction of pain on 
structures lying deep in the body (Wright and Davies, 1989). High energy 
ultrasound induces both thermal and mechanical stimulation to the tissues 
although the exact biophysical effects of this technique are not well understood. 
The unpredictable transfer of local energy prevents precise stimulus control and 
can cause damage to tissues (Handwerker and Kobal, 1993). A major criticism of 
this type of experimental pain induction is that mechanoreceptors, as well as 
nociceptors, are stimulated during the procedure (Humphries et al, 1994, 
Handwerker and Kobal, 1993). Another factor influencing the validity of the 
results with mechanical pain induction is that the effective compression varies 
according to the compliance of the underlying tissues and the speed at which the 
compression is carried out (Procacci et al, 1979). 
6.4.3: Electrical 
Electrical stimulation is used widely in pain research, particularly for cutaneous 
stimulation (Procacci et al, 1979). This is most likely due to its qualities of being 
quantifiable and easily controlled (Gracely, 1994). The resistance provided by the 
skin can vary greatly and now, therefore, many stimulators have the facility to 
maintain a constant current throughout every variation of cutaneous resistance 
(Procacci et al, 1979). The problem offered by skin resistance has been addressed 
with the use of percutaneous electrical techniques but this method, as with 
transcutaneous techniques, has the drawback of stimulating a range of nerve fibres 
(e. g. non-noxious mechanoreceptors) and not just those associated with pain 
stimulation (Humphries et al, 1994; Handwerker and Kobal, 1993). 
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A number of studies have used electrical stimuli as a method of experimental pain 
induction when investigating the pain-relieving effects of TENS (Jette, 1986; 
O'Brien, Rutan, Sanborn and Omer, 1984). A form of electrical pain induction 
which has emerged in recent literature is the stimulation of tooth pulp. This 
procedure of pain induction is though to improve the selectivity of electrical 
stimuli as a more homogeneous group of afferent nerve fibres can be stimulated 
(Handwerker and Kobal, 1993) and tooth pulp stimulation has also been 
employed in previous TENS studies (Widerstrom, Aslund, Gustafsson, 
Mannheimer, Carlsson and Andersson, 1992). The main disadvantages of 
electrical stimulation have been considered to be its short duration and poor 
qualitative relationship with clinical pain (Humphries et al, 1994). 
6.4.4: Heat 
Heat stimulation, like electrical methods, has been used widely for experimental 
pain induction. Heat stimuli can either be controlled by delivery from contact 
thermodes (Price, McGrath, Rafii and Buckingham, 1983), or by radiation 
(Arendt-Nielsen, Zacharie and Bjerring, 1990). Handwerker and Kobal (1993) 
suggested that thermodes and radiation devices were not necessarily comparable 
as the intracutaneous temperature varied depending on the wavelength, when heat 
was applied by radiation, or by the type of contact between thermode and skin. 
Laser beams are now frequently used as a form of experimental pain induction as 
they produce a rapid stimulus onset and provide uniform radiation (Gracely, 
1994). Care must be taken, however, with powerful heating devices as fast rises in 
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skin temperature have been thought to excite sensitive mechanoreceptors in 
addition to warmth receptors and nociceptors (Handwerker and Kobal, 1993). 
6.4.5: Cold 
Cold stimuli are most often applied to humans in experimental pain studies using 
the cold pressor method. This technique involves the subjects immersing their 
upper limb in water/ice baths and has the advantages of being repeatable and of 
prolonged duration. The cold pressor method has been used in trials involving 
TENS (Johnson, Ashton, Bousfield and Thompson, 1989). The authors found 
TENS current frequency to be the major determinant of stimulation-produced 
analgesia and reported that frequencies in the range 20-80Hz were most effective 
in relieving pain with this particular experimental pain model. The main 
disadvantage of the cold pressor method has been reported as being the long 
interstimulus interval required to achieve homeostatic equilibrium. This has been 
suggested as being due to the effects of the pain induction method on 
physiological variables such as blood pressure, blood flow rates, and vasomotor 
activity (Humphries et al, 1994; Handwerker and Kobal, 1993). 
6.4.6: Ischaemic 
Ischaemic pain induction procedures vary slightly throughout the range of human 
experimental pain studies but are usually based on, to a greater or lesser degree, 
the submaximum effort tourniquet technique established by Smith, Egbert, 
Markowitz, Mosteller and Beecher in 1966. The technique has since been 
modified by other experimenters (Pertovaara, Nurmikko and Pontinen, 1984; 
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Roche, Gjisbers, Belch and Forbes, 1984; Woolf, 1979) but the basic concept 
involves the occlusion of blood flow to the upper limb using a pneumatic cuff, in 
conjunction with hand gripping exercises which are carried out whilst the limb is 
in the ischaemic state. If the limb is maintained at rest only ischaemic paraesthesia 
is achieved (tingling and numbness) and the muscular contractions are therefore 
required in order for the subject to experience pain (Procacci et al, 1979). Moore, 
Weissman, Thomas and Whitman (1971) put forward a number of 
recommendations concerning the gripping exercises in order to standardise the 
technique and reduce variability between subjects. It was suggested by the authors 
that the exercises should be carried out at a fixed percentage of maximal grip 
strength and the contractions carried out over a fixed duration. 
The pain produced by the submaximal tourniquet test has been thought to be a 
result of a build-up of metabolites in the tissue spaces (Lewis, 1950, in Procacci et 
al, 1979). The author was reported to have stressed that allowing blood to return 
to the limb did not result in complete recovery of the tissues but instead the 
metabolites were reduced to a level that was not perceived as being painful. The 
same author (Lewis, 1942, in Keele and Neil, 1965) was reported to have found 
that this recovery time, which allowed pain to return to pre-test levels once 
circulation was returned, was between 2 and 4 seconds. 
Another theory for the mechanism of experimental ischaemic pain and which may 
work in conjunction with the metabolite build-up is that ischaemia of nerve fibres 
causes an increase in their excitability. This would allow previously non-noxious 
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stimuli to reach noxious threshold values (Nathan, 1953, in Procacci et al, 1979). 
Yamada, Muroga and Kimura (1981) carried out a study which investigated 
somatosensory evoked potentials (SEPs) in nerves affected by ischaemia. The 
results of the study suggested that mechanical compression of the nerve induced 
ischaemic pain. Pertovaara et al (1984) identified that subjects exposed to the 
submaximal effort tourniquet test were able to distinguish between the exercise- 
induced metabolite arm pain and the pain caused by the cuff pressure. 
Pain produced by this method of experimental pain induction has been found to be 
responsive to relatively small doses of pharmacological analgesics such as 
morphine and aspirin (Smith et al, 1966; Posner, 1984). Assessment of analgesic 
efficacy using this technique has been found appropriate as the stimulus is 
considered sufficient to produce an affective component which is associated with 
clinically significant pain, but is not usually found with short-lasting discrete 
stimuli (Gracely, 1994). The ischaemic model has also been used to test the 
efficacy of nonpharmaco logical treatments such as TENS (see Section 6.5). The 
variability in results that is obtained from analgesia studies may be due to a 
number of factors such as experimental error or the use of an inadequate stimulus 
but is most likely to be due to the mechanism of action of both the experimental 
pain model being employed and the modality being tested. 
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6.5 : Past studies using TENS with experimentally induced ischaemic pain 
(for summary of studies see Table 1) 
An early study looking at human experimental pain and TENS was carried out by 
Woolf in 1979. The author employed various methods of pain induction, one of 
which was the ischaemic pain tourniquet technique. Eight healthy male subjects 
were used in a cross-over design, the two groups (n=4) acting both as a control 
(no TENS) and treatment group (TENS), the tests being one week apart. Woolf 
(1979) applied high frequency TENS (frequency 100Hz, pulse duration 250µs, 
intensity `definite non-noxious paraesthesia') for 30 minutes prior to pain 
induction and during cuff inflation which was maintained until the subject reached 
their perceived pain tolerance level. The electrodes were applied over the median 
and ulnar nerves proximal to the cuff. Pain intensity VASs were marked by the 
subjects at one minute intervals during the pain induction period and these, as well 
as the pain tolerance time, were used as the outcome measures. No cross-over 
effect was found between the two groups and pain tolerance time was found to be 
increased from 12.9±1.6 minutes (S. E.; n=8; p<0.001) in the control group to 
20.3±1.7 minutes (S. E.; n=8; p<0.001) in the group receiving high frequency 
TENS. A decrease in VAS pain intensity scores was also reported in the TENS 
group but no statistics were available to support these findings. The VAS 
outcomes should be regarded with caution as the VAS scores could have been 
dependent on the duration of the pain induction which was not consistent between 
subjects. 
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Roche et al (1984) used variations in stimulation parameters when investigating 
the pain-relieving effect of TENS on experimental ischaemic pain. Forty-eight 
healthy volunteers (24 male, 24 female, mean age 24) were randomly assigned to 
one of four groups (1 control group and 3 TENS groups). Each subject was 
tested only once and, in the groups receiving TENS, electrodes were applied over 
the radio-ulnar joint and cubital fossa of the affected arm 10 minutes prior to 
starting pain induction. The electrodes delivered current throughout the pain 
induction period which lasted for 25 minutes. The three treatment parameters of 
TENS were (1) frequency 100Hz, pulse duration 1000µs (continuous current), 
intensity `high but non-noxious'; (2) frequency 5Hz, pulse duration 1000µs (burst 
current of duration 100ms), intensity `high but non-noxious'; and (3) frequency 
5Hz, pulse duration 1000µs (burst current 100µs), intensity `just feel a pricking 
sensation'. Outcome measures included measuring pain threshold and pain 
tolerance times, as well as marking a pain intensity VAS and present pain intensity 
(PPI) 5-point VRS at one minute intervals during pain induction. Each subject 
also completed the McGill Pain Questionnaire (MPQ) at the end of the test. Two- 
tailed t-tests showed TENS (3) to have a significant effect on pain threshold while 
TENS (2) was found to be significantly greater than the control group when 
comparing tolerance times. No significant differences was found between the 
groups using the VAS pain intensity scores. The only difference between the 
TENS (2) and TENS (3) was the current intensity with all the other current 
parameters remaining the same. The results suggest that the 5Hz current was 
more effective than the 100Hz current in decreasing pain perception, regardless of 
the current intensity selected. 
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Walsh, Liggett, Baxter and Allen (1993) compared the treatment and placebo 
pain-relieving effects of low frequency TENS and H-wave therapy (a form of 
electrical stimulation similar to TENS but possessing a double-spiked stimulus) 
using the ischaemic model of experimentally-induced pain. Forty-six healthy 
volunteers were randomly assigned to one of five groups and were tested twice 
with 48 hours between the tests. The first test was used to gather baseline data 
(no TENS) while in the second test each subject received their appropriate TENS 
combination (TENS treatment 4Hz frequency, 287µs pulse duration, `strong but 
comfortable' intensity; TENS placebo machine switched on but no current). 
Stimulation began 10 minutes before pain induction and lasted throughout the 12 
minutes of the test. In each case the electrodes were placed lateral to C6/7 and 
over Erb's point on the affected side. Subjects marked a pain intensity VAS at 
one minute intervals during pain induction and completed the MPQ at the end of 
the test. The pain-relieving efficacy of the selected interventions was established 
in each case by comparing the pain scores (VAS intensity and MPQ) obtained for 
the two tests (1-way ANOVA and difference scores). Analysis of results using an 
ANOVA showed H-wave therapy at the chosen parameters as having a 
significantly greater pain-relieving effect than the other treatment applications, as 
assessed using pain intensity VASs and the MPQ (PPI score). This study used the 
outcome of the 1 st test as a measure on which to base the effectiveness of each 
intervention. The assumption was therefore made that the pain reporting in the 1 st 
exposure to the test produced stable baseline values. It has been identified in the 
literature that a large number of psychological variables, including subject mood 
state and patient-therapist interaction, can influence pain perception (Gielen, 
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1989; Klaber Moffett and Richardson, 1997; Turner et al, 1994). It is therefore a 
possibility that making direct comparisons between 2 sets of pain scores, as done 
in this study, did not accurately reflect the pain-relieving efficacy of each 
treatment intervention. 
A similar study design was selected by Walsh et al (1995) when they compared 
the pain-relieving effects of high frequency and low frequency TENS. Thirty-two 
female volunteers were randomly assigned to one of four groups (n=8). As 
before, subjects were tested twice to initially collect baseline data. Treatment with 
TENS was dependent on group allocation; group 1 (control - no TENS), group 2 
(placebo - no current), group 3 (frequency 110Hz, pulse duration 287µs, intensity 
`strong but comfortable') or group 4 (frequency 4Hz, pulse duration 287µs, 
intensity `strong but comfortable'). Electrode placement and pain assessment 
procedure was the same as for the previous study. A one-factor ANOVA showed 
a significant difference in VAS scores between the groups and a follow-up Fisher 
test indicated that the low frequency TENS produced a significantly greater pain- 
relieving effect than the other treatments using the same outcome measure. No 
significant difference was found between the groups using the MPQ scores. As 
for the study carried out by Walsh et al (1993), the experimental design used in 
this study may not have allowed for an accurate reflection of the pain-relieving 
efficacy of each treatment intervention. 
Another study based on a similar design as Walsh et al (1993) was carried out by 
Foster, Walsh, Baxter and Allen in 1995. Fort-eight healthy subjects (24 male, 24 
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female, age range 18-39, mean age 19.4) were assigned to one of six groups. The 
experimental design was as before except the TENS parameters consisted of 
combinations of pulse frequencies 110Hz and 4Hz, and pulse durations 200µs and 
50µs. Pulse intensity remained the same in each case as `strong but comfortable'. 
Electrodes were placed over C6/7 and Erb's point and TENS stimulation was 
experienced by the subjects for a total of 30 minutes (applied 23 minutes prior to 
pain induction). Pain assessment followed the same procedure as the studies 
conducted by Walsh et al (1993,1995). Results showed no significant difference 
between the groups in either VAS or MPQ scores, however the authors suggested 
a trend towards the 4Hz, 200µs TENS combination as the optimal pain-relieving 
parameters. 
The results of the reviewed studies did not unequivocally support a given set of 
TENS parameters as producing a pain-relieving effect on healthy volunteers using 
the ischaemic experimental model of pain. The variations found between the 
studies for both the pain induction procedure (gripping exercises, pain duration), 
and TENS application (electrode placement, current parameters, control of 
current intensity, timing of application relative to pain induction) makes it difficult 
to draw any definite conclusions from the findings. The outcome of the study by 
Roche et al (1984), however, did suggest that the current frequency could have 
influenced pain perception and the difference in pain-relieving effect between 
current frequencies was further highlighted in the studies by Walsh et al (1995) 
and Foster et al (1995). The study outcomes, although suggesting that low 
frequency currents had a greater pain-relieving effect than high frequency currents 
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on experimental ischaemic pain, were still inconclusive and warrant further 
investigation. 
6.6 : Conclusions 
(1) TENS is used with a wide range of clinical pain conditions. The outcomes of 
clinical trials investigating the efficacy of TENS are inconclusive and this is 
probably due to the large number of differences in variables between studies and 
the outcome measures used. 
(2) Experimental pain induction is used in human pain studies to reduce the 
number of variables. The ischaemic method of pain induction has been a popular 
choice with past experimenters investigating the efficacy of TENS. 
(3) Past studies using the experimental ischaemic pain model have found current 
frequency to be a possible variable influencing pain perception during the 
application of TENS. 
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CHAPTER 7: THE ASSESSMENT OF PAIN 
7.1 : Introduction 
Pain has long been recognised as a multidimensional experience, a view supported 
by neurophysiological evidence (Fields, 1987; Guilbaud et al, 1994; Jones, 1997; 
Lima, 1997; Wade et al, 1996), but this has not always been reflected in the 
measurement of the pain response. Pain can be considered as being made up of two 
principal measurable components, sensory and affective (Gracely, 1994; Gracely, 
McGrath and Dubner, 1978; Price and Harkins, 1992) which has already been 
identified in Chapters 3 and 4. The sensory component of pain is activated by 
ascending noxious information in the lateral systems and is primarily concerned with 
the physical nature of the pain, such as the location, intensity, duration, and quality 
of the sensation (Guilbaud et al, 1994; Jessell and Kelly, 1991; Jones, 1997). The 
affective component, on the other hand, is activated by ascending noxious 
information in the medial systems and deals with the degree of discomfort or 
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unpleasantness which is associated with the physical pain sensation (Guilbaud et al, 
1994; Jessell and Kelly, 1991; Jones, 1997). Gracely (1994) stated that single 
measures of pain magnitude create confusion as the underlying meaning of the pain 
magnitude is unknown and suggested that the confusion could be minimised by 
employing scales that essentially ask "how intense is your sensation, and how much 
does it bother you". The aim of this chapter is to review assessment tools which are 
multi-dimensional in nature and, with particular relevance to the present study, have 
been employed using the ischaemic model of experimental pain induction. 
Several studies have identified intensity and unpleasantness as two distinct 
components of the pain response in both clinical (Marchand et al, 1993; Leavitt, 
Garron, Whisler and Sheinkop, 1978), and experimental (Duncan, Bushnell and 
Lavigne, 1989; Price, Von der Gruen, Miller, Rafii and Price, 1985) pain trials. Price 
et al (1985) exposed 47 volunteers to four graded intensities of experimentally 
induced heat pain. The authors found that responses to pain intensity and pain 
unpleasantness were both reduced by intravenous administration of morphine 
sulphate in a dose-dependent manner. A different intravenous analgesic, fentanyl, 
was used by Gracely, Dubner and McGrath (1979). Perceived pain levels of 
electrical stimulation of tooth pulp (n=40) were measured before and after drug 
intervention, with the results showing that fentanyl significantly reduced the 
intensity, but not the unpleasantness, of the painful stimuli. The findings indicate that 
the components of the pain response can alter independently of each other when 
pain-relieving treatments are introduced and highlights the need to measure pain 
intensity and pain unpleasantness separately. 
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7.2 : Pain measurement techniques 
Three types of methodology which have been found capable of assessing the 
multiple pain dimensions during experimental pain studies are; (1) the 
multidimensional scaling of experimentally-induced pain sensations in order to 
determine the dimensions of a scale, (2) the multidimensional scaling of verbal 
descriptor items in order to construct or validate the structure of an existing scale, 
or (3) the use of existing scales to assess experimentally-induced pain sensations 
(Gracely, 1994). 
It has been thought beyond the scope of this thesis to develop a measurement tool 
specific to the experiments being undertaken, and instead approach (3) will be 
adopted. This approach makes it easier to compare previous investigations in this 
topic area with the present study and eliminates the need of establishing the validity 
and reliability of a new pain assessment tool. 
A wide range of pain assessment techniques have been employed with the use of 
clinical TENS trials (see Section 6.2) and, within the specific area of TENS and 
experimental ischaemic pain, a number of measurement tools stand out as being 
commonly used (see Section 6.5). Walsh et al (1995) identified two types of pain 
estimation that require individual attention whilst investigating the pain-relieving 
effects of TENS using the ischaemic model of experimental pain. The authors 
described these measures as being the `current level of pain' experienced (assessed 
at regular intervals during the pain induction period) and the `worst pain' 
experienced (measured immediately after the painful stimulus has been removed). 
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The review of TENS studies which have used the experimental ischaemic pain 
model (see Section 6.5) indicated that investigations in this particular research area 
have, without exception, selected a unidimensional approach to `current level of 
pain' assessment. The limitations of this form of pain assessment have been 
highlighted (see Section 7.1) and therefore only scales which are well recognised 
and established multidimensional pain measures will be reviewed. 
Two types of scale which can be adapted to rate both present pain intensity and 
present pain unpleasantness are the visual analogue scale (VAS) and the verbal 
rating scale (VRS). The McGill Pain Questionnaire (MPQ) is a multidimensional 
pain assessment tool which has been considered appropriate for measuring the 
4 worst pain' experienced (. Walsh et al, 1995). Each of the three scales will be 
considered in more detail below. 
7.2.1 : The visual analogue scale (VAS) 
A VAS takes the form of a line, usually 10 centimetres long, with the ends of the 
line labelled as the extremes of pain. The anchors used are reflective of the 
component of pain being assessed. For example, the minimum scale anchor could be 
`no sensation' for pain intensity, or `not bad at all' for pain unpleasantness. The 
subject is asked to rate their pain by marking the scale at some point along its 
length. The distance (usually expressed in millimetres) from the minimum anchor is 
given as a measure of the subject's pain response. 
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There is much evidence supporting the validity of the VAS as a measure of both 
components of pain in clinical and laboratory settings (Price, Harkins and Baker, 
1987; Price et al, 1983; Price et al, 1985). The scale is also thought to produce data 
that has interval / ratio qualities and can therefore be treated as such statistically 
(Waterfield and Sim, 1996; Price et al, 1987; Price et al, 1983). It should be 
emphasised that not all types of VAS are bias-free and it has been suggested that the 
sensitivity and reliability of the VAS are influenced both by the length of the line and 
the anchors applied to it (Seymour et al, 1985, in Jensen and Karoly, 1992; 
Sriwatanakul, Kelvie, Lasagna, Calimlim, Weis and Mehta, 1983). Seymour et al 
(1985), in Jensen and Karoly (1992), found that scales in the length range 10 to 15 
centimetres and employing words that best described the extremes of the pain 
sensation were least susceptible to biases in scoring. 
Scale orientation has also been raised as a factor affecting scale reliability, with 
Sriwatanakul et al, (1983) finding that vertical scales were less normally distributed, 
and had a greater coefficient of variation than an identical scale placed horizontally. 
Brevik, Haanaes and Skoglund (1996), however, found dissimilar results using a 
patient population (n=93) with dental pain. The scores obtained from the two 10 
centimetre long scales were found to correlate highly with one another (r=0.97, 
p=0.0005). The former study enrolled healthy volunteers and the scales were 
marked by comparison to six verbal descriptors of pain intensity which were called 
out by the experimenter. The pain-free status of the population employed in the 
study carried out by Sriwatanakul et al (1983) questions the validity of the results 
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and it remains a matter of debate whether VAS orientation, indeed, has any bearing 
on the scale's ability to produce reliable data. 
The main disadvantages of the VAS could be seen as being the two steps required in 
its marking (marking by the subject and measuring by the experimenter), which may 
introduce a source of error to the procedure (Jensen and Karoly, 1992). The same 
authors also suggested that certain subject groups, such as the elderly, may find the 
scale confusing due to its lack of structure. The scale's advantages, however, are 
that it is economical, easy to administer, and provides a wide range of response 
categories (Jensen and Karoly, 1992; Jensen, Karoly and Braver, 1986). 
7.2.2 : The verbal rating scale (VRS) 
The VRS uses a list of adjectives describing different levels of pain, including 
adjectives which reflect the extremes of the particular pain component. For example, 
`no sensation' and `the most intense sensation imaginable' for pain intensity. As with 
the VAS, the words used are reflective of the component of pain being assessed. 
The number of adjectives listed for each pain component can vary between scales, 
although a number between 4 and 15 is usual (Jensen and Karoly, 1992). The VRS, 
in its basic format, takes the form of a ranked ordinal scale, with each adjective 
being assigned a score as a function of its rank (Jensen and Karoly, 1992). The 
major criticism which this type of scale frequently receives is that it assumes equal 
intervals between the adjectives which, of course, is unjustified. The VRS, if treated 
correctly as a category scale, yields ordinal data with qualities unsuitable for 
parametric statistical analysis. This makes the scale less attractive for use in studies 
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as non-parameteric statistical tests carry less statistical power and require fewer 
assumptions about the data than their parametric equivalents (Payton, 1994). 
Cross-modality matching is a procedure which can transform the VRS into a scale 
more likely to have interval/ratio properties (Duncan et al, 1989; Gracely et al, 
1978). The procedure involves matching each adjective with another modality such 
as the loudness of a tone or handgrip force (Jensen and Karoly, 1992), and provides 
relatively bias-free interval/ratio data which allows parametric analyses of the 
subjects' responses (Duncan et al, 1989). Cross-modality matching can be a time- 
consuming procedure and one way around this problem is to assign standardised 
scores for each word based on data from groups of previously tested individuals 
(Duncan et al, 1989; Gracely et al, 1978). This technique has been considered 
appropriate as long as a comparable population is selected, taking into consideration 
the type of pain stimulus (clinical or experimental) involved (Jensen and Karoly, 
1992). 
The strengths of VRSs include the ease with which they are administered and 
scored. Also, compliance with this form of scale has been found to be higher than 
that found with other measurement tools such as a VAS and a numerical rating scale 
(similar to a VAS except with numerical graduations) (Jensen et al, 1986). The 
weaknesses of the scale, on the other hand, have been reported as including the 
sometimes small number of category responses available to subjects and the literary 
skills required by the subjects in order to understand the meanings of the adjectives 
listed (Jensen and Karoly, 1992). The use of language in a scale automatically makes 
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it susceptible to error due to the fact that individuals in a group of subjects are likely 
to interpret the same pain descriptor differently (Jensen et al, 1986; Chapman, 
Casey, Dubner, Foley, Gracely and Reading, 1985). 
7.2.3: VAS versus VRS 
Comparisons have been made between the VAS and VRS as pain assessment tools, 
with Merskey (1974) comparing a5 point VRS, which had undergone a procedure 
of cross-modality matching (loudness of a tone), with a 10cm long VAS. The author 
reported a high correlation between the scales (r>0.8, p<0.01, no other statistical 
details given), and this corresponds with the findings of a later study carried out by 
Roche et al (1984). Forty-eight subjects were exposed to a maximum of 25 minutes 
of experimental ischaemic pain, during which time the subjects were asked to rate 
their pain intensity on both a VAS and a5 point VRS at one minute intervals. The 
correlations between these scales for individual subjects were found to be significant 
at a p<0.05 level (no other statistical details given). No information is given as to 
how the data from the scales were compared and the results should be viewed 
cautiously as the comparison involves data from both an ordinal and an interval/ratio 
scale. Wallenstein, 1984 (in Bromm, 1984) used, among other methods, power 
functions to compare pain intensity scores marked on a 10cm VAS and a5 point 
VRS in a group of 35 cancer patients. The correlation between the scales, in terms 
of a power curve, was quite high (r=0.89) and were found not to be influenced by 
age or sex within the population. 
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Ohnhaus and Adler (1975) used both a 10cm VAS and a5 point VRS to assess the 
analgesic efficacy of pharmacological medications used in the treatment of patients 
with cancer pain. Six patients (2 female, 4 male, mean age 54 years) suffering from 
relatively constant pain due to malignant disease with metastases were exposed to 3 
treatment conditions (2 types of drug, I placebo). The 3 treatment days were at 
least 24 hours apart and the drugs were given in a randomised order. Patients were 
asked to rate their pain intensity on both scales immediately before each treatment 
session and then at 30,60,120, and 180 minutes after the treatment had been given. 
The correlation between the two scales was found to be highly significant (x0.81, 
p<0.001) but the VRS data was converted into a digital system in order to carry out 
the comparison. The median descriptor in the scale was issued a score of 0, while 
descriptors adjacent were valued + or -1 accordingly. The extreme descriptors were 
valued + or - 3. The authors correctly felt that this inappropriate handling of an 
ordinal scale with interval-type assumptions, resulted in an artificial measurement of 
effects by the analgesics. The authors therefore concluded that the VAS used in 
their study assessed more closely what a patient actually experiences with respect to 
change in pain intensities. 
A study which identified the multidimensional nature of pain and compared verbal 
and visual analogue scales for measuring both pain intensity and pain unpleasantness 
was carried out by Duncan et al (1989). Eight healthy volunteers (4 male, 4 female; 
age range 21-26) were asked to rate the intensity and unpleasantness of thermal 
stimuli, using either a VRS (11 point intensity, 9 point unpleasantness) or a 10cm 
horizontal VAS (intensity anchors `no sensation' and `the most intense that one 
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could imagine'; unpleasantness anchors `not bad at all' and `the most unpleasant 
imaginable'). The heat stimuli consisted of 6 different intensities (42-51 °C) via a 
skin contact thermode, each presented 6 times 25 seconds apart. Each type of scale 
(VAS intensity, VAS unpleasantness, VRS intensity, and VRS unpleasantness) was 
presented twice consecutively but the order in which the subjects received them was 
randomised. The VRS scores assigned to all the pain descriptors were from 
standardised cross-modality matching scores from a previous experiment (Duncan, 
Duquette and Bushnell, 1985). In this earlier study 90 healthy volunteers were asked 
to rank order lists of frequently-used pain intensity and pain unpleasantness 
descriptors and then rate the relative magnitude of each descriptor using a VAS. 
Duncan et al (1989) reported no significant differences between the two types of 
scales being compared (intensity p>0.93; unpleasantness p=0.17; no other statistics 
given) but these results were only to be expected as the pre-assigned VRS scales 
had been matched with VAS scores. This procedure marked a major flaw in the 
methodology of the study and may have influenced the validity of the results 
obtained. 
The review of papers which have compared the VRS and VAS indicate that the two 
scales produce significantly similar data in both laboratory and clinical settings. An 
attempt has also been made to demonstrate the multidimensional qualities of the 
scales (Duncan et al, 1989; Duncan et al, 1985), as well as their ability to assess 
analgesic efficacy (Ohnhaus and Adler, 1975). Care should be taken when statistical 
analyses of the VAS and VRS are being carried out, particularly with regards to the 
latter - the VRS is an ordinal scale which cannot assume equal numerical distance 
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between its various descriptors. It has not been possible to state which of the two 
scales is most appropriate for any given research experiment and it should be noted 
that the statistical power of the tests in the two main studies (Duncan et al, 1989; 
Ohnhaus and Adler, 1975) were limited due to the small subject numbers used. The 
success of either scale is dependent on what exactly is being measured, as well as 
the subject group marking them. It appears necessary to initially use both scales in 
conjunction, and then consider their relative strengths and weaknesses. 
7.2.4: The McGill Pain Questionnaire (MPQ) 
The MPQ is a self-report instrument that presents subdivisions of pain descriptors, 
organised into 3 main categories (sensory, affective, and evaluative). The major 
measures which can be achieved from the MPQ are the pain rating index (PRI) 
(individual score from each category or an overall total score), the number of words 
chosen (NWC) from the list of descriptors, and a present pain intensity (PPI) score 
based on a 1-5 intensity category scale. 
The MPQ was originally devised as a multidimensional pain assessment tool for use 
in the clinical setting, with literature supporting the scale's ability to distinguish 
between different types of clinical pain (Melzack, 1975; Melzack and Katz, 1992). 
The MPQ, as with all other pain measures, has its limitations. Wolf, Gersh and Rao 
(1981) used the MPQ with 114 patients with chronic pain and reported that a large 
proportion of the patients were unable to understand many of the descriptors listed 
in the scale. For this reason PRI scores were not found to be accurate reflections of 
the patient's pain experience and a poor correlation was found between the various 
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PRI scores and the figure achieved in the simpler PPI category scale. A recent study 
carried out by Fernandez and Towery (1996) identified a number of descriptors 
within the MPQ which were considered inappropriate due to their ambiguity and 
suggested that the scale needs to be refined in order to increase its validity. 
The MPQ has also been tested in the laboratory setting, with Chen, Dworkin and 
Gehrig (1989) finding the scale repetitively consistent over five studies using the 
cold pressor method of pain induction. Walsh et al (1995) employed the MPQ to 
assess the pain-relieving effects of TENS during experimental ischaemic pain. The 
MPQ was scored by the subjects (n=32) at the end of the test, with the results 
showing no statistically significant changes in any of the PRI scores during the 
TENS application. During the same study, the subjects were presented with VAS 
intensity scales at one minute intervals during the pain induction period. Unlike the 
MPQ scores, the reduction in VAS scores was found to be statistically significant 
with TENS intervention. The authors accepted that the discrepancy in the two 
scales' findings may be due to poor recall of the pain experience when marking the 
MPQ. The memory for experimental ischaemic pain was examined by Roche and 
Gijsbers (1986) and it was reported that the affective component of the MPQ is 
particularly susceptible to recall inaccuracy. This finding underlines the necessity to 
assess both sensory and affective components of pain during the period of pain 
induction. 
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7.3 : Conclusions 
(1) It has been recognised, based on the neurophysiological evidence for a multi- 
dimensional pain response, that pain measures should assess both pain intensity and 
pain unpleasantness. 
(2) Treatment interventions have been found to selectively alter the components of 
the pain response. 
(3) Past studies involving TENS and the experimental ischaemic pain model have 
only assessed pain intensity during pain induction, with the MPQ being employed as 
a multi-dimensional pain assessment tool after the cuff has been deflated. 
(4) The VAS and VRS have been identified as scales which can be adapted to assess 
1 st stage pain intensity and pain unpleasantness. 
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7.4 : Summary of the review of literature and implications for the present 
Stay 
The aim of the review of literature is to highlight the theoretical building blocks of 
the thesis and to establish the current state of knowledge in these areas. The review 
of the literature, therefore, identifies gaps in the body of knowledge and carries 
implications for the experimental procedure of the present study. The key points 
that have been raised by the review of literature and the implications that they had 
for the present study are as follows: 
7.4.1 : Model of pain induction 
TENS has been established as a pain-relieving modality which operates through the 
stimulation of peripheral nerve fibres. It is used for a variety of different clinical pain 
conditions but the efficacy of TENS is still in question due to varied and often 
contradictory study outcomes. This difference in study outcomes can be attributed 
to the wide number of variables between the studies including the selected current 
parameters of TENS, the environmental context of the treatment and the type of 
patients being used. A way of reducing the number of external variables in a human 
pain study is by using an experimental model of pain induction. The review of 
experimental pain methods, although recognising the strengths of each of the other 
models, resulted in the ischaemic model being selected. There were various reasons 
as to why the ischaemic pain model was selected in preference over other pain 
induction techniques and these included (i) possession of a standardised procedure 
which theoretically allowed the painful stimulus to be easily reproduced (based on 
the sub-maximal ischaemic tourniquet test initially standardised by Moore et al 
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(1971), (ii) the ability of the model to produce a painful stimulus which could be 
tolerated over a prolonged period of time (Pertovaara et al, 1984) and (iii) a short 
recovery period (Lewis, 1942, in Keele and Neil, 1965 was reported as noting that 
once circulation was returned to the ischaemic limb a time period of 2-4s allowed 
pain to return to pre-test levels). 
7.4.2.: Subject group 
The ability of a subject to control a stimulus is a variable which has been found to 
affect pain perception but to date no work has been published investigating the 
influence of control on pain perception during the use of TENS. Neurophysiological 
evidence has suggested that control could have an effect on both the first and 
second phase of pain perception, in the first stage influencing both the sensory- 
discriminative and the motivational-affective components of the pain response. The 
present study investigated one aspect of control specific to TENS, the influence of 
experimenter and subject control of the current intensity on pain perception. Healthy 
undergraduate students from Queen Margaret College were used as subjects in the 
present study as, theoretically, a psychological variable such as control was easier to 
manipulate with students on medically-related courses familiar with the experiment, 
test environment and physiotherapy procedures in general. In this way attentional 
mechanisms and placebo effects should have been minimised or at least maintained 
at a comparable level between subjects. 
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7.4.3: Experimental design 
A repeated measures experimental design was used in the present study with each 
subject being tested on three separate occasions approximately 48 hours apart. The 
time between testing sessions was based on previous studies carried out using the 
ischaemic pain tourniquet test (Foster et al, 1995; Walsh et al, 1993; Walsh et al, 
1995). The three conditions under which each subject was tested were (i) pain 
induction + TENS where the subject controlled the current intensity (ii) pain 
induction + TENS where the experimenter controlled the current intensity and (iii) 
pain induction without TENS. The ordering of the three conditions was carried out 
using a Latin Square design to minimise any possible carry-over effects of treatment 
and then subjects were randomly assigned to each ordering combination. 
No placebo or sham TENS condition was incorporated in the present study due to 
the subject group being used (see Section 7.4.2). The subjects being used in the 
present study were undergraduate students from medically-related courses at Queen 
Margaret College, primarily Physiotherapy. The subjects were therefore familiar 
with TENS and the sensations that it produces. The inclusion of a placebo group in 
the present study, taking into consideration the repeated measures design, could 
have decreased the validity of the results. In such a case the subjects would have 
experienced both the active and sham TENS and, based on their knowledge of 
TENS and the sensations that they would have expected to be produced, the 
subjects would have been likely to have then perceived the effectiveness of the 
modality to have been different in each case. This in turn may have led them to mark 
their pain scales differently. On the basis of this argument no placebo condition was 
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included in the present study. A no treatment control condition was seen to be 
useful for inclusion in the present study as then comparisons could be made between 
pain responses when subjects received TENS treatment under both subject and 
experimenter control conditions and pain responses when no TENS was applied at 
all. 
7.4.4: Current intensity 
Previous studies which have investigated the efficacy of TENS using the ischaemic 
model of experimental pain induction have found frequency to play a role in 
outcome success. The influence of experimenter and subject control of the current 
intensity on the pain-relieving efficacy of both a high frequency (100Hz) and low 
frequency (5Hz) TENS current was investigated in the present study. 
With both high and low frequency TENS a low current intensity (`just perceptible') 
was used. This selection was based on neurophysiological research which proposed 
that, at current intensities less than 6-7 times greater than sensory threshold, TENS 
operates through the stimulation of peripheral Aß fibres (Levin and Hui-Chan, 
1993). The stimulation of Aß afferent fibres has been associated with the activation 
of spinal segmental mechanisms (Garrison and Foreman, 1994; Melzack and Wall, 
1965), with higher intensities of current stimulating nociceptive A5 and C fibres 
through supraspinal mechanisms (Sjolund and Eriksson, 1979). The choice of TENS 
current intensity in the present study was therefore made to theoretically minimise 
the level of neural processing at brainstem, and particularly, cortical level. In this 
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way it was considered that the effect of control of the TENS intensity was not 
masked by neurophysiological mechanisms activated directly by the TENS current. 
The psychological variables of control have been found to influence 1 st stage pain 
perception through the stimulation of target sites such as the cingulate gyrus and the 
temporal lobe (Jessell and Kelly 1991; Jones, 1997) and, to a greater extent, 2nd 
stage processing through higher level neural processing in the association cortices 
(Guilbaud et al, 1994; Jones, 1997). Maintaining TENS current intensities at a level 
which are thought to selectively activate spinal segmental mechanisms therefore 
theoretically reduced the possibility of interference between mechanisms activated 
directly by the TENS current and those activated by the variable of control. 
7.4.5: Pulse duration and electrode placement 
A pulse duration of 200µs was selected with both high and low frequency TENS 
currents in the present study as it represented a mid value in the parameter range 
most frequently used in the clinical setting (Kahn, 1994) and was similar to those 
selected by experimenters who have carried out TENS studies using experimental 
ischaemic pain induction (Foster et al, 1995; Walsh et al, 1993; Walsh et al, 1995; 
Woolf, 1979). Parameter selection in past ischaemic pain studies (Foster et al, 1995; 
Walsh et al, 1993; Walsh et al, 1995) was also a principle determinant in the choice 
of electrode placements in the present study as, in order to compare and contrast the 
results of the present study with those carried out previously, it was preferable to 
maintain similar current parameters as to those already investigated. 
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7.4.6: Pain assessment 
An important aspect of the present study was the decision to use a multi- 
dimensional approach to the assessment of pain perception during the induction of 
experimental pain. The decision to assess pain intensity and pain unpleasantness 
during the pain induction period was based on the neurophysiological evidence for 
there being two distinct components of initial (1 st stage) pain processing, sensory- 
discriminative and motivational-affective, activated by ascending noxious 
information in the lateral and medial ascending systems respectively (Fields, 1987; 
Guilbaud et al, 1994; Jones, 1997; Lima, 1997). Pain perception during pain 
induction, and not after removal of the painful stimulus, was assessed in the present 
study because of the subject group being used and the neurophysiological evidence 
for different stages of pain 'perception. It has been suggested that the perception of 
pain occurs in 2 stages, with an immediate reaction (sensory-discriminative and 
motivational-affective components), followed by a later (2nd) stage of pain 
perception which is influenced to a much greater extent by cognitive appraisal 
(cognitive-evaluative component) (Price and Harkins, 1992; Wade et al, 1996). It 
has been recognised that experimental pain cannot reproduce psychological features 
typical of clinical pain such as anxiety or depression (Bromur, 1984) and therefore 
assessment of 2nd stage pain perception in the present experimental pain study was 
considered to be of limited relevance. 
123 
Chapter 8: Experiment 1-A comparison of a visual analogue scale (VAS) 
and a verbal rating scale (VRS) as assessment tools of pain intensity and pain 
unpleasantness using the ischaemic pain tourniquet test on healthy female 
volunteers. 
8.1 : Introduction 
The assessment of pain has been reviewed (see Chapter 7) and it has been 
established that it involves the recording of a subjective experience which is 
multidimensional in nature (see Section 7.1). The principal criteria for an ideal pain 
assessment procedure have been listed by Price and Harkins (1992) and include 
being able to separately measure the sensory-discriminative (pain intensity) and 
affective (pain unpleasantness) aspects of pain. These dimensions of the pain 
experience were explicitly recognised by Melzack and Casey in 1968 (see Section 
3.4) and take into consideration that the perception of a noxious stimulus is 
associated with activity in separate neurophysiological pathways corresponding to 
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both sensory-discriminative and motivational-affective responses to pain (Fields, 
1987; Guilbaud et al, 1994; Jones, 1997). Affective responses to pain are, 
therefore, a primary response to noxious stimulation and can be assessed at the 
same time as pain intensity. The sensory-discriminative and affective components of 
pain may co-vary in both clinical and experimental conditions but treatment 
interventions such as TENS have the ability to selectively alter either or both of the 
pain components (see Section 7.1). It is therefore important to measure both 
components of pain (intensity and unpleasantness) separately. 
Two scales which have been adapted to separately measure pain intensity and pain 
unpleasantness are the visual analogue scale (VAS) and the verbal rating scale 
(VRS) (see Sections 7.2.1 - 7.2.3). Both types of scale have been used with the 
ischaemic experimental model of pain but to date have only been used to measure 
pain intensity (see Section 6.5 and Table 1). 
The specific characteristics of the VASs used in this study were based on 
adaptations of validated pain intensity and pain unpleasantness VASs described by 
Jensen and Karoly (1992) and Price et al (1983). Both VASs were 10cm in length, 
horizontal in orientation and possessed no graduations along their length. The 
anchors for the pain intensity scale were `no sensation' and `the worst sensation 
imaginable' while the pain unpleasantness scale had `not bad at all' and `the worst 
sensation imaginable'. In each case the minimum anchor was at the left hand side of 
the scale (see Appendix 9). 
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The VRSs used in this study were taken from a study carried out by Duncan et al in 
1985. The authors translated from English to French two lists of words previously 
validated for measuring pain intensity and pain unpleasantness (no reference given). 
Two groups of healthy subjects (70 dental students and 20 dentists) separately 
rank-ordered the two lists of words and rated the relative magnitude of each 
descriptor by comparing it to a line length on a VAS (cross-modality matching). 
Intra-subject and inter-subject reliability for both scales were found to be high 
(r>_0.99). Both Duncan et al (1989) and Gracely et al (1978) reported that using 
previously-assigned cross-modality matching scores from a comparable population 
is appropriate and, indeed, the original devisors of the VRSs used them in a later 
study (Duncan et al, 1989) and found a high correlation between the VAS and VRS 
when used with healthy French volunteers experiencing experimental heat pain (see 
Section 7.2.3). The cross-modality matching procedure gives the VRS interval / 
ratio scaling properties and therefore allows parametric statistical analysis of the 
results (Payton, 1994). 
The pain intensity and pain unpleasantness VRSs contained 11 and 9 pain 
descriptors respectively. The scores for both VRSs ranged from 0 to 100, with the 
phrases at either extreme of the scale being the same as the anchor phrases used for 
the VASs (see Appendix 9). The difference between pain intensity and pain 
unpleasantness was explained to the subjects before marking the scales and an 
analogy written by Price et al (1983) was used. The analogy asked the subjects to 
think of listening to a sound, such as the radio, and then distinguish between how 
loud the sound is (intensity) and how unpleasant it is to hear it (unpleasantness). 
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8.2 : Aim 
It was the aim of this study to investigate which of the two scales (VAS or VRS) is 
most appropriate as a pain assessment tool for measuring pain intensity and pain 
unpleasantness during experimental ischaemic pain induction. 
8.3 : Design 
A correlational design tested the relationship between the scores obtained from the 
verbal rating scale (VRS) and the visual analogue scale (VAS) at each one minute 
interval during pain induction. 
8.4 : Methodology 
8.4.1 : Materials and instrumentation (photograph in Appendix 8) 
* information sheet / consent form (Appendix 7) 
* visual analogue scales (VAS) (Appendix 9) 
* verbal rating scales (VRS) (Appendix 9) 
* hand - held dynamometer (PyMaH TrimlineTM) 
* elastic bandage 
* sphygmomanometer cuff (SylgardTM 125mm wide) 
* stopwatch 
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8.4.2 : Subject Recruitment 
Twelve subjects (all female; mean age 19.3 years; range 18-20) were recruited from 
Queen Margaret College student population by means of poster advertising. The 
posters outlined the basic nature of the study and were placed on noticeboards 
throughout the College. Once subjects expressed a willingness to participate in the 
study, a timetable was agreed upon when the subject would attend the session. 
8.4.3: Ethics 
Ethical approval was granted by the College Ethical Committee before commencing 
the study. Each subject was asked to read an information sheet during their initial 
attendance. In the information sheet the subject was asked if they were aware of 
having any of the listed contra-indications to the procedure. These included having 
any current or a recent history of significant pain in the body, a history of heart 
complaints, or analgesic substance intake within the 24 hours prior to the study. 
Positive replies for these questions resulted in elimination from the study. All 12 
subjects fulfilled the selection criteria (see Appendix 7) and did not have to be 
eliminated from the study. Subjects were reminded of their right to withdraw from 
the study at any time without giving reason. The information sheet outlined the 
basic procedure and the possible sensations that could be experienced by the pain 
induction procedure (see Appendix 7). The subjects were then encouraged to ask 
any necessary questions regarding the information they have been given and asked 
to sign a consent form (see Appendix 7). The consent form stated the 
responsibilities of the experimenter under the data protection legislation (Data 
Protection Act 1984). 
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8.4.4: Pain Induction 
Subjects were asked which hand they usually write with and this was taken to be 
the dominant arm. The non-dominant arm was used in each case to standardise 
conditions. Maximum grip strength was measured in the non-dominant arm using a 
hand-held dynamometer (the higher of two readings was taken as the result). The 
non-dominant arm was then elevated for 60 seconds while an elastic bandage was 
wrapped tightly around the distal two-thirds of its length. The cuff (SylgardTM 
125mm depth) was then applied just above the elbow and inflated as quickly as 
possible to a pressure of 250mmHg. The bandage was then removed and the arm 
lowered and rested horizontally on a plinth. Twenty seconds later the subject 
carried out 20 repetitions of gripping exercises (2 seconds grip /2 seconds release) 
at 75% of maximum grip strength. Immediately after the last repetition had been 
completed the time was taken as zero and the stopwatch started. The maximum 
time that the cuff remained inflated was 15 minutes although subjects were 
informed of their right to request deflation before this time had elapsed. 
8.4.5: Pain Assessment 
Once the stopwatch had been started the subject was handed 2 sheets of paper, 
immediately after one another, at one minute intervals until cuff deflation. Each 
piece of paper contained a visual analogue scale (VAS) and a verbal rating scale 
(VRS) (see Appendix 9). The first sheet assessed pain intensity, while the second 
sheet assessed pain unpleasantness. The VAS was comprised of a straight 10cm 
line but the anchor words differed depending on which dimension of pain the scale 
was assessing. The pain intensity VAS possessed the anchors "no pain" and "the 
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worst pain imaginable" while the pain unpleasantness VAS had " not bad at all" and 
"the most unpleasant sensation imaginable". The VRSs both contained a ranked list 
of verbal pain descriptors, in each case the words being appropriate for the 
dimension of pain being assessed. The difference between the two pain dimensions 
was explained to the subjects and they were instructed how to mark the scales prior 
to starting the test. It was stressed to the subjects to mark the scales according to 
how they felt exactly at the time of marking. Previously marked scales were not 
visible to subjects during the pain induction period in an attempt to prevent subjects 
marking the scales based on their last mark. Quantitative data from the VAS was 
obtained by measuring the distance of the vertical line marked by the subject from 
the left-sided anchor point of the scale to the nearest millimetre (mm) - this 
measurement was carried out by the experimenter. The responses given in the VRS 
were quantified by using numerical values previously assigned to the descriptors by 
a comparable population using cross-modality matching techniques (Duncan et al, 
1985). 
8.4.6: Data analysis 
The mean score for both scales at each minute interval was calculated and the 
relationship between the means of the two scales was tested using Pearson's 
Product Moment Correlations (Winer, Brown and Michels, 1991). The relationship 
between the scales at each minute interval was computed by the ExcelTM software 
programme using a PC. The coefficient of determination (r2) was determined at 
each time point. This figure is an estimate of the degree of similarity of the paired 
means and measures the proportion of variance in one score which can be 
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accounted by another (Winer et al, 1991). Correlations were be classed as being 
high (r2>0.81), moderately high (r2>0.64) moderate (r`'>0.49) or low (r2<0.49) 
(Payton, 1994). 
8.5 : Hypotheses 
The following hypotheses were tested in experiment 1: 
(I) Hypothesis (H, ) 
There will be a high / moderately high (r2>0.64) correlation between the 
VAS and VRS pain intensity scores assessed at minute 1` during the 
induction of experimental ischaemic pain. 
Null Hypothesis (Ho) 
There will not be a high / moderately high (r2>0.64) correlation between 
the VAS and VRS pain intensity scores assessed at minute 12 during the 
induction of experimental ischaemic pain. 
` The H, for VAS and VRS pain intensity scores will be repeated 15 times so that each of the 
assessment time points can be addressed separately 
i. e. min 2, min 3 ... min 15. 
2 The II for VAS and VRS pain intensity scores will be repeated 15 times so that each of the 
assessment time points can be addressed separately i. e. min 2, min 3 ... min 15. 131 
(II) Hypothesis (H2) 
There will be a high / moderately high (r'`>0.64) correlation between the 
VAS and VRS pain unpleasantness scores assessed at minute 13 during 
the induction of experimental ischaemic pain. 
Null Hypothesis (Ho) 
There will not be a high / moderately high (r2>0.64) correlation between 
the VAS and VRS pain unpleasantness scores assessed at minute 1' 
during the induction of experimental ischaemic pain. 
8.6 : Results 
None of the subjects involved in the study completed the full 15 minutes of the pain 
induction procedure - the average length of time that the cuff was inflated was 8 
minutes (range 2- 11 minutes). 
The graphs and data for experiment 1 are shown either here in the text or in 
Appendix 1. A graph of the mean pain intensity scores during the pain induction 
period (Figure I in Appendix 1) showed a general upward trend for both scales, 
with similar mean scores being reported at minutes 4,10 and 11. No one scale was 
scored consistently higher than the other and instead they appeared to fluctuate 
throughout the test. The graph of the mean unpleasantness scores (Figure II in 
3 The HI for VAS and VRS pain unpleasantness scores will be repeated 15 times so that each of 
the assessment time points can be addressed separately i. e. min 2, min 3 ... min 15. 4 The Ho for VAS and VRS pain unpleasantness scores will be repeated 15 times so that each of 
the assessment time points can be addressed separately i. e. min 2, min 3 ... min 15. 
132 
Appendix 1) showed, as for the mean intensity scores, that the subject groups rated 
their mean pain unpleasantness higher towards the end of the pain induction period. 
With the unpleasantness scales, however, the VAS was marked consistently higher 
than the VRS at each assessment time point. The two scales both showed a slight 
drop in mean scores at minute 2 and then had a shared peak at minute 8. It was 
only at minute 10 that both scales appeared to have been given the same score. 
The raw scores and descriptive statistics summary for each of the 12 subjects are 
shown in Tables 1c-1h in Appendix 1. The Pearson Product Moment Correlations 
carried out for each set of data collected during pain induction found a high / 
moderately high correlation (r2>0.64) between the VAS and VRS mean pain 
intensity scores at each of the 11 time assessment points during pain induction as 
shown in Table Ia below. 
Table la : Pearson's Product Moment Correlation Coefficients (r) and 
Coefficients of Determination (r) for VAS and VRS pain intensity scores at 
one minute intervals during pain induction period in experiment 1 
Time (mins) 1 2 3 4 5 6 7 8 9 10 11 
n 12 12 10 10 10 10 9 9 6 6 2 
r value . 89 . 92 . 87 . 89 . 87 . 95 . 91 . 
90 . 91 . 99 1.00 
r-2 value . 79 . 85 . 76 . 79 . 
76 . 90 . 83 . 81 . 83 . 98 1.00 
Correlations between the mean pain unpleasantness scores during experimental 
ischaemic pain induction were high / moderately high (r`>0.64) at each time point 
except minutes I (r2=0.59), 4 (r2=0.59), 7 (r`'=0.53) and 8 (r2=0.50) as shown in 
Table 1 bon the next page. 
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Table lb : Pearson's Product Moment Correlation Coefficients (r) and 
Coefficients of Determination (r) for VAS and VRS pain unpleasantness 
scores at one minute intervals during pain induction period in experiment 1 
Time (mies) 1 2 3 4 5 6 7 8 9 10 11 
n 12 12 10 10 10 10 9 9 6 6 2 
r value . 77 . 90 . 95 . 77 . 91 . 92 . 73 . 71 . 93 . 95 1.00 
r= value . 59 . 81 . 90 . 59 . 83 . 85 . 53 . 50 . 86 . 90 1.00 
All the pain intensity null hypotheses from minutes 1-11 could therefore be 
rejected, along with the pain unpleasantness null hypotheses for minutes 
2,3,5,6,9,10 and 11. The hypotheses (intensity and unpleasantness) from minutes 
12-15 could be ignored as no subjects tolerated that length of ischaemic pain 
induction. The statistical results supported the graphical data that the two scales 
showed a high / moderately high correlation. This indicated that the scales were 
related in the present experiment. 
8.7 : Discussion 
The aim of the study was to compare the suitability of the two scales for measuring 
pain intensity and pain unpleasantness during experimental ischaemic pain. The 
Pearson Product Moment Correlation was calculated at each time assessment point 
(1 minute intervals) during the pain induction period and the range of 
corresponding coefficients of determination for the intensity and unpleasantness 
scores were found to be (intensity r2=0.76-1.00) and (unpleasantness r2=0.50-1.00) 
respectively. The results showed that there was a high correlation between the VAS 
and VRS at the majority of time assessment points but that, regarding the pain 
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unpleasantness component, there were periodic discrepancies between the two 
assessment tools. 
The discrepancy between the two pain unpleasantness scales at the identified time 
points may have been attributable to the features of the scales. The VAS consisted 
of a line that had, theoretically, an indefinite number of response categories. The 
VRS, on the other hand, possessed only 9 different choices for rating pain 
unpleasantness. In practice, therefore, a subject was able to rate pain 
unpleasantness on a continuum at each consecutive time point on the VAS while on 
the VRS only a relatively large change in pain perception would have registered as 
a change in response category. 
In order for the VRS to have interval/ratio scaling properties the procedure of 
cross-modality matching was employed (see Section 7.2.2). The scores used to 
quantify the two VRS scales were obtained from a comparable experimental 
population (Duncan et al, 1985) and this was considered to be an appropriate time- 
saving procedure (Duncan et al, 1989; Gracely et al, 1978). The original scoring of 
the scale, however, was done using French translations of the descriptors which 
might not be similar when translated back into the English language. The high 
correlation found by Duncan et al (1989) in a later experiment may have been due 
to the fact that the subjects were using the French adaptation of the scale or that 
the scale was suitable for use with experimental heat pain. It appears that the VRS 
categories in the chosen scales may not always have been sensitive to changes in 
perceived pain during ischaemic pain induction and this may have been due to them 
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not being specific to the subjects and experimental pain model being employed in 
the present study. 
Both the VAS and VRS have qualities that make them a suitable tool for assessing 
pain intensity and pain unpleasantness during ischaemic pain induction (see 
Sections 7.2.1-7.2.3) but in order for the VRS to have interval / ratio scaling 
properties cross-modality matching must be carried out. The procedure is 
extremely time consuming and would involve devising scales that were specific to 
the ischaemic pain tourniquet test. The results of this experiment supported the 
view that either scale would be appropriate for assessing pain intensity and pain 
unpleasantness during ischaemic pain induction and in future studies the VAS will 
be used exclusively as the assessment tool. The aim of the next study was to 
identify variables within the pain induction procedure which cause an increase in 
pain perception and manipulate the methodology so that fewer subjects drop-out 
before the full 15 minutes of pain induction has been completed. 
8.8 : Conclusions 
(1) The VAS and VRS used in the present experiment were found to produce 
similar pain measures (intensity and unpleasantness) during pain induction. 
(2) The VAS will be used alone in successive studies due to the time required to 
match cross-modality scores to a VRS specific to the study. 
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Chapter 9: Experiment 2- Investigation of the effect of cuff pressure on 
VAS scores measuring pain intensity and pain unpleasantness using the 
ischaemic pain tourniquet test on healthy female volunteers. 
9.1 : Introduction 
An issue raised by experiment 1 was the methodology of the pain induction 
procedure, with subjects only tolerating the test for an average of 8 minutes. The 
literature (see Section 6.4.6 and 6.5) referred to experimenters using between 7 
and 25 minutes duration of the ischaemic pain tourniquet test and no significant 
numbers of drop-outs of the test were reported before the full time had elapsed. 
A paper published by Pertovaara et al (1984) suggested that both cuff pressure and 
exercise intensity have an effect on pain scores and tolerance time for the 
ischaemic pain tourniquet test. Smith et al (1966) who first standardised a test of 
ischaemia of a limb with contraction of the ischaemic muscles used a cuff pressure 
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of 250mmHg and carried out 20 gripping exercises (2 seconds grip /2 seconds 
release) of a hand spring at a pre-determined tension (tension not stated). 
Experimenters using this model of experimental pain have since commonly used 
cuff pressures of either 200mmHg (Walsh et al, 1995; McDowell, Lowe, Walsh, 
Baxter and Allen, 1995) or 250mmHg (Woolf, 1979; Roche et al, 1984; Posner, 
1984). The variable of exercise intensity has been slightly more varied, with some 
experimenters selecting a set tension, for example, 2.5kg (Woolf, 1979) while 
others used a percentage of the subject's maximum grip strength ranging from 
25% (Roche et al, 1984) to 75% (Foster et al, 1995; Walsh et al, 1995). A large 
number of the ischaemic pain studies have selected 20 as the number of exercise 
repetitions (Woolf, 1979; Roche et al, 1984; Foster et al, 1995, Walsh et al, 1995) 
but the time taken to carry out these exercises has not been consistent across 
methodologies. Foster et al (1995) and Walsh et al (1995) suggested I minute for 
carrying out the exercises while others were more specific and gave actual grip and 
release times for the exercises; 1 second grip (McDowell et al, 1995) or 2 seconds 
grip /2 seconds release (Smith et al, 1966; Roche et al, 1984). From reviewing a 
range of methodologies used with the experimental ischaemic pain model it is clear 
to see that no one set of variables has been consistently selected. 
Pertovaara et al (1984) stated that cuff pressure and exercise intensity were 
responsible for different types of pain (pain caused by direct pressure of the cuff on 
the arm and pain distal to the cuff caused by the build-up of metabolites, 
respectively). This opinion reflected that of Procacci et al (1979) who proposed 
that pain was multifactorial and contained both a metabolic and neurological 
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component. Nathan (1953, in Procacci et al, 1979) was reported to have observed 
that pressure-induced ischaemia of a nerve produced an increase in pain fibre 
excitability. This allowed previously subliminal pain stimuli in the region of the 
affected nerve to reach a threshold level. These findings suggest that it is the 
variable of cuff pressure that ultimately determines the amount of exercise-induced 
pain felt during the ischaemic pain tourniquet test. The study by Pertovaara et al 
(1984) showed that subjects could distinguish between cuff and arm pain and 
found that higher intensities of exercise increased the ratings given for arm pain. It 
could be, however, that arm pain is secondary, and dependent on, the amount of 
pressure produced by the cufff. 
The variable of cuff pressure was therefore the primary focus of this study, with 
the two most commonly used cuff pressures of 200mmHg and 250mmHg being 
compared. Exercise intensity was kept constant throughout the study, using 20 
gripping exercises at 75% of maximum grip strength (1 second grip /1 second 
release). These variables of exercise intensity were selected as they are within the 
range most commonly used in this experimental model of pain. Experiment 1 
identified the need for a more structured method of recording subjective reportings 
of the ischaemic pain test. In light of the findings by Pertovaara et al (1984), a 
questionnaire was designed for use in this study to ask subjects, among other 
questions, if two separate types of pain had been identified during the test (see 
Appendix 11). 
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It was noted during the pain induction procedure in Experiment 1 that some of the 
subjects expressed a concern as to the change in appearance of the affected arm 
due to the blood occlusion. During this study, therefore, the non-dominant arm 
was covered with a blanket to minimise the subjects' anxiety. 
9.2: Aim 
The aim of the present study was to compare two cuff pressures (200mmHg and 
250mmHg) used in the ischaemic pain induction procedure to investigate their 
influence on the degree of pain reported. 
9.3 : Design 
An experimental design with 2 factors was used in this study. There were repeated 
measures on both factors, with the first factor of cuff pressure containing two 
levels (200mtnHg and 250mmHg). The second factor was time and consisted of 15 
levels representing pain assessment times spaced equally one minute apart. A 
cross-over design was incorporated into the study with half the subjects receiving 
the 200mmHg cuff pressure first while the other half received the 250mmHg cuff 
pressure during the initial testing session. All subjects received both cuff pressures 
and there were approximately 48 hours between testing sessions. 
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9.4 : Methodology 
9.4.1 : Materials and instrumentation (photograph in Appendix 8) 
The same materials and instrumentation were used in the present study as was 
used in experiment 1 except for the following items: 
* blanket 
* visual analogue scales (VAS) (Appendix 10) 
* questionnaire (Appendix 11) 
9.4.2: Subject Recruitment 
The same recruitment procedure was used as in experiment 1. Eight subjects were 
recruited from Queen Margaret College student population (all female; age range 
21-31 years; mean age 24.25 years). 
9.4.3: Ethics 
Ethical approval was granted by the College Ethical Committee before 
commencing the study. The same information / consent form (Appendix 7) was 
used as in experiment 1. All subjects fulfilled the selection criteria and no one had 
to be eliminated from the study. 
9.4.4: Pain Induction 
The same pain induction procedure was used as in experiment 1 except that the 
cuff (SylgardTM 125mm depth) was inflated to a pressure of either 200mmHg or 
250mmHg, as appropriate. The mercury pressure recorder was turned to face 
away from the subject throughout the experimental procedure so that the subject 
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was unaware of what pressure the cuff had been inflated to. The other difference 
between the pain induction procedure for this experiment and that used in 
experiment I was that the timing of the 20 gripping exercises (75% of maximum 
grip strength) was reduced from 2 seconds grip /2 seconds release to I second 
grip /1 second release. Also, the affected limb was covered with a blanket 
throughout the test to minimise anxiety which could arise due to changes in the 
arm's appearance. 
9.4.5: Pain Assessment 
The same pain assessment procedure was used as in experiment 1 except that only 
the VAS was used to measure both pain intensity and pain unpleasantness. Each 
sheet was identical, containing a pain intensity VAS and a pain unpleasantness 
VAS (Appendix 10). Each scale consisted of a straight 10cm line, with different 
anchor words depending on which dimension of pain the scale was assessing. The 
pain intensity VAS possessed the anchors "no sensation" and `! he most intense 
sensation imaginable" while the pain unpleasantness VAS had "not bad at all" and 
"the most unpleasant sensation imaginable" (Price and Harkins, 1992). Prior to 
starting the test the difference between the two pain dimensions was explained to 
the subjects and they were instructed how to mark the scales. The distinction 
between the 2 dimensions of pain, as in experiment 1, was explained using the 
analogy of Price et al (1993) and it was stressed to the subjects to mark the scales 
according to how they felt exactly at the time of marking. The orientation of each 
scale was different on each sheet of paper (intensity VAS - horizontal; 
unpleasantness VAS - vertical) to highlight the difference between the two 
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different components of pain being assessed. The minimum anchor was placed at 
the left hand side of the horizontal VAS and at the top of the vertical VAS. 
Previously marked scales were not visible to the subjects during the pain induction 
period in an attempt to prevent subjects marking the scales based on their last 
mark. Quantitative data from the VAS was obtained by measuring the distance of 
the vertical line marked by the subject from the left-sided anchor point of the scale 
to the nearest millimetre (mm) - this measurement was carried out by the 
experimenter. 
9.4.6: Data analysis 
Homogeneity of variance was assessed with the Hartley test (Winer et al, 1991) by 
manually calculating the ratio of the minimum and maximum variances. The 
Shapiro-Wilk test of normality of data in small groups was then computed using 
the SPSSTM computer package to test for deviation from normal distribution. 
Overall differences among means were investigated by a two way (2x15) analysis 
of variance (ANOVA) with repeated measures on both factors (Winer et al, 1991) 
using the SPSSTM computer package. Any interaction effects were investigated 
manually by analysis of simple main effects with differences between specific 
means being analysed, also manually, by the post-hoc Scheffe test (Philips, 1978). 
In all cases statistical significance was accepted at the p50.05 level. 
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9.5 : Hypotheses 
The following hypotheses were tested in experiment 2: 
(1) Hypothesis (H, ) 
There will be a statistically significant difference between mean VAS pain 
intensity scores during the ischaemic pain tourniquet test dependent on 
whether a cuff pressure of 200mmHg or 250mmHg is used. 
Null Hypothesis (Ho) 
There will be no statistically significant difference between mean VAS pain 
intensity scores during the ischaemic pain tourniquet test dependent on 
whether a cuff pressure of 200mmHg or 250mmHg is used. 
(II) Hypothesis (H2) 
There will be a statistically significant difference between mean VAS pain 
unpleasantness scores during the ischaemic pain tourniquet test dependent 
on whether a cuff pressure of 200mmHg or 250nunHg is used. 
Null Hypothesis (Ho) 
There will be no statistically significant difference between mean VAS pain 
unpleasantness scores during the ischaemic pain tourniquet test dependent 
on whether a cuff pressure of 200mmHg or 250mmHg is used. 
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9.6 : Results 
One of the subjects did not complete the full 15 minutes of the pain induction 
procedure and was therefore not included in the statistical analysis of the results. 
There were no other drop-outs from the study. 
Graphs and tables of the data are shown either here in the text or in Appendix 2. A 
graph of the mean pain intensity scores at both cuff pressures is shown below in 
Figure V. 
Figure V: Mean VAS pain intensity scores at both cuff pressures (200mmHg 
and 250mmHg) 
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Subject groups showed a general upward trend in mean pain intensity rating 
throughout the pain induction period but no one cuff pressure produced noticeably 
higher mean pain intensity scores. 
Mean pain unpleasantness scores at the two cuff pressures are also shown in 
Figure VI on the next page and again both followed a very similar upward trend 
throughout the test. 
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Figure VI : Mean VAS pain unpleasantness scores at both cuff pressures 
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The raw scores for all subjects, including the descriptive statistics, are shown in 
tables 2c (intensity) and 2d (unpleasantness) in Appendix 2. Only pain intensity 
measurements at minute' 7 using the 250mmHg cuff pressure and pain 
unpleasantness measurements at minute 1 using the 200mmHg cuff pressure 
showed a statistically significant deviation from normal distribution (p<0.05). The 
assumption of homogeneity of variance, measured by the Hartley test, was rejected 
(intensity F=5.17; d. f. =30,6; p>0.05; unpleasantness F=4.00; d. f. =30,6; p>0.05). 
Overall differences between the means of the two cuff pressures were investigated 
by a two way (2x15) analysis of variance (ANOVA) with repeated measures on 
both factors (Tables 2a and 2b shown on the next page). The ANOVA of the pain 
scores showed no statistically significant effect of cuff pressure on either VAS pain 
intensity measures (F=0.09; d. f. =1 y6; p=0.771) or VAS pain unpleasantness 
measures (F=0.04; d. f. =1,6; p=0.851). The effect of time was found to be 
significant on VAS intensity scores for both pain measures (intensity F=17.53; 
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d. f. =14,84; p<0.001; unpleasantness F=17.79; d. f. =14,84; p<0.001) but there was 
no significant interaction effect of cuff pressure over time (intensity F=0.22; 
d. f. =14,84; p=0.999; unpleasantness F=0.15; d. f. =14,84; p=1.00). 
Table 2a : ANOVA table for experiment 2 pain intensity scores 
VAS INTENSITY 
SS d. f. MS F 
Effect of Cuff 
Cuff 162.98 1 162.98 0.09 0.771 
Error (Within + Residual) 10581.79 6 1763.63 
Effect of Time 
Time 25274.70 14 1805.34 17.53 <0.001 
Error (Within + Residual) 8651.44 84 102.99 
Interaction (Cuff x Time) 
Cuff x Time 163.67 14 11.69 0.22 0.999 
Error (Within + Residual) 4512.07 84 53.72 
Table 2b : ANOVA table for experiment 2 pain unpleasantness scores 
VAS 
UNPLEASANTNESS SS d. f. MS F p 
Effect of Cuff 
Cuff 112.93 1 112.93 0.04 0.851 
Error (Within + Residual) 17645.60 6 2940.93 
Effect of Time 
Time 35248.55 14 2517.75 17.79 <0.001 
Error (Within + Residual) 11884.98 84 141.49 
Interaction (Cuff x Time) 
Cuff x Time 148.21 14 10.59 0.15 1.000 
Error (Within + Residual) 6094.26 84 72.55 
Results of the questionnaire are summarised in Table 2e in Appendix 2. With the 
exception of one subject, all tolerated 15 minutes of pain induction. All the 
subjects in the study reported that they were able to distinguish between pain 
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intensity and pain unpleasantness and marked the VAS appropriately. At the higher 
cuff pressure all the subjects distinguished between the cuff and arm pain while 
only 5 reported noticing a difference at the lower cuff pressure. Of those who 
distinguished between the pains, the numbers were equally divided as to which 
pain was worse (4 reported arm, 4 reported cuff) at the higher cuff pressure. At 
the lower cuff pressure 3 reported that the arm pain was perceived as being more 
painful while 2 reported that it was the cuff pain. 
9.7 : Discussion 
The results of this study showed that, using the selected pain induction 
methodology, 200mmHg and 250mmHg cuff pressures produced mean VAS pain 
intensity and mean VAS pain unpleasantness scores that were not statistically 
significantly different from each other. The significant F ratio for the time factor 
(in each case p<0.001) and visual examination of the data showed that the subjects 
found the pain induction procedure progressively more intense and unpleasant the 
longer the cuff was inflated. This finding supported the idea that the submaximal 
tourniquet method is an effective model of experimental pain induction. The 
differences between pain scores dependent on cuff pressure, however, were not 
significant and neither null hypothesis could be rejected. The findings indicated 
that if the same pain induction procedure were followed in future experiments, the 
pain scores obtained (intensity and unpleasantness) would be similar regardless of 
whether a cuff pressure of 200mmHg or 250mmHg were selected. 
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It is possible that the heterogeneity of variances found with both the intensity and 
unpleasantness scores (Hartley test) may have compromised the statistical power 
of the ANOVA. This is unlikely, however, as the equal numbers in each group 
make it robust against departures from the assumptions about parametric 
requirements of normal distribution of data and permit it to be a valid statistical 
test (Winer et al, 1991). 
It was proposed before the study, based on reported observations by Nathan 
(1953, in Procacci et al, 1979), that cuff pressure was most likely to be the primary 
determinant of pain ratings and pain tolerance during the ischaemic pain tourniquet 
test. The author was reported to have found that once pressure-induced ischaemia 
had been produced, pain in the affected limb became greater due to increased 
excitability of the pain fibres. Pertovaara et al (1984) proposed that two types of 
pain occur in the ischaemic model of pain induction and that these were due to (1) 
nerve pressure caused by the cuff and (2) accumulation of metabolites caused by 
exercise of ischaemic muscles. The findings of Nathan (1953, in Procacci et al, 
1979) and Pertovaara et al (1984) suggested that exercise-induced pain due to 
metabolite build-up may be secondary and dependent on the cuff pressure used. 
All subjects, except one, participating in the present experiment tolerated the full 
15 minutes of pain induction at cuff pressure 250mmHg while in experiment 1 the 
average time endured was only 8 minutes (the cuff pressure was also 250mmHg). 
Exercise intensity in the present experiment (2s grip / 2s release) was less than that 
carried out in experiment 1 (Is grip / Is release) which would, theoretically, have 
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reduced the amount of arm pain experienced by the subjects. It has been proposed 
that arm pain could be dependent on cuff pressure and, therefore, in experiment 1, 
the cuff pressure had the effect of increasing the arm pain to the extent that pain 
tolerance was reduced. It would also follow that the reduction of exercise intensity 
in the present study could consequently have reduced arm pain to produce a level 
of pain which allowed the full 15 minutes of pain induction to be tolerated. 
The results of the questionnaire supported the theory that perception of arm pain is 
dependent on cuff pressure as all of the 8 subjects reported noticing a difference in 
cuff and arm pain at the higher cuff pressure, while only 5 reported noticing the 
distinction when the lower cuff pressure was used. The questionnaire responses 
showed, however, that the arm pain was not always perceived as being more 
painful than the pain produced by the cuff. It could be that the higher cuff pressure 
allows the distinction between the two types of pain to be made but does not allow 
for a clear distinction to be made as to which pain is worse. This is reflected in the 
result that the numbers of subjects who reported that one type of pain (arm or 
cuff) was worse than the other were almost equally split at both cuff pressures. 
An important point of note in the questionnaire responses can be observed in the 
`extra info' column (Table 2e). Subject number 7 commented that they had not 
found the pain induction procedure using the 250mmHg cuff pressure to be painful 
but instead it had produced a `strange' sensation. At the higher cuff pressure 
(250mmHg), another subject (number 6) reported a feeling of `discomfort' as 
opposed to pain. Comments of this type were not made by all the subjects 
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participating in the experiment but the analysis of the VAS scores showed that the 
higher cuff pressure (250mmHg) did not produce sensations that were perceived 
as being more painfully intense or unpleasant than the lower (200mmHg) cuff 
pressure. The responses of the questionnaire in the present experiment indicated 
that the higher cuff pressure (250mmHg) did allow a greater number of subjects to 
distinguish between cuff and arm pain but did not allow one to be perceived as 
being more painful than the other. Cuff pressure in the present experiment, 
therefore, was found to influence the subjective reporting of sensations produced 
by the ischaemic pain induction but these sensations were not perceived as being 
painful (intensity or unpleasantness). A cuff pressure of 200mmHg was therefore 
used in future experiments. 
Subjects in the study were tested twice and the time between testing sessions was 
taken to be 48 hours based on previous ischaemic pain studies (Foster et al, 1995; 
McDowell et al, 1995; Walsh et al, 1995) and time-tabling considerations. This 
study used a cross-over design and therefore any carry-over effects of the test 
would have been minimised. For future studies of a repeated measures design, 
however, the repeatability of the test over the selected time period was 
investigated. 
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9.9 : Conclusions 
(1) Analysis of the VAS scores in the present experiment indicated that subjects 
did not perceive one cuff pressures to be more painful (intensity or unpleasantness) 
than the other. 
(2) The questionnaire responses in the present experiment indicated that the higher 
cuff pressure (250mmHg) did produce different subjective reportings of sensation 
from the lower cuff pressure (200mmHg) but that these sensations were not 
perceived as being painful. 
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Chapter 10 : Experiment 3- Investigation of pain scores during pain 
induction when healthy female volunteers are subjected to repeated 
exposure to the ischaemic pain tourniquet test. 
10.1 : Introduction 
The ischaemic tourniquet test is an established model of experimental pain (see 
Sections 6.4.6 and 6.5) but little literature has been published regarding its 
repeatability. Studies using repeated tests of the ischaemic model of experimental 
pain have used gaps between successive tests ranging from 48 hours (Foster et al, 
1995; McDowell et al, 1995; Walsh et al, 1995) to periods of up to 1 week 
(Woolf, 1979) and 3 weeks (Pertovaara et al, 1984). None of these experimenters 
stated why they chose their selected time period and only Pertovaara et al (1984) 
made reference to the repeatability of the pain model. Pertovaara et al (1984) 
exposed 12 subjects to a total of 4 tests, 2 of which were identical in procedure 
(1 st and 4th test). The time gap between testing was reported to have been 
153 
between I and 3 weeks although the actual number of days was not stated. VAS 
scores of ischaemic pain intensity and pressure pain intensity (from cuff) were 
marked by the subjects at 2 minute intervals during the 15 minutes of pain 
induction. Graphical representation of the results showed that a similar trend in 
pain reporting was found between the 2 identical tests although the pain scores in 
the 2nd exposure to the test were slightly lower than in the initial testing session. 
The authors concluded that the similarity of the 2 successive sets of VAS scores 
indicated that the ischaemic pain tourniquet test was reliable over repeated 
sessions. The graph displayed in the paper by Pertovaara et al (1984) was only 
able to show similarities between mean scores and, as there was no statistical 
analysis of these results to identify any statistically significant differences, this 
conclusion cannot be firmly established. 
Literature regarding the mechanism of experimental ischaemic pain induction (see 
Section 6.4.6) suggested that the pain experienced was due to a build-up of 
metabolites in the affected limb in combination with pain produced by cuff 
pressure (Lewis, 1950, in Procacci et al, 1979; Pertovaara et al, 1984). It would 
therefore follow that pain perception would return to pre-test levels shortly after 
the cuff has been deflated and equilibrium in the tissues has been restored. Lewis 
(1942, in Keele and Neil, 1965) was reported as noting that once circulation is 
restored, a time period of 2-4 seconds allows pain to return to pre-test levels. This 
report is in agreement with subjective statements made in the 2 earlier 
experiments. For this reason, and for time-tabling considerations, a period of 48 
hours between tests will be used. It is important to note that using a repeated test 
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in a repeated measures experimental design can cause major threats to the internal 
validity of the study (Payton, 1994). Threats to internal validity not only arise due 
to physiological carry-over effects but are also due to learning effects and 
increased familiarity with the equipment and procedure. This in turn can produce 
a change in outcome measures not associated with a change in the variable being 
assessed. 
10.2: Aim 
The aim of the experiment was to investigate if the present experimental model of 
pain produced a repeatable measure of pain perception (intensity and 
unpleasantness) when subjects were exposed to 3 experimental testing sessions 48 
hours apart. 
10.3: Design 
An experimental design with 2 factors was used in this study. There were 
repeated measures on both factors, with the first factor of testing session 
containing three levels (Ist, 2nd and 3rd test). The second factor was time and 
consisted of 15 levels representing pain assessment times spaced equally one 
minute apart. All subjects were tested 3 times, with the identical procedure being 
followed each time. 
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10.4 : Methodology 
10.4.1 : Materials and instrumentation (photograph in Appendix 8) 
The same materials and instrumentation were used as in experiment 2 except there 
was no questionnaire. 
10.4.2: Subject Recruitment 
The same procedure was used as in previous experiments. Six female subjects 
aged 22-32 years (mean age 25.33 years) were recruited for the study. 
10.4.3: Ethics 
Ethical approval was granted by the Queen Margaret College Ethical Committee 
before commencing the study. The same information sheet and consent form (with 
the appropriate timetable alterations) were used as in previous experiments. No 
subjects had to be eliminated from the study. 
10.4.4: Pain Induction 
The same pain induction procedure was used as in experiment 2 except a cuff 
pressure of 200mmHg was maintained throughout the study. 
10.4.5: Pain Assessment 
The same pain assessment procedure was used as in experiment 2 except there 
was no questionnaire at the end of the final testing session. 
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10.4.6: Data analysis 
The same statistical tests were carried out as in experiment 2. Overall differences 
among means were investigated by a two way (3x15) analysis of variance 
(ANOVA) with repeated measures on both factors (Winer et al, 1991). The 2 
factors were order of test (Ist, 2nd or 3rd) and time (1 minute intervals x 15). 
10.5: Hypotheses 
The following hypotheses were tested in experiment 3: 
(I) Hypothesis (H1) 
VAS pain intensity scores will be statistically significantly different 
between 3 different sessions of the ischaemic pain tourniquet test. 
Null Hypothesis (Ho) 
VAS pain intensity scores will not be statistically significantly different 
between 3 different sessions of the ischaemic pain tourniquet test. 
(II) Hypothesis (H2) 
VAS pain unpleasantness scores will be statistically significantly different 
between 3 different sessions of the ischaemic pain tourniquet test. 
Null Hypothesis (Ho) 
VAS pain unpleasantness scores will not be statistically significantly 
different between 3 different sessions of the ischaernic pain tourniquet test. 
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10.6 : Results 
One subject did not complete the full 15 minutes of the pain induction procedure 
and was therefore not included in the analysis of the results. The number of 
subjects involved in the statistical analysis of the results was 5. 
Graphs and tables of the data in experiment 3 are shown either here in the text or 
in Appendix 3. The Hartley test, carried out manually, showed that assumption of 
homogeneity of variance was unlikely for either the intensity (F=35.01; d. f. =45,4; 
p>0.05) or unpleasantness scores (F=19.28; d. f. =45,4; p>0.05). A graph of the 
mean VAS pain intensity scores over all 3 testing sessions is shown in Figure VII 
below. 
Figure VII : Mean VAS pain intensity scores over all 3 testing sessions 
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The graph showed a general upward trend in mean VAS pain intensity scores 
over time throughout the period of pain induction for all 3 tests but the scores for 
test 1 were higher than those for either of the later tests which showed similar 
results. The mean pain intensity score in the 1 st test was also higher at minute I 
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than at minute 2 which was uncharacteristic of the 2nd or 3rd test. This relative 
high scoring of pain intensity in the initial stages of the I st test was reflected in 
the raw data (Tables 3e and 30 and the graphs of the individual pain intensity 
scores of all 5 subjects are shown in Figures IX(i)-(iii) in Appendix 3. It can be 
seen from these 3 graphs that in the 1 st test subjects gave a VAS pain intensity 
score of between 20 and 40 which dropped to below 20 in tests 2 and 3. 
Figure VIII below showed the VAS pain unpleasantness scores during pain 
induction for all 3 testing sessions. 
Figure VIII : Mean VAS pain unpleasantness scores over all 3 testing 
sessions 
. $0 E 70 E 
d 60 o 50 
U 
H 40 
Cl) 
Q 30 
20 
10 
0 
--0 1st test VAS 
unpleasantness scores 
p 2nd test VAS 
unpleasantness scores 
I 3rd test VAS 
unpleasantness scores 
123456789 10 11 12 13 14 15 
Time during pain Induction (rains) 
As with the mean pain intensity scores, the scoring of mean pain unpleasantness in 
all of the tests followed a similar upward trend but generally decreased the more 
times that the subjects were exposed to the procedure. The graphs of the 
individual scores for all 5 subjects over the 3 tests are shown in Figures X(i)-(iii) 
in Appendix 3. Figure X(i) explains why, as for the VAS mean pain intensity 
scores, there was a relatively high mean pain unpleasantness score at minute 1 in 
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the Ist test. Subject 1 gave a pain unpleasantness score of 89 which quite 
dramatically increased the mean score for that particular time assessment point. 
Subject number 2, on the other hand, gave a lower than average pain 
unpleasantness rating at the same time point but this appears to have been 
reflective of this particular subject's pain reporting in general. 
A two way (3x15) analysis of variance (ANOVA) with repeated measures on both 
factors was carried out on the VAS pain intensity scores. The ANOVA (Table 3a 
shown below) showed a statistically significant difference between the 3 testing 
sessions in the study (F=12.21; d. f. =2,8; p=0.004). There was no statistically 
significant interaction effect (F=0.98; d. f. =28,112; p=0.505) indicating that there 
was no statistically significant difference between the conditions that was 
dependent on time. 
Table 3a : ANOVA table for experiment 3 VAS pain intensity scores 
VAS INTENSITY 
SS d. f. MS F p 
Effect of Test 
Test 14537.21 2 7268.60 12.21 0.004 
Error (Within + Residual) 4761.77 8 595.22 
Effect of Time 
Time 44273.82 14 3162.42 16.88 <0.001 
Error (Within + Residual) 10491.69 56 187.35 
Interaction (Test x Time) 
Test x Time 1051.32 28 37.55 0.98 0.505 
Error (Within + Residual) 4299.03 112 38.38 
A test of simple main effects was carried out manually on the VAS pain intensity 
scores to establish at which time points the pain scores were statistically 
significantly different from each other (Table 3d). Post-hoc Scheffe tests were 
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then performed to identify where the statistically significant differences could be 
found between the 3 testing sessions (Table 3b shown below). 
Table 3b : Scheffe Test for VAS pain intensity scores in experiment 3 
Time 1st test / 2nd test 1st test / 3rd test 2nd test / 3rd test 
Minute 1 4.77 7.12* 0.23 
Minute 5 0.30 3.10 1.47 
Minute 6 1.33 13.26* 6.19* 
Minute 7 4.51 16.54* 4.14 
Minute 8 1.00 11.75* 5.89 
Minute 9 1.33 15.10* 7.46* 
Minute 10 1.55 18.57* 9.39* 
Minute 11 0.88 14.62* 8.32* 
Minute 12 10.47* 15.57* 0.50 
Minute 13 11.22* 15.18* 0.30 
Minute 14 9.70* 13.49* 0.52 
Minute 15 5.43 5.12 0.004 
Critical Value = 6.14-8.92 
*= statistically significant (p50.05) 
The tests showed that the mean VAS pain intensity scores were statistically 
significantly lower in the 3rd test compared to the ist test at the majority of the 
pain assessment time points. Differences which reached statistical significance 
could also be seen in the earlier and middle stages of the test (minutes 6,9,10 and 
I 1) between the 2nd test and the 3rd test and between the 1st test and 2nd test at 
minutes 12,13 and 14. 
Regarding the statistical analysis of the VAS pain unpleasantness scores, the 
ANOVA (Table 3c shown on the next page) showed no statistically significant 
difference between the conditions (F=2.48; d. f. =2,8; p=0.146). This was also the 
case with the interaction effect (F=1.30; d. f. =28,112; p=0.172) and means that 
there was no statistically significant difference between treatment conditions that 
was dependent on time. 
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Table 3c : ANOVA table for experiment 3 VAS pain unpleasantness scores 
VAS 
UNPLEASANTNESS SS M. MS F 
Effect of Test 
Test 9495.90 2 4747.95 2.48 0.146 
Error (Within + Residual) 15345.30 8 1918.16 
Effect of Time 
Time 55794.62 14 3985.33 14.97 <0.00I 
Error (Within + Residual) 14910.98 56 266.27 
Interaction (Test x Time) 
Test x Time 731.70 28 26.13 1.30 0.172 
Error (Within + Residual) 2257.10 112 20.15 
10.7: Discussion 
The results of this experiment showed a statistically significant difference in VAS 
pain intensity scores between 3 different sessions of the ischaemic pain tourniquet 
test. The descriptive statistics (Table 3e in Appendix 3) for the intensity scores 
showed that the standard deviations and variation for each testing session became 
less as the test order increased and indicated that the subjects were less erratic in 
their pain rating the more times they were exposed to the test. This was also 
reflected in the outcomes of the Shapiro-Wilk test as only one value (minute 2) 
deviated from a normal distribution in the 3rd test while 3 values deviated in the 
1st (minutes 13,14 and 15) and 2nd test (minutes 6,12 and 13). A similar trend 
could be seen with the VAS pain unpleasantness scores (Table 3f in Appendix 3) 
although the standard deviations and variations were generally higher than with 
the intensity scores. This could be due to unpleasantness, based on 
neurophysiological evidence of specific pain pathways, being open more to 
modulation (Fields, 1987; Guilbaud et al, 1994; Jones, 1997; Lima, 1997). The 
sensory-discriminative component of pain (pain intensity) is neurophysiologically 
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well defined as it is served by the lateral ascending pathways which have few 
synaptic junction and have discrete target sites (Lima, 1997). This is not the case 
with the motivational-affective component of pain as it is served by the multi- 
synaptic medial ascending systems which have diffuse supraspinal target sites 
(Jones, 1997; Lima, 1997). The motivational-affective component of pain is 
thought to be influenced by an individual's subjective interpretation of the 
stimulus and the psychological context in which the painful stimulus is delivered 
(Jones, 1997, Price and Harkins, 1992; Wade et al, 1996) and it this way it is 
open to a great deal of variation. The variability in the pain unpleasantness scores 
should not have affected the outcome of the ANOVAs, however, as the test 
remains robust when equal group numbers are used (Winer et al, 1991). 
The outcomes of both components of pain assessment indicated that subjects 
required time to familiarise themselves with the testing procedure and that the 
results of the initial test may not have been reflective of their pain perception. 
Neither of the null hypotheses could be rejected. The significant F ratios for the 
effect of time with both pain measures (intensity F=16.88; d. f. =14,56; p<0.001; 
unpleasantness F=14.97; d. f. =14,56; p<0.01) indicated that, as in experiment 2, 
the test was serving its purpose in producing measurable levels of pain. 
The results of the experiment indicated that repeated exposure to the experimental 
procedure decreased measures of pain perception and supported the findings of 
Pertovaara et al (1984). It was only in the 1st test that subject groups rated both 
mean pain intensity and mean pain unpleasantness higher at minute 1 than in 
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successive time assessment points and this may just have been due to the initial 
shock of experiencing the pain sensations. The graphs of the individual subject 
pain scores in Figures IX(i)-(iii) and X(i)-(iii) in Appendix 3 showed that all the 
subjects rated their pain intensity higher in minute I of the 1 st test than in either 
test 2 or 3 but for the pain unpleasantness scores the high minute 1 score in the 
1 st test may have been attributable to the exceptionally high score given by 
subject number 1. It can be stated, however, that the graphs of the mean VAS 
pain scores (Figures VII and VIII) generally represented an accurate trend in 
reporting of both the mean pain intensity and mean pain unpleasantness scores. 
These graphical trends were reflected in the statistical analysis of the data as the 
similar shape of each line (representing the 1 st, 2nd and 3rd test) meant that there 
was no statistically significant interaction effect between the different tests (i. e. 
there was no statistically significant difference between the tests that was 
dependent on time). The statistically significant test effect with the mean pain 
intensity scores can be seen in Figure VII as the scores in test 1 were noticeably 
higher than in either of the successive tests. The same degree of difference 
between the tests was not evident with the mean pain unpleasantness scores 
(Figure VIII). 
Aspects of the results of this experiment may have been be due to decreased 
anxiety in the subjects as the test procedure became more familiar or they gained 
greater familiarity with the pain assessment tools. In order to decrease the amount 
of variation in pain reporting between testing sessions in later experiments an 
introductory session was set up which exposed the subjects to the procedure that 
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they would be experiencing. In the introductory session the subjects were able to 
see the instrumentation and feel the sensations that the ischaemic pain tourniquet 
test produces. Based on the results of the present experiment, the subjects 
received only a couple of minutes exposure to the pain induction procedure 
during the introductory session. The pain scores indicated that it was primarily the 
initial shock to the painful stimulus that caused the irregular high pain scores to be 
given. 
10.8: Conclusions 
(1) Subjects in the present experiment rated their pain lower (intensity and 
unpleasantness) in successive exposures to the test, with the greatest difference 
being noted between the 1 st and 2nd test. 
(2) Erratic pain scores given by subjects in the initial minutes of the first test 
suggested the need for an introductory session to be set up in future experiments. 
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Chapter 11 : Experiment 4- Investigation of the effect of high frequency TENS 
on pain intensity and pain unpleasantness of the ischaemic pain tourniquet test 
using healthy female volunteers. Subject control versus experimenter control of 
TENS. 
11.1 : Introduction 
The word `control' can be used in the global sense to mean `to exercise power over' 
or to regulate'. With regards to pain research, Thompson (1981) defined control as 
"the belief that one has at one's disposal a response that can influence the 
aversiveness of an event". Control can therefore take many forms ranging from 
forewarned knowledge regarding the event (Staub et al, 1971) to the perceived ability 
to physically prevent a noxious stimulus from occurring (Weisenberg et al, 1985). 
Within the context of the present study, however, control was considered to mean the 
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ability of either the subject or the experimenter to alter the intensity dial on the TENS 
machine. 
Control has been found to be an important factor in determining the response to pain 
(Kanfer and Seidner, 1973; Staub et a), 1971; Thompson, 1981; Toomey et al, 1991 
and Weisenberg et al, 1985) (see Section 5.5) and the neurophysiological rationale 
supporting pain as a multidimensional experience recognises that the context in which 
a painful stimulus is received can alter the resultant pain perception (see Section 3.4). 
Neurophysiological research has provided evidence to support the view that 
psychological variables such as control can influence both Ist and 2nd stage pain 
perception. It has been proposed that altering a person's attention whilst they are 
experiencing pain can reduce their 1 st stage pain perception by directly stimulating 
supraspinal target sites of the medial ascending nociceptive tracts (Guilbaud et al, 
1994; Lima, 1997). This can result in activation of brainstem descending inhibitory 
mechanisms in areas including the cingulate gyrus and so decrease sensory- 
discriminative and motivational-affective components of pain perception (Lima, 
1997). No studies investigating the influence of control on pain perception have been 
carried out specifically with TENS although the modality has been suggested as being 
suitable for testing such a relationship (Toomey et al, 1991). An aspect of control 
which is particularly relevant to TENS because of its use by patients in their own 
homes is the issue of who controls the current intensity, the therapist or patient. 
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Some studies investigating the use of TENS with chronic pain have been carried out 
with the therapist controlling the current intensity (Deyo et al, 1990; Lehmann et al 
1986), while others have examined the use of the modality when controlled by the 
patient in their own home (Ellis, 1995; Johnson et al, 1991 a and 1991 b). Diversity 
regarding control is also evident in trials involving acute pain. Smith et al (1986) 
reported that women with post-caesarean pain controlled the TENS intensity 
themselves, while Conn et al (1986) reported that post-operative patients had the 
TENS intensity controlled by the hospital staff. 
The difficulty in carrying out experiments within the clinical environment in a 
controlled manner highlights the necessity for laboratory based TENS studies. In the 
laboratory situation the ischaemic model of experimental pain induction has been 
used by researchers in the past to investigate the pain-relieving effects of TENS (see 
Section 6.5 and Table 1). None of the papers reviewed investigating the use of TENS 
on the ischaemic pain model have addressed the issue of control of the current 
intensity. The study methodologies did not always make it clear who was controlling 
the current intensity during the TENS application but all of the studies suggested that 
either the subject or the experimenter was consistently responsible for altering the 
current intensity throughout the TENS procedures. 
The studies which tested the efficacy of TENS using experimental ischaemic pain 
covered a range of different parameters such as current frequency, current intensity, 
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electrode placement and treatment duration (see Section 6.5 and Table 1). The results 
of these studies have been inconsistent and this may have been due to differences in 
experimental design and parameter selection. There is inconclusive evidence for a 
relationship between specific current parameters and optimal pain-relieving effect and 
positive outcomes were received with both high frequency (Woolf, 1979) and low 
frequency (Roche et al, 1984; Walsh et al, 1995) currents. A high frequency current 
was selected for the present experiment and a low current intensity (sensation 
threshold) was maintained throughout the TENS application based on the rationale 
outlined in Section 7.4.4. 
11.2: Aims 
The aims of this experiment were to (1) investigate the efficacy of high frequency 
(100Hz) TENS using the selected experimental procedure and (2) investigate if the 
efficacy of high frequency (100Hz) TENS is affected by the degree of perceived 
control that the subject is given over the TENS current intensity. These aims were 
not listed in order of priority. 
11.3: Design 
Each subject was tested on three separate occasions approximately 48 hours apart. 
An introductory session was also included for each subject prior to their first 
exposure to the test to familiarise them with both the pain induction procedure and 
the TENS machine. All subjects experienced each of the three testing conditions; no 
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TENS (n=12), experimenter controlling TENS (n=12), and subject controlling TENS 
(n=12). The order in which subjects received the three different conditions was 
randomised to minimise order effects. The randomising procedure involved writing 
all 6 of the possible ordering combinations on separate pieces of paper. Each 
combination was written twice to bring the total number of pieces of paper to 12. A 
person not familiar with the study was then asked to pull out one of these pieces of 
paper from a container and match it to a subject number. After a piece of paper 
containing an order combination was selected from the container, it was not replaced. 
The procedure was repeated until each of the twelve subjects had been assigned an 
ordering combination. 
11.4: Methodology (Experimental procedure shown in Appendix 13) 
11.4.1: Materials and instrumentation (Photographs in Appendix 8 and Appendix 
12) 
The same materials and instrumentation as used in experiment 2 including: 
* TENS machine (Endomed 482, Enraf Nonius Delft) 
*2 silicone rubber electrodes + sponge pads (6cm x 4cm) 
* MicroporeTM adhesive tape 
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11.4.2 : Subject Recruitment 
The same subject recruitment procedure was used as in experiments 1-3. Twelve 
healthy female volunteers (mean age 21.3 years; range 20-24 years) were recruited 
from Queen Margaret College student population. There were no drop-outs from the 
study. 
11.4.3: Ethics 
Ethical approval was granted by Queen Margaret College Ethical Committee before 
commencing the study. The same information sheet and consent form (except 
timetabling alterations) were used as in previous experiments. 
11.4.4: Introductory session 
Subjects attended an initial introductory session approximately 48 hours before the 
first testing session which involved them being shown the pain induction equipment 
and the pain assessment scales. They were then exposed to the pain induction 
procedure (see Section 11.4.5) but the cuff was only inflated for a period of 2 
minutes. All subjects also had the TENS electrodes put in place and experienced the 
current at the selected parameters (see Section 11.4.6). The TENS current was 
switched on for a total of 4 minutes -2 minutes prior to pain induction and the 2 
minutes during cuff inflation. During this period the experimenter adjusted the current 
intensity until the subject reported it to be `just perceptible'. 
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11.4.5: Pain Induction 
The same pain induction procedure was used as in experiment 3. 
11.4.6: TENS 
The TENS machine calibrated was checked before the experiment began. This 
involved passing a selected current frequency through the oscilloscope and ensuring 
that the frequency on the TENS machine matched that being registered by the 
oscilloscope. The two readings were found to be comparable on the first calibration 
attempt and the TENS machine did not have to be re-calibrated. Subjects receiving 
TENS had 2 padded electrodes (dampened with water) attached; one placed adjacent 
to C6 /7 on the affected side, and the other over Erb's point (a point approximately 2 
cm inferior to the clavicle two-thirds distally along its length on the same side). Both 
these electrodes were secured in place using MicroporeTM adhesive tape. In each case 
the parameters of TENS incorporated a rectangular, symmetrical biphasic current 
with frequency 100Hz and pulse width 200µs. The duration of TENS stimulation 
totaled 30 minutes - application began 15 minutes prior to pain induction and 
continued throughout the cuff inflation period. Throughout this stimulation time the 
intensity was altered by either the subject or experimenter, as appropriate, until the 
subject reported the TENS sensation to be "just perceptible". 
11.4.7: Pain Assessment 
The same pain assessment procedure was used as in experiments 3. 
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11.4.8: Data analysis 
The same statistical tests were used as outlined in experiment 2. The factors being 
tested in the two separate (intensity and unpleasantness) 2-factor analysis of variance 
(ANOVA) for repeated measures were experimental conditions (no TENS, 
experimenter controlling TENS, subject controlling TENS) and time (one minute 
intervals x 15). A 2-factor ANOVA for repeated measures was also selected to 
investigate the difference in mean current intensities used between the experimenter 
and subject control conditions. 
11.5: Hypotheses 
The following hypotheses were tested in experiment 4: 
(I) Hypothesis (H1) 
There will be a statistically significant difference in VAS pain intensity scores 
between the 3 treatment conditions: no TENS; experimenter controlling 
100Hz TENS; subject controlling 100Hz TENS. 
Null Hypothesis (Ho) 
There will be no statistically significant difference in VAS pain intensity 
scores between the 3 treatment conditions: no TENS; experimenter 
controlling 100Hz TENS; subject controlling 100Hz TENS. 
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(II) Hypothesis (H2) 
There will be a statistically significant difference in VAS pain unpleasantness 
scores between the 3 treatment conditions: no TENS; experimenter 
controlling 100Hz TENS; subject controlling 100Hz TENS. 
Null Hypothesis (Ho) 
There will be no statistically significant difference in VAS pain unpleasantness 
scores between the 3 treatment conditions: no TENS; experimenter 
controlling 100Hz TENS; subject controlling 100Hz TENS. 
11.6 : Results 
The graphs and tables of data for experiment 4 are shown either here in the text or in 
Appendix 4. From the graph showing the VAS intensity scores for all 3 conditions 
(Figure XI on the next page) it can be seen that the subject groups, irrespective of 
treatment condition, reported a mean increase in pain intensity over time during pain 
induction. Each of the 3 treatment conditions started marking the VAS intensity 
scales at a similar point but by the end of the pain induction period the subject group 
controlling the TENS current intensity gave higher mean pain intensity scores than 
either the experimenter control condition or the condition receiving no TENS. 
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Figure XI : Mean VAS pain intensity scores for all 3 conditions in experiment 4 
(100Hz TENS) 
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The graph of the mean VAS unpleasantness scores (Figure XII below) showed that in 
all 3 treatment conditions mean pain unpleasantness was rated lower than mean pain 
intensity at the start of the pain induction period. 
Figure XII : Mean VAS pain unpleasantness scores for all 3 conditions in 
experiment 4 (100Hz TENS) 
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All the conditions followed a similar upward trend in mean pain reporting over time 
while the cuff was inflated, with the no TENS condition marking the unpleasantness 
scales slightly higher than the 2 conditions receiving TENS. At the end of pain 
induction the condition receiving no TENS reported the highest mean pain 
unpleasantness score, with all 3 conditions displaying mean scores slightly higher than 
those marked on the VAS intensity scales at the final minute of pain induction. 
The Shapiro-Wilk test (Table 4f in Appendix 4) showed normality of distribution for 
most of the scores, with the VAS intensity scores (experimenter control condition - 
minute 1) possessing only one value (p=0.04) which fell just below the accepted 
statistical significance value of p<0.05. The VAS unpleasantness scores (Table 4h in 
Appendix 4) possessed three values when the same test of normality was used (no 
tens condition - minute 1; subject control condition - minutes I and 2). The results of 
the Hartley test suggested that homogeneity of variance could be assumed with the 
intensity scores (F=2.24; d. f. =45,11; p<0.05) but not with the unpleasantness scores 
(F=4.76; d. f. =45,11; p>0.05). 
The results of the ANOVA (Table 4a on the next page) showed that the mean pain 
intensity scores could be seen to increase with time though this increase was not 
significantly different between the three conditions (F=0.60; d. f. =28,308; p=0.946). 
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Table 4a : ANOVA Table for VAS pain intensity scores in experiment 4 (100Hz 
TENS) 
SS d. f. MS F 
Effect of Condition 
Condition 531.40 2 265.70 0.22 0.806 
Error (Within + Residual) 26904.51 22 1222.93 
Effect of Time 
Time 41568.49 14 2969.18 24.90 < 0.001 
Error (Within + Residual) 18362.09 154 119.23 
Interaction (ConditionxTime) 
Condition x Time 514.65 28 18.38 0.60 0.946 
Error (Within + Residual) 9374.77 308 30.44 
The results also showed that, as with the mean VAS intensity scores, the mean VAS 
unpleasantness scores (Table 4b below) followed a similar mean increase over time 
but with no statistically significant difference between the three conditions (F=0.66; 
d. f. =28,308, p=0.907). 
Table 4b : ANOVA Table for VAS pain unpleasantness scores in experiment 4 
(100Hz TENS) 
SS d. f. MS F p 
Effect of Condition 
Condition 1030.23 2 515.12 0.28 0.755 
Error (Within + Residual) 39790.08 22 1808.64 
Effect of Time 
Time 69258.83 14 4947.06 28.32 <0.001 
Error (Within + Residual) 26905.74 154 174.71 
Interaction (ConditionxTime) 
Condition x Time 881.43 28 31.48 0.66 0.907 
Error (Within + Residual) 14690.26 308 47.70 
Both pain components possessed a significant F ratio on the effect of time (intensity 
F=24.90; d. f. =14,154; p=0.946; unpleasantness F=28.32; d. f. =14,154; p=0.907). 
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Figure XII below showed the mean current intensities used by both the experimenter 
and subject control conditions before and during pain induction. The graph showed 
that both conditions used similar levels of current in the 15 minutes before pain 
induction (both increase in steps) but once the pain was induced the subject control 
condition began to administer a noticeably higher level of current intensity than the 
experimenter control condition, with the difference becoming greater pain induction 
time increased. 
Figure XII : Mean VAS pain unpleasantness scores for all 3 conditions in 
experiment 4 (100Hz TENS) 
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Results of the ANOVAs (Tables 4c and 4d in Appendix 4) reflected the graphical 
findings of Figure XIII shown on the next page, with no statistically significant 
difference in mean current intensities being found between the experimenter and 
subject control conditions (F=0.21; d. f. =1,11; p=0.655) either before or during pain 
induction. 
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Figure XIII : Mean currrent intensities (mA) before and during pain induction 
in experiment 4 (100Hz TENS) 
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N. B. In figure XIII above minute 16 represents the Ist minute of pain induction. 
A statistically significant effect of time was found during the same period (F=25.71; 
d. f. =14,154; p<0.001) but this effect was not significant with respect to the control 
condition (F=1.43; d. f. =14,154; p=0.144). The ANOVA results for the 15 minutes 
during pain induction showed no statistically significant effect of condition (F=1.73; 
d. f. =1,11; p=0.216) but a statistically significant effect of condition with respect to 
time (F=2.79; d. f. =14,154; p=0.001). 
11.7: Discussion 
The aims of the present study were to (1) investigate the efficacy of high frequency 
(100Hz) TENS using the selected experimental procedure and (2) investigate if the 
efficacy of high frequency (100Hz) TENS is affected by the degree of perceived 
control that the subject is given over the TENS current intensity. The experimental 
179 
hypotheses were based on these aims and the results of the study showed no 
statistically significant difference in VAS pain intensity or VAS pain unpleasantness 
scores between the 3 treatment conditions: no TENS; experimenter controlling 
100Hz TENS; subject controlling 100Hz TENS. Neither null hypothesis, therefore, 
could be rejected. 
The results implied that the subjects rated their pain similarly regardless of the 
different conditions they were being tested under and this was reflected in the 
similarity of the data obtained for each of the conditions (Tables 4e-4h in Appendix 
4). The means and standard deviations were comparable between the conditions for 
both pain and unpleasantness scores but, as observed in experiment 3, there was a 
greater variance with the unpleasantness scores (reflected in the Hartley test). As 
before, this could be attributable to unpleasantness, based on neurophysiological pain 
mechanisms, being subject to greater levels of pain modulation (Fields, 1987; 
Guilbaud et al, 1994; Jones, 1997; Lima, 1997). The variability in the pain 
unpleasantness scores, as already mentioned in experiment 3, should not have 
affected the outcome of the ANOVA as the test remains robust when equal group 
numbers are used (Winer et al, 1991). 
The results suggested that control of the current intensity in the present experiment 
had no effect on mean VAS scores of pain intensity or pain unpleasantness. With 
regards to the efficacy of TENS, the results suggested that high frequency (100Hz) 
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TENS was no more effective in relieving pain (intensity or unpleasantness) than no 
TENS at all. A possible reason, therefore, for no statistically significant effect being 
found with the variable of control of the current intensity could be due to the 
ineffectiveness of the TENS. The inability of TENS in the present experiment to 
decrease mean pain scores (intensity or unpleasantness) meant that, regardless of who 
controlled the current intensity, no pain-relief was achieved. Analysis of the mean 
current intensities used by the experimenter and subject control conditions suggested 
that when the subjects were given an opportunity to control the current intensity 
themselves, they gave themselves higher mean levels of current intensity in an attempt 
to find pain-relief. In this sense control of the current intensity could be thought of as 
being "in the hand as well as the head" as subjects, when in control themselves, had 
the ability to increase the amount of peripheral afferent input they were receiving 
from the TENS. 
The results of the previous studies using TENS with experimental ischaemic pain 
supported the use of the pain model in testing the efficacy of TENS and suggested 
that current frequency could be a determining factor to the experimental outcome. In 
the study by Walsh et al (1995) TENS at 4Hz was shown to produce a pain-relieving 
effect while TENS at 110Hz was found to be no more effective than no TENS at all 
(a similar result to the present experiment). Foster et al (1995) reported a trend, 
although the difference was not statistically significant at the selected p value of less 
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than or equal to 0.5, towards a greater pain-relieving effect using a low frequency 
current (4Hz) than that with a high frequency (110Hz) current. 
It is important, however, not to be led by majority opinion as the results of these 
studies may have been dependent on the pain assessment tool used. Roche et al 
(1984) reported an increase in pain tolerance time following high frequency TENS 
compared to a control condition of no TENS (see Table 1). Similar findings were 
also reported by Woolf (1979) using pain tolerance times as an outcome measure 
with the ischaemic pain test (see Table 1). It could be, therefore, that pain tolerance 
time produce different outcomes than when VASs are employed or that other 
methodological variables (for example, cuff pressure or exercise intensity) were 
responsible for the variation in results. The issue of current frequency, however, 
cannot be dismissed as it has been found to be a determining factor, although not 
always statistically significant, in the outcome of TENS studies with the experimental 
ischaemic pain model. For this reason it was considered appropriate to repeat the 
same experimental procedure using a low frequency TENS current. 
11.8 : Conclusions 
(1) High frequency (100Hz) TENS was found to be no more effective in relieving 
pain (intensity or unpleasantness) than no TENS at all. 
(2) Control of the current intensity, whether by the experimenter or the subject, had 
no effect on mean VAS pain scores (intensity or unpleasantness). 
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Chapter 12 : Experiment 5- Investigation of the effect of low frequency 
TENS on pain intensity and pain unpleasantness of the ischaemic pain 
tourniquet test using healthy female volunteers. Subject control versus 
experimenter control of TENS. 
12.1 : Introduction 
The results of experiment 4 showed that (1) high frequency (100Hz) TENS had 
no statistically significantly greater effect on mean VAS pain scores (intensity or 
unpleasantness) than no TENS at all and that (2) differences in control of the 
current intensity had no statistically significant effect on VAS pain intensity or 
VAS pain unpleasantness scores. The results of the previous experiment therefore 
indicated that high frequency (100Hz) TENS had no effect on decreasing the 
intensity or unpleasantness of experimentally induced ischaemic pain regardless of 
whether the experimenter or the subject controlled the current intensity. 
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Research with TENS using the ischaemic model of experimental pain has not 
conclusively established optimal current parameters for pain-relief, with positive 
TENS outcomes being found with a range of current and methodological 
variables including electrode placement and treatment duration. With regards to 
the variable of current frequency, Woolf (1979) obtained positive outcomes using 
a high frequency current (although not statistically supported) while papers 
comparing high and low frequency currents have produced evidence supporting 
the use of low frequency currents (Foster et al, 1995; Walsh et al, 1995) (see 
Section 6.5 and Table 1). The results of Foster et al (1995) and Walsh et al 
(1995), although not always reaching statistical significance, have suggested that 
low frequency currents produce a greater pain-relieving effect than high frequency 
currents with the ischaemic experimental pain model. The influence of TENS 
current frequency on pain perception is therefore still under debate and warranted 
further investigation. The present experiment followed a similar procedure to that 
used in experiment 4 except a low current frequency (5Hz) was used. 
12.2: Aims 
It was the aims of this experiment to (1) investigate the pain-relieving efficacy of 
low frequency (5Hz) TENS and (2) investigate if the pain-relieving efficacy of 
low frequency (5Hz) TENS is affected by whether the experimenter or the subject 
is given control over the TENS current intensity. These aims were not listed in 
order of priority. 
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12.3: Design 
The same experimental design was used as in experiment 4. 
12.4: Methodology (Experimental procedure shown in Appendix 13) 
12.4.1 : Materials and instrumentation (Photographs in Appendix 8 and 
Appendix 12) 
The same materials and instrumentation were used as in experiment 4. 
12.4.2 : Subject Recruitment 
The same subject recruitment procedure was used as in experiments 1-4. Twelve 
healthy female volunteers (mean age 20.25 years; range 18-25 years) were 
recruited from Queen Margaret College student population. There were no drop- 
outs from the study 
12.4.3: Ethics 
Ethical approval was granted by Queen Margaret College Ethical Committee 
before commencing the study. The same information sheet and consent form as 
used in experiments 1-4 (except timetabling alterations) were used. 
12.4.4: Introductory session 
The same procedure for the introductory session was used as in experiment 4 
except that the TENS was applied at a frequency of 5Hz instead of 100Hz. 
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12.4.5: Pain Induction 
The same pain induction procedure was used as in experiments 3 and 4. 
12.4.6: TENS 
The TENS procedure was the same as in experiment 4 except that the TENS 
frequency was 5Hz (all the other current parameters remained the same). 
12.4.7: Pain Assessment 
The same pain assessment procedure was used as in experiments 2-4. 
12.4 : Data Analysis 
The same statistical tests were used as outlined in experiment 2. As in the 
previous experiment (experiment 4) the two factors in the separate ANOVAs 
(intensity and unpleasantness) were experimental conditions (no TENS, 
experimenter controlling TENS, subject controlling TENS) and time (one minute 
intervals x 15). A 2-factor ANOVA for repeated measures was also selected to 
investigate the difference in mean current intensities used between the 
experimenter and subject control conditions. 
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12.5: Hypotheses 
The following hypotheses were tested in experiment 5: 
(I) Hypothesis (H, ) 
There will be a statistically significant difference in VAS pain intensity 
scores between the 3 treatment conditions: no TENS; experimenter 
controlling 5Hz TENS; subject controlling 5Hz TENS. 
Null Hypothesis (Ho) 
There will not be a statistically significant difference in VAS pain intensity 
scores between the 3 treatment conditions: no TENS; experimenter 
controlling 5Hz TENS; subject controlling 5Hz TENS. 
(II) Hypothesis (H2) 
There will be a statistically significant difference in VAS pain 
unpleasantness scores between the 3 treatment conditions: no TENS; 
experimenter controlling 5Hz TENS; subject controlling 5Hz TENS 
Null Hypothesis (Ho) 
There will not be a statistically significant difference in VAS pain 
unpleasantness scores between the 3 treatment conditions: no TENS; 
experimenter controlling 5Hz TENS; subject controlling 5Hz TENS. 
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12.6 : Results 
The graphs and tables of data for experiment 5 are shown either here in the text or 
in Appendix 5. The mean VAS intensity scores during pain induction for all 3 
conditions are shown below in Figure XIV. 
Figure XIV : Mean VAS pain intensity scores for all 3 conditions in 
experiment 5 (5Hz TENS) 
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The scoring in all of the conditions was very similar in the first 3 or 4 minutes and 
then the subject control condition began to give lower mean pain scores than the 
other two conditions. The mean difference between the subject control condition 
and the other 2 conditions (experimenter controlling TENS and no TENS) 
became greater as the pain duration increased. 
Regarding the VAS pain unpleasantness scores, Figure XV on the next page 
showed the mean scores during pain induction for all 3 conditions. 
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Figure XV : Mean VAS pain unpleasantness scores for all 3 conditions in 
experiment 5 (5Hz TENS) 
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Subject groups in all conditions rated mean pain unpleasantness lower than mean 
pain intensity in the first minute of pain assessment. After approximately 5 
minutes of cuff inflation the subject control condition began to rate pain 
unpleasantness lower than the other 2 conditions (experimenter controlling TENS 
and no TENS). At the end of the pain induction period the no TENS condition 
gave the highest mean pain unpleasantness scores with the subject control 
condition giving the lowest. 
The Hartley test suggested that homogeneity of variance could not be assumed by 
either the intensity (F=2.87, d. f. =45,11; p>0.05) or unpleasantness (F=4.80; 
d. f. =45,11; p>0.05) scores. Normality of data, however, was achieved by all the 
data when calculated by the Shapiro-Wilk test. 
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A 2-factor analysis of variance (ANOVA) for repeated measures was used to 
investigate the relationship between the VAS intensity scores and the 
experimental conditions. The results of the ANOVA (Table 5a below) showed no 
statistically significant difference in VAS mean pain intensity scores between the 3 
conditions in the study (subject controlling 5Hz TENS; experimenter controlling 
5Hz TENS; no TENS). 
Table 5a : ANOVA Table for experiment 5 VAS pain intensity Scores (5Hz 
TENS) 
SS M. MS F p 
Effect of Condition 
Condition 3611.88 2 1805.94 3.08 0.066 
Error (Within + Residual) 12904.26 22 586.56 
Effect of Time 
Time 41147.73 14 2939.12 42.78 <0.001 
Error (Within + Residual) 10580.13 154 68.7 
Interaction (ConditionxTime) 
Condition x Time 1854.46 28 66.23 3.76 <0.001 
Error (Within + Residual) 5428.08 308 17.62 
There was, however, a statistically significant interaction effect (F=3.76; 
d. f. =28,308; p<0.001). This means that there was a statistically significant 
difference between the conditions that was dependent on time. The effect of time 
on increasing VAS intensity scores was also significant (F=42.78; d. f. =14,154; 
p<0.001). 
A test of simple main effects was carried out manually on the VAS intensity 
scores to identify the time points at which the differences between the conditions 
were statistically significant. These were found to be minutes 9-15 and are shown 
in Table 5e in Appendix 5. Post-hoc Scheffe tests were then manually performed 
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to identify between which conditions the differences lie. The Scheffe tests (Table 
5b below) showed that the mean VAS pain intensity scores were lower in the 
subject control condition compared to the experimenter control condition and the 
condition receiving no TENS. 
Table 5b : Scheffe Test for experiment 5 VAS pain intensity scores (5Hz 
TENS) 
Time no TENS / expt 
control (F) 
no TENS / sub 
control (F) 
expt control / sub 
control (F) 
Minute 9 0.02 6.92* 6.22* 
Minute 10 0.02 8.60* 7.81 * 
Minute 11 0.30 10.10* 6.92* 
Minute 12 0.55 14.72* 9.60* 
Minute 13 0.72 12.30* 7.06* 
Minute 14 1.59 16.22* 7.66* 
Minute 15 1.88 13.48* 5.30 
*= statistically significant (p<0.05) 
The differences between mean scores in the experimenter control condition 
compared to the condition receiving no TENS became statistically significant 
from the 9th minute until the end of the pain induction period with the exception 
of the 15th minute. At this point the difference between the mean scores in the 
subject control condition and the experimenter control condition was not 
statistically significant. 
A separate 2-factor analysis of variance (ANOVA) for repeated measures was 
used to investigate the relationship between the VAS unpleasantness scores and 
the experimental conditions. The ANOVA (Table 5c on the next page) showed no 
statistically significant difference between the conditions (F=3.00; d. f. =2,22; 
P=0.071). 
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Table 5c : ANOVA Table for experiment 5 VAS pain unpleasantness scores 
(5Hz TENS) 
SS d. f. MS F p 
Effect of Condition 
Condition 4124.54 2 2062.27 3.00 0.071 
Error (Within + Residual) 39790.08 22 1808.64 
Effect of Time 
Time 47527.99 14 3394.86 52.98 <0.001 
Error (Within + Residual) 9868.86 154 64.08 
Interaction (ConditionxTime) 
Condition x Time 2092.57 28 74.73 3.33 <0.001 
Error (Within + Residual) 6907.92 308 22.43 
The statistically significant interaction effect (F=3.33; d. f. =28,308; p<0.001), 
however, means that there was a statistically significant difference between 
treatment conditions that was dependent on time. As with the intensity scores, 
there was a significant F ratio with the effect of time (F=52.98; d. f. =14,154; 
P=0.001). 
A test of simple main effects and post hoc Scheffe tests were carried out as before 
except using the VAS unpleasantness scores. The test of Simple Main Effects 
identified that differences between the experimental conditions could be found at 
minutes 10,13 and 15. Minutes 12 and 14 were included in the Scheffe test as 
their F values fell just below the critical value of 3.00 (see Table 5f in Appendix 
5). The results of the Scheffe test (Table 5d on the next page) showed that the 
mean VAS pain unpleasantness scores were lower in the subject control condition 
than in the condition receiving no TENS. 
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Table 5d : Scheffe Test for experiment 5 VAS pain unpleasantness scores 
(5Hz TENS) 
Time no TENS / expt 
control (F) 
no TENS / sub 
control (F) 
expt control / sub 
control (F) 
Minute 10 2.03 6.80* 1.40 
Minute 12 1.61 6.28* 1.53 
Minute 13 1.28 6.68* 2.10 
Minute 14 1.66 7.54* 2.13 
Minute 15 2.40 9.51 * 2.35 
*= statistically significant (p: 50.05) 
These differences in means were statistically significant from the 10th minute until 
the end of pain induction, apart from the 11th minute when the differences were 
not statistically different. Differences between experimenter control and no TENS 
and between subject control and no TENS were not shown to be statistically 
significant. Figure XVI below showed the mean current intensities used by the 
experimenter and subject control conditions both before and during pain 
induction. 
Figure XVI : Mean current intensities (mA) before and during pain 
induction in experiment 5 (5Hz TENS) 
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N. B. In figure XVI above minute 16 represents the 1st minute of pain induction. 
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The graph showed that both the experimenter and subject control conditions 
administered higher intensities of current during pain induction compared to the 
15 minutes before but that similar levels of current intensity were used by both 
conditions over the full 30 minute period. The similarity in mean current 
intensities by the experimenter and subject control conditions was reflected in the 
results of the ANOVAs (tables 5g and 5h shown in Appendix 5), with no 
statistically significant effect of control condition being found either before 
(F=0.05; d. f. =1,11; p=0.831) or during (F=0.33; d. f. =1,11; p=0.575) pain 
induction. 
12.7: Discussion 
The results of the present experiment showed that there was a statistically 
significant difference in both mean VAS pain intensity and mean VAS pain 
unpleasantness scores between the 3 treatment conditions: no TENS; 
experimenter controlling 5Hz TENS; subject controlling 5Hz TENS. Both null 
hypotheses were therefore rejected. 
The results of this experiment suggested that the degree of perceived control that 
a subject had over current intensity influenced mean VAS scores of pain intensity 
and pain unpleasantness using the selected experimental procedure. The present 
experiment showed, with regards to the VAS mean pain intensity scores, that 
there was no statistically significant difference in scores given by the experimenter 
control condition and those in the no TENS condition. Statistically significant 
differences, however, were found between the subject control condition and the 
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other two experimental conditions. Results of the post-hoc tests supported the 
observation that the subject group, when given control of the TENS current 
intensity, rated their mean pain intensity lower than when either in the 
experimenter control group or the no TENS condition. The results indicated that 
the subject group in the present experiment rated their mean pain intensity lowest 
when they controlled the TENS current intensity themselves. The results also 
showed that the subject control condition, but not the experimenter control 
condition, was more effective in reducing mean VAS pain intensity scores than 
the no TENS condition. In the present experiment using a low frequency current, 
therefore, experimenter control of the TENS current intensity was no more 
effective in reducing mean pain intensity than no TENS at all. 
A slightly different result was found with the pain unpleasantness VAS scores, 
with the Scheffe test producing insufficient evidence to show a statistically 
significant difference between the experimenter control condition and the 
condition receiving no TENS. A possible explanation for this may be that the 
Scheffe test was too conservative to detect small but overall statistically 
significant differences (Winer, 1991). Increased variance in the unpleasantness 
scores could explain the reason why mean differences between conditions were 
not detected. This suggested that while there may have been a relatively small 
pain-relieving effect, with regards to the VAS pain unpleasantness scores, the 
statistical power of the test may not have been sufficient to reveal these mean 
differences as statistically significant. The argument that there may be small pain- 
relieving effects of low frequency TENS is consistent with an interpretation of the 
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findings of Foster et al (1995) who reported a possible trend towards a pain- 
relieving effect in the absence of statistical significance. 
The results of the present experiment indicated that the pain-relieving efficacy of 
low frequency (5Hz) TENS, with respect to both the pain intensity and pain 
unpleasantness scores, was dependent on who controlled the current intensity. 
TENS, in the present experiment, was found to be effective in relieving pain when 
the subjects controlled the current intensity. Analysis of the mean current 
intensities (Tables 5g and 5h in Appendix 5) used by the experimenter and subject 
control conditions before and during pain induction showed that there was no 
statistically significant difference between the levels of current intensity used by 
the experimenter and subject control conditions during the full 30 minute 
measurement period. This outcome was in contrast with the results found in 
experiment 4 where the subject control condition administered statistically 
significantly higher amounts of high frequency current to themselves than the 
experimenter control condition during pain induction. It could have been that, in 
the present experiment using low frequency TENS, subjects did not have to 
increase the current intensity to find pain-relief as the TENS was effective in 
reducing pain intensity and pain unpleasantness scores when compared to the no 
TENS condition. The results therefore suggested that subject control of the pain 
intensity was more effective in reducing mean VAS scores of pain intensity and 
pain unpleasantness than the experimenter control condition because the TENS 
was perceived to be effective in relieving pain. 
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The proposed theoretical effect of psychological variables such as control on 1st 
stage pain perception has been discussed in Section 3.4 and it has been suggested 
that the context in which a stimulus is delivered may have an influence on the 
sensory-discriminative (pain intensity) and motivational-affective (pain 
unpleasantness) components of the pain response. In the present experiment the 
results indicated that both components of pain were influenced to a similar degree 
when the subjects controlled the current intensity. It could be proposed that the 
subjects were perhaps unable to distinguish between the two VAS scales and so 
marked them both similarly but the difference in variance between the two sets of 
data (see Tables 5j and 51), as well as the questionnaire responses from a 
comparable subject group in experiment 2, gave evidence to support the view that 
the subjects were able to distinguish between pain intensity and pain 
unpleasantness and mark the scales accordingly. 
The results of experiment 4, when compared with the results of the present 
experiment, raised the question as to why different outcomes were found. The 
results of experiment 4, which used a high frequency current, found that TENS 
was not effective in relieving pain regardless of whether the experimenter or 
subject controlled the current intensity. A possible reason for the results could be 
that the subjects noticed qualitative differences between the high frequency 
current and the low frequency currents which in turn influenced their perceived 
efficacy of the TENS in relieving pain. It has been suggested that giving subjects 
control of the current intensity decreased pain perception with the 5Hz current but 
not the 100Hz TENS current because the latter was not perceived to be effective 
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in relieving pain. It could therefore be suggested that the pain-relieving efficacy of 
TENS was dependent on qualitative differences noticed between high and low 
current frequencies. 
Low frequency currents are thought to be more effective than higher frequency 
currents in stimulating motor, as well as sensory afferent fibres at a given current 
intensity (Low and Reed, 1990; Thompson and Woolf, 1994) and, therefore, it is 
a possibility that the subjects in the present experiment experienced different 
sensations than with the 100Hz current. The results of the present experiment, 
when compared with experiment 4, indicated that there could indeed be a 
qualitative difference in the subjects' perception between the 5Hz and 100Hz 
currents. This in turn may have influenced the effectiveness of each of the TENS 
currents in relieving pain. Observation of the graphs showing mean current 
intensities used in experiments 4 and 5 (Figures XIII and XVI) indicated that 
subjects used higher levels (mA) of current with the low frequency current than 
the high frequency current. These figures cannot validly be compared statistically 
as they were taken from different subject groups in separate experiments. It was 
therefore the aims of the next study to (1) compare the pain-relieving effects of 
TENS when subjects are in control of both a low frequency (5Hz) and high 
frequency (100Hz) current and (2) identify if subjects perceived there to be any 
qualitative differences between the two currents and, if so, how this influenced 
how the two currents were applied. 
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12.8: Conclusions 
(1) Low frequency (5Hz) TENS when the subjects controlled the current intensity 
was found to be more effective in relieving pain (intensity or unpleasantness) than 
when the experimenter controlled the current intensity. 
(2) Low frequency (5Hz) TENS when the experimenter controlled the current 
intensity was found to be no more effective in relieving pain (intensity or 
unpleasantness) than when no TENS was used at all. 
(3) The results of the present experimenter, when compared with those in 
experiment 4, suggested that giving subjects control of the current intensity 
decreased pain perception (intensity and unpleasantness) only when the TENS 
current was perceived as being effective in relieving pain. 
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Chapter 13 : Experiment 6- Investigation of the effect of high and low 
frequency TENS on pain intensity and pain unpleasantness of the ischaemic 
pain tourniquet test using healthy female volunteers. 
13.1 : Introduction 
The results of experiment 4 and 5 showed that subject control of the TENS current 
intensity statistically significantly decreased pain scores (intensity and 
unpleasantness) during the ischaemic pain tourniquet test when a low frequency 
current was used (5Hz) but not when a high frequency (100Hz) current was used. 
The only difference between the two experiments was the frequency at which the 
TENS currents were delivered and therefore it was suggested that a possible reason 
for experiment 4 and experiment 5 obtaining different results may have been due to 
qualitative differences between the two currents which resulted in subjects 
perceiving one to be less effective than the other in relieving pain. It was also 
suggested that qualitative differences between the two currents may have caused 
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subjects to select higher intensities of one type of current over another. A 
questionnaire was designed specifically for the present experiment to assess 
perceived qualitative differences between the two currents (Appendix 14). A 
comparison of actual current intensities selected (mA) was also recorded during the 
pain induction procedure and this data was analysed to investigate if, indeed, 
subjects did select statistically significantly higher current intensities of either a high 
or low frequency TENS current. 
13.2: Aims 
The aims of this study were to (1) compare the pain-relieving effects (pain intensity 
and pain unpleasantness) of TENS when subjects are in control of both a low 
frequency (5Hz) and high frequency (100Hz) current and (2) identify if subjects 
select different levels of current intensity depending on the current frequency. These 
aims were not listed in order of priority. 
13.3: Design 
The same experimental design was used as in experiments 4 and 5. All subjects 
experienced each of the three testing conditions; no TENS (n=12), high frequency 
(HF = 100 Hertz) TENS (n=12), and low frequency (LF=5 Hertz) TENS (n=12). 
The same randomisation procedure was followed as in previous experiments. 
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13.4: Methodology (Experimental procedure shown in Appendix 13) 
13.4.1 : Materials and instrumentation (Photographs in Appendix 8 and 
Appendix 12) 
The same materials and instrumentation were used as in experiments 4 and 5. 
13.4.2 : Subject Recruitment 
The same subject recruitment procedure was used as in previous experiments. 
Twelve healthy female volunteers (mean age 21.58 years; range 19 - 30 years) were 
recruited from Queen Margaret College student population. There were no drop- 
outs from the study. 
13.4.3: Ethics 
Ethical approval was granted by Queen Margaret College Ethical Committee before 
commencing the study. The same information sheet and consent form (except 
timetabling alterations) as used in previous experiments were used. 
13.4.4: Introductory session 
The introductory session followed the same procedure as in experiments 4 and 5 
except that the subject, and not the experimenter, adjusted the TENS current 
intensity until they reported it to be `just perceptible'. 
13.4.5 : Pain Induction 
The same pain induction procedure was used as in experiments 3-5. 
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13.4.6: TENS 
The same TENS procedure was used as in experiments 4 and 5 except that all 
subjects experienced both the 100Hz and 5Hz frequency TENS currents during 
different testing sessions. The subjects were in control of the TENS intensity in each 
case. The digital readout display of the TENS machine was covered throughout all 
the experiments so that only the experimenter, and not the subject, could read which 
frequency they were receiving, or how much current they were giving themselves. 
13.4.7: Pain Assessment 
The same pain assessment procedure as in experiments 3-5 was used except that 
once the cuff was deflated after the final test each subject was asked to complete a 
questionnaire, constructed specifically for the experiment, to assess the qualitative 
aspects of the 2 TENS currents used (Appendix 14). 
13.4.8: Data analysis 
The same statistical tests were used as outlined in experiment 2. Two separate 2- 
factor analysis of variance (ANOVA) for repeated measures were used to 
investigate the relationship between the VAS (intensity and unpleasantness) scores 
and the experimental conditions (no TENS, HF TENS, and LF TENS). A 2-factor 
ANOVA was also carried out to compare the amount of current (milliamps) 
selected by the subjects using the different TENS frequencies. 
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13.5 : Hypotheses 
The following hypotheses were tested in experiment 6: 
(I) Hypothesis (H, ) 
There will be a statistically significant difference in VAS pain intensity 
scores between the 3 treatment conditions: no TENS; subject controlling 
100Hz TENS; subject controlling 5Hz TENS. 
Null Hypothesis (Ho) 
There will not be a statistically significant difference in VAS pain intensity 
scores between the 3 treatment conditions: no TENS; subject controlling 
100Hz TENS; subject controlling 5Hz TENS. 
(II) Hypothesis (H2) 
There will be a statistically significant difference in VAS pain 
unpleasantness scores between the 3 treatment conditions: no TENS; 
subject controlling 100Hz TENS; subject controlling 5Hz TENS. 
Null Hypothesis (Ho) 
There will not be a statistically significant difference in VAS pain 
unpleasantness scores between the 3 treatment conditions: no TENS; 
subject controlling 100Hz TENS; subject controlling 5Hz TENS. 
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(III) Hypothesis (H3) 
There will be a statistically significant difference in the current intensities 
selected in the 5Hz TENS condition and the 100Hz TENS condition. 
Null Hypothesis (Ho) 
There will not be a statistically significant difference in the current 
intensities selected in the 5Hz TENS condition and the 100Hz TENS 
condition. 
13.6 : Results 
The data and graphs for experiment 6 are shown either here in the text or in 
Appendix 6. The graph showing the mean VAS intensity scores for all 3 conditions 
(Figure XVII below) indicated that all the subject groups, irrespective of treatment 
condition, reported an increase in mean pain intensity over time during pain 
induction. 
Figure XVII : Mean VAS pain intensity scores for all 3 conditions in 
experiment 6 
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The low frequency TENS condition gave lower mean pain intensity scores than the 
other two conditions over the first 14 minutes of the test, while the no TENS 
condition gave the highest mean pain intensity scores (not significant) from minute 7 
onwards. 
The graph of the mean VAS unpleasantness scores (Figure XVIII below) showed 
that all 3 treatment conditions rated mean pain unpleasantness very similarly at the 
start of the test but from minute 7 onwards the low frequency TENS condition rated 
their mean pain unpleasantness lower (not significantly) than the other two 
conditions. 
Figure XVIII : Mean VAS pain unpleasantness scores for all 3 conditions in 
experiment 6 
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The Hartley test suggested that homogeneity of variance could not be assumed with 
the intensity (F=4.86; d. f. =45,11; p<0.05) or unpleasantness (F=4.24; d. f. =45,11; 
p<0.05) scores in the present experiment. The Shapiro-Wilk test (Tables 6h and 6j 
in Appendix 6) showed normality of distribution for the majority of scores, with the 
VAS intensity data possessing only a small selection of scores whose p value fell 
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below the 0.05 level. These scores were at minutes 13-15 in the no TENS condition, 
minutes 1 and 5-15 in the high frequency TENS condition and minute 15 in the low 
frequency TENS condition. VAS intensity scores that were close to the p=0.05 level 
were all in the high frequency TENS group and were at minutes 2 (p=0,. 07), 3 
(p=0.08) and minute 4 (p=0.06). The high frequency TENS condition, as with the 
VAS intensity scores, gave the largest number of deviations from the normal 
distribution of data with the VAS unpleasantness scores. These were found at 
minutes 1-6 and minute 9, with minutes 7 and 12 just falling outwith the accepted p 
value. There were no scores in this category in the no TENS experimental condition 
and, in the low frequency TENS condition, scores with ap value less than or equal 
to 0.05 were found at minutes 1 and 2 (minutes 3,6 and 8 were just above this 
value). 
The raw and mean VAS scores for pain intensity in each of the 3 conditions (no 
TENS; subject controlling 100Hz TENS; subject controlling 5Hz TENS) are shown 
in Tables 6g and 6h in Appendix 6. The results of the ANOVA (Table 6a on the 
next page) showed that the mean pain intensity scores could be seen to increase with 
time (F=16.05; d. f. =14,154; p<0.001) though this increase was not significantly 
different between the three conditions (F=1.19; d. f. =28,308; p=0.239). 
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Table 6a : ANOVA table for VAS pain intensity scores in experiment 6 
VAS INTENSITY 
SS d. f. MS F 
Effect of TENS 
TENS 1199.13 2 599.56 0.28 0.761 
Error (Within + Residual) 47809.10 22 2173.14 
Effect of Time 
Minute 37825.16 14 2701.80 16.05 < 0.001 
Error (Within + Residual) 25920.93 154 168.32 
Interaction 
TENS x Minute 1103.49 28 29.41 1.19 0.239 
Error (Within + Residual) 10213.63 308 33.16 
The results also showed that, as with the VAS intensity scores, the mean VAS 
unpleasantness scores (Table 6b below) followed a similar mean increase over time 
(F=18.98; d. f. =14,154; p<0.001) but with no statistically significant difference 
between the three conditions (F=1.36; d. f. =28,308, p=0.110). 
Table 6b : ANOVA table for VAS pain unpleasantness scores in experiment 6 
VAS 
UNPLEASANTNESS SS d. f. MS F p 
Effect of TENS 
TENS 1023.11 2 511.56 0.19 0.829 
Error (Within + Residual) 59584.40 22 2708.38 
Effect of Time 
Minute 64162.19 14 4583.01 18.98 < 0.001 
Error (Within + Residual) 37190.39 154 241.50 
Interaction 
TENS x Minute 1607.39 28 57.41 1.36 0.110 
Error (Within + Residual) 12993.10 308 42.19 
Analysis of the current intensities used in the two conditions receiving TENS 
(Tables 6c and 6e) showed that the subjects selected significantly higher intensities 
of low frequency current both before (F=7.38; d. f. =1,11; p=0.020) and during 
(F=7.21; d. f. =1,11; p=0.021) pain induction although neither showed a statistically 
208 
significant interaction effect (before F=0.67; d. f. =14,154; p=0.805: during F=1.34; 
d. f. =14,154; p=0.188). Simple main effects, carried out manually, identified that the 
TENS current intensities were statistically different at all of the 15 one minute 
intervals before pain induction (see Table 6d in Appendix 6) while during pain 
induction statistically significant differences were found from minutes 7 to 15 (see 
Table 6f in Appendix 6). These results, including the standard deviations, are 
illustrated in Figure XIX below (the means and standard deviations for the current 
intensity data are shown in tables 61 and 6n in Appendix 6). 
Figure XIX : Mean current intensities for both 100Hz and 5Hz TENS in 
experiment 6 (including standard deviations) 
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N. B. In figure XIX above minute 16 represents the 1st minute of pain induction. 
A summary of the questionnaire findings are shown in Table 6o in Appendix 6. All 
the subjects, except one, thought the two currents felt different from each other. 
This was reflected in the descriptors selected for each current, with the lower 
frequency current being described as "pulsed" and "throbbing", while the sensation 
produced by the higher frequency current was described as "fuzzy" and "buzzing". 
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Only 7 of the 12 subjects felt that they had used a higher intensity with one type of 
current and, interestingly, 6 of these subjects thought it was with the high frequency 
current. 
13.7: Discussion 
The aims of this study were to (1) compare the pain-relieving effects (pain intensity 
and pain unpleasantness) of TENS when subjects are in control of both a low 
frequency (5Hz) and high frequency (100Hz) current and (2) identify if subjects 
select different levels of current intensity depending on the current frequency. The 
results of the study showed no statistically significant difference in either mean VAS 
pain intensity or mean VAS pain unpleasantness scores between the 3 treatment 
conditions: no TENS; subject controlling 100Hz TENS; subject controlling 5Hz 
TENS. The first two null hypotheses could not, therefore, be rejected. A statistically 
significant difference was found, however, between the mean current intensities 
selected with the 5Hz TENS condition and the 100Hz TENS condition and the third 
null hypothesis could be rejected. As in previous experiments, deviations from 
qualities required of parametric data (Hartley test and Shapiro-Wilk test) could be 
assumed to minimally affect the ANOVA as the statistical test remains robust to 
such deviations when equal numbers in groups are used (Winer et al, 1991). The 
outcomes of the present study could therefore be taken to be valid. 
Observation of the ANOVA results for the pain intensity and pain unpleasantness 
scores showed that the p values were 0.239 and 0.110 respectively. In the case of 
the unpleasantness scores, this level of statistical significance was still relatively high 
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and, therefore, although the relevant null hypothesis could not be rejected, the result 
could not be dismissed as representing a strong statistical trend. This trend was 
reflected in the graph which showed the mean VAS pain unpleasantness scores 
during pain induction for all 3 treatment conditions (Figure XVIII). The graph 
indicated that the 5Hz TENS condition gave noticeably lower mean pain 
unpleasantness scores than the other two conditions, especially in the later stages of 
pain induction. 
The findings of this experiment reinforced those reported in experiment 5 with 
respect to pain unpleasantness. The mean reporting of pain intensity by the low 
frequency TENS condition in the present experiment, however, did not reach a high 
level of statistically significant difference from that in the no TENS condition. 
Experiment 3 (see Chapter 10) found that, after an initial exposure to the 
experimental procedure, subjects marked VAS pain scales (intensity and 
unpleasantness) in a similar manner when repeatedly exposed to the ischaemic pain 
tourniquet test. It could be proposed, therefore, that in both the present experiment 
and experiment 5, the pain scores of intensity and unpleasantness were valid and 
that the decrease in mean pain intensity reported in experiment 5 using low 
frequency TENS was a weak, non-repeatable effect. None of the studies which have 
used TENS with the ischaemic pain tourniquet test (Foster et al, 1995; Roche et al, 
1984; Walsh et al, 1993; Walsh et al, 1995; Woolf, 1979) used a repeated test 
design where TENS was applied more than once to the same subject. It is therefore 
not possible to speculate about whether TENS would have produced similar pain 
scores as the 1 st test exposure if the experiment had been repeated. 
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The majority of subjects in the study (n=11) did notice qualitative difference 
between the two frequencies of current and this was identified by the questionnaire 
responses (see Table 6o). Seven of these subjects felt that the qualitative difference 
between the two TENS frequencies had caused them to use a higher intensity with 
one of the currents. Six out of the seven thought they had used a higher intensity of 
current with the high frequency (100Hz) TENS, with only one subject stating that 
the low frequency (5Hz) TENS had required a higher intensity of current to reach a 
4 just perceptible' level. This was in complete contradiction to the actual intensities 
(mA) selected by all the subjects, with the ANOVA of the intensity scores showing 
a statistically significant effect of frequency both before (F=7.38; d. f. =1,11; p=0.02) 
and during (F=7.21; d. f. =1,11; p=0.021) pain induction. The low frequency (5Hz) 
TENS intensity was found to be consistently lower than that of the high frequency 
(100Hz) TENS and this difference was statistically significant at all 15 one minute 
time intervals prior to pain induction and from minutes 7-15 during cuff inflation. 
It could be suggested that the differences in perceived sensation between the two 
currents resulted in the dissimilar results being found with the selected levels of 
intensity. The requirement of higher intensities of current at lower frequencies is 
supported by Johnson et al (1991a) who found that chronic pain patients required 
significantly more current to attain sensory threshold, therapy level and pain 
threshold at 20Hz as opposed to 100Hz TENS. The findings were also in agreement 
with theoretical electrical principles of TENS and strength-duration curves which 
propose that at similar pulse durations, low frequency currents require greater 
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intensities of current than high frequency currents to reach the rheobase (Low and 
Reed, 1990; Woolf and Thompson, 1994) (see Section 2.4 and Figure 3b). The 
results of the present experiment therefore supported the evidence that current 
frequency affects the intensity of current that subjects administer to themselves at a 
given subjective level such as sensation threshold and this may be due to perceived 
qualitative differences between high and low frequency TENS currents. 
13.8: Conclusions 
(1) Neither null hypothesis regarding mean VAS pain scores was able to be rejected 
but a strong statistical trend was found with the pain unpleasantness scores, 
indicating that lower mean VAS scores were given by the subject control condition 
than either of the other two test conditions (no TENS and experimenter control). 
(2) The results of the present experiment suggested that subjects perceived high 
frequency and low frequency TENS currents differently. This difference in perceived 
sensation appear to have led subjects to administer different levels of current 
intensity to themselves when they were controlling the TENS current, with 
statistically significantly greater mean levels of current being administered when the 
low frequency current was used. 
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CHAPTER 14: DISCUSSION 
14.1 : Introduction 
A review of the literature at the beginning of this thesis aimed to identify the 
current state of knowledge in the relevant topic areas. Gaps in the literature with 
regard to the pain-relieving efficacy of TENS were noted as including; (i) multi- 
dimensional assessment of both 1 st and 2nd stage pain perception, (ii) optimal 
current frequency of TENS and (iii) the influence of control. A series of six 
experiments was carried out, based on the gaps identified in the literature, to 
investigate whether experimenter or subject control of the current intensity 
influenced the pain-relieving effects (1st stage intensity and unpleasantness) of 
TENS using an ischaemic model of experimental pain. Experiments 1-3 were 
carried out to establish appropriate methodologies for the pain induction and pain 
assessment procedure used in the present study. Experiments 4-6 then went on to 
investigate the influence of control of the current intensity on pain perception 
using both a high frequency (100Hz) and a low frequency (5Hz) TENS current. 
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The findings of experiments 1-6 suggested that the outcomes of the present study 
would be best discussed under the following headings; research design, 
experimental pain model, pain assessment, TENS parameters, control, 
implications for clinical practice, future work and conclusions. 
14.2 : Research design 
An experimental model of pain induction was selected in the present study. The 
decision to use an experimental pain model arose from the review of literature. 
The review of literature identified different methodologies and outcome measures 
between clinical TENS trials and this has led to conflicting outcomes assessing the 
efficacy of TENS in the clinical setting. An example of contradictory study 
outcomes included those reported by Deyo et al (1990) and Marchand et al 
(1993). Deyo et al (1990) found TENS to be no better than placebo treatment 
when used with patients with chronic low back pain while Marchand et al (1993) 
reported that TENS was significantly more effective than placebo in reducing pain 
intensity immediately following treatment in a comparable subject group (see 
Sections 5.4 and 6.2 respectively). It has been highlighted in this thesis that it is 
extremely important, if the pain-relieving efficacy of TENS is to be established, 
that the mechanisms of effect are identified. Mechanisms of effect cannot be 
established from clinical trials of varying methodology because comparison of 
results is too difficult. The necessity and usefulness of clinical trials is not disputed 
but more rigid control of methodological variables is required if the complex 
neurophysiological mechanisms involved in TENS are to be identified. The 
present study was therefore carried out using a controlled experimental design. In 
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this way the present study design can be viewed as adopting an approach whereby 
the choice of subjects, TENS parameters and pain assessment procedure aimed to 
reduce the number of variables which could theoretically have confounded the 
effects of the variable being investigated (the effect of control of the current 
intensity). These aspects of the experimental design will be dealt with individually 
later in the discussion. 
There is evidence which supports the view that TENS can act at different levels of 
neural processing of sensory input, namely spinal cord, brainstem and cortical (see 
Chapter 4). The modulation of pain perception is dependent on the complex 
interaction of these mechanisms and is thought to be contributed to by factors 
such as the TENS current parameters (Eriksson et al, 1979; Garrison and 
Foreman, 1994), characteristics of the patient group (Richardson, 1994), the 
patient-therapist interaction and perception of control (Gielen, 1989; Klaber 
Moffett and Richardson, 1997; Turner et al, 1994). It has been suggested that 
variables are easier to control during experimental pain induction than in the 
clinical setting and it has been proposed that intervention under laboratory 
conditions is necessary to identify mechanisms of analgesic action (Gracely, 
1994). 
The employment in the present study of an experimental pain model using healthy 
students from Queen Margaret College was an important aspect of the present 
study's tightly controlled approach. It was identified in the review of literature, 
supported by neurophysiological evidence, that psychological variables such as 
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control can influence both the I st and 2nd stage of pain perception (Guilbaud et 
al, 1994, Lima, 1997) (see Sections 3.4 and 5.5). The influence of control on 1st 
stage pain perception is thought to be a result of stimulation of target sites of the 
medial ascending tracts (motivational-affective component of pain) (Guilbaud et 
al, 1994; Lima, 1997) while 2nd stage pain perception is thought to be influenced 
to a greater extent by cognitive-evaluative cortical processing or so-called 
placebo effects (Price and Harkins, 1992). The present study, in order to decrease 
the number of variables which could have masked the effect of control on pain 
scores chose to assess 1st stage pain perception. Although the 1st stage of pain 
perception is not greatly affected by placebo effects, it has been shown that the 
stimulation of the motivational-affective target sites, under the influence of 
attentional mechanisms, is dependent on the emotional context in which a 
stimulus is delivered (Lima, 1997). It was therefore considered extremely 
important in the present study to reduce the number of variables between subjects 
which could have modulated attentional mechanisms. Marchand et al (1993) 
reported that, with respect to pain reporting and changes in attention, variations in 
pain perception can occur due to subjects being placed in an unfamiliar 
environment. In the present study subjects were all familiar with the environment, 
experimenter and equipment and this should have minimised variations in 
attentional mechanisms and placebo effects and maintained them at a comparable 
level between subjects. 
The subject numbers used for the experiments in the present study ranged from 
between five and twelve. This was in accordance with subject numbers used in 
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other experimental studies using TENS, taking into consideration variation in 
study design (Foster et al, 1995; Roche et al, 1984; Walsh et al, 1993; Walsh et 
al, 1995; Woolf, 1979). The subject numbers were also found to be appropriate 
for the statistical test employed (ANOVA) as, even with small numbers such as 
n=5 in experiment 3, the statistical power of the test was calculated as being 0.95 
for the pain intensity scores and 0.78 for the pain unpleasantness scores. It was 
thought that increasing the subject number could have led to methodological bias 
as large subject numbers are more appropriate when it is necessary to detect a 
small effect such as a dangerous side-effect in a drug trial. In this instance then, if 
the null hypothesis of the drug not being harmful is falsely not rejected (Type II 
error), the drug will be incorrectly considered to be safe. The purpose of the 
present study was to establish the efficacy of TENS when the current intensity 
was controlled by (1) the experimenter and (2) the subject. The present study was 
therefore investigating the pain-relieving effects of TENS under different 
experimental conditions and it would not have been advantageous to have the 
actual therapeutic significance of relatively small pain-relieving effects magnified. 
14.3: Experimental pain model 
An ischaemic model of experimental pain induction was used in the present study. 
A summary of popular experimental pain techniques was reviewed in Section 6.4. 
While each pain model has its own usefulness, the ischaemic pain model was 
considered the most appropriate pain induction technique for use in the present 
study due to its standardised procedure, prolonged duration of the painful 
stimulus and short recovery period. The duration of the ischaemic pain induction 
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was originally planned as 15 minutes. The drop-out rate in experiment 1 which 
occurred before this period had elapsed addressed the need to adjust the 
parameters of the ischaemic pain induction procedure so as to increase the 
tolerance time to 15 minutes while still producing an appropriate level of pain. 
This was achieved by decreasing the exercise grip / release time from 2 seconds to 
I second. The mean VAS scores of both pain intensity and pain unpleasantness in 
experiments 2-6, supported by the graphical and statistical evidence, suggested 
that the subject groups perceived the experimental ischaemic pain to be 
progressively more painful (intensity and unpleasantness) as the pain induction 
time increased, with almost all subjects tolerating the full 15 minutes. 
The results of the present study, which distinguished between pain intensity and 
pain unpleasantness, provided important information about the mechanisms of 
experimental ischaemic pain. Two mechanisms of action for the ischaemic pain 
tourniquet test were identified as being due to (1) a build-up of exercise-induced 
metabolites in the arm and (2) mechanical pressure applied by the cuff (Pertovaara 
et al, 1984). The first mechanism is activated by noxious levels of chemical by- 
products of exercise which, based on the properties of afferent nociceptors, 
stimulate C fibres (Meyer at al, 1994). The second mechanism is thought to occur 
as a result of noxious levels of mechanical stimulation which therefore stimulate 
both AS and C fibres (Fields, 1987; Meyer et al, 1994). AS and C fibres have been 
found to relay noxious information in the lateral and medial ascending tracts and 
contribute to the sensory-discriminative and motivational-affective components of 
the pain response, respectively. The results of experiment 2 in the present study 
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suggested that the contribution of each of the identified mechanisms was not 
dependent on the cuff pressure used (200mmHg or 250mmHg) as both pain 
intensity and pain unpleasantness scores followed similar trends under both 
experimental conditions (intensity F=0.22; d. f. =14,84; p=0.999: unpleasantness 
F=0.15; d. f. =14,84; p=1.000). 
Experiment 3 addressed another important issue regarding the experimental pain 
model used in the present study - investigating the pain response of subjects when 
placed under repeated exposures of the pain induction procedure. The graphs of 
the experimental results (see Figures VII-VIII in Appendix 3) indicated that there 
was a trend for decreased pain reporting, particularly with the mean pain intensity 
scores, over repeated test exposures. The mean scores for both pain intensity and 
pain unpleasantness decreased during successive exposures to the pain induction 
procedure, with the greatest difference in mean scores being noted between the 
1 st and 2nd test. Graphs of the individual scores (see Figures IX i-iii and X i-iii) 
showed that subjects gave higher pain scores in the initial minutes of the first test 
than in either the second or third. This finding stressed the need for an 
introductory session which allowed the subjects to experience the pain induction, 
pain assessment and TENS (when applicable), so reducing the probability of a 
`shock' reaction by subjects to the painful stimulus and increasing the probability 
of obtaining data that was reflective of the subjects' pain response. 
The possible disadvantages of a repeated measures experimental design were 
highlighted in the review of literature when referring to the studies carried out by 
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Foster et al (1995), Walsh et al (1993) and Walsh et al (1995) (see Section 6.5). 
In each of these studies all subjects were tested twice, the first time to collect 
baseline data (ischaemic pain test with no intervention). Test 2,48 hours later, 
involved the same method of experimental pain induction except that subjects 
were assigned to an experimental group to receive some form of treatment 
intervention. The pain-relieving efficacy of the selected interventions was 
established in each case by comparing the pain scores (VAS intensity and MPQ) 
obtained for the two tests (1-way ANOVA and difference scores). The 
experimental design of these studies therefore made the assumption that the data 
collected in the first test was a reliable baseline measure upon which to compare 
pain scores from the second test. The findings of experiment 3 in the present 
study suggested that the pain measures in the 1 st exposure to the test were not 
consistently representative of the subjects' pain reporting in later tests. If the VAS 
pain intensity scores were statistically significantly higher in the initial test than in 
successive exposures, as found in experiment 3, then it would follow that the 
pain-relieving effects of the interventions would have been magnified. High 
baseline values mean that pain scores would have decreased in the second test, 
regardless of the intervention, but simply due to repeated exposure to the test 
procedure. Valid comparisons could have made between the different 
interventions being tested in any individual study but the therapeutic significance 
of a particular intervention may have been over-estimated with the chosen 
experimental design. To minimise these problems in the present study a cross-over 
design was used in experiment 2 and a randomisation procedure was used in 
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experiments 4-6. In this way, although still retaining the repeated measures 
experimental design, order effects were reduced. 
14.4: Pain assessment 
Two important aspects of the present study, based on neurophysiological 
evidence, were incorporated into the pain assessment procedure; (1) the decision 
to use a multi-dimensional approach to the assessment of pain perception and (2) 
the decision to distinguish between 1st and 2nd stage pain perception. The 
concept of a multi-dimensional pain response is not new and, indeed, has been 
addressed in both experimental (Duncan et al, 1989; Gracely et al, 1979; Price et 
al, 1983; Price et al, 1987) and clinical studies (Marchand et al, 1993; Price et al, 
1987). Distinguishing between Ist and 2nd stage pain perception, however, is a 
relatively new concept and although it has been discussed theoretically (Price and 
Harkins, 1992), differences between the two stages of pain perception have not 
been considered in any of the reviewed TENS studies in the present thesis (clinical 
or experimental). It was identified in the review of literature that the subject 
group and the type of pain being investigated influence the relative input of each 
of the two stages of pain perception, with 2nd stage playing a larger role in 
clinical chronic pain conditions (Price and Harkins, Wade et al, 1986). It is 
therefore important that pain studies base their choice of assessment tool and 
timing of pain assessment on the specific needs of their study design. It was 
decided from the review of the literature that, with the present experimental study 
design using healthy subjects, pain assessment tools would be required which 
were able to assess 1 st stage pain intensity and pain unpleasantness. 
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Having selected the ischaemic tourniquet model as the most appropriate method 
of experimental pain induction for the present study, the first experiment was 
designed to select a suitable measurement tool for assessing I st stage pain 
perception (pain intensity and pain unpleasantness). The review of measurement 
techniques identified the VAS and VRS as tools which could be adapted for the 
task (see Sections 7.2.1 - 7.2.3) and a comparison was carried out between these 
two scales in experiment 1. The results showed the scales to produce very similar 
pain scores, especially with the pain intensity scores (intensity r"=0.76-100: 
unpleasantness r2=0.50-1.00). Discrepancies between the pain unpleasantness data 
obtained from the VAS and VRS were found at a number of time points but were 
attributed to the cross-modality procedure used to score the VRS (see Section 
8.7). The limitations of both scales were taken into consideration and, based on 
the time consuming nature of the cross-modality procedure required to give the 
VRS interval/ratio scoring properties, the decision was made to select the VAS 
for sole use in the succeeding experiments. 
Previous experimenters using the ischaemic pain model (Foster et al, 1995; Roche 
et al, 1984; Walsh et al, 1993, Walsh et al, 1995; Woolf, 1979) have only 
measured pain intensity during the pain induction period. A number of these 
studies (Foster et al, 1995; Roche et al, 1984; Walsh et al, 1993, Walsh et al, 
1995) selected the MPQ as a multi-dimensional pain assessment tool after cuff 
deflation. Walsh et al (1995) explained the purpose of the MPQ as assessing `the 
worst pain experienced' which implied that a cognitive-evaluative (2nd stage) 
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level of pain perception was measured in the study. The two stages of pain 
perception were not identified by any of the authors and so it could not be 
established if the MPQ was meant to be assessing the first or second stage of pain 
unpleasantness. 
Results of the MPQ scores in the study carried out by Walsh et al (1995) were 
shown graphically in terms of differences between the 1 st and 2nd tests and 
observation of the data indicated that, with both the high and low frequency 
TENS currents, the affective component of the pain response was decreased to a 
much lesser extent (between approximately a half and a third) than the sensory 
component. The difference between the two components was greater when the 
high frequency TENS current was used. These MPQ results did not correspond 
with the VAS results found in the present study, with mean pain unpleasantness 
scores being influenced to a similar extent (relative to mean pain intensity scores) 
with the high frequency current and to a greater extent with the low frequency 
current when the subject controlled the pain intensity. This indicated that the 
VASs used in the present study and the MPQ used in the study carried out by 
Walsh et al (1995) were assessing different stages of pain perception from each 
other. This finding reinforces the need for pain studies to identify the stage of pain 
perception which they aim to assess and choose an appropriate measuring tool. 
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14.5: TENS parameters 
The pain-relieving efficacy of both a high frequency (100Hz) and low frequency 
(5Hz) TENS current was investigated in the present study. The results of 
experiment 4 which investigated the efficacy of high frequency TENS found that 
the modality was ineffective in reducing either pain intensity or pain 
unpleasantness. The outcome suggested that 100Hz TENS, when either the 
subject or the experimenter controlled the current intensity dial, was no more 
effective in decreasing pain reporting than when no TENS was applied at all 
(F=0.60; d. f. =28,308; p=0.946: unpleasantness F=0.66; d. f. =28,308; p=0.907). In 
the same experiment, when the levels of current intensity (mA) were investigated, 
it was found that subjects selected statistically significantly higher levels of current 
during pain induction when they controlled the current intensity dial themselves as 
opposed to when the intensity was controlled by the experimenter (F=2.79; 
d. f. =14,154; p=0.001). Taking into consideration that neither control condition 
provided pain-relief (as suggested by the VAS scores) it was proposed that 
subjects in experiment 4, when given the opportunity to increase the current 
intensity themselves, did so in an attempt to help relieve their pain, although 
unsuccessfully. Different results were observed in experiment 5 which 
investigated the efficacy of low frequency (5Hz) TENS. In this experiment 
measures of pain intensity and pain unpleasantness were both statistically 
significantly reduced using TENS when compared with the no TENS condition 
(intensity F=3.76; d. f. =28,308; p<0.001: F=3.33; d. f. =28,308; p<0.001). 
Interestingly, when investigating the current intensities selected with the low 
frequency TENS during pain induction, it was found that there was no statistically 
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significant difference between the subject and experimenter control conditions 
(F=0.56; d. f. =14,154; p=0.892). This was interpreted as meaning that, because 
the low frequency TENS was successful in reducing pain perception (as suggested 
by the VAS scores), subjects did not have to take advantage of control of the 
current intensity in order to apply higher levels of current to themselves in search 
of pain-relief. It should be stressed that, although subjects were requested in each 
case to only turn up the current intensity until a `just perceptible' level of 
stimulation was achieved, as a subjective measure it was based entirely on subject 
honesty. The mean VAS scores (intensity and unpleasantness) in the present study 
showed that subjects found the low frequency current, but not the high frequency 
current, to be effective at a statistically significantly level in decreasing pain 
perception. It is therefore reasonable to suggest, based on the result that the 
subject control condition used higher levels of current than the experimenter 
control condition with the low frequency but not the high frequency TENS 
current, that perception of current sensation was influenced by the expectation of 
pain reduction. 
The difference in outcomes found between the high and low frequency TENS 
currents in experiments 4 and 5 respectively can be linked with previous TENS 
studies which have used the ischaemic pain model (see Section 6.5 and Table 1). 
The findings of Walsh et al (1995) were in agreement with the findings of the 
present study, supporting the use of low frequency currents for increased pain- 
relief using TENS and reporting that high frequency TENS was no more effective 
in relieving pain than no TENS at all. The results of the present study, however, 
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posed the question as to why clinical studies such as that carried out by Marchand 
et al (1993) have found that high frequency currents statistically significantly 
reduced patient pain perception. Possible reasons for such discrepancies in study 
outcome include the patient group being assessed and the timing of the pain 
assessment procedure. Marchand et al (1993) used VASs to assess both pain 
intensity and pain unpleasantness. Unlike the present study, pain assessment was 
carried out at a number of time points before and after treatment over a period of 
six months and was therefore assessing 2nd stage pain perception. The subject 
group used in the study were chronic low-back pain patients and pain perception 
would have been greatly influenced by the cognitive-evaluative component of the 
pain response (Price and Harkins, 1992). The effect that the low-back pain had on 
the patients' lifestyles and mood states would have influenced the VAS scores but 
this is not the case with the present study which assessed I st stage pain 
perception in healthy subjects. Differences in outcome between the two types of 
study are therefore to be expected as they were assessing different stages of pain 
perception in different subject groups. 
It is important to stress the reason why the present study chose to assess 1 st 
stage, and not 2nd stage, pain perception. If a positive pain-relieving effect with 
TENS when the subjects controlled the current intensity had been found with 2nd 
stage pain assessment in the present study, the result could not necessarily have 
been attributed to the variable of control. Instead it could have been due to a 
combination of variables which have been thought to influence 2nd stage pain 
perception such as subject mood state and subject-experimenter interaction 
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(Gielen, 1989; Klaber Moffett and Richardson, 1997; Turner et al, 1994). Healthy 
subjects were used in the present study and so assessing their pain perception 
after the painful stimulus had been removed would not have been reflective of the 
clinical scenario. The effect of low frequency TENS in decreasing I st stage pain 
perception found in the present study when the subjects controlled the current 
intensity indicates that the variable of control influenced the outcome. The 
methodology of the present study, using a tightly controlled experimental design, 
was able to minimise the effect of other possible variables which are thought to 
influence Ist stage pain perception (e. g. unfamiliar environment). In this way the 
results of the present experiment indicate that subject control of the current 
intensity will theoretically decrease pain perception in the clinical situation as 2nd 
stage pain processing can allow the effects to be magnified. 
14.6: Control 
Experiments 4-6 in the present study, as well as looking at the effect of TENS 
current frequency on pain perception, aimed to also investigate the effect of 
control of the current intensity on the efficacy of TENS during experimental 
ischaemic pain induction. No previous studies have incorporated control of the 
current intensity as a variable in TENS trials. Indeed, with the exception of the 
study by Walsh et al (1995) who stated that the subjects controlled the TENS 
intensity, none of the other reviewed experimental ischaemic pain studies reported 
who controlled the TENS intensity. In light of the aims of the present study, 
which included investigating the effect of experimenter and subject control of the 
current intensity on pain perception, it cannot be easily compared with past 
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research. The pain-relieving efficacy of high and low frequency TENS currents 
was investigated in experiments 4 and 5 respectively and, with particular reference 
to the variable of control, the results of the present study indicated that subject 
control of the current intensity, in conjunction with a low current frequency, 
optimised the pain-relieving effects of TENS. The low frequency current, but not 
the high frequency current was found to decrease the perception (intensity and 
unpleasantness) of experimentally induced ischaemic pain and therefore it is 
suggested that subject control of the current intensity only optimised pain-relief 
with TENS when the TENS current was capable of decreasing pain perception. 
The present study found that subject control of the current intensity statistically 
significantly decreased Ist stage pain perception (intensity and unpleasantness) 
with TENS when a low frequency (5Hz) current was used. The assessment of 1 st 
stage pain perception in the present study allowed mechanisms of pain-relieving 
effect by TENS which occur below cortical level to be identified. This is because 
assessment of 1 st stage pain perception does not theoretically incorporate 
significant input from the cognitive-evaluative component of the pain response. It 
is important to emphasise, therefore, that the pain-relief produced by TENS in the 
present study was not a placebo response. 
The results of experiment 6 which compared the 100Hz and 5Hz TENS currents 
when the subject controlled the TENS did not reject the null hypothesis that there 
was no statistically significant difference in VAS pain intensity scores between the 
3 treatment conditions: no TENS; subject controlling 100Hz TENS; subject 
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controlling 5Hz TENS (F=1.19; d. f. =28,308; p=0.239). This was not the same 
outcome as that obtained in experiment 5 (F=3.76; d. f. =28,308; p<0.001) and 
suggested that the pain-relieving efficacy of the low frequency TENS current was 
not a strong repeatable effect. The outcome of each experiment in the present 
study was based on the decision to reject, or not, the null hypotheses. In order for 
the null hypotheses in the present study to be operational a statistical significance 
level of p: 50.05 was selected. The selection of ap value therefore, although 
allowing the null hypotheses to be operational, did not allow for identification of 
statistical trends. A selected level of significance is concerned with helping to 
define, in very specific terms, what kind of chances are being taken when a 
decision is made to reject, or not, a null hypothesis (Payton, 1994). Ap value of 
0.05 therefore presents with a five percent risk of making the incorrect decision. 
Statistical significance should never be confused with real He significance and, as 
suggested by Payton (1994), a statistical statement of probability should always 
be interpreted by human reason. The ANOVA results in experiment 6 (see Tables 
6i and 6j - Appendix 6) showed the p values for the effect of TENS frequency 
over time to be 0.239 (F=1.19; d. f. =28,308) for the pain intensity scores and 
0.110 (F=1.36; d. f. =28,308) for the pain unpleasantness scores. In the case of the 
pain unpleasantness scores, the p value was low enough to propose that there was 
a difference in perception of pain unpleasantness between the experimental 
conditions (no TENS, subject controlling high frequency TENS, subject 
controlling low frequency TENS) and this difference would have been considered 
statistically significant at the level of p=0.110. Observation of the graphical data 
(see Figure XVI - Appendix 6) indicated that the low frequency TENS condition 
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gave lower mean VAS pain unpleasantness scores than the high frequency TENS 
and no TENS conditions and that this difference was greatest between minutes 10 
and 14 inclusive. Mean pain unpleasantness scores were found to be similar 
between the experimenter control and no TENS conditions. The results of 
experiment 6, therefore, reinforced the results of experiment 5 which indicated 
that subject control of the current intensity of low frequency (5Hz) TENS 
decreased 1st stage pain unpleasantness of experimentally induced ischaemic pain. 
Mean current intensities selected by subjects with both TENS current frequencies 
were also investigated in experiment 6 and it was highlighted that the subject 
group administered statistically significantly higher mean intensities of low 
frequency (5Hz) current than high frequency (100Hz) current when controlling 
the intensity themselves. Possible reasons for this difference in mean current 
intensity selection were identified in the replies from the questionnaire designed 
specifically for the study (see Table 6h in Appendix 6). The questionnaire 
responses identified that 11 out of 12 subjects noticed a qualitative difference 
between the two currents, with 5 of these subjects reporting that they had 
perceived one of the currents to be stronger than the other. These subjects then 
gave descriptions of each of the two currents, with the choice of words indicating 
that the perceived difference in current strength may have been related to the 
perceived current sensations. Words used to describe the 5Hz TENS included 
`pulsing', `beating' and `throbbing' which all correspond with a stimulus applied 
intermittently (i. e. at a low frequency). The words used to describe the 100Hz 
current, on the other hand, included `buzzing', `fuzzy' and `tingling' which are 
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more consistent with a stimulus delivered at high frequency. The questionnaire in 
experiment 6 also asked subjects if they felt they had selected higher intensities of 
one current over the other. Of the 7 positive replies, 6 thought they had applied 
higher intensities of the high frequency TENS in order to achieve a `just 
perceptible' level of current sensation. Subjects were asked to achieve a "just 
perceptible" level of current with both high and low frequency TENS and it 
follows, therefore, that if subjects thought they were taking more current with the 
100Hz TENS, then it felt `weaker' than the 5Hz TENS and higher intensities 
were required in order to reach the same level of sensation. 
The identification of qualitative differences between the 100Hz and 5Hz currents 
has implications as to the different pain-relieving effectiveness of one current over 
the other. Walsh et al (1995) suggested that low frequency currents may operate 
by producing a `counter-irritant' effect and this comment was based on the 
observation that muscle contractions had been produced by the low frequency 
TENS current in the region of the electrodes. In the present study a low current 
intensity (sensation threshold) was used and it is therefore extremely unlikely that 
the current intensity was high enough to produce a muscle contraction. Walsh et 
al (1995) also suggested that the low frequency TENS current may have reduced 
pain scores by producing a distraction from the experimental ischaemic pain. The 
results of experiment 6 indicated that the low frequency current may have been 
perceived as being stronger than the high frequency current. It is therefore 
reasonable to suggest, supporting the views of Walsh et al (1995), that the low 
frequency current in the present study was perceived as being stronger, providing 
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subjects with a distraction from the ischaemic pain and decreasing their pain 
perception. This viewpoint is also supported by the findings published by Johnson 
et al (1991 a) who reported that in patients with chronic pain, even those who did 
not produce a significant decrease in pain reporting with the use of TENS, 
continued to use the modality stating that "TENS does not reduce my pain, but it 
distracts, or takes my mind off it". The results of the study by Johnson et al 
(1991 a) have important implications for distinguishing between 1 st and 2nd stage 
pain perception as pain assessment in the study was carried out when the TENS 
was not in situ. Different results may have been found if 1st stage pain assessment 
during the application of TENS had been carried out as the TENS may have 
provided a distraction from their pain and so decreased their pain perception. 
The distraction hypothesis was not, however, the only explanation of the effects. 
Lima (1997) provided neurophysiological evidence for differences in pain- 
relieving efficacy between high and low frequency currents. The author proposed 
that the signals sent supraspinally by lamina 1 neurones may be dependent on the 
qualitative properties of the stimulus and suggested that stimuli which are 
perceived to be qualitatively dissimilar activate different distributions of cells 
within the spinal cord in response to sensory input. This variation in cell activation 
between different stimuli also implies that qualitative differences between TENS 
currents involve neurophysiological modulatory mechanisms at spinal cord, 
brainstem and cortical level which influence pain perception. It was discussed 
earlier in the thesis (see Section 3.4) that 1st stage pain perception is primarily a 
reflection of processing of noxious and non-noxious information within the spinal 
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cord and at the target sites within the brainstem and cortex (Jones, 1997; Lima, 
1997). In this respect it is proposed that in the present study subject control of the 
TENS intensity was more effective with the low frequency current because target 
sites influencing the effect of control on pain perception (for example, cingulate 
gyrus and temporal lobe) may have been, to a greater extent, stimulated by the 
low frequency TENS than by the high frequency TENS. 
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CHAPTER 15 : IMPLICATIONS FOR CLINICAL PRACTICE AND 
FUTURE RESEARCH 
15.1 : Introduction 
The rationale for the present study is laid out in Section 7.4. This methodology is 
considered appropriate and necessary for the experimental approach used. As with 
all study designs, from RCTs to single case studies, the method has limitations. 
These must be addressed if clinical inferences are to be made. A number of issues 
are raised and are sub-headed in order of their possible effect on the clinical 
relevance of the present study. These are listed as; model of pain induction, TENS 
current intensity, subject group, omission of a sham TENS condition and 
electrode placement. In each instance the present study methodology is compared 
with the clinical situation and suggestions made as to how this may have 
influenced study outcome. A final section, based on the limitations and inferences 
already mentioned, is then presented on other clinical implications of the present 
study and the possibilities for future research. 
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15.2: Model of pain induction 
Before the specific limitations of the ischaemic pain tourniquet test are raised, it is 
important to re-emphasise that experimental pain, regardless of how rigorously 
the technique is carried out, cannot replicate clinical pain. It is well recognised 
within the field of pain research that experimental pain is dissimilar to clinical pain 
both physically and psychologically (Gracely, 1994). In the case of experimental 
ischaemic pain the painful stimulus is transient in that it is present only once the 
exercises are performed and lasts until a short time after the cuff is deflated. There 
is no residual tissue damage to the involved limb and clinical symptoms such as 
allodynia or hyperalgesia are not present. The transient nature of the stimulus 
contributes to the psychological disparity between clinical and experimental pain 
as with the latter the person experiencing the pain knows that there will be no 
negative lasting effects and that the stimulus can be removed at their request. In 
this way the person does not experience the same degree of anxiety, depression or 
suffering that can be associated with clinical pain (Bromur, 1984). 
A specific problem with the tourniquet method of experimental ischaemic pain 
induction is that there is the possibility of sensory disturbances to the involved 
limb due to nerve compression. This could have the effect of distorting sensory 
perception distal to the cuff and in turn influence the pain VAS scores. Another 
implication of nerve compression is that the TENS current may have been unable 
to stimulate the nerves distal to the cuff. This is discussed in greater detail under 
`Electrode placement'. 
236 
15.3 : TENS current intensity 
The selection of a `just perceptible' level of current throughout the TENS 
stimulation in the present study was based on a neurophysiological rationale 
which aimed to allow TENS, theoretically, to modify pain at a spinal segmental 
level during both the high and low frequency TENS experiments (for greater 
detail see Section 7.4.4). In the clinical setting, however, TENS is more 
commonly used at a level which is perceived by the patient to be strong but 
comfortable (Frampton, 1996). It could be argued, therefore, that TENS' inability 
to reduce pain scores using the high frequency (100Hz) current may have been 
due to there being an insufficient level of current. This is a possibility but cannot 
be resolved in the present study. It therefore addresses the need for a similar study 
to be carried out using various different levels of current intensity. 
15.4: Subject group 
The subject group used in each of the experiments in the present study were 
healthy female students from Queen Margaret College and represented a sample 
population which were of the same sex and of similar age, race and educational 
status. This population was not, therefore, representative of the clinical situation 
where patients are socially and demographically different from one another. 
Inferences as to how a clinical population would have rated their pain using the 
pain induction model in the present study are difficult to make, taking into 
consideration that research has indicated that factors such as sex, age and cultural 
background can influence a person's reporting of pain (French, 1989; Heath and 
Thomas, 1993). The issue is further complicated by the pain-free status of the 
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subjects in the present study, making it difficult to compare them to patients 
experiencing clinical pain. 
The results of the present study indicated that greatest pain-relief was achieved 
when the subject controlled the TENS intensity of a low frequency (5Hz) current 
and it was suggested that this may have been due to qualitative preferences for 
that particular current parameter. The subjective nature of the pain experience 
means that making broad generalisations about pain responses are inappropriate 
but it is important to be aware of factors thought to influence pain ratings when 
investigating the outcome of a study. 
15.5: Omission of a sham TENS condition 
The treatment conditions used in the present study were either active TENS 
conditions (subject or experimenter controlling the current intensity) or a non- 
treatment control condition. During the control condition subjects were not issued 
with any of the relevant TENS instructions, nor did not have electrodes attached 
to them, as subjects in the active TENS procedure did. There is, therefore, the 
possibility that in the instances where the active TENS conditions gave 
statistically significantly lower pain scores than the control (no treatment) 
condition that it was the complete process of applying the TENS that produced 
the result. In other words, the omission of a sham TENS condition in the present 
study does not allow it to be established if pain-relief from TENS was due to the 
stimulation of nerves by an electrical current or solely due to the process of 
having TENS applied. The subjects used in the present study were all familiar 
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with TENS which would have made it extremely difficult to give an effective 
sham treatment. The situation was further complicated by the repeated measures 
design used in the TENS experiments. The use of a sham TENS condition in the 
present study, if perceived by the subjects as being a sham, could have had the 
effect of contaminating the succeeding tests and decreasing the validity of the 
results. It was therefore viewed that the disadvantages of a sham TENS condition 
in the present study outweighed the advantages. Importantly, what the results of 
the present study were able to inform us about was whether TENS, under the 
intensity control of either the subject or experimenter, was more effective in 
relieving pain than no TENS at all. 
15.6: Electrode placement 
The electrode placements used in the present study were (i) lateral to C6/7 on the 
affected side and (ii) over Erb's point on the affected side. The former electrode 
position represents an attempt to provide TENS stimulation to the dermatone 
served by C6/7 which is in the lateral and distal aspect of the arm. The latter 
electrode position, on the other hand, is designed to stimulate the nerve course of 
the brachial plexus at a position where it is relatively superficial to the skin 
surface. The rationale for selecting these placements, as outlined at the end of the 
review of literature (see Section 7.4), was based on their use in previous TENS 
studies which have used the ischaemic pain model (Foster et al, 1995; Walsh et al, 
1993; Walsh et al, 1995). 
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As already mentioned in Section 15.2, a possible problem with the tourniquet 
method of experimental ischaemic pain induction is the sensory disturbance to the 
nerves in the arm distal to the cuff and this is a potential source of error in the 
experimental ischaemic pain study carried out by Roche et at (1984) (see Section 
6.5). The possible influence of nerve compression on nerve function results in 
electrode positioning at the site of pain being unsuitable with this model of 
experimental pain induction. In the clinical situation it is advantageous to position 
the electrodes close to the site of pain so as to ensure that the TENS stimulation 
is entering the same spinal levels as the original pain. In the present study it should 
be stressed that both the electrode placed lateral to C6/7 and the electrode over 
Erb's point were theoretically stimulating the same spinal segment in the arm as 
the ischaemic pain and were, therefore, positioned appropriately. In future 
experimental ischaemic pain studies it is necessary to address ideal electrode 
placement, taking into consideration the issue of nerve compression by the cufff. 
What does appear to be advantageous with this particular pain model is that the 
electrodes are positioned proximal, and not distal, to the cuff. 
15.7: Implications for clinical practice and possibilities for future research 
Other issues which have been raised in the present study and that have important 
implications for the use of TENS in the clinical setting include the need for clinical 
pain reports, based on neurophysiological evidence, to state clearly what patient 
group is being treating (acute or chronic pain), what parameters of TENS are 
being used (frequency, intensity, pulse duration, waveform, electrode placement, 
treatment duration) and under what conditions they are applied (location, 
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operator). The findings of the present study have indicated that subjects gave 
lower ratings of pain whilst receiving TENS stimulation and that the efficacy of 
the treatment was further enhanced when the subject, and not the experimenter, 
controlled the current intensity. It therefore seems appropriate for clinical pain 
reports to clearly state who controls the TENS stimulus during treatment. 
The present study has also addressed the importance of pain assessment 
procedure on pain outcomes and has identified the need for careful consideration 
of choice of measurement tools. The components of the pain response being 
assessed at either 1 st or 2nd stage of pain perception should be distinguishable, 
should be assessed separately and should be specific to the type of pain being 
assessed (e. g. 2nd stage pain perception with chronic pain). 
The results of the present study suggested that subject control of the current 
intensity was most beneficial when the mean pain scores given by subjects in the 
two TENS conditions (subject and experimenter control) were significantly lower 
than the mean pain scores given by the condition receiving no TENS at all. In the 
present study TENS was more effective in relieving pain than the no treatment 
condition when a low frequency (5Hz) current was employed. In the case of the 
high frequency (100Hz) TENS the modality, under subject or experimenter 
control, was no more effective in relieving pain than no TENS. It presents, 
therefore, that only when TENS was found to be more effective in relieving pain 
than no TENS that subject control was an enhancing factor. 
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It could therefore be argued that pain-relief with TENS would be optimised if 
subjects were allowed to select all their preferred TENS parameters (e. g. 
frequency, intensity, pulse duration, waveform, electrode placement) as in the 
studies carried out by Johnson et al (1991a and 1991b). In this way subjects 
would be able to control their own treatment with TENS using the parameters 
which they found most beneficial in relieving their pain. It is suggested that 
clinical TENS trials evaluating the effects of TENS should use the modality in the 
manner which it is most commonly used in the clinical setting. For example, 
patients receiving TENS treatment for chronic pain should be given the modality 
for everyday prolonged use as opposed to 20 minute treatment sessions 3 times a 
week. This is not to say that all TENS studies should be carried out in this 
manner, such as experimental studies which attempt to tightly control variables, 
but all those that aim to investigate clinical efficacy. 
Future work to be carried out in this research area should include the investigation 
of how the variable of control affects other models of experimental pain and also 
clinical pain. Taking into account the possible limitations of the ischaemic model 
of pain induction used in the present study, it appears beneficial to carry out 
similar studies under tightly controlled experimental conditions. It would then be 
useful to progress onto clinical studies investigating the effect of control on pain- 
relief using TENS. Second stage pain perception could be assessed, as well as first 
stage, in order to investigate the long-term influences of TENS on pain and daily 
functioning. This would provide valuable information as to how TENS can help in 
the management of chronic pain conditions but caution will be needed in the 
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interpretation of the results when attributing the outcomes to other external 
variables. The present study used a transient form of experimental pain and 
therefore it was thought more appropriate to measure pain during pain induction. 
The pain-relieving action of TENS, regardless of the parameters used, is relatively 
short-lasting once the current stimulus is removed (Eriksson et at, 1979; Sjolund 
and Eriksson, 1979). The results of the present study also supported the evidence 
that TENS provides a distraction from the original pain and indicated that TENS 
is most effective in relieving pain when the current is actually operational. It 
therefore appears more beneficial for patients in clinical TENS studies to rate their 
pain or related function whilst the modality is in situ. Take, for example, a 
person's pain being assessed at regular intervals after they had received oral 
analgesia. What the outcome measures would be providing information about is 
the duration and quality of pain-relief that the drug was providing. In the same 
way, assessing a person's pain once TENS has been removed provides 
information about how long pain-relief is achieved, and to what extent, once the 
stimulus is no longer present. Pain assessment after TENS has been removed, 
therefore, is useful to give guidelines as to how regularly treatment should be 
given and identify mechanisms of action but does not directly reflect how TENS 
influences a person's pain whilst in operation. This is not to say that pain 
measures should only be taken during TENS treatment but that for all types of 
TENS study, the experimenter must decide the measurement tool and timing of 
that tool which provides most meaningful results. 
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The present study was investigating the difference between subject and 
experimenter control of the TENS current intensity and therefore was not 
concerned with the degree of the perceived degree of control that the subject 
believed they had over their treatment. Perceived Locus of Control (PLOC) scales 
are often used in studies involving control (see Section 5.5) and it would be useful 
to monitor this perception of control during further studies. It would also be 
interesting to see further work being carried out, using a similar approach to the 
present study, to establish the effect of other TENS parameters such as current 
intensity or pulse duration on pain perception as these are features which 
contribute to the qualitative nature of the TENS stimulus. In this way the 
parameters of TENS could be altered to increase the clinical relevance of the 
results. Ultimately, any further work into control and TENS should identify 
factors involved in the application of the modality which can then be manipulated 
to optimise pain-relief for its users. 
15.8: Conclusions 
(1) Greatest pain-relief with TENS was achieved in the present study when the 
subject controlled the current intensity and a low frequency (5Hz) current was 
used. The results of experiment 5 found that mean pain scores were statistically 
significantly lower in the subject controlling TENS condition than in either the 
experimenter controlling TENS condition or the no TENS condition (intensity 
F=3.76; d. f=28,308; p<0.001: unpleasantness F=3.33; d. f. =28,308; p<0.001). 
The results of experiment 6 found a statistical trend which indicated that the pain- 
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relieving effect of the low frequency current was repeatable at p values of 0.239 
(intensity) and 0.110 (unpleasantness). 
(2) Subject control of the current intensity was found to be more effective than 
experimenter control in the present study when subjects in both the two TENS 
conditions (experimenter and subject control) gave lower mean pain scores than 
the no TENS condition (i. e. TENS was found to be more effective than no 
TENS). The result suggested that optimal pain-relief with TENS is most likely to 
be achieved when patients are allowed to select their own preferred parameters. 
(3) The ischaemic model of experimental pain induction is responsive to testing 
the efficacy of TENS. This was indicated graphically by the gradual increase in 
mean pain scores rated by the subjects during the pain induction procedures in 
each experiment and reflected by the significant F values in the `time' condition 
calculated in the respective ANOVAs. 
(4) TENS independently influences VAS measures of both present pain intensity 
and present pain unpleasantness. This was indicated by the difference in variance 
of scores given for the two pain components and supported by the questionnaire 
responses in experiments 2 and 6. 
(5) The present study highlighted the need for pain studies to distinguish between 
1 st and 2nd stage pain perception and assess separately the sensory- 
discriminative, motivational-affective and cognitive-evaluative components of the 
pain response. This is based on the differences noted in the present study between 
the variance of pain intensity and pain unpleasantness scores. 
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APPENDICES 
Appendix 1: Experiment 1- Graphs and Tables 
Figure I: Mean VAS and VRS pain intensity scores during pain induction 
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N. B. It is important to note that due to the drop-out rate in this experiment that 
the number of subjects at all of the minute pain assessment intervals is not the 
same. The actual number of subjects at each time point is indicated by the `n' 
numbers listed in the table below. 
Time (mins) 1 2 3 4 5 6 7 8 9 10 11 
n 12 12 10 10 10 10 9 9 6 6 2 
Figure II : Mean VAS and VRS pain unpleasantness scores during pain 
induction 
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same. The actual number of subjects at each time point is indicated by the `n' 
numbers listed in the table below. 
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Figure III : Correlation of mean VAS and VRS pain intensity scores 
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Figure IV : Correlation of mean VAS and VRS pain unpleasantness scores 
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Tables 1a and 1b in text (Chapter 8) 
Table Ic : Raw VAS pain intensity scores for experiment I 
Subject 1 2 3 4 5 6 7 8 9 10 11 12 
Min 1 58 69 36 45 72 54 19 49 19 38 43 36 
Min 2 48 77 39 56 85 50 38 48 25 47 34 54 
Min 3 42 87 39 60 66 40 48 29 33 48 
Min 4 56 93 38 66 67 39 50 30 33 55 
Min 5 62 88 40 59 65 44 46 33 37 58 
Min 6 63 97 50 75 67 63 52 38 40 56 
Min 7 73 48 75 78 71 66 44 39 57 
Min 8 80 55 82 74 84 78 48 48 55 
Min 9 58 92 89 76 61 65 
Min 10 61 94 90 94 58 71 
Min 11 92 70 
Table Id : Raw VRS pain intensity scores for experiment 1 
Subject 1 2 3 4 5 6 7 8 9 10 11 12 
Min 1 64.5 72.6 38.2 20.5 95.8 44.8 13.6 38.2 20.5 38.2 44.8 38.2 
Min 2 44.8 84.8 38.2 38.2 95.8 44.8 38.2 38.2 20.5 38.2 38.2 38.2 
Min 3 38.2 95.8 38.2 38.2 64.5 38.2 38.2 38.2 38.2 38.2 
Min 4 64.5 95.8 38.2 44.8 64.5 38.2 44.8 38.2 38.2 44.8 
Min 5 64.5 95.8 38.2 38.2 64.5 44.8 38.2 38.2 44.8 44.8 
Min 6 64.5 100 44.8 64.5 72.6 64.5 44.8 38.2 38.2 64.5 
Min 7 72.6 44.8 64.5 84.8 84.8 64.5 38.2 38.2 44.8 
Min 8 84.8 44.8 72.6 84.8 95.8 72.6 44.8 44.8 64.5 
Min 9 64.5 84.8 95.8 84.8 64.5 72.6 
Min 10 64.5 95.8 95.8 95.8 64.5 72.6 
Min 11 95.8 64.5 
Table le : Summary of descriptive statistics (VAS and VRS intensity scores) 
for experiment 1 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
VAS 
Min 1 44.83±16.89 44.00 285.24 0.68 0.02 -0.49 
Min 2 50.08±16.97 48.00 288.08 0.35 0.87 0.74 
Min 3 49.20±17.45 45.00 304.62 0.31 1.18 1.28 
Mina 52.70±19.25 52.50 370.68 0.44 0.89 0.76 
Min 5 53.20±16.55 52.00 273.96 0.44 0.88 0.81 
Min 6 60.10±17.40 59.50 302.77 0.53 0.88 1.19 
Min 7 61.22±14.63 66.00 213.94 0.35 -0.43 -1.60 
Min 8 67.11±15.26 74.00 232.86 0.06 -0.25 -2.18 
Min 9 73.50±14.54 70.50 211.50 0.28 0.37 -2.15 
Min 10 78.00±16.70 80.50 278.80 0.08 -0.21 -2.67 
Min 11 81.00±15.56 81.00 242.00 N/A N/A N/A 
VRS 
Min 1 44.16±23.52 38.20 553.24 0.26 0.95 0.83 
Min 2 46.51±21.45 38.20 460.13 <0.01 1.70 2.33 
Min 3 46.59±19.16 38.20 367.28 <0.01 2.37 5.38 
Min 4 51.20±18.68 44.80 349.09 <0.01 1.78 3.07 
Min 5 51.20±18.68 44.80 349.09 <0.01 1.78 3.07 
Min 6 59.67±19.01 64.50 361.24 0.15 0.85 1.01 
Min 7 59.69±18.84 64.50 355.13 0.22 0.18 -1.71 
Min 8 67.72±19.38 72.60 375.74 0.28 -0.08 -1.50 
Min 9 77.83±12.67 78.70 160.56 0.35 0.23 -1.56 
Min 10 81.50±15.94 84.20 254.14 0.02 -0.13 -3.01 
Min 11 80.15±22.13 80.15 489.84 N/A N/A N/A 
Table If : Raw VAS pain unpleasantness scores for experiment 1 
Subject 1 2 3 4 5 6 7 8 9 10 11 12 
Min 1 52 61 31 61 63 71 15 39 19 58 41 53 
Min 2 39 77 36 58 88 62 28 49 25 67 28 36 
Min 3 51 90 37 34 51 32 50 29 31 43 
Min 4 56 88 41 61 44 42 56 30 30 57 
Min 5 60 91 45 47 59 52 53 33 44 56 
Min 6 63 98 45 76 70 67 60 38 40 61 
Min 7 66 54 79 81 73 63 44 44 69 
Min 8 92 60 79 80 88 76 48 55 63 
Min 9 62 87 90 82 61 68 
Min 10 77 91 93 96 58 74 
Min 11 93 70 
A, 
Table lg : Raw VRS pain unpleasantness scores for experiment I 
Subject 1 2 3 4 5 6 7 8 9 10 11 12 
Min 1 50.2 50.2 27.6 27.6 62.4 62.4 18.7 36.6 27.6 62.4 27.6 36.6 
Min 2 36.6 62.4 27.6 27.6 73.9 62.4 27.6 36.6 27.6 62.4 27.6 27.6 
Min 3 36.6 73.9 27.6 27.6 50.2 27.6 36.6 27.6 27.6 27.6 
Min 4 50.2 73.9 27.6 27.6 50.2 36.6 50.2 27.6 27.6 36.6 
Min 5 50.2 86.5 27.6 27.6 62.4 50.2 50.2 27.6 36.6 36.6 
Min 6 50.2 100 36.6 50.2 62.4 62.4 62.4 27.6 36.6 50.2 
Min 7 62.4 50.2 50.2 73.9 62.4 62.4 27.6 50.2 50.2 
Min 8 86.5 62.4 50.2 73.9 73.9 62.4 36.6 62.4 62.4 
Min 9 62.4 73.9 73.9 73.9 50.2 62.4 
Min 10 73.9 86.5 86.5 86.5 50.2 73.9 
Min 11 86.5 62.4 
Table 1h: Summary of descriptive statistics (VAS and VRS unpleasantness 
scores) for experiment 1 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
VAS 
Min 1 47.00±18.01 52.50 324.54 0.39 -0.64 -0.70 
Min 2 49.42±20.83 44.00 433.90 0.39 0.56 -0.87 
Min 3 44.80±18.05 40.00 325.73 <0.01 1.95 4.55 
Min 4 50.50±17.21 50.00 296.06 0.30 0.97 1.54 
Min 5 54.00±15.31 52.50 234.44 0.08 1.53 3.96 
Min 6 61.80±18.06 62.00 326.18 0.54 0.53 0.56 
Min 7 63.67±13.80 66.00 190.50 0.44 -0.39 -1.16 
Min 8 71.22±15.29 76.00 233.69 0.66 -0.17 -1.35 
Min 9 75.00±12.90 75.00 166.40 0.19 0.02 -2.63 
Min 10 81.50±14.57 84.00 212.30 0.39 -0.78 -0.37 
Min 11 81.50±16.26 81.50 264.50 N/A N/A N/A 
VRS 
Min 1 40.82±15.95 36.60 254.28 0.08 0.31 -1.53 
Min 2 41.66±18.01 32.10 324.29 <0.01 0.81 -1.23 
Min 3 36.29±15.13 27.60 229.03 <0.01 2.08 4.28 
Min 4 40.81±15.25 36.60 232.55 0.04 1.15 1.09 
Min 5 45.55±18.72 43.40 350.28 0.10 1.16 1.38 
Min 6 53.86±20.20 50.20 408.14 0.18 1.20 2.48 
Min 7 54.39±13.04 50.20 170.13 0.24 -0.76 1.66 
Min 8 63.41±14.36 62.40 206.32 0.51 -0.38 0.81 
Min 9 66.12±9.62 68.15 92.54 0.08 -0.92 -0.07 
Min 10 76.25±14.18 80.20 200.97 0.04 -1.52 2.31 
Min 11 74.45±17.04 74.45 290.40 N/A N/A N/A 
Appendix 2 : Experiment 2- Tables 
Figures V and V1 in text (Chapter 9) 
Tables 2a and 2b in text (Chapter 9) 
"r 
"r 
C 
"r 
u 
'C 
c«. 
O 
E 
L 
a 
aý L 
I 
cc 
4.0 cc 
"C3 
L' 
H 
C 
cl) 
Q 
u 
N 
B 
cc 
H 
0 
t ýO ýO Qý '? N N N M "r N V1 0 M ýO O 00 fý O ý, N -- M ýD C' _ M W! 't O V1 C' Vl N CT N N Qý f M V) N M M N 't ýO O Z 
2 
00 h l'- fý 
ý 
Q Q Q r4 rq Q 9 Q v O 
r i M N N - 
ri 
r. 
Oo 
- 
M ' V1 r-- 
\D 
"f N w' Oo 1 00 N 
Z 
9 ö ö 
; 
4 
- 
4 4 ö ö ö ý 9 9 9 9 9 9 9 0 0 0 9 9 .... ý .., (D o 
L_ 
O 'D 00 C' C' O O O M O 'n tN N O vn C> -t C v) N \O v, 00 N -f c, 'o - N N 
- M M '. D C' Q, C' C' Q '. G -t v1 -t M -t O -P N O O - M O C' 00 00 C' \O N - 
Cl) O O O O O O O O O O O C O O O O O O O O O O O O C O O O C C 
C N ON O O C\ O 00 O N N -t O -t -t v1 C' N, - W1 00 O ^- ^-r N -t -t S O C% N 
V') N C ON N C "t O '0 \O N 0% N N QN N v1 Gý 'T Q-ý coo 00 84-1 f- N N C> N `O 
L N O Vl M N O '/1 C' O 00 "t C' 00 h r, D h N D ^+ 00 0 F 
'0 '0 M C' N M V1 
'Q 00 "! '. O [N C' o - O O M N 00 M 'C'. N N C -P N - N 00 N aý '. D - '. O -t rr1 
C' 
- M N N N M Il 'n "t "t M M M M M 't I/'1 (") M M N - - C - N - N - ^ 
O O O O O O O O O O O O O O O C O O O O O O O O C O O O O 
O O O O O O O O O O O O O O O C O O O O O C O J O O O O O 
ý+ O N v1 N O Cý O N 
t 
-- O 00 C' N ýO C' -f N Cý '. O C' - 00 00 N 
M N C'. v, ý 
iG M M M ! V1 `t V7 `? V' ýD 'D '. O In \O N M -t In In In In 14 vl Vl "0 '. 
O \o '. O iN 
O vl 00 "fi O N O ýO N `t M v1 c\ 00 -e N M N N 1,0 M N - C. ý O O C' '? n 
A N `T N -r ^+ C' N V1 O C'. "t N M OC `t 00 N In O %0 ^ Vý N 00 OC 
'0 O In In C 
M Oo '. D '. O N 00 N N O O N 00 00 N V1 M M N "t M h "-- M 
-FI H I 'M ýi +I 
i 
+I +r 
y 
+ý + -I -H -H -H +I 
c 4 + -H + -H +I + 
g- 
+I ii +I +I -H H 
N O M N O \C O O M C' - - C' N N O M '. D C' '. D -t - O - --" O C' N c 
14 N V) O -t In C 00 O O -t N N N N In kn O -t- 00 N o0 ý-- tN C N tN O N v) -T 
N In N M N O N N In 00 O . N In -t N M N O In N O cn '. O C '. O O -t N 00 C 
M M M "t -t In In In In er \O V '. J V' % M M -P 't '7 vl In In In In \o \o %0 %z 
N 
C "f N '. J OC C' VI In - 'D -t In - M - fN V ^ -P N C, % C' ---ý 00 In -P -p 
C' N 
M N M m "f -t -t -f -t 'T -t "h "t "f M 't V1 V) N V-1 
V' h h 
Z -t N e' N C C O N cV -f - O 00 vn N "! M M M N N 't V' \Z O cV 'J 
N 
' 
^ 
' 
'n 
Gn M M -t "t In "f In -r In "0 '. D %4 '. 0 In V' In In V 110 V' \J' V' V' V' V \. V' V V 
N 
WO 
00 -- h C' N Qý N C' N `t ýO M N '. v1 In 't M 't 
O 00 V1 In M M ^ N 
V) N 'T M -t '. O '. O V' '. D N N N N N N N h V In vn V' V' 'J '. D In 
%Z '. J '. V' N V N 
`T 
.0 O - N N M N In M N N 00 N V' OC N "! M '. O M -t c' M C' N 't ' 
M -- 'T ' Cl) M M M 'T In In '. '. C '. o N N 00 00 00 C' 00 00 - N N M M M -t M -t v 1 ýO \. J 
M 
00 't N "--ý ^^ý M M M % C. 1 OC O\ C' M N M '? Vt ýO 
O O V' ^' OC M 'C V7 : i0 N 
cl) -+ --" ^-" N N N N N N N M M 't "f "t 
C' - N N N "t Vn Vn '. In N N 00 N N 
7 f N M cý ýO --t --ý M C'. O Z `t N ^ 00 In In ^ r, `? r^ V 00 
In M ', N Z\ 
0 
C/) N N M M M M M M f'M "'t -f ul In In In N N N f'' M f'" m M 
In -P -P VZ I+ V N 
r-. 
. -, N C'. -t N 00 C'. 00 M ' t C O OC N '. 0 V' Vl m - 
OC v\ VN Vl N M M "f Vl 'T 
N 00 00 00 00 00 Gý G1 OC xC In In 1,0 V 'o \G \J \O CN N OC OC 0C 00 OC 
x x O N M `7 1%J E C r N M 't In 
. -ý N M 't In 'D N 00 O' .ý - . --i .ý . -r "-ý "-ý N M ýt Iii 'O N 00 C' - - ' - 
C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C r r r r _ _ ý _ ýr 
r 
rr _ ýr rr _ _ _ r 
C r _ ý _ _ _ _ ýr _ 
r r _ ýr 
r 
rr _ r 
r 
AM u 
t 
V 
C 
.L 
v 
c 
L 
ce 
, wo 
'C7 
'0 
N 
E"ý 
"r 
0 
% \O O 00 N r- "! 
N 
C\ 
N 
M 
0' 
C 
' 
M r- 00 Z C - r-4 
C 
"t v\ V) 
ý 
r- 
N 
vi 
.. 
00 
.. 
[- ýt 
Q Q Q Q 
0 0 N 
--' 
Q 
S . i M . r O O O O " s " s 
C vý 
S 
' 
N M 0' O 'D (N ? w1 V) N Q O M 7 - '/1 00 N 'O V 1 ý-+ -f -r N M --ý O N V1 M N N N N 1 ý 
V) N . . . O O 
Q Q 9 9 9 Q Q 9; Q O O Q O O O O i Q Q Q Q Q `ý 
Q 
x O N "t 'C - 00 00 00 O --+ v1 0' r1 N 00 00 N N \O N O cV C' 00 - -t ' O 'ee N 
- -i "! ' e C> Qý C% 00 'C M N N 00 "f - "! N -! 00 00 00 "t N N "t O - . - N 
V1 V O O O O O O O O O C O O O O O O O O O O O O O O O O O O O 
N "t fN -P N "t N CN 00 00 CN ['N N 't al% `t V1 O - N v 't N Cl, in `t r4 -t N 't 
"C" 
'C N V1 
; 
N \o - vl N `t `t N V1 %Z N N N (> ON 00 v) C% - V' N Cý - \O N V1 - 
O in c 00 Q' M N rf -? M O in `T in N N M O 'D 00 N M C. ' O M Vl i1 "--- 00 00 
1,0 
`T 
in 
N 
'C 
in 
C' 
in 
M 
in 
ke) 
i 
C\ 
VC 
- 
'C 
N \O 
"t 
00 O 
- 
N 
- 
- O 
- 
in 
t 
00 \D (> \O N fN n N ON c% Q\ 
- 
"0 in 
- 
N 
` l in in t M t ! M M N N N - - N N M r vl r r 
"- O O O O O C O C O 0 C O C O C O O O O O O 0 O O 0 O O O O O 
O C O O O O O O O O O O O C C O O O C O O C C O C O O O O O 
00 O -- 'C N -t -' N 116 O ý O 'C i1 M O N O O tN a Z N o0 -t in tN N M in N M M M `t in 'C 'C \O N N 00 (- N S M r -r in `? -t in \O N %m \O N 00 00 00 
ýO \O 00 'C M N N 00 N M C' `T C. N VA %C N - in r''1 C' Vr 00 00 '? O - M 'C C' in Q `t Vl 'Z -t N vl M N Q' in O - N N C O i/1 00 M -T N Qlý O 00 h CN N N ON 
. . M . M . -r . M M. \O . . -P . M -. "p O - P 
_ 
O . - CC' OC n. VC -P N. -P `T N-. Q\ . N . M 0 00 
t1 TI Yi ti ti tt tl t1 tt ti 'rl tl ti i H -H tl tl +1 C N --r Cl, - O 'C C' M \O -t tN C' C - tN N - N O N C' -t ON M C - M O CN O X v) N N tN O 00 N -t 00 - v1 N C N v1 vi r- v'1 O v'1 N - N -! C N -t O (, q O 
r c; 00 00 -t 00 "! N 00 00 M V1 O Q' --' "t O M 00 \O N N M 00 \O M "h G'1 N O' N 
iG M M cß'1 "t "f N in Vl in \O 'C N VC N S M M M -r -t in in in V'1 \O VC '. D `O "C N 
N 
D 00 'C M V0 N M M N 00 O in r 'C V' V0 O 00 CT - C% N 0' N M `t N 00 'O N C Vi N (N N M M -t "r "r M 't M '7 M "t -t V) l! 1 V1 \D Vl Ml V) Vi M M M -t -t 
.C 00 v'n in in C' O S O N C' 00 O - CN M O -r '. O C in 00 -7 in - -t 00 O M "-- -t V) N rf h ý/ 1 N N N Iý [ý N 00 00 r- 00 V) in 'n r- N N N N S 00 00 C. % Qll cý C\ 
ii 
vn in 00 O C - vn in '. D O \J C  in M C N C O N N %C -'t 00 -t v'n N \O O N Vi N '7 M vi -r 1,0 1,0 r 'C N N 00 N N N M M rt h "t "f Vl \J in \C '. J N "O V 
00 O O M N -t - N N in N N V' V' 00 C 'C \O M N M -f 'C v1 M O - G'ý 00 
Vi N M M M -r in 'C '. O N N 00 00 00 00 0' N - ^ N M M M M M M -t `t 't in 
'. 3 N in -11 M 'C 00 M O -7 -f (N -t - r) M N 't 'C 00 'C'' in O C% O - in 00 c. - in 
V2 - "--4 - - - - "--- N (N M M '7 in in In N - - N N -f "F \O 1,0 N N 00 00 Q' 00 
N 
C \D "t - v/ N in tN V1 1,0 N -- v1 N V) r- Wn 'C N "-- N 'C IN N V1 - N M M M "t 't "t "t in \J 'C v1 ýO N "-- N M M M '? "t 7 V') \O 'C in \O iN 
im 
Z N J' [N - ^' M 'n in "t N v V' N ýC N 00 V' wt "h "t 00 OC 00 N N 00 C' Qý M 00 
vý N 00 00 CN c' v. c' CN c' C\ ^ Ja rr -r v, v> in in [- 00 00 00 00 00 00 
ac ac 
x x 
-0 N M `t e [- 00 Cr\ 9-4 "m p" "m r. "q -4 N M `7 Iri ýQ t- 00 C\ V-q rr r m » r " r 
C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C . _ r _ _ ýr r _ r _ _ ýr . _ ýrr rr _ ýr _ ýr 
r _ _ r _ ýr ýrr ýrr 
.. r r _ 
Table 2e : Summary of experiment 2 questionnaire responses 
cuff time why test diff. VAS difference more extra info 
pressure test stopped in int. marked between pain - 
(mmHg) lasted and approp.? cuff and cuff 
(mins) unp. arm? or 
arm? 
subject I 
1st test) 200 15 yes no no 
subject 1 less pain 
2nd test) 250 15 yes yes yes arm than 1st 
subject 2 
1st test) 200 15 yes yes yes arm 
subject 2 more pain 
(2nd test) 250 15 yes yes yes arm unp, esp 
hand 
subject 3 worst pain 
(1st test) 250 15 yes yes yes cuff unp - cuff 
deflation 
subject 3 less pain 
2nd test) 200 15 yes no no than 1st 
subject 4 
1st test) 200 15 es es es cuff 
subject 4 
2nd test 250 15 es yes yes cuff 
subject 5 VAS scales 
1st test) 200 15 es no no too hi 
subject 5 same pain 
(2nd test) 250 15 yes es yes cuff as Ist 
subject 6 pain and discomfort, 
1st test) 250 12 nausea yes yes yes arm not pain 
subject 6 dizzy, time of day 
(2nd test) 200 9 flushed yes yes yes arm increased 
and pain - early 
nausea morning 
subject 7 strange, 
(1st test) 250 15 yes yes yes cuff not pain - 
VAS too 
high 
subject 7 less anxiety 
(2nd test) 200 15 es yes es cuff than 1st 
subject 8 arm less pain 
(Ist test) 250 15 yes yes yes and than 
hand expected 
subject 8 
(2nd test) 200 15 yes yes yes arm 
Total and / 
or mean 14.25 yes = yes=7 yes =5 cuff _ 
(200mmHg) 8 no= 1 no =3 2 
arm = 
3 
Total and / 
or mean 14.625 yes = yes= 8 yes =8 cuff = 
(250mmHg) 8 4 
arm = 
4 
Appendix 3: Experiment 3- Graphs and Tables 
Figures VII and VIII in text (Chapter 10) 
Tables 3a, 3b and 3c in text (Chapter 10) 
Figure IX (i) Individual pain VAS intensity scores in Ist test 
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Figure IX (ii) Individual pain VAS intensity scores in 2nd test 
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Figure IX (iii) Individual pain VAS intensity scores in 3rd test 
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Figure X(i) : Individual VAS pain unpleasantness scores in Ist test 
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Figure X(ii) : Individual VAS pain unpleasantness scores in 2nd test 
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Figure X(iii) : Individual VAS pain unpleasantness scores in 3rd test 
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Table 3d : Simple main effects for VAS pain intensity scores in experiment 3 
A= test (1st, 2nd and 3rd test) 
b= time bl =min 1 
b2=min2..... 
Critical value = 3.07-4.46 
*= significant result pS0.05 
Mean Square (MS) F value 
Aat b1: 436.47 5.79* 
A at b2: 171.67 2.28 
A at b3 : 171.67 2.28 
A at b4: 174.60 2.31 
A at b5 : 241.80 3.21 * 
A at b6: 468.87 6.22* 
A at b7: 661.07 8.77* 
A at b8: 519.27 6.89* 
A at b9: 614.47 8.15 * 
A at b 10 : 664.80 8.82* 
A at bl l: 744.87 9.88* 
A at b12: 928.47 12.31 * 
A at b13 : 828.80 10.99* 
A at b14 : 698.07 9.26* 
A at bl5: 469.40 6.22* 
Table 3e : Raw VAS intensity data for experiment 3 (including summary of 
descriptive statistics) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Mean ± S. D. Median Variance Shapiro 
- Wilk 
Skew 
ness 
Kurt 
osis 
IST 
TEST 
Min 1 35 38 29 23 28 30.60±5.94 29.00 35.30 0.57 0.06 -1.22 
Min 2 30 12 24 26 32 24.80±7.82 26.00 61.20 0.37 -1.38 2.10 
Min 3 30 8 42 21 34 27.00±13.04 30.00 170.00 0.76 -0.63 -0.01 
Min 4 38 5 30 30 38 28.20±13.57 30.00 184.20 0.07 -1.76 3.35 
Min S 35 5 37 35 43 31.00±14.90 35.00 222.00 0.08 -1.95 4.16 
Min 6 46 9 52 39 47 38.60±17.18 46.00 295.30 0.10 -1.85 3.58 
Min 7 60 15 54 38 56 44.60±18.54 54.00 343.80 0.21 -1.32 0.99 
Min 8 57 11 51 45 59 44.60±19.57 51.00 382.80 0.09 -1.82 3.45 
Min 9 60 16 50 56 65 49.40±19.46 56.00 378.80 0.16 -1.81 3.48 
Min 10 75 12 51 55 74 53.40±25.56 55.00 653.30 0.25 -1.30 1.77 
Min 11 75 18 55 65 79 58.40±24.43 65.00 596.80 0.27 -1.50 2.25 
Min 12 80 15 65 73 82 63.00±27.65 73.00 764.50 0.06 -1.93 3.83 
Min 13 79 17 71 81 84 66.40±28.03 79.00 785.80 0.03 -2.08 4.39 
Min 14 76 18 80 89 87 70.00±29.54 80.00 872.50 0.03 -2.06 4.37 
Min 15 87 21 77 92 91 73.60±30.00 87.00 899.80 0.03 -2.03 4.19 
2ND 
TEST 
Min 1 22 13 8 18 19 16.00±5.52 18.00 30.50 0.50 -0.71 -0.51 
Min 2 17 8 12 20 22 15.80±5.76 17.00 33.20 0.44 -0.47 -1.53 
Min 3 26 8 12 21 23 18.00±7.65 21.00 58.50 0.30 -0.51 -2.12 
Min 4 24 12 18 23 22 19.80±4.92 22.00 24.20 0.26 -1.27 0.86 
Min 5 21 12 17 24 24 19.60±5.13 21.00 26.30 0.23 -0.88 -0.53 
Min 6 31 16 30 29 28 26.80±6.14 29.00 37.70 0.04 -2.05 4.35 
Min 7 21 15 38 31 34 27.80±9.52 31.00 90.70 0.39 -0.52 -1.71 
Min 8 22 16 49 30 39 31.20±13.18 30.00 173.70 0.61 0.33 -1.18 
Min 9 32 20 45 36 42 35.00±9.80 36.00 96.00 0.50 -0.91 0.56 
Min 10 36 20 52 41 46 39.00±12.17 41.00 148.00 0.65 -1.00 1.21 
Min 11 30 19 60 45 55 41.80±17.14 45.00 293.70 0.40 -0.42 -1.77 
Min 12 25 21 59 55 57 43.40±18.73 55.00 350.80 0.02 -0.61 -3.14 
Min 13 32 24 61 60 63 48.00±18.51 60.00 342.50 0.03 -0.70 -2.70 
Min 14 38 21 72 69 69 53.80±23.02 69.00 529.70 0.06 -0.89 -1.60 
Min 15 42 22 87 79 74 60.80±27.62 74.00 762.70 0.25 -0.77 -1.55 
3RD 
TEST 
Min 1 17 10 6 15 18 13.20±5.07 15.00 25.70 0.30 -0.75 -1.30 
Min 2 17 8 8 17 19 13.80±5.36 17.00 28.70 0.02 -0.50 -3.14 
Min 3 17 7 15 19 22 16.00±5.66 17.00 32.00 0.61 -1.12 1.69 
Min 4 15 6 17 20 26 16.80±7.33 17.00 53.70 0.97 -0.48 1.05 
Min 5 14 6 24 21 27 18.40±8.44 21.00 71.30 0.45 -0.80 -0.50 
Min 6 14 8 25 21 29 19.40±8.44 21.00 71.30 0.54 -0.40 -1.31 
Min 7 20 8 29 25 31 22.60±9.18 25.00 84.30 0.38 -1.22 1.18 
Min 8 16 12 33 26 36 24.60±10.43 26.00 108.80 0.29 -0.20 -2.45 
Min 9 26 11 34 28 39 27.60±10.60 28.00 112.30 0.62 -0.99 1.37 
Min 10 31 7 44 33 38 30.60±14.12 33.00 199.30 0.36 -1.53 2.87 
Min 11 33 12 46 36 46 34.60±13.92 36.00 193.80 0.22 -1.32 1.81 
Min 12 30 8 55 39 52 36.80±18.99 39.00 360.70 0.41 -0.89 0.20 
Min 13 38 11 57 43 59 41.60±19.31 43.00 372.80 0.34 -1.14 1.22 
Min 14 44 11 65 47 68 47.00±22.75 47.00 517.50 0.35 -1.12 1.24 
Min 15 45 13 78 59 78 54.60±27.10 59.00 734.30 0.28 -0.99 0.35 
Table 3f : Raw VAS unpleasantness data for experiment 3 (including summary of 
descriptive statistics) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Meant S. D. Median Variance Shapiro 
- Wilk 
Skew 
ness 
Kurt 
osis 
IST 
TEST 
Min 1 89 3 17 19 36 32.80±33.53 19.00 1124.20 0.28 1.60 2.74 
Min 2 69 2 19 18 39 29.40±25.74 19.00 662.30 0.50 0.97 0.72 
Min 3 70 2 24 20 40 31.20±25.56 24.00 653.20 0.75 0.81 0.84 
Min 4 62 4 36 24 42 33.60±21.51 36.00 462.80 0.99 -0.14 0.36 
Min 5 57 3 21 27 44 30.40±20.88 27.00 435.80 0.79 -0.01 -0.72 
Min 6 68 9 35 26 45 36.60±21.98 35.00 483.30 0.97 0.37 0.40 
Min 7 67 7 45 34 50 40.60±22.23 45.00 494.30 0.87 -0.72 1.06 
Min 8 63 9 57 37 60 45.20±22.65 57.00 513.20 0.14 -1.34 0.97 
Min 9 59 9 53 47 65 46.60±22.06 53.00 486.80 0.21 -1.74 3.28 
Min 10 77 14 64 54 69 55.60±24.70 64.00 610.30 0.27 -1.64 2.88 
Min 11 83 12 68 66 76 61.00±28.21 68.00 796.00 0.09 -1.91 3.94 
Min 12 88 15 76 76 84 67.80±29.97 76.00 898.20 0.03 -2.07 4.42 
Min 13 77 17 79 81 88 68.40±29.03 79.00 842.80 0.02 -2.12 4.62 
Min 14 89 19 85 90 93 75.20±31.55 89.00 995.20 <0.01 -2.19 4.83 
Min 15 89 19 95 94 95 78.40±33.30 94.00 1108.80 <0.01 -2.21 4.88 
2ND 
TEST 
Min 1 23 8 7 17 23 15.60±7.80 17.00 60.80 0.05 -0.23 -2.99 
Min 2 25 9 12 22 27 19.00±8.03 22.00 64.50 0.16 -0.47 -2.63 
Min 3 24 8 19 24 33 21.60±9.13 24.00 83.30 0.85 -0.56 1.22 
Min 4 23 14 21 27 36 24.20±8.11 23.00 65.70 0.97 0.44 0.80 
Min 5 21 15 28 33 37 26.80±8.90 28.00 79.20 0.52 -0.32 -1.46 
Min 6 16 15 33 34 37 27.00±10.61 33.00 112.50 0.03 -0.52 -3.15 
Min 7 19 16 48 37 44 32.80±14.55 37.00 211.70 0.13 -0.32 -2.83 
Min 8 25 19 50 40 48 36.40±13.83 40.00 191.30 0.19 -0.41 -2.50 
Min 9 32 21 54 39 55 40.20±14.55 39.00 211.70 0.31 -0.24 -1.73 
Min 10 38 20 56 47 58 43.80±15.50 47.00 240.20 0.36 -1.00 0.34 
Min 11 31 20 57 58 66 46.40±19.78 57.00 391.30 0.20 -0.63 -2.12 
Min 12 38 20 70 69 69 53.20±22.99 69.00 528.70 0.04 -0.94 -1.41 
Min 13 37 22 77 74 70 56.00±24.89 70.00 619.50 0.08 -0.76 -2.12 
Min 14 43 23 96 81 76 63.80±29.91 76.00 894.70 0.40 -0.57 -1.53 
Min 15 43 22 95 84 86 66.00±31.74 84.00 1007.50 0.15 -0.77 -1.84 
3RD 
TEST 
Min 1 10 3 7 14 23 11.40±7.64 10.00 58.30 0.72 0.84 0.65 
Min 2 15 3 8 16 31 14.60±10.60 15.00 112.30 0.62 0.90 1.15 
Min 3 16 6 14 25 30 18.20±9.44 16.00 89.20 0.64 0.03 -1.08 
Min 4 11 3 19 26 34 18.60±12.18 19.00 148.30 0.75 -0.04 -1.08 
Min 5 15 5 26 29 36 22.20±9.44 26.00 149.70 0.57 -0.56 -0.81 
Min 6 11 4 34 35 39 24.60±15.92 34.00 253.30 0.07 -0.65 -2.61 
Min 7 21 9 36 39 40 29.00±13.55 36.00 183.50 0.11 -0.98 -0.90 
Min 8 21 7 45 43 42 31.60±16.85 42.00 283.30 0.08 -0.96 -1.18 
Min 9 21 9 48 47 48 34.60±18.39 47.00 338.30 0.03 -0.84 -1.97 
Min 10 31 9 57 49 50 39.20±19.42 49.00 377.20 0.31 -1.15 0.43 
Min 11 34 10 58 53 55 42.00±20.21 53.00 408.50 0.14 -1.29 0.70 
Min 12 39 11 63 61 57 46.20±21.84 57.00 477.20 0.13 -1.39 1.22 
Min 13 48 14 68 66 64 52.0022.67 64.00 514.00 0.07 -1.66 2.46 
Min 14 39 14 77 68 70 53.60±24.68 68.00 701.30 0.21 -1.01 -0.58 
Min 15 50 16 85 75 82 61.60±28.97 75.00 839.30 0.19 -1.24 0.60 
Appendix 4: Experiment 4- Tables 
Figures XI, XII and XIII in text (Chapter 11) 
Tables 4a and 4b in text (Chapter 11) 
Table 4c : ANOVA Table for TENS current intensity scores before pain induction in 
experiment 4 (100Hz TENS) 
SS d. f. MS F 
Effect of Condition 
Condition 25.07 1 25.07 0.21 0.655 
Error (Within + Residual) 1304.23 11 118.57 
Effect of Time 
Time 272.07 14 19.43 25.71 <0.001 
Error (Within + Residual) 116.40 154 0.76 
Interaction (Condition x Time) 
Condition x Time 13.39 14 0.96 1.43 0.144 
Error (Within + Residual) 102.81 154 0.67 
Table 4d : ANOVA Table for TENS current intensity scores during pain induction in 
experiment 4 (100Hz TENS) 
SS d. f. MS F p 
Effect of Condition 
Condition 183.47 1 183.47 1.73 0.216 
Error (Within + Residual) 1169.16 11 106.29 
Effect of Time 
Time 85.23 14 6.09 7.18 <0.001 
Error (Within + Residual) 130.50 154 0.85 
Interaction (Condition x Time) 
Condition x Time 28.32 14 2.02 2.79 0.001 
Error Within + Residual) 111.54 154 0.72 
Table 4e : Raw VAS intensity data for experiment 4 (100Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min 1 38 6 10 7 29 55 39 3 6 2 49 27 
Min 2 41 8 14 10 34 60 40 7 8 2 55 32 
Min 3 43 10 18 13 30 67 55 12 7 2 59 36 
Min 4 42 12 15 14 34 59 60 12 10 4 53 36 
Min 5 42 12 14 19 39 57 61 15 18 6 63 33 
Min 6 43 14 15 22 39 65 58 26 24 4 61 39 
Min 7 43 12 13 24 53 62 62 33 21 5 64 36 
Min 8 37 18 18 27 52 64 63 19 25 9 69 38 
Min 9 39 15 14 24 50 68 62 28 38 5 66 45 
Min 10 43 22 17 33 58 67 65 41 42 5 71 42 
Min 11 40 20 19 43 55 69 68 45 44 9 68 42 
Min 12 40 22 18 47 56 78 68 49 40 7 68 42 
Min 13 46 23 17 47 61 80 73 44 49 7 77 41 
Min 14 36 22 37 44 67 85 72 44 43 5 80 47 
Min 15 42 28 21 55 71 88 74 59 51 11 81 47 
EXPT. 
CONTROL 
Min 1 36 13 5 9 20 69 57 8 5 4 39 22 
Min 2 32 16 5 9 32 65 62 13 12 1 42 24 
Min 3 24 20 10 5 24 63 67 17 13 1 43 31 
Min 4 29 22 9 8 27 65 68 19 13 3 37 31 
Min 5 25 22 13 5 30 69 65 14 16 5 45 37 
Min 6 40 27 10 12 38 70 70 26 19 5 49 38 
Min 7 45 23 14 8 45 77 73 21 19 4 54 35 
Min 8 40 29 11 8 40 81 73 27 17 5 50 37 
Min 9 39 33 8 20 39 88 72 39 16 10 52 38 
Min 10 35 37 14 22 40 94 74 34 20 7 59 39 
Min 11 46 33 10 28 52 94 73 38 21 6 62 42 
Min 12 53 36 13 34 55 95 76 46 23 7 65 46 
Min 13 51 34 13 37 69 96 78 43 25 9 66 45 
Min 14 47 32 13 31 78 96 76 44 21 8 70 51 
Min 15 43 35 12 46 75 98 76 65 28 10 74 42 
SUB. 
CONTROL 
Min 1 38 7 11 9 17 66 33 8 1 19 47 28 
Min 2 40 12 13 18 12 73 30 7 1 23 55 28 
Min 3 40 14 13 28 13 67 36 7 4 23 55 33 
Min 4 47 11 12 33 18 76 36 15 1 22 55 37 
Min 5 54 13 12 30 22 77 35 18 5 31 60 36 
Min 6 50 15 16 30 21 73 39 22 4 29 63 34 
Min 7 47 18 15 47 24 81 42 23 6 28 66 36 
Min 8 55 25 16 56 37 82 46 26 6 28 65 37 
Min 9 50 28 14 62 37 85 41 30 6 35 70 40 
Min 10 47 30 20 63 50 84 47 37 7 33 59 32 
Min 11 56 32 19 63 53 90 52 42 8 28 66 32 
Min 12 51 37 19 70 57 91 51 67 5 21 77 33 
Min 13 51 28 18 68 70 92 48 67 7 17 75 36 
Min 14 60 36 22 76 74 97 61 79 9 27 69 32 
Min 15 49 38 20 87 77 98 60 80 10 26 72 34 
Table 4f : Summary of VAS intensity descriptive statistics for experiment 4 (10011z 
TENS 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 22.58±19.25 18.50 370.45 0.09 0.46 -1.41 
Min 2 25.92±20.23 23.00 409.36 0.17 0.44 -1.30 
Min 3 29.33±22.37 24.00 500.42 0.32 0.48 -1.27 
Min 4 29.25±20.59 24.50 424.02 0.10 0.39 -1.54 
Min 5 31.58±20.51 26.00 420.81 0.19 0.45 -1.40 
Min 6 34.17±19.92 32.50 396.88 0.57 0.23 -1.11 
Min 7 35.67±21.14 34.50 446.97 0.40 0.07 -1.49 
Min 8 36.58±20.72 32.00 429.72 0.28 0.43 -1.34 
Min 9 37.83±21.20 38.50 449.42 0.65 0.02 -1.20 
Min 10 42.17±20.73 42.00 429.79 0.62 -0.26 -0.72 
Min 11 43.50±19.87 43.50 394.82 0.34 -0.30 -0.75 
Min 12 44.58±21.42 44.50 456.81 0.82 -0.21 -0.57 
Min 13 47.08±23.33 46.50 544.26 0.59 -0.20 -0.73 
Min 14 48.50±23.69 44.00 563.36 0.63 -0.04 -0.38 
Min 15 52.33±24.09 53.00 580.24 0.91 -0.24 -0.81 
EXPT. 
CONTROL 
Min 1 23.92±21.80 16.50 475.17 0.04 1.08 0.11 
Min 2 26.08±21.25 20.00 451.72 0.24 0.83 -0.34 
Min 3 26.50±21.27 22.00 452.45 0.20 0.96 0.41 
Min 4 27.58±20.86 24.50 435.17 0.11 1.04 0.39 
Min 5 28.83±21.50 23.50 462.15 0.21 0.88 -0.22 
Min 6 33.67±21.58 32.50 465.70 0.43 0.53 -0.54 
Min 7 34.83±24.30 29.00 590.51 0.42 0.56 -0.79 
Min 8 34.83±24.25 33.00 587.97 0.41 0.70 -0.18 
Min 9 37.83±24.07 38.50 579.24 0.33 0.82 0.41 
Min 10 39.58±25.21 36.00 635.54 0.33 0.98 0.69 
Min 11 42.08±25.65 40.00 657.72 0.90 0.55 0.10 
Min 12 45.75±25.54 46.00 652.20 0.96 0.31 -0.12 
Min 13 47.17±26.28 44.00 690.51 0.92 0.32 -0.49 
Min 14 47.25±27.95 45.50 780.93 0.74 0.27 -0.97 
Min 15 50.33±27.45 44.50 753.33 0.67 0.10 -0.85 
SUB. 
CONTROL 
Min 1 23.67±19.37 18.00 375.15 0.30 1.00 0.48 
Min 2 26.00±21.08 20.50 444.18 0.22 1.17 0.96 
Min 3 27.75±19.47 25.50 379.11 0.44 0.76 -0.10 
Min 4 30.25±21.49 27.50 462.02 0.56 0.79 0.32 
Min 5 32.75±21.54 30.50 463.84 0.46 0.81 0.05 
Min 6 33.00±20.38 29.50 415.45 0.53 0.74 -0.03 
Min 7 36.08±21.84 32.00 476.81 0.58 0.77 0.18 
Min 8 39.92±21.79 37.00 474.63 0.94 0.40 -0.25 
Min 9 41.50±22.55 38.50 508.45 0.86 0.43 0.01 
Min 10 42.42±20.59 42.00 424.08 0.97 0.33 0.45 
Min 11 45.08±22.77 47.00 518.63 0.96 0.27 -0.001 
Min 12 48.25±25.93 51.00 672.57 0.96 -0.07 -0.82 
Min 13 48.08±26.98 49.50 727.72 0.67 -0.04 -1.19 
Min 14 53.50±27.39 60.50 750.09 0.58 -0.16 -1.17 
Min 15 54.25±28.84 54.50 831.48 0.70 -0.04 -1.36 
Table 4g: Raw VAS unpleasantness data for experiment 4 (100Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min 1 15 3 2 2 21 8 33 3 0 3 58 30 
Min 2 21 8 7 3 23 16 35 12 0 1 62 34 
Min 3 25 11 4 4 23 33 53 15 7 4 71 38 
Min 4 25 9 14 3 34 30 53 14 10 9 73 38 
Min 5 32 12 12 4 37 43 55 20 16 10 76 36 
Min 6 32 9 12 5 39 40 60 31 19 10 78 42 
Min 7 27 11 13 6 34 42 66 34 28 21 79 39 
Min 8 35 14 15 12 49 49 60 29 31 30 81 37 
Min 9 32 14 12 6 50 49 64 33 32 38 84 55 
Min 10 32 11 13 14 49 49 70 42 36 37 86 47 
Min 11 35 15 16 19 49 59 74 52 45 38 82 43 
Min 12 28 16 14 17 56 60 70 49 50 45 83 50 
Min 13 26 17 18 15 74 64 82 54 48 48 91 45 
Min 14 30 20 28 14 80 68 79 66 57 49 92 59 
Min 15 36 20 16 30 90 79 81 78 58 58 90 54 
EXPT. 
CONTROL 
Min 1 14 18 3 1 11 37 45 0 7 2 39 21 
Min 2 16 20 5 1 22 28 47 7 15 1 39 20 
Min 3 15 20 8 3 16 41 67 9 12 2 33 28 
Min 4 22 21 7 2 20 49 69 12 15 5 22 38 
Min 5 21 20 11- 2 24 60 78 10 15 4 51 39 
Min 6 14 25 11 1 33 59 72 14 20 7 51 44 
Min 7 25 22 15 2 38 71 80 18 18 9 52 37 
Min 8 27 18 13 5 25 64 82 22 19 13 58 38 
Min 9 25 28 5 5 30 72 85 31 18 14 54 36 
Min 10 24 27 9 6 32 76 90 29 20 11 68 44 
Min 11 21 31 7 12 46 81 86 41 18 13 74 44 
Min 12 26 30 10 14 64 79 94 44 24 12 77 61 
Min 13 26 35 11 17 73 92 96 37 27 18 76 57 
Min 14 32 36 12 21 78 93 94 40 27 20 78 61 
Min 15 27 42 11 23 90 98 96 53 34 26 84 57 
SUB. 
CONTROL 
Min 1 11 12 15 2 3 17 23 4 1 7 57 31 
Min 2 23 13 13 4 3 21 26 5 5 22 69 33 
Min 3 25 16 17 13 1 36 31 10 4 22 62 31 
Min 4 36 18 18 14 1 34 32 9 8 32 66 38 
Min 5 35 18 11 14 4 30 34 13 8 28 67 35 
Min 6 31 18 10 17 4 28 31 12 13 45 71 38 
Min 7 36 19 10 22 12 35 31 19 10 45 73 35 
Min 8 32 21 7 22 14 43 34 27 10 50 79 36 
Min 9 39 25 12 23 22 52 34 28 15 57 82 18 
Min 10 41 26 18 31 27 50 41 37 11 43 67 28 
Min 11 44 26 11 16 36 59 43 38 11 41 65 33 
Min 12 38 31 12 39 48 71 48 65 14 44 75 41 
Min 13 40 31 11 47 68 76 49 68 11 56 83 42 
Min 14 43 25 15 55 74 65 52 82 13 53 70 38 
Min 15 32 28 12 79 86 78 62 89 12 61 86 36 
Table 4h : Summary of VAS unpleasantness descriptive statistics for experiment 4 
(100Hz TENS) 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 14.83±17.78 5.50 316.15 <0.01 1.50 1.96 
Min 2 18.50±18.12 14.00 328.27 0.09 1.32 1.83 
Min 3 24.00±21.46 19.00 460.73 0.09 1.10 0.59 
Min 4 26.00±20.92 19.50 437.64 0.14 1.15 0.89 
Min 5 29.42±21.35 26.00 455.90 0.34 0.94 0.48 
Min 6 31.42±22.20 31.50 492.81 0.38 0.78 0.19 
Min 7 33.33±21.62 31.00 467.33 0.34 0.96 0.65 
Min 8 36.83±20.32 33.00 413.06 0.41 0.83 0.61 
Min 9 39.08±22.77 35.50 518.63 0.80 0.37 -0.12 
Min 10 40.50±22.49 39.50 505.73 0.45 0.53 0.21 
Min 11 43.92±21.38 44.00 456.99 0.63 0.27 -0.50 
Min 12 44.83±22.07 49.50 486.88 0.46 -0.03 -0.80 
Min 13 48.50±25.96 48.00 673.91 0.47 0.16 -1.13 
Min 14 53.50±25.49 58.00 649.91 0.60 -0.21 -1.20 
Min 15 57.50±26.81 58.00 718.82 0.31 -0.31 -1.40 
EXPT. 
CONTROL 
Min 1 16.50±15.93 12.50 253.91 0.09 0.77 -0.83 
Min 2 18.42±14.41 18.00 207.72 0.45 0.67 -0.05 
Min 3 21.17±18.71 15.50 349.97 0.07 1.46 2.26 
Min 4 23.50±19.62 20.50 385.00 0.08 1.31 1.47 
Min 5 27.92±24.00 20.50 576.08 0.17 1.01 0.07 
Min 6 29.25±22.59 22.50 510.20 0.42 0.67 -0.70 
Min 7 32.25±24.39 23.50 594.93 0.26 0.92 -0.06 
Min 8 32.00±23.79 23.50 566.00 0.08 1.10 0.21 
Min 9 33.58±25.09 29.00 629.72 0.22 0.98 0.29 
Min 10 36.33±27.64 28.00 763.88 0.13 0.91 -0.33 
Min 11 39.50±27.85 36.00 775.54 0.21 0.62 -1.00 
Min 12 44.58±29.39 37.00 863.54 0.32 0.36 -1.40 
Min 13 47.08±30.40 36.00 924.08 0.21 0.51 -1.34 
Min 14 49.33±29.85 38.00 891.15 0.18 0.42 -1.51 
Min 15 53.42±31.29 47.50 987.99 0.24 0.32 -1.53 
SUB. 
CONTROL 
Min 1 15.25±15.97 11.50 255.11 0.01 1.82 3.76 
Min 2 19.75±18.37 17.00 337.48 <0.01 1.87 4.48 
Min 3 22.33±16.56 19.50 274.24 0.37 1.14 1.99 
Min 4 25.50±17.80 25.00 317.00 0.37 0.85 1.12 
Min 5 24.75±17.37 23.00 301.66 0.11 1.23 2.12 
Min 6 26.50±18.66 23.00 348.27 0.24 1.23 1.78 
Min 7 28.92±18.03 26.50 325.17 0.09 1.30 2.24 
Min 8 31.25±19.88 29.50 395.11 0.33 1.20 2.02 
Min 9 33.92±20.59 26.50 424.08 0.09 1.30 1.40 
Min 10 35.00±14.97 34.00 224.00 0.84 0.54 0.79 
Min 11 35.25±17.23 37.00 296.75 0.58 0.10 -0.55 
Min 12 43.83±19.83 42.50 393.24 0.55 -0.02 -0.43 
Min 13 48.50±23.35 48.00 545.36 0.63 -0.30 -0.68 
Min 14 48.75±22.68 52.50 514.20 0.66 -0.30 -0.95 
Min 15 55.08±29.52 61.50 871.36 0.10 -0.32 -1.62 
Table 4i : Raw data for current intensity before pain induction in experiment 4 
(100Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
EXPT. 
CONTROL 
Min l 7 5 12 8 6 8 5 9 8 5 7 6 
Min 2 7 5 12 9 7 8 5 9 8 5 7 6 
Min 3 7 5 12 9 7 8 5 9 10 5 7 6 
Mini 10 6 11 9 7 8 6 9 10 5 7 6 
Min 5 10 6 11 10 8 8 6 9 10 6 7 6 
Min 6 10 8 11 10 8 11 6 9 10 6 7 6 
Min 7 10 8 11 10 8 11 6 9 10 6 7 6 
Min 8 10 8 11 10 8 11 7 9 10 6 7 6 
Min9 10 8 11 10 8 11 7 9 10 6 7 6 
Min 10 11 8 11 10 8 11 7 9 10 7 7 6 
Min ll 11 8 11 10 8 11 7 12 10 7 7 7 
Min 12 11 8 11 10 9 11 8 12 10 7 7 7 
Min 13 11 8 11 10 9 11 8 12 10 7 7 7 
Min 14 11 8 11 10 9 11 8 12 10 7 7 7 
Min 15 11 8 11 10 9 11 8 12 10 7 7 7 
SUB. 
CONTROL 
Mini 5 7 5 4 12 5 3 10 11 4 7 6 
Mint 6 11 5 4 12 5 3 12 11 6 10 6 
Min 3 6 11 6 4 13 5 3 12 12 6 11 6 
Mind 6 11 6 5 13 6 3 12 13 6 11 6 
Min 5 6 12 6 5 13 6 3 12 13 6 12 6 
Min 6 7 12 6 5 13 6 3 12 15 8 13 8 
Min 7 7 12 6 5 13 6 3 12 15 8 13 8 
Min 8 8 12 6 5 13 6 3 12 15 8 13 8 
Min 9 8 12 6 5 13 6 3 12 15 8 13 8 
Min 10 8 12 6 5 15 6 8 12 15 10 13 8 
Min 11 9 12 6 6 15 6 8 12 15 10 13 8 
Min 12 9 12 6 6 15 6 8 12 15 10 13 8 
Min 13 10 12 6 6 15 6 8 12 15 10 13 8 
Min 14 10 12 6 6 15 6 8 12 15 10 13 8 
Min 15 10 12 6 6 15 6 8 12 15 10 13 8 
Table 4j : Summary of current intensity before pain induction descriptive statistics in 
experiment 4 (100Hz TENS) 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
EXPT. 
CONTROL 
Min 1 7.17±2.04 7.00 4.15 0.13 1.12 1.71 
Min 2 7.33±2.06 7.00 4.24 0.27 0.88 1.06 
Min 3 7.50±2.19 7.00 4.82 0.39 0.65 -0.08 
Min 4 7.83±1.95 7.50 3.79 0.50 0.19 -1.31 
Min S 8.08±1.89 8.00 3.54 0.09 0.15 -1.64 
Min 6 8.50±1.93 8.50 3.73 0.16 -0.14 -1.59 
Min 7 8.50±1.93 8.50 3.73 0.16 -0.14 -1.59 
Min 8 8.58±1.83 8.50 3.36 0.31 -0.11 -1.48 
Min 9 8.58±1.83 8.50 3.36 0.31 -0.11 -1.48 
Min 10 8.75±1.81 8.50 3.29 0.22 0.007 -1.60 
Min 11 9.08±1.93 9.00 3.72 0.04 0.13 -1.84 
Min 12 9.25±1.81 9.50 3.29 0.22 -0.007 -1.60 
Min 13 9.25±1.81 9.50 3.29 0.22 -0.007 -1.60 
Min 14 9.25±1.81 9.50 3.29 0.22 -0.007 -1.60 
Min 15 9.25±1.81 9.50 3.29 0.22 -0.007 -1.60 
SUB. 
CONTROL 
Min 1 6.58±2.94 5.50 8.63 0.17 0.83 -0.54 
Min 2 7.58±3.34 6.00 11.17 0.07 0.23 -1.78 
Min 3 7.92±3.59 6.00 12.81 0.07 0.22 -1.78 
Min 4 8.17±3.54 6.00 12.51 0.04 0.26 -1.66 
Min 5 8.33±3.70 6.00 13.70 0.01 0.21 -1.87 
Min 6 9.00±3.84 8.00 14.73 0.45 0.10 -1.34 
Min 7 9.00±3.84 8.00 14.73 0.45 0.10 -1.34 
Min 8 9.08±3.80 8.00 14.45 0.47 0.04 -1.26 
Min 9 9.08±3.80 8.00 14.45 0.47 0.04 -1.26 
Min 10 9.83±3.51 9.00 12.33 0.38 0.21 -1.36 
Min 11 10.00±3.36 9.50 11.27 0.28 0.24 -1.35 
Min 12 10.00±3.36 9.50 11.27 0.28 0.24 -1.35 
Min 13 10.08±3.34 10.00 11.17 0.30 0.16 -1.33 
Min 14 10.08±3.34 10.00 11.17 0.30 0.16 -1.33 
Min 15 10.08±3.34 10.00 11.17 0.30 0.16 -1.33 
Table 4k : Raw data for current intensity during pain induction in experiment 4 
(100Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
EXPT. 
CONTROL 
Min 1 10 9 9 10 10 12 8 13 12 7 12 7 
Min 2 11 9 9 10 10 12 8 13 12 7 12 7 
Min 3 11 9 9 11 10 12 8 13 12 7 12 7 
Mint 12 9 9 11 10 12 9 13 12 8 12 7 
Min5 12 9 9 11 10 12 10 14 12 8 12 7 
Min6 12 10 9 11 10 12 10 14 12 8 12 7 
Min? 12 10 9 11 10 12 10 14 12 8 12 7 
Min 8 12 10 8 10 10 12 10 14 12 8 13 7 
Min 9 12 10 8 10 10 12 10 14 12 8 13 7 
Min 10 12 11 8 10 10 12 10 14 12 10 13 7 
Min 11 12 11 8 10 10 12 10 15 12 10 13 7 
Min 12 13 11 8 10 10 12 10 15 12 10 13 7 
Min 13 13 11 8 9 10 12 10 15 12 10 13 7 
Min 14 13 11 8 9 10 12 10 15 12 10 13 7 
Min 15 13 11 8 9 10 12 10 15 12 10 13 7 
SUB. 
CONTROL 
Min 1 9 14 9 6 15 8 7 12 15 10 14 7 
Min2 9 14 9 6 19 8 8 12 15 11 14 7 
Min 3 9 14 10 6 19 8 8 12 15 11 15 7 
Min4 9 14 10 6 19 8 8 12 15 11 15 7 
Min 5 9 15 11 6 19 8 8 12 16 11 15 7 
Minh 10 15 11 6 19 8 8 14 16 11 15 7 
Min 7 10 15 11 6 19 8 8 14 17 11 15 8 
Min 8 10 15 12 6 19 8 8 14 17 11 15 8 
Min 9 10 15 12 6 19 8 11 14 17 11 15 8 
Min 10 10 15 12 6 19 8 11 14 17 11 15 8 
Min 11 10 15 12 6 19 8 11 16 18 11 15 8 
Min 12 10 15 12 6 19 8 10 16 17 11 18 8 
Min 13 10 15 12 6 19 8 12 16 18 11 19 8 
Min 14 10 15 12 6 19 8 12 16 19 11 19 8 
Min 15 10 15 12 6 19 8 12 16 19 11 19 8 
Table 41 : Summary of current intensity during pain induction descriptive statistics 
in experiment 4 (100Hz TENS) 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
EXPT. 
CONTROL 
Min 1 9.92±2.02 10.00 4.08 0.42 -0.02 -1.14 
Min 2 10.00±2.04 10.00 4.18 0.45 -0.15 -1.24 
Min 3 10.08±2.06 10.50 4.26 0.39 -0.28 -1.29 
Min 4 10.33±1.92 10.50 3.70 0.34 -0.29 -1.22 
Min 5 10.50±2.02 10.50 4.09 0.68 -0.12 -0.55 
Min 6 10.58±1.97 10.50 3.90 0.65 -0.23 -0.22 
Min 7 10.58±1.97 10.50 3.90 0.65 -0.23 -0.22 
Min 8 10.50±2.15 10.00 4.64 0.53 -0.07 -0.86 
Min 9 10.50±2.15 10.00 4.64 0.53 -0.07 -0.86 
Min 10 10.75±2.01 10.50 4.02 0.64 -0.32 -0.13 
Min 11 10.83±2.07 10.50 4.70 0.71 0.06 0.33 
Min 12 10.92±2.23 10.50 4.99 0.79 0.007 -0.06 
Min 13 10.83±2.29 10.50 5.24 0.95 0.08 -0.35 
Min 14 10.83±2.29 10.50 5.24 0.95 0.08 -0.35 
Min 15 10.83±2.29 10.50 5.24 0.95 0.08 -0.35 
SUB. 
CONTROL 
Min 1 10.50±3.34 9.50 11.18 0.21 0.21 -1.66 
Min 2 11.00±3.88 10.00 15.09 0.47 0.69 -0.16 
Min 3 11.17±3.93 10.50 15.42 0.59 0.60 -0.39 
Min 4 11.17±3.93 10.50 15.42 0.59 0.60 -0.39 
Min 5 11.42±4.08 10.50 16.63 0.55 0.46 -0.83 
Min 6 11.67±4.10 11.00 16.79 0.61 0.28 -1.02 
Min 7 11.83±4.11 11.00 16.88 0.54 0.32 -1.05 
Min 8 11.92±4.10 11.50 16.81 0.65 0.25 -1.06 
Min 9 12.17±3.93 11.50 15.42 0.92 0.16 -0.76 
Min 10 12.17±3.93 11.50 15.42 0.92 0.16 -0.76 
Min 11 12.42±4.17 11.50 17.36 0.72 0.13 -1.10 
Min 12 12.50±4.36 11.50 19.00 0.49 0.13 -1.42 
Min 13 12.83±4.51 12.00 20.33 0.46 0.09 -1.34 
Min 14 12.92±4.62 12.00 21.36 0.36 0.12 -1.35 
Min 15 12.92±4.62 12.00 21.36 0.36 0.12 -1.35 
Appendix 5: Experiment 5- Tables 
Figures XIV, XV and XVI in text (Chapter 12) 
Tables 5a, 5b, 5c and 5d in text (Chapter 12) 
Table 5e : Simple main effects for experiment 5 VAS pain intensity scores (5Hz 
TENS) 
A= group 
b=time bl=minl 
b2 = min 2. 
Critical value = 3.00-3.40 
*= significant result p< 0.05 
Mean Square (MS) F value 
A at bI: 63.5278 1.05 
Aatb2: 13 0.21 
Aatb3: 18.75 0.31 
A at b4 : 2.25 0.04 
A at b5 : 3 7.4444 0.62 
A at b6 : 118.0278 1.95 
A at b7: 71.3611 1.18 
A at b8 : 148.7778 2.46 
A at b9 : 243.3 611 4.02* 
AatblO: 303.8611 5.02* 
A at bl 1: 320.4444 5.30* 
A at b12: 459.6944 7.60* 
A at b13 : 371.5833 6.14* 
A at b14 : 471.1944 7.79* 
A at b15 : 382.1111 6.32* 
Table 5f : Simple main effects for experiment 5 VAS pain unpleasantness scores (5Hz 
TENS) 
A=group 
b= time bl =min 1 
b2=min2..... 
Critical value = 3.00 - 3.40 
*= significant result pS0.05 
Mean Square (MS) F value 
A at bI 29.25 0.19 
Aatb2: 6.7778 0.04 
A at b3 : 17.5278 0.16 
A at b4: 24.6944 0.16 
A at b5 : 27.25 0.18 
A at b6: 101.6944 0.67 
A at b7: 73.4444 0.48 
A at b8: 238.7778 1.57 
A at b9: 290.25 1.91 
A at b 10 : 482.6944 3.18* 
A at b 11 : 343.5833 2.27 
A at b12: 444.1111 2.93 
A at b13 : 503.0278 3.32* 
A at b14 : 436.3611 2.88 
A at b15 : 713.0278 4.70* 
Table 5g : ANOVA Table for TENS current intensity (mA) before pain induction in 
experiment 5 (5Hz TENS) 
SS d. f. MS F p 
Effect of Condition 
Condition 5.88 1 5.88 0.05 0.831 
Error (Within + Residual) 1353.19 11 123.02 
Effect of Time 
Time 194.71 14 13.91 8.90 < 0.001 
Error (Within + Residual) 240.63 154 1.56 
Interaction (Condition x Time) 
Condition x Time 12.37 14 0.88 1.30 0.212 
Error (Within + Residual) 104.56 154 0.68 
Table 5h : ANOVA Table for TENS current intensity (mA) during pain induction in 
experiment 5 (5Hz TENS) 
SS d. f. MS F 
Effect of Condition 
Condition 90.00 1 90.00 0.33 0.575 
Error (Within + Residual) 2958.33 11 268.94 
Effect of Time 
Time 166.92 14 11.92 6.34 < 0.001 
Error (Within + Residual) 289.48 154 1.88 
Interaction (Condition x Time) 
Condition x Time 9.25 14 0.66 0.56 0.892 
Error (Within + Residual) 181.42 154 1.18 
Table 5i : Raw VAS intensity data for experiment 5 (5Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min 1 10 7 21 32 18 50 6 38 40 12 31 21 
Min 2 21 14 23 34 27 51 7 39 41 14 34 19 
Min 3 22 16 32 37 28 57 9 44 36 15 37 24 
Min 4 28 10 36 38 38 59 10 46 46 21 40 26 
Min 5 24 8 37 41 47 65 11 43 46 24 42 29 
Min 6 30 9 35 47 43 63 16 47 52 26 42 35 
Min 7 32 12 40 49 52 65 15 48 41 28 46 39 
Min 8 35 12 39 52 50 66 15 48 40 36 49 47 
Min 9 37 19 41 52 55 67 17 48 50 44 55 45 
Min 10 36 24 46 53 58 69 16 53 48 47 56 53 
Min 11 36 25 45 64 53 73 20 57 55 55 58 55 
Min 12 40 27 43 69 54 79 22 63 50 58 65 56 
Min 13 45 36 45 75 54 81 22 55 51 62 66 56 
Min 14 60 34 45 74 61 81 21 58 57 66 68 58 
Min 15 69 39 45 78 56 80 23 59 57 67 72 64 
EXPT. 
CONTROL 
Min 1 32 11 19 26 25 53 18 41 35 18 29 33 
Min 2 36 8 18 28 31 52 12 37 34 17 33 36 
Min 3 38 5 20 34 33 53 28 38 31 19 35 38 
Min 4 35 7 22 37 27 57 18 38 30 23 37 38 
Min 5 34 11 24- 37 32 65 23 39 28 25 39 44 
Min 6 41 13 23 45 35 64 25 41 27 29 44 41 
Min 7 52 15 25 48 36 64 27 42 28 33 41 46 
Min 8 45 17 25 56 37 69 28 42 35 35 46 53 
Min 9 54 18 26 63 38 73 29 44 36 34 53 55 
Min 10 68 25 26 64 40 71 30 45 35 36 55 59 
Min 11 59 25 25 67 45 77 34 45 39 38 59 63 
Min 12 71 31 30 68 42 77 32 46 32 43 63 64 
Min 13 77 22 30 73 42 74 33 47 39 47 66 67 
Min 14 70 30 30 73 42 72 35 49 43 51 68 74 
Min 15 80 29 30 74 38 73 43 48 42 54 71 77 
SUB. 
CONTROL 
Min 1 21 12 15 30 35 53 6 32 39 18 28 18 
Min 2 30 14 18 31 33 52 10 31 38 17 28 19 
Min 3 33 16 21 34 33 57 14 32 37 19 29 21 
Min 4 37 19 23 36 30 57 15 33 38 23 34 22 
Min 5 38 21 24 36 38 57 13 36 37 25 34 25 
Min 6 37 21 21 37 34 58 14 36 33 29 38 26 
Min 7 39 26 23 39 40 63 15 36 40 33 45 24 
Min 8 35 30 27 43 37 65 16 35 32 35 46 28 
Min 9 38 34 27 45 39 61 16 38 32 34 48 29 
Min 10 36 36 27 49 36 67 17 39 31 36 50 35 
Min 11 39 40 26 53 36 68 17 44 32 38 50 41 
Min 12 36 42 25 57 33 60 21 43 32 43 55 44 
Min 13 42 47 28 66 29 61 20 43 34 47 61 46 
Min 14 34 55 30 63 33 66 18 41 40 51 61 48 
Min 15 41 60 32 65 43 67 18 42 37 54 63 55 
Table 5j : Summary of VAS intensity descriptive statistics for experiment 5 (5Hz 
TENS) 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 23.83±14.29 21.00 204.33 0.53 0.41 -0.93 
Min 2 27.00±13.03 25.00 169.82 0.91 0.29 -0.65 
Min 3 29.75±13.58 30.00 184.39 0.92 0.38 0.01 
Min 4 33.17±14.76 37.00 217.97 0.69 -0.17 -0.37 
Min 5 34.75±16.24 39.00 263.66 0.69 -0.08 -0.08 
Min 6 37.08±15.27 38.50 233.17 0.95 -0.31 -0.09 
Min 7 38.92±15.24 40.50 232.26 0.70 -0.39 -0.001 
Min 8 40.75±15.25 43.50 232.57 0.33 -0.67 0.52 
Min 9 44.17±14.46 46.50 209.06 0.33 -0.76 0.48 
Min 10 46.58±14.79 50.50 218.63 0.28 -0.91 0.68 
Min 11 49.67±15.57 55.00 242.42 0.27 -0.77 0.07 
Min 12 52.17±16.84 55.00 283.42 0.88 -0.42 -0.31 
Min 13 54.00±16.24 54.50 263.82 0.96 -0.23 0.31 
Min 14 56.92±16.69 59.00 278.45 0.39 -0.91 0.85 
Min 15 59.08±16.69 61.50 278.63 0.50 -0.90 0.55 
EXPT. 
CONTROL 
Min 1 28.33±11.55 27.50 133.33 0.77 0.65 0.57 
Min 2 28.50±12.54 32.00 157.18 0.48 -0.06 -0.22 
Min 3 31.00±12.10 33.50 146.36 0.43 -0.55 1.37 
Min 4 30.75±12.68 32.50 160.75 0.62 0.15 1.08 
Min 5 33.42±13.44 33.00 180.63 0.45 0.86 2.18 
Min 6 35.67±13.32 38.00 177.51 0.65 0.40 0.81 
Min 7 38.50±13.69 39.00 187.36 0.97 0.11 -0.26 
Min 8 41.25±14.78 39.50 218.39 0.97 0.22 -0.30 
Min 9 43.75±16.43 41.00 269.84 0.90 0.21 -0.76 
Min 10 46.17±16.62 42.50 276.15 0.37 0.23 -1.54 
Min 11 48.00±16.85 45.00 283.82 0.61 0.19 -1.04 
Min 12 49.92±17.57 44.50 308.81 0.10 0.26 -1.70 
Min 13 51.42±19.14 47.00 366.45 0.35 0.01 -1.55 
Min 14 53.08±17.42 50.00 303.54 0.08 -0.02 -1.79 
Min 15 54.92±19.08 51.00 363.90 0.18 0.03 -1.76 
SUB. 
CONTROL 
Min 1 25.58±13.15 24.50 172.99 0.85 0.58 0.22 
Min 2 26.75±11.78 29.00 138.75 0.51 0.61 0.46 
Min 3 28.83±11.82 30.50 139.61 0.20 1.05 1.85 
Min 4 30.58±11.31 31.50 127.90 0.35 0.94 1.57 
Min 5 32.00±11.29 35.00 127.45 0.36 0.52 1.28 
Min 6 32.00±11.26 33.50 126.73 0.37 0.72 1.81 
Min 7 35.25±12.49 37.50 156.02 0.48 0.57 1.26 
Min 8 35.75±12.02 35.00 144.57 0.26 1.09 2.82 
Min 9 36.75±11.34 36.00 128.57 0.78 0.43 1.35 
Min 10 38.25±12.59 36.00 158.39 0.27 0.83 1.86 
Min 11 40.33±13.07 39.50 170.79 0.83 0.38 1.18 
Min 12 40.92±12.27 42.50 150.63 0.71 0.04 -0.76 
Min 13 43.67±14.28 44.50 204.06 0.68 0.02 -0.78 
Min 14 45.00±14.85 44.50 220.54 0.83 -0.20 -0.81 
Min 15 48.08±15.05 48.50 226.45 0.52 -0.52 -0.38 
Table 5k: Raw VAS unpleasantness data for experiment 5 (5Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min l 10 3 12 35 27 42 3 29 7 11 29 20 
Min 2 16 3 15 36 33 45 3 31 13 12 31 24 
Min 3 26 7 18 36 43 47 7 32 17 14 33 25 
Min 4 17 2 19 37 51 67 6 34 19 18 34 27 
Min 5 19 5 17 39 54 66 7 33 23 22 32 26 
Min 6 20 4 21 42 50 73 9 33 26 23 33 28 
Min 7 25 3 21 49 52 78 7 38 24 25 36 30 
Min 8 30 8 22 59 55 79 8 39 26 34 38 36 
Min 9 32 15 20 65 59 79 10 43 31 38 39 37 
Min 10 36 19 26 66 70 83 16 45 37 42 43 45 
Min 11 46 11 24 68 70 84 19 46 40 46 46 46 
Min 12 47 26 26 76 69 85 16 47 29 52 49 50 
Min 13 46 29 24 78 71 84 22 47 37 55 55 54 
Min 14 57 31 24 81 76 86 17 48 41 59 65 55 
Min 15 67 33 27 80 77 91 20 48 47 60 68 65 
EXPT. 
CONTROL 
Min 1 38 1 10 22 36 44 6 21 14 15 26 27 
Min 2 41 4 22* 21 36 50 9 23 18 16 25 29 
Min 3 39 1 28 23 34 52 9 24 22 18 27 33 
Min 4 39 1 30 26 36 57 11 24 20 20 28 36 
Min 5 38 4 34 27 37 70 12 27 22 23 30 38 
Min 6 47 5 36 32 37 70 16 28 22 26 33 39 
Min 7 44 5 43 36 35 75 14 32 27 28 35 40 
Min 8 46 8 41 38 41 78 19 31 27 31 39 43 
Min 9 59 10 47 45 46 79 19 29 26 29 43 45 
Min 10 57 14 45 48 49 74 18 29 27 30 46 46 
Min 11 62 14 42 49 48 79 16 33 33 35 50 48 
Min 12 69 18 48 57 49 78 20 34 22 39 53 55 
Min 13 75 16 47 68 45 82 21 35 29 46 55 61 
Min 14 82 21 48 75 49 79 19 36 33 47 56 68 
Min 15 89 23 52 77 50 77 20 36 35 49 59 73 
SUB. 
CONTROL 
Min 1 27 3 13 31 31 32 4 15 24 12 24 19 
Min 2 31 8 15 33 37 50 8 16 25 13 24 19 
Min 3 28 5 19 35 37 46 11 17 25 14 25 24 
Min 4 30 3 18 36 41 61 9 17 27 16 26 25 
Min 5 30 8 22 39 31 67 11 18 27 18 28 25 
Min 6 30 8 21 40 40 58 11 19 17 19 30 23 
Min 7 31 15 22 41 42 64 11 20 25 22 33 26 
Min 8 27 16 22 41 41 66 10 21 20 24 35 26 
Min 9 29 21 22 43 42 70 12 23 22 28 38 28 
Min 10 28 26 24 45 41 73 12 25 20 30 40 31 
Min 11 39 32 25 4 45 74 14 25 23 35 43 34 
Min 12 33 35 30 49 40 74 17 26 24 37 46 37 
Min 13 35 42 29 51 43 78 12 27 26 40 48 39 
Min 14 28 58 28 56 48 81 12 28 27 41 53 44 
Min 15 44 58 30 58 47 79 11 27 21 47 60 51 
Table 51 : Summary of VAS unpleasantness descriptive statistics for experiment 5 
(5Hz TENS) 
Mcan±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 19.00±13.14 16.00 172.72 0.39 0.35 -1.21 
Min 2 21.83±13.48 20.00 181.79 0.56 0.12 -1.04 
Min 3 25.42±13.22 25.50 174.81 0.73 0.11 -1.01 
Min 4 27.58±18.45 23.00 340.45 0.49 0.79 0.59 
Min 5 28.58±17.88 24.50 319.54 0.47 0.84 0.51 
Min 6 30.17±18.53 27.00 343.42 0.44 1.00 1.62 
Min 7 32.33±20.47 27.50 418.97 0.51 0.81 1.13 
Min 8 36.17±20.57 35.00 423.24 0.57 0.61 0.43 
Min 9 39.00±20.42 37.50 417.09 0.65 0.56 -0.09 
Min 10 44.00±20.30 42.50 412.18 0.47 0.56 -0.21 
Min 11 45.50±21.27 46.00 452.27 0.45 0.15 -0.23 
Min 12 47.67±21.25 48.00 451.70 0.53 0.29 -0.66 
Min 13 50.17±20.32 50.50 412.88 0.62 0.23 -0.86 
Min 14 53.33±22.14 56.00 490.06 0.85 -0.17 -0.91 
Min 15 56.92±22.17 62.50 491.36 0.77 0.30 -0.88 
EXPT. 
CONTROL 
Min 1 21.67±13.25 21.50 175.51 0.94 0.17 -0.81 
Min 2 24.50±13.04 22.50 170.09 0.90 0.46 0.09 
Min 3 25.83±13.38 25.50 179.06 0.95 0.02 0.74 
Min 4 27.33±14.32 27.00 204.97 0.89 0.21 1.08 
Min 5 30.17±16.30 28.50 265.79 0.23 1.00 2.91 
Min 6 32.58±16.22 32.50 262.99 0.53 0.73 2.06 
Min 7 34.50±17.14 35.00 293.73 0.27 0.72 2.62 
Min 8 36.83±16.98 38.50 288.33 0.22 0.89 2.95 
Min 9 39.75±18.60 44.00 345.84 0.63 0.48 0.64 
Min 10 40.25±17.15 45.50 294.20 0.62 0.23 -0.09 
Min 11 42.42±18.15 45.00 329.36 0.63 0.26 0.47 
Min 12 45.17±19.16 48.50 367.06 0.66 0.32 -0.79 
Min 13 48.33±20.89 46.50 436.24 0.92 0.04 -0.89 
Min 14 51.08±21.61 48.50 466.99 0.54 0.003 -1.17 
Min 15 53.33±22.38 51.00 500.97 0.67 0.003 -1.09 
SUB. 
CONTROL 
Min 1 19.58±10.22 21.50 104.45 0.38 -0.38 -1.12 
Min 2 23.25±12.69 21.50 161.11 0.50 0.74 0.14 
Min 3 23.83±11.66 24.50 135.97 0.98 0.31 -0.18 
Min 4 25.75±15.46 25.50 239.11 0.58 0.88 1.41 
Min 5 27.00±15.31 26.00 234.36 0.05 1.62 3.97 
Min 6 26.33±14.17 22.00 200.79 0.39 0.97 0.88 
Min 7 29.33±14.40 25.50 207.33 0.29 1.26 2.04 
Min 8 29.08±14.94 25.00 223.17 0.11 1.40 2.53 
Min 9 31.50±15.20 28.00 231.00 0.05 1.52 3.07 
Min 10 32.92±15.66 29.00 245.36 0.08 1.53 3.41 
Min 11 36.33±15.43 34.50 238.06 0.32 1.16 2.49 
Min 12 37.33±14.65 36.00 214.61 0.23 1.35 2.99 
Min 13 39.17±16.32 39.50 266.33 0.41 0.90 2.43 
Min 14 42.00±18.70 42.50 349.82 0.63 0.48 0.36 
Min 15 44.42±19.17 47.00 367.36 0.84 -0.12 -0.25 
Table 5m : Raw data for current intensity before pain induction in experiment 5 
(5Hz TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
EXPT. 
CONTROL 
Mini 4 8 10 13 19 15 5 6 9 12 7 9 
Min 2 4 8 10 13 25 21 5 6 9 12 7 9 
Min 3 4 8 10 13 25 21 5 7 9 12 7 11 
Min 4 4 8 10 13 30 21 5 7 9 12 7 11 
Min5 6 8 10 13 30 21 5 7 9 12 7 12 
Min 6 6 10 13 18 30 21 5 7 9 12 7 12 
Min 7 6 10 13 18 30 21 5 7 9 12 7 12 
Min 8 6 10 13 18 30 21 5 7 9 12 7 12 
Min 9 6 10 13 18 30 21 5 7 9 12 7 12 
Min 10 6 10 13 18 30 21 5 7 9 12 7 12 
Min 11 6 10 13 18 30 24 5 7 9 12 7 12 
Min 12 6 10 13 18 30 24 5 7 9 12 7 12 
Min 13 6 10 13 18 30 24 5 7 9 12 7 12 
Min 14 6 10 13 18 30 24 5 7 9 12 7 12 
Min 15 6 10 13 18 30 24 5 7 9 12 7 12 
SUB. 
CONTROL 
Min 1 12 13 10 8 20 14 6 6 8 12 8 10 
Min2 12 14 1f 8 20 14 6 6 8 12 8 10 
Min3 12 14 11 8 20 14 6 6 8 14 9 11 
Min4 12 14 11 10 20 14 6 6 8 14 9 11 
MinS 12 14 11 10 24 14 6 6 8 14 9 11 
Min 6 13 14 11 10 24 14 6 6 8 14 9 11 
Min 7 13 14 11 10 24 19 6 6 8 14 9 11 
Min8 13 14 13 10 24 19 6 6 8 14 9 11 
Min9 13 14 13 10 24 19 6 6 8 14 9 11 
Min 10 13 14 13 10 24 19 6 6 8 14 9 11 
Min 11 13 14 13 10 24 19 6 6 8 14 9 11 
Min 12 13 14 13 10 24 19 6 6 8 14 9 11 
Min 13 13 14 13 10 24 19 6 6 8 14 9 11 
Min 14 13 14 13 10 24 19 6 6 8 14 9 11 
Min 15 13 14 13 10 24 19 6 6 8 14 9 11 
Table 5n : Summary of current intensity before pain induction descriptive statistics 
in experiment 5 (5Hz TENS) 
Mcan±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
EXPT. 
CONTROL 
Min 1 9.75±4.37 9.00 19.11 0.65 0.79 0.32 
Min 2 10.75±6.35 9.00 40.39 0.04 1.40 1.40 
Min 3 11.00±6.27 9.50 39.27 0.06 1.34 1.35 
Min 4 11.42±7.35 9.50 54.08 0.01 1.76 3.15 
Min 5 11.67±7.19 9.50 51.70 <0.01 1.83 3.32 
Min 6 12.50±7.30 11.00 53.36 0.06 1.41 1.88 
Min 7 12.50±7.30 11.00 55.36 0.06 1.41 1.88 
Min 8 12.50±7.30 11.00 55.36 0.06 1.41 1.88 
Min 9 12.50±7.30 11.00 55.36 0.06 1.41 1.88 
Min 10 12.50±7.30 11.00 55.36 0.06 1.41 1.88 
Min 11 12.75±7.66 11.00 58.75 0.05 1.33 1.15 
Min 12 12.75±7.66 11.00 58.75 0.05 1.33 1.15 
Min 13 12.75±7.66 11.00 58.75 0.05 1.33 1.15 
Min 14 12.75±7.66 11.00 58.75 0.05 1.33 1.15 
Min 15 12.75±7.66 11.00 58.75 0.05 1.33 1.15 
SUB. 
CONTROL 
Min 1 10.58±3.96 10.00 15.72 0.24 1.14 1.74 
Min 2 10.75±4.02 10.50 16.20 0.31 0.98 1.21 
Min 3 11.08±4.05 11.00 16.45 0.41 0.74 0.67 
Min 4 11.25±3.96 11.00 15.66 0.47 0.70 0.91 
Min 5 11.58±4.83 11.00 23.36 0.06 1.49 3.49 
Min 6 11.67±4.85 11.00 23.52 0.07 1.41 3.24 
Min 7 12.08±5.26 11.00 27.72 0.28 1.10 1.22 
Min 8 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 9 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 10 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 11 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 12 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 13 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 14 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Min 15 12.25±5.26 12.00 27.66 0.33 1.00 1.05 
Table 5o : Raw data for current intensity during pain induction in experiment 5 (5Hz 
TENS) 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
EXPT. 
CONTROL 
Min 1 10 14 12 18 38 16 5 9 12 15 9 11 
Min 2 10 14 12 18 38 16 5 9 12 15 9 11 
Min 3 10 14 12 18 40 16 8 9 12 15 10 11 
Min4 10 14 17 18 40 16 8 10 12 15 10 11 
Min5 12 14 17 19 40 16 8 10 12 15 10 12 
Min6 12 13 17 19 40 16 8 10 12 15 11 12 
Min 7 12 13 17 19 40 16 8 10 12 15 11 12 
Min 8 12 13 17 19 40 16 8 11 12 15 12 12 
Min 9 12 13 17 19 40 20 8 11 12 15 12 12 
Min 10 12 13 17 19 40 20 8 11 12 16 12 12 
Min 11 12 13 17 19 40 20 8 12 12 16 12 12 
Min 12 12 13 17 19 40 20 8 12 12 16 12 12 
Min 13 12 13 17 19 40 20 10 12 12 16 12 12 
Min 14 12 13 17 19 40 20 10 12 12 16 12 12 
Min 15 12 13 17 19 40 20 10 12 12 16 12 12 
SUB. 
CONTROL 
Min 1 16 14 12 17 26 26 6 10 8 17 11 13 
Min 2 25 16 12 17 26 26 6 10 8 17 11 13 
Min 3 25 16 12 13 32 26 6 10 8 17 11 14 
Min 4 26 16 15 13 32 26 6 11 8 18 11 14 
Min 5 26 16 15 13 32 26 6 11 8 18 11 14 
Min 6 26 16 15 13 32 26 6 11 8 18 11 14 
Min 7 29 16 15 13 32 26 6 11 8 18 14 14 
Min 8 29 16 15 13 32 27 6 11 8 18 14 14 
Min 9 29 16 15 13 32 27 6 11 8 19 14 14 
Min 10 29 16 15 13 32 27 6 12 8 19 16 15 
Min 11 20 16 15 13 32 27 6 12 8 19 16 15 
Min 12 20 16 15 13 32 27 6 12 8 20 16 15 
Min 13 25 16 15 13 32 27 6 12 8 20 16 15 
Min 14 24 16 15 13 32 27 6 12 8 20 16 15 
Min 15 24 16 15 13 32 27 6 12 8 20 16 15 
Table 5p : Summary of current intensity during pain induction descriptive statistics 
in experiment 5 (5Hz TENS) 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
EXPT. 
CONTROL 
Min 1 14.08±8.32 12.00 69.17 <0.01 2.39 7.03 
Min 2 14.08±8.32 12.00 69.19 <0.01 2.39 7.03 
Min 3 14.58±8.54 12.00 72.99 <0.01 2.75 8.43 
Min 4 15.08±8.47 13.00 71.72 <0.01 2.63 7.93 
Min 5 15.42±8.37 13.00 70.08 <0.01 2.61 7.85 
Min 6 15.42±8.33 12.50 69.54 <0.01 2.66 8.02 
Min 7 15.42±8.33 12.50 69.54 <0.01 2.66 8.02 
Min 8 15.58±8.24 12.50 67.90 <0.01 2.70 8.27 
Min 9 15.92±8.34 12.50 69.54 <0.01 2.48 7.10 
Min 10 16.00±8.33 12.50 69.45 <0.01 2.45 7.01 
Min 11 16.08±8.28 12.50 68.63 <0.01 2.47 7.12 
Min 12 16.08±8.28 12.50 69.63 <0.01 2.47 7.12 
Min 13 16.25±8.12 12.50 66.02 <0.01 2.60 7.60 
Min 14 16.25±8.12 12.50 66.02 <0.01 2.60 7.60 
Min 15 16.25±8.12 12.50 66.02 <0.01 2.60 7.60 
SUB. 
CONTROL 
Min 1 14.67±6.29 13.50 39.51 0.31 0.80 0.14 
Min 2 15.58±6.95 14.50 48.26 0.29 0.47 -1.00 
Min 3 15.83±7.93 13.50 62.88 0.29 0.92 -0.001 
Min 4 16.33±7.90 14.50 64.42 0.37 0.80 -0.16 
Min 5 16.33±7.90 14.50 62.42 0.37 0.80 -0.16 
Min 6 16.33±7.90 14.50 62.42 0.37 0.80 -0.16 
Min 7 16.83±8.13 14.50 66.15 0.29 0.77 -0.31 
Min 8 16.92±8.24 14.50 67.90 0.25 0.76 -0.43 
Min 9 17.00±8.26 14.50 68.18 0.30 0.72 -0.50 
Min 10 17.33±8.12 15.50 65.88 0.35 0.64 -0.44 
Min 11 16.58±7.32 15.50 53.54 0.46 0.80 0.75 
Min 12 16.67±7.35 15.50 54.06 0.48 0.76 0.61 
Min 13 17.08±7.69 15.50 59.17 0.57 0.59 -0.16 
Min 14 17.00±7.60 15.50 57.82 0.62 0.61 -0.16 
Min 15 17.00±7.60 15.50 57.82 0.62 0.61 -0.16 
Appendix 6: Experiment 6- Tables 
Figures XVII, XVIII and XIX in text (Chapter 13) 
Tables 6a and 6b are shown in text (Chapter 13) 
Table 6c : ANOVA table for mean TENS current intensities before pain induction in 
experiment 6 
TENS CURRENT 
(BEFORE PAIN) SS d. f. MS F p 
Effect of frequency 
Frequency 451.14 1 451.14 7.38 0.02 
Error (Within + Residual) 672.03 11 61.09 
Effect of Time 
Minute 147.60 14 10.54 7.79 < 0.001 
Error (Within + Residua})- 208.47 154 1.35 
Interaction 
Frequency x Minute 5.16 14 0.37 0.67 0.805 
Error (Within + Residual) 85.18 154 0.55 
Table 6d : Simple main effects for mean TENS current intensities before pain 
induction in experiment 6 
A= experimental group (high frequency or low frequency TENS) 
b=time bl =min 1 
b2 = min 2..... 
Critical value = 3.92-4.84 
*= significant result pS0.05 
Mean Square (MS) F value 
A at bI : 28.17 6.14* 
A at b2 : 18.375 4.01 * 
A at b3 : 18.375 4.01 * 
Aatb4: 26.04 5.68* 
A at b5 : 32.67 7.12* 
A at b6 : 35.04 7.64* 
A at b7: 32.67 7.12* 
A at b8 : 30.375 7.64* 
A at b9 : 26.04 5.68* 
A at b10 : 30.375 6.62* 
A at bl l: 42.67 9.30* 
A at b12: 37.50 8.18* 
Aatb13: 32.67 7.12* 
A at b14: 32.67 7.12* 
A at b15 : 2.67 7.12* 
Table 6e : ANOVA table for mean TENS current intensities during pain induction in 
experiment 6 
TENS CURRENT 
(DURING PAIN) SS d. f. MS F 
Effect of frequency 
Frequency 893.02 1 893.02 7.21 0.021 
Error (Within + Residual) 1362.48 11 123.86 
Effect of Time 
Minute 380.33 14 27.17 4.47 < 0.001 
Error (Within + Residual) 936.73 154 6.08 
Interaction 
Frequency x Minute 65.77 14 4.70 1.34 0.188 
Error (Within + Residual) 538.23 154 3.50 
Table 6f : Simple main effects for mean TENS current intensities during pain 
induction in experiment 6 
A= experimental group (high frequency or low frequency TENS) 
b= time bl= min 1 
b2=min2..... 
Critical value = 3.92-4.84 
*= significant result pS0.05 
Mean Square (MS) F value 
A at b l. : 42.67 3.70 
A at b2 : 35.04 3.04 
A at b3 : 26.04 2.26 
A at b4 : 28.17 2.44 
A at b5: 28.17 2.44 
A at b6: 42.67 3.70 
A at b7: 50.04 4.43 * 
A at b8: 50.04 4.43 * 
A at b9: 60.17 5.22 * 
A at NO: 54.00 4.69* 
A at bll: 70.04 6.08* 
A at b12: 96.00 8.33* 
A at b 13 : 126.04 10.94* 
Aatb14: 117.04 10.16* 
A at b15 : 130.67 11.34* 
Table 6g : Raw VAS intensity data for experiment 6 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min 1 16 37 18 12 7 28 28 18 46 8 44 12 
Min 2 12 41 20 11 5 20 34 29 47 16 38 10 
Min 3 14 42 29 16 14 19 39 34 60 19 31 14 
Min 4 13 47 33 22 13 19 42 40 59 18 41 15 
Min 5 19 45 33 20 16 25 44 38 62 23 39 17 
Min 6 23 55 26 21 18 28 45 36 59 29 40 18 
Min 7 25 60 33 26 14 29 45 35 65 45 37 19 
Min 8 25 59 36 30 16 29 42 38 65 65 39 18 
Min 9 24 49 30 35 15 35 45 41 72 78 47 20 
Min 10 28 55 41 38 26 31 45 44 75 83 45 28 
Min 11 28 52 41 38 22 25 44 45 71 93 53 23 
Min 12 33 59 34 42 33 25 46 45 76 98 50 23 
Min 13 39 53 33 50 26 24 49 44 81 100 35 25 
Min 14 36 54 41 49 30 27 57 41 79 100 42 34 
Min 15 39 54 38 48 42 29 53 46 89 100 50 35 
HF 
(100 Hz) 
TENS 
Min 1 13 26 17 17 5 15 26 21 64 34 24 10 
Min 2 13 27 19 19 8 16 42 23 69 43 28 8 
Min 3 18 32 19 27 11 19 56 26 82 52 30 7 
Min 4 16 28 20 30 11 20 43 25 84 60 33 8 
Min .5 20 26 25 32 15 16 39 26 90 57 31 11 
Min 6 19 31 20 33 14 18 39 26 89 69 32 10 
Min 7 19 32 29 34 19 20 35 26 91 73 33 9 
Min 8 18 27 26 31 25 16 40 27 92 74 42 15 
Min 9 22 35 30 38 29 17 44 28 90 84 35 13 
Min 10 21 27 30 36 28 19 46 29 93 91 36 17 
Min 11 25 31 41 37 38 25 44 28 94 91 38 11 
Min 12 28 28 36 37 60 26 45 30 96 93 32 13 
Min 13 26 35 39 39 38 22 43 31 96 98 46 15 
Min 14 27 30 40 47 64 25 46 30 95 99 45 16 
Min 15 30 30 34 49 66 19 41 30 96 100 42 16 
LF (5Hz) 
TENS 
Min 1 15 22 19 6 3 39 38 9 25 3 20 6 
Min 2 22 15 14 5 4 38 43 15 47 4 31 9 
Min 3 23 18 22 6 15 51 40 20 53 7 27 10 
Min 4 24 20 21 6 21 53 41 21 55 14 30 13 
Min 5 23 23 28 9 18 72 42 25 63 19 35 12 
Min 6 29 21 27 10 18 74 40 29 57 24 40 15 
Min 7 31 22 29 11 24 75 42 30 58 26 36 15 
Min 8 22 25 33 11 26 76 40 30 66 32 47 18 
Min 9 21 19 29 11 31 75 40 31 74 35 35 22 
Min 10 21 25 25 11 49 77 45 30 76 41 33 28 
Min 11 24 23 33 17 36 71 45 31 77 49 32 31 
Min 12 23 23 33 22 44 73 44 31 78 59 42 33 
Min 13 28 31 35 25 50 72 40 33 80 70 39 37 
Min 14 28 29 31 27 62 72 45 33 77 75 52 39 
Min 15 31 30 39 30 59 76 40 34 83 83 45 38 
Table 6h : Summary of VAS intensity descriptive statistics for experiment 6 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 22.83±13.61 18.00 185.24 0.24 0.64 -0.94 
Min 2 23.58±13.83 20.00 191.17 0.47 0.39 -1.24 
Min 3 27.58±14.39 24.00 20717 0.08 1.04 0.73 
Min 4 30.17±15.48 27.50 239.61 0.25 0.45 -1.06 
Min .5 31.75±14.21 29.00 202.02 0.30 0.79 
0.05 
Min 6 33.17±13.97 28.50 195.06 0.26 0.77 -0.57 
Min 7 36.08±15.47 34.00 239.36 0.63 0.61 -0.21 
Min 8 38.50±16.83 37.00 283.18 0.33 0.50 -0.81 
Min 9 40.92±19.18 38.00 367.72 0.44 0.75 0.13 
Min 10 44.92±18.20 42.50 331.36 0.06 1.16 0.65 
Min 11 44.58±21.02 42.50 441.72 0.18 1.16 1.37 
Min 12 47.00±21.84 43.50 476.91 0.10 1.32 1.62 
Min 13 46.58±23.12 41.50 534.45 0.04 1.40 1.63 
Min 14 49.17±21.33 41.50 455.06 0.04 1.50 2.01 
Min 15 51.92±21.36 47.50 456.08 0.01 1.56 1.78 
HF TENS 
Min 1 22.67±15.23 19.00 232.06 0.02 1.94 4.96 
Min 2 26.25±17.64 21.00 311.36 0.07 1.40 2.07 
Min 3 31.58±21.61 26.50 467.17 0.08 1.31 1.47 
Min 4 31.50±21.82 26.50 476.10 0.06 1.48 2.12 
Min 5 32.33±21.93 26.00 480.79 <0.01 1.91 4.03 
Min 6 33.33±23.26 28.50 545.51 0.01 1.62 2.21 
Min 7 35.00±23.60 30.50 556.73 <0.01 1.66 2.35 
Min 8 36.08±23.75 27.00 564.08 <0.01 1.65 2.08 
Min 9 38.75±24.19 32.50 584.93 <0.01 1.48 1.43 
Min 10 39.42±25.83 29.50 667.17 <0.01 1.64 1.60 
Min 11 41.92±25.27 37.50 638.45 <0.01 1.46 1.49 
Min 12 43.67±26.30 34.00 691.88 0.01 1.32 0.79 
Min 13 44.00±26.30 38.50 691.82 <0.01 1.52 1.53 
Min 14 47.00±26.58 42.50 706.73 0.05 1.15 0.44 
Min 15 46.0827.65 37.50 764.26 0.04 1.17 0.39 
LF TENS 
Min 1 17.08±12.54 17.00 157.17 0.25 0.63 -0.59 
Min 2 20.58±15.51 15.00 240.63 0.16 0.61 -1.11 
Min 3 24.33±15.90 21.00 252.79 0.18 0.84 -0.34 
Min 4 26.58±15.48 21.00 239.54 0.13 0.89 -0.12 
Min 5 30.75±19.48 24.00 379.29 0.07 1.23 0.78 
Min 6 32.00±18.37 28.00 337.64 0.18 1.24 1.34 
Min 7 33.25±18.01 29.50 324.20 0.15 1.29 1.67 
Min 8 35.50±19.21 31.00 369.18 0.22 1.10 0.69 
Min 9 33.58±22.05 31.00 486.08 0.15 0.88 0.68 
Min 10 38.42±20.64 31.50 426.08 0.14 0.98 0.28 
Min 11 39.08±18.56 32.50 344.63 0.07 1.16 0.59 
Min 12 42.08±18.97 37.50 359.90 0.11 0.89 -0.24 
Min 13 45.00±18.73 38.00 350.72 0.04 0.98 -0.52 
Min 14 47.50±19.45 42.00 378.27 0.07 0.50 -1.50 
Min 15 49.00±20.74 39.50 430.00 0.01 0.90 -0.91 
Table 6i : Raw VAS unpleasantness data for experiment 6 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
NO TENS 
Min l 10 26 22 5 16 27 33 8 59 9 33 5 
Min 2 9 31 28 6 22 21 38 19 63 14 26 8 
Min 3 17 36 28 9 29 16 50 31 59 18 34 9 
Min 4 18 41 28 14 35 19 54 28 60 17 32 9 
Min 5 23 43 23 17 32 21 53 30 70 23 28 10 
Min 6 27 40 24 17 37 23 50 36 74 30 51 7 
Min 7 33 50 25 22 39 30 54 37 71 46 45 9 
Min 8 33 54 27 26 44 26 63 36 74 60 46 10 
Min 9 38 52 34 29 47 34 60 36 80 75 51 10 
Min 10 39 60 25 28 70 32 67 45 77 81 44 10 
Min 11 41 61 23 32 84 38 62 38 78 95 56 9 
Min 12 49 57 27 30 90 35 66 45 76 98 56 12 
Min 13 47 58 25 35 97 41 76 56 85 99 46 15 
Min 14 49 55 30 39 98 42 71 59 84 100 50 9 
Min 15 54 59 28 42 100 41 72 63 90 100 49 15 
HF (100Hz) 
TENS 
Min1 6 16 11 6 13 17 40 19 64 13 19 4 
Min 2 12 14 14 9 16 17 54 19 74 27 26 4 
Min 3 15 21 12 13 24 17 61 21 88 38 32 4 
Min 4 17 19 20 19 27 20 50 24 87 51 34 4 
Min 5 20 23 20 24 35 23 51 23 91 48 32 4 
Min 6 24 27 22 26 43 28 48 25 92 71 34 5 
Min 7 26 23 22 26 58 31 47 28 92 82 31 4 
Min 8 27 26 23 33 66 35 42 30 94 88 44 4 
Min 9 29 24 23 30 71 34 46 34 94 90 31 6 
Min 10 33 30 26 35 72 39 45 36 96 91 25 7 
Min 11 38 31 23 39 91 42 56 36 96 95 28 8 
Min 12 41 30 24 43 94 34 54 39 95 95 46 8 
Min 13 44 35 18 46 97 44 58 41 97 97 57 7 
Min l4 46 33 25 52 100 44 68 40 97 99 51 8 
Min 15 45 28 19 47 100 38 79 44 98 100 53 9 
LF (5Hz) 
TENS 
Mini 12 9 19 2 8 64 54 9 45 5 7 3 
Min 2 21 13 23 3 9 75 54 18 53 7 26 6 
Min 3 28 17 16 4 24 80 55 21 58 9 26 6 
Min 4 30 17 14 5 23 81 61 25 63 15 37 5 
Min 5 30 14 28 5 20 84 67 27 60 16 37 7 
Min 6 36 15 25 7 30 82 73 28 68 25 22 6 
Min 7 32 15 25 9 39 84 69 33 66 24 28 6 
Min 8 35 20 23 6 40 84 79 33 74 30 25 9 
Min 9 37 19 26 8 47 87 78 38 78 33 29 9 
Min 10 45 17 20 8 68 81 84 34 78 32 29 8 
Min 11 46 20 28 7 51 87 76 39 79 44 33 10 
Min 12 43 20 25 6 57 82 78 40 85 61 36 8 
Min 13 56 23 20 10 72 85 79 40 83 60 30 8 
Min 14 61 33 22 12 54 88 85 41 89 71 34 11 
Min 15 67 31 22 14 76 88 84 43 93 90 50 11 
Table 6j : Summary of VAS unpleasantness descriptive statistics for experiment 6 
Mean±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
NO TENS 
Min 1 21.08±15.85 19.00 251.36 0.09 1.22 1.73 
Min 2 23.75±15.75 21.50 248.02 0.13 1.40 2.72 
Min 3 28.00±15.50 28.50 240.18 0.44 0.69 -0.02 
Min 4 29.58±15.85 28.00 251.17 0.44 0.74 -0.23 
Min 5 31.08±16.76 25.50 280.81 0.09 1.31 1.57 
Min 6 34.67±17.82 33.00 317.51 0.74 0.75 1.03 
Min 7 38.42±16.40 38.00 268.81 >0.99 0.19 0.48 
Min 8 41.58±18.66 40.00 348.08 0.91 0.15 -0.63 
Min 9 45.50±19.75 42.50 389.91 0.75 0.24 0.04 
Min 10 48.17±22.67 44.50 513.97 0.72 -0.03 -1.12 
Min 11 51.42±25.84 48.50 667.72 0.92 0.16 -0.72 
Min 12 53.42±25.95 52.50 673.17 0.95 0.26 -0.60 
Min 13 56.67±27.40 51.50 750.79 0.64 0.27 -0.97 
Min 14 57.17±27.23 52.50 741.61 0.79 0.14 -0.37 
Min 15 59.42±27.20 56.50 740.08 0.70 0.18 -0.75 
HF TENS 
Min 1 19.00±17.00 14.50 288.91 <0.01 2.04 4.29 
Min 2 23.83±20.27 16.50 410.91 <0.01 1.81 2.88 
Min 3 28.83±23.85 21.00 568.88 0.01 1.70 2.74 
Min 4 31.00±22.21 22.00 493.27 0.02 1.61 2.94 
Min 5 32.83±22.32 23.50 497.97 0.02 1.71 3.84 
Min 6 37.08±23.76 27.50 564.63 0.05 1.32 1.71 
Min 7 39.17±26.01 29.50 676.33 0.06 1.07 0.46 
Min 8 42.67±26.89 34.00 723.15 0.15 0.92 0.19 
Min 9 42.67±27.64 32.50 763.88 0.04 1.00 -0.04 
Min 10 47.92±27.86 37.50 775.90 0.32 0.59 -0.69 
Min 11 48.58±29.69 38.50 881.54 0.06 0.76 -0.71 
Min 12 50.25±29.18 42.00 851.29 0.07 0.68 -0.64 
Min 13 53.42±29.95 45.00 896.99 0.21 0.38 -0.66 
Min 14 55.25±30.06 48.50 903.48 0.33 0.39 -0.77 
Min 15 55.00±31.90 46.00 1017.64 0.26 0.35 1.18 
LF TENS 
Min 1 19.75±21.69 9.00 470.39 <0.01 1.31 0.18 
Min 2 25.69±22.88 19.50 523.51 0.04 1.19 0.43 
Min 3 28.67±23.52 22.50 552.97 0.06 1.18 0.60 
Min 4 31.33±24.59 24.00 604.79 0.12 0.96 -0.14 
Min 5 32.92±24.96 27.50 622.81 0.19 0.98 0.03 
Min 6 34.75±25.60 26.50 655.48 0.06 0.92 -0.43 
Min 7 35.83±24.73 30.00 611.42 0.23 0.85 -0.26 
Min 8 38.17±26.59 31.50 707.06 0.08 0.81 -0.62 
Min 9 40.75±26.87 35.00 722.20 0.20 0.67 -0.74 
Min 10 42.00±28.64 33.00 820.00 0.15 0.41 -0.48 
Min 11 43.33±26.37 41.50 695.33 0.53 0.37 -0.86 
Min 12 45.08±27.77 41.50 771.17 0.50 0.10 -1.27 
Min 13 47.17±28.88 48.00 833.79 0.31 -0.002 -1.68 
Min 14 50.08±28.83 47.50 831.17 0.38 0.09 -1.46 
Min 15 55.75±31.08 58.50 966.20 0.23 -0.22 -1.68 
Table 6k : Raw data for current intensity before pain induction in experiment 6 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
HF (100Hz) 
TENS 
Mint 14 5 6 8 8 5 6 4 8 10 6 7 
Min 2 15 6 6 9 10 5 6 5 7 13 5 7 
Min 3 17 7 7 11 10 5 6 5 7 13 5 7 
Min4 17 7 7 11 10 5 7 5 7 13 5 7 
Min 5 17 7 7 11 10 5 7 5 6 13 5 7 
Min 6 17 7 7 11 10 5 7 5 6 13 5 7 
Min 7 18 7 7 11 10 6 7 5 6 13 5 7 
Min 8 19 7 7 11 10 6 7 5 6 13 5 7 
Min 9 20 7 7 11 10 6 7 5 6 15 5 7 
Min 10 20 7 7 11 10 7 7 5 6 15 5 7 
Min 11 20 7 7 11 10 7 7 5 6 15 5 7 
Min 12 21 7 7 11 10 8 8 5 6 15 5 7 
Min 13 21 7 8 11 10 8 8 6 6 18 5 7 
Min 14 21 7 8 11 10 8 8 6 6 18 5 7 
Min 15 21 7 8 11 10 8 8 6 6 18 5 7 
LF (5Hz) 
TENS 
Min 1 21 7 7' 12 10 5 8 6 9 12 10 6 
Min 2 21 7 7 12 12 5 8 6 9 12 10 6 
Min3 24 7 9 12 12 6 8 6 9 12 10 6 
Min 4 25 7 9 15 12 7 8 6 9 12 10 6 
Min5 26 7 9 15 12 8 8 6 9 12 10 6 
Min 6 26 7 9 15 12 8 9 6 9 12 10 6 
Min 7 27 7 9 15 12 8 9 6 9 12 10 6 
Min 8 27 7 9 15 12 8 9 6 9 12 10 6 
Min 9 27 7 9 15 12 9 9 6 9 12 10 6 
Min 10 28 7 9 15 12 9 9 6 9 12 10 7 
Min 11 29 7 9 16 12 9 9 6 9 12 13 7 
Min 12 29 7 9 16 12 9 9 6 9 12 13 7 
Min 13 31 7 9 16 12 9 9 7 9 12 13 7 
Min 14 31 7 9 16 12 9 9 7 9 12 13 7 
Min 15 31 7 9 16 12 9 9 7 9 12 13 7 
Table 61 : Summary of current intensity before pain induction descriptive statistics in 
experiment 6 
Mcan±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
HF TENS 
Min 1 7.25±2.70 6.50 7.29 0.08 1.48 2.79 
Min 2 7.83±3.30 6.50 10.88 0.02 1.31 0.76 
Min 3 8.33±3.73 7.00 13.88 0.02 1.36 1.35 
Min 4 8.42±3.68 7.00 13.54 0.02 1.35 1.42 
Min 5 8.33±3.73 7.00 13.88 0.02 1.36 1.36 
Min 6 8.33±3.73 7.00 15.00 0.02 1.36 1.35 
Min 7 8.50±3.87 7.00 16.81 0.01 1.57 2.27 
Min 8 8.58±4.10 7.00 20.70 <0.01 1.73 3.01 
Min 9 8.83±4.55 7.00 20.70 <0.01 1.69 2.45 
Min 10 8.83±4.55 7.00 20.70 <0.01 1.69 2.45 
Min 11 8.83±4.55 7.00 22.54 <0.01 1.69 2.45 
Min 12 9.00±4.75 7.00 23.54 <0.01 1.78 3.03 
Min 13 9.42±5.05 7.50 23.54 <0.01 1.65 1.84 
Min 14 9.42±5.05 7.50 25.54 <0.01 1.65 1.84 
Min 15 9.42±5.05 7.50 25.54 <0.01 1.65 1.84 
LF TENS 
Min 1 9.42±4.32 8.50 18.63 0.01 1.89 4.51 
Min 2 9.58±4.38 8.50 19.17 0.02 1.69 3.66 
Min 3 10.08±4.96 9.00 24.63 <0.01 2.21 5.97 
Min 4 10.50±5.32 9.00 28.27 <0.01 2.07 4.99 
Min 5 10.67±5.52 9.00 30.42 <0.01 2.20 5.65 
Min 6 10.75±5.48 9.00 30.02 <0.01 2.20 5.71 
Min 7 10.83±5.73 9.00 32.88 <0.01 2.30 6.17 
Min 8 10.83±5.73 9.00 32.88 <0.01 2.30 6.17 
Min 9 10.92±5.70 9.00 32.45 <0.01 2.30 6.24 
Min 10 11.08±5.88 9.00 34.63 <0.01 2.46 6.93 
Min 11 11.50±6.22 9.00 38.63 <0.01 2.29 6.11 
Min 12 11.50±6.22 9.00 38.63 <0.01 2.29 6.11 
Min 13 11.75±6.66 9.00 44.39 <0.01 2.51 7.12 
Min 14 11.75±6.66 9.00 44.39 <0.01 2.51 7.12 
Min 15 11.75±6.66 9.00 44.39 <0.01 2.51 7.12 
Table 6m : Raw data for current intensity during pain induction in experiment 6 
Sub 
1 
Sub 
2 
Sub 
3 
Sub 
4 
Sub 
5 
Sub 
6 
Sub 
7 
Sub 
8 
Sub 
9 
Sub 
10 
Sub 
11 
Sub 
12 
HF (100 Hz) 
TENS 
Min1 24 8 8 11 10 7 8 6 6 18 7 8 
Mint 24 8 8 12 10 8 8 6 8 18 6 8 
Min 3 27 9 8 12 10 9 9 6 8 18 6 9 
Min 4 28 9 8 12 9 10 9 6 8 18 6 9 
Min 5 29 9 8 12 9 11 9 6 8 17 6 9 
Min 6 29 10 8 12 9 5 10 6 8 17 6 9 
Min 7 29 10 9 12 9 8 10 6 8 17 5 9 
Min 8 30 11 9 12 9 9 10 6 8 17 5 9 
Min 9 30 11 9 12 9 9 11 6 8 17 5 9 
Min 10 30 11 9 12 9 9 12 6 9 17 6 9 
Min 11 30 11 9 12 9 9 12 6 9 18 6 9 
Min 12 31 11 9 12 9 10 13 6 9 18 6 9 
Min 13 31 11 9 12 9 9 13 6 9 18 7 9 
Min 14 32 12 9 12 9 9 14 6 9 20 7 9 
Min 15 32 12 9 12 9 9 14 6 9 20 7 9 
LF (5Hz) 
TENS 
Min 1 32 7 10 16 14 12 9 7 9 14 14 9 
Min 2 32 7 10 16 14 11 9 7 9 14 15 9 
Min 3 32 8 10 16 14 13 9 7 9 14 15 9 
Min 4 33 8 11- 16 14 13 9 7 9 14 15 9 
Min 5 33 8 11 16 14 14 9 7 9 14 15 9 
Min 6 33 8 11 16 14 14 9 7 11 14 15 9 
Min 7 36 8 11 16 15 14 9 7 13 15 14 9 
Min 8 36 10 11 16 15 14 9 7 14 15 14 9 
Min 9 37 10 12 16 15 14 10 7 14 16 14 9 
Min 10 38 10 12 16 15 14 10 7 14 16 14 9 
Min 11 41 10 11 16 15 15 11 7 14 18 14 9 
Min 12 51 10 11 16 15 15 11 7 14 18 14 9 
Min 13 56 10 11 16 15 15 11 7 16 18 14 9 
Min 14 57 11 11 16 15 15 11 7 16 19 14 9 
Min 15 60 11 11 16 15 15 11 7 16 19 14 9 
Table 6n : Summary of current intensity during pain induction descriptive statistics 
in experiment 6 
Mcan±S. D. Median Variance Shapiro- 
Wilk 
Skewness Kurtosis 
HF TENS 
Min 1 10.08±5.45 8.00 29.72 <0.01 1.99 3.50 
Min 2 10.33±5.38 8.00 28.97 <0.01 1.94 3.33 
Min 3 10.92±5.96 9.00 35.54 <0.01 2.16 4.80 
Min 4 11.00±6.21 9.00 38.54 <0.01 2.24 5.24 
Min 5 11.08±6.36 9.00 40.45 <0.01 2.38 6.16 
Min 6 10.75±6.57 9.00 43.11 <0.01 2.26 5.69 
Min 7 11.00±6.42 9.00 41.27 <0.01 2.31 5.99 
Min 8 11.25±6.63 9.00 44.02 <0.01 2.35 6.31 
Min 9 11.33±6.62 9.00 43.88 <0.01 2.32 6.21 
Min 10 11.58±6.50 9.00 42.26 <0.01 2.37 6.38 
Min 11 11.67±6.58 9.00 43.33 <0.01 2.28 5.78 
Min 12 11.92±6.82 9.50 46.45 <0.01 2.29 5.95 
Min 13 11.92±6.78 9.00 45.90 <0,01 2.36 6.15 
Min 13 12.33±7.22 9.00 52.06 <0.01 2.17 5.04 
Min 15 12.33±7.22 9.00 52.06 <0.01 2.17 5.04 
LF TENS 
Min 1 12.75±6.76 11.00 45.66 <0.01 2.34 6.57 
Min 2 12.75±6.80 10.50 46.20 <0.01 2.30 6.32 
Min 3 13.00±6.70 11.50 44.91 <0.01 2.30 6.37 
Min 4 13.17±6.93 12.00 47.97 <0.01 2.37 6.78 
Min 5 13.25±6.93 12.50 48.02 <0.01 2.33 6.60 
Min 6 13.42±6.84 13.50 46.81 <0.01 2.35 6.79 
Min 7 13.92±7.60 14.00 57.72 <0.01 2.48 7.44 
Min 8 14.17±7.47 14.00 55.79 <0.01 2.53 7.70 
Min 9 14.50±7.66 14.00 58.63 <0.01 2.58 7.94 
Min 10 14.58±7.93 14.00 62.81 <0.01 2.63 8.18 
Min 11 15.08±8.76 14.00 76.81 <0.01 2.66 8.20 
Min 12 15.92±11.50 14.00 132.26 <0.01 2.99 9.71 
Min 13 16.50±12.87 14.50 165.73 <0.01 3.05 10.02 
Min 14 16.75±13.12 14.50 172.20 <0.01 3.05 10.00 
Min 15 17.00±13.96 14.50 194.91 <0.01 3.10 10.22 
Table 6o : Summary of experiment 6 questionnaire responses 
time diff. VAS TENS one words for words for higher 
test in int. marked feel current HF TENS LF TENS intensity 
lasted and approp.? diff. in stronger selected- 
(mins) unp. 2 tests? than HF or 
another? LF 
TENS 
sub 1 
15 yes yes yes no HF 
sub 2 tingling pulsed 
15 yes yes yes yes continuous HF 
vibrating 
sub 3 buzzing beating 
15 yes yes yes yes fast stabbing 
soft rickin 
4 sub fuzzy pulsing 
15 yes yes yes yes constant throbbing 
sub 5 intense interrupted 
15 yes yes yes yes HF 
sub 6 pins and painful 
15 yes yes yes yes needles LF 
sub 7 
15 yes yes yes no 
sub 8 
15 yes yes yes no 
sub 9 
15 yes no no no 
sub 10 
15 yes yes yes no HF 
sub 11 
15 yes ves yes no HF 
sub 12 
15 yes ves yes no HF 
Total 
and / or mean = yes = yes = 11 yes= 11 yes =5 HF =6 
mean 15 12 no= 1 no= 1 no =7 LF I 
Appendix 7: Information sheet and consent form for experiments 1-6. 
7a : Information sheet for participation in ischaemic pain tourniquet test (Queen 
Margaret College, Edinburgh). 
Title 
An investigation of the pain relieving effects of Transcutaneous Electrical Nerve Stimulation 
(TENS) using the ischaemic pain tourniquet test. 
Outline Explanation 
You are invited to participate in a study conducted by a postgraduate Chartered 
Physiotherapist on the analgesic (pain relieving) effects of a therapy called Transcutaneous 
Electrical Nerve Stimulation (TENS). This study has gained approval from the College's 
Ethical Committee. 
You will be asked to take part in an experimental pain induction procedure which involves a 
tourniquet cuff (similar to the cuff used in blood pressure measurement) being applied to 
your non-dominant arm ( the arm that you don't usually write with) and inflated to cause a 
gradual increase in pain intensity. The procedure produces an aching or throbbing in the 
forearm caused by restricting the amount of blood flowing in the arm. It also produces a 
numb or "pins and needles" sensation in the arm and hand. These sensations will only persist 
for the length of time that the cuff is inflated. While the cuff is in place you will be asked to 
complete a number of hand exercises, and rate your pain at various intervals using validated 
pain assessment scales. The time that the cuff is inflated will last no longer than 15 minutes 
on the occasion(s) that you will be tested, however you may request for the procedure to 
be stopped at any time. The pain induction procedure as used here is safe for healthy 
human volunteers and produces no lasting effect. 
There are certain criteria that must be met for inclusion in this study and these are: 
- female aged between 18 and 35 years 
- student or staff at Queen Margaret College 
- no current significant pain / injury in any region of the body 
- no recent history (within 6 weeks) of significant pain / injury in any region of the 
body 
- no history of heart problems (e. g. pacemaker) 
- no intake of painkillers within the previous 24 hours 
- no alcohol consumption within the previous 24 hours 
These criteria apply for each time that the test is used. If you are unsure about any 
condition, illness or current use of medication please ask the investigator before you 
take part in the test (on each occasion if necessary). 
During the pain induction procedure you may be treated with TENS. This is a non-invasive 
therapy which is in routine clinical use and involves the placement of two electrodes on the 
affected arm to produce an electrical stimulus. The stimulus may cause you to experience a 
"buzzing" sensation, with or without associated involuntary muscle contractions. The 
sensations that you may experience will only last for the length of time that the electrodes 
are in place and the TENS machine is switched on (i. e. maximum duration of 30 minutes). 
The amount of time that you will be asked to donate in order to participate in the study will 
be approximately 30-40 minutes per testing session. These sessions will take place at 
approximately the same time of the day (your choice) two days (48 hours) apart. 
Note: 
(i) You are reminded of your right to withdraw from the study at any time without 
explanation; 
(ii) All data collected will be treated in the strictest confidence. Records stored on 
computer under the provisions of the Data Protection Act. 
Please keep this information sheet and if you should have any queries regarding your 
participation in the study please do not hesitate to contact either of the following people; 
INVESTIGATOR: Kerry Kirk 
Room G79 
Leith Campus, Q. M. C. 
Tel: 0131 317 3663 
SUPERVISOR: Denis Martin 
Room G87B 
Leith Campus, Q. M. C. 
Tel: 0131 317 3655 
7b : Consent form for participation in ischaemic pain tourniquet test (Queen 
Margaret College, Edinburgh). 
An investigation of the pain relieving effects of Transcutaneous Electrical Nerve 
Stimulation (TENS) using the ischaemic pain tourniquet test. 
I (name) 
...................................... 
Course (including year) .......................................... 
hereby consent to take part in the above investigation, the nature and purpose of which has 
been explained to me. Any questions I wished to ask have been answered to my satisfaction. 
I understand that I may withdraw from the investigation at any stage without necessarily 
giving a reason for doing so. 
Signed (Volunteer) 
........................................................... Date ................. (Investigator) 
........................................................ Date ................. 
If you should have any queries regarding your participation in the study please do not 
hesitate to contact either of the following people; 
INVESTIGATOR: 
SUPERVISOR: 
Kerry Kirk 
Room G79 
Leith Campus, Q. M. C. 
Tel: 0131 317 3663 
Denis Martin 
Room G87B 
Leith Campus, Q. M. C. 
Tel: 0131 317 3655 
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Appendix 9: Pain assessment scales for experiment 1. 
9a : VAS for pain intensity 
PAIN INTENSITY 
no sensation the most intense 
sensation imaginable 
9b : VRS for pain intensity (including cross modality matching scores which 
were not visible to the subjects) 
no sensation 0.0 
barely perceptible 4.5 
very mild 13.6 
mild 20.5 
moderate 38.2 
barely strong 44.8 
strong 64.5 
intense 72.6 
veryintense 84.8 
extremely intense 95.8 
the most intense sensation imaginable 100.0 
9c : VAS for pain unpleasantness 
PAIN UNPLEASANTNESS 
not bad at all the most unpleasant 
sensation imaginable 
9d : VRS for pain unpleasantness (including cross modality matching scores 
which were not visible to the subjects) 
not bad at all 0.0 
annoying 18.7 
unpleasant 27.6 
disagreeable 36.6 
slightly distressing 50.2 
distressing 62.4 
intolerable 73.9 
very intolerable 86.5 
the most unpleasant sensation imaginable 100.0 
Appendix 10 : Pain intensity and pain unpleasantness visual analogue scales for 
experiments 2-6. 
PAIN INTENSITY 
no sensation 
PAIN UNPLEASANTNESS 
not bad at all 
the most intense 
sensation imaginable 
the most unpleasant 
sensation imaginable 
Appendix 11 : Ischaemic pain tourniquet test questionnaire for experiment 2. 
(1) Did you ask for the cuff to be deflated before 15 minutes of the test had elapsed? 
yes / no 
(2) If you answered "yes" to question (1), why did you request for the test to stop? 
(i) you felt dizzy / light-headed 
(ii) you felt sick 
(iii) it was too painful to tolerate 
(iv) none of the above; please briefly state reason --------------------------------- 
(3) Did you find it easy to distinguish between pain intensity and pain unpleasantness? 
yes / no 
(4) With regards to question (3), do you think you marked the VAS scales 
appropriately? yes / no 
(5) Did you notice a difference between the pain produced by the cuff pressure and the 
pain in the rest of your arm? yes / no 
(6) If you answered "yes" to question (5), from where did you find the most pain? 
cuff / rest of arm 
(7) Any other comments ------------------------------------------------------------------------ 
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Appendix 13 : Line diagram of experimental procedure in experiments 4-6. 
TENS 
13 minutes 2 minutes 
TENS applied begin cuff inflation 
(as necessary) 
TENS + pain assessment 
(1 minute intervals) 
15 minutes 
min 1- 1st measurement 
cuff inflated 
TIME ZERO 
cuff deflated 
TENS removed 
Appendix 14 : Ischaemic pain tourniquet test questionnaire for experiment 6. 
(1) Did you ask for the cuff to be deflated before 15 minutes of the test had elapsed? 
yes / no 
(2) If you answered "yes" to question (1), why did you request for the test to stop? 
(I) you felt dizzy / light-headed 
(ii) you felt sick 
(iii) it was too painful to tolerate 
(iv) none of the above; please briefly state reason 
(3) Did you find it easy to distinguish between pain intensity and pain unpleasantness? 
yes / no 
(4) With regards to question (3), do you think you marked the VAS scales 
appropriately? 
yes / no 
(5) Did the sensations from the TENS current feel different in the two tests? 
yes/no 
(6) If you answered "yes" to question (5), in what way did the TENS current feel 
different; 
(a) Did the TENS current in test I feel stronger than in test 2? 
yes/no 
(b) Use 3 words to describe the TENS current you received the first time. 
(c) Use 3 words to describe the TENS current you received the second time. 
(7) Do you think your selection of TENS current intensity differed between the two 
tests? 
yes/no 
(8) If you answered "yes" to question (7), during which test do you think you used the 
higher intensity of TENS current. 
Ist test / 2nd test 
(9) Any other comments 
